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Stimulus  control  (SC)  is  a  core  component  of  cognitive  behavioural  therapy 
(CBT)  for  insomnia  and  is  the  single  intervention  for  which  there  is  most  empirical 
evidence.  Nonetheless,  little  is  known  about  whether  all  of  the  elements  within  SC 
are  critical  to  sleep  improvement.  This  study,  therefore,  investigated  the  impact  on 
sleep  of  the  Quarter  of  an  Hour  Rule  (QHR)  a  single,  situational  element  considered 
central  to  SC  for  insomnia.  The  mechanisms  of  effect  of  SC  intervention  remain  also 
unclear.  An  associated  aim  of  the  present  study,  therefore,  was  to  contrast  two  forms 
of  administration  of  the  QHR  to  test  aspects  of  the  learning  theory  presumed  to 
underlie  the  SC  model.  In  addition  adherence  to  the  behavioural  intervention  was 
investigated  and  the  possibility  of  using  actigraphy  to  measure  adherence  objectively 
was  explored. 
Prior  to  the  randomised  controlled  trial  (primary  study),  two  preliminary  studies 
were  conducted.  The  first  preliminary  study  aimed  at  determining  the  optimal  cut-off 
to  represent  normalcy  in  sleep  onset  latency  (SOL).  The  results  indicated  it  to  be 
fifteen  minutes  and,  therefore,  participants  in  studies  two  and  three  were  asked  to 
apply  the  QHR  if  they  were  not  asleep  within  a  quarter  of  an  hour.  Study  two 
comprised  three  single  cases  and  tested  the  feasibility  of  the  QHR  as  a  standalone 
therapy  for  insomnia.  Visual  inspection  of  the  data  and  interrupted  time  series 
analyses  evidenced  SOL,  wake  after  sleep  onset  (WASO)  and  sleep  efficiency  (S.  E.  ) 
improvements  in  two  out  of  three  participants.  Their  Pittsburgh  Sleep  Quality  Index 
(PSQI)  score  at  the  end  of  the  intervention  was  reduced  by  50%  compared  to 
baseline.  The  participant,  whose  sleep  was  not  improved,  following  the  intervention, 
had  not  applied  the  QHR.  The  results  of  this  exploratory,  single  case,  study 
warranted  further  investigation  of  the  QHR. 
In  study  three  forty-one  GP  and  self  referred  volunteers,  aged  18-72  years,  with 
SOL  and/or  WASO  complaints,  formed  3  randomised  groups:  QHRin  bed,  QHRout 
of  bed  and  control.  Both  QHR  conditions  required  to  `read  if  not  asleep  within  a 
quarter  of  an  hour',  with  groups  differing  only  with  the  location  (in  bed  versus  out  of 
bed)  where  to  apply  the  QHR.  Sleep  diary  pre-treatment  (two  weeks)  and  post- 
treatment  (three  weeks),  home  polysomnography  (PSG)  (two  nights  pre-,  two  post- 
1 treatment)  and  sleep  related  questionnaire  (pre  and  post)  data  were  collected. 
Adherence  with  the  QHR  was  measured  objectively  (actigraphy  +  light  monitoring) 
and  subjectively  (adherence  diary). 
Following  QHR  treatments,  statistically  significant  reductions  in  SOL  (QHRout) 
and  WASO  (QHRin  and  QHRout),  an  increase  in  S.  E.  (QHRin  and  QHRout)  and  a 
decrease  in  PSQI  score  (QHRin  and  QHRout)  were  found.  Trends  also  indicated 
increased  total  sleep  time  (TST).  Clinically  significant  improvements  (SOL  and 
WASO  S  31  minutes  or  reduced  by  50%,  PSQI  : 55  or  reduced  by  50%)  were 
obtained  in  33-57%  of  active  groups  participants.  Furthermore,  43%  of  QHRin  and 
66%  of  QHRout  participants  achieved  S.  E. 
_85%. 
Magnitude  of  effect  was  greater 
for  the  QHRout  than  the  QHRin  and  changes  were  achieved  within  the  first  week  of 
treatment.  No  differences  were  found  in  PSG  defined  sleep  variables.  Nevertheless, 
subjective-objective  discrepancies  (i.  e.  differences  between  sleep  diary  and  PSG 
defined  sleep)  were  reduced  following  intervention.  Sleep  related  questionnaires 
indicated  fewer  sleep  pattern  problems,  less  cognitive  and  somatic  arousal  and  less 
cognitive  activity  (sleep  effort,  problem  solving  and  sensory  engagement)  following 
QHR  interventions.  Participants  tended  to  adhere  in  categorical  terms  (either 
adhering  most  times  (majority)  or  not  adhering  at  all).  Adherence  was  adequate 
indicating  that  the  QHR  is  well  tolerated  and  accepted.  Importantly,  the  combination 
of  actigraphy  and  light  provided  a  tool  to  measure  adherence  objectively. 
The  QHR,  a  single  instruction  administered  in  the  form  of  brief  therapy,  was 
found  to  improve  subjectively  reported  sleep  both  statistically  and  clinically.  The 
finding  that  both  QHRin  and  QHRout  were  efficacious  for  WASO  sheds  doubt  on 
the  argument  that  for  difficulties  maintaining  sleep,  the  QHR  component  works 
solely  via  conditioning  principles.  However  it  is  possible  that  re-conditioning  effects 
apply  not  only  to  external  (environmental)  factors  as  posited  by  SC  theory  but,  also, 
to  internal  (cognitive)  factors.  The  finding  that  sub-ob  discrepancies  decreased 
following  QHR  intervention  is  discussed  in  terms  of  levels  of  arousal  and  stimuli 
engagement  at  the  time  of  falling  asleep  and  during  PSG  defined  sleep.  Further 
research  is  warranted. 
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12 CHAPTER  1 
Introduction 
4 
1.1  Overview 
This  chapter  presents  an  overview  of  insomnia,  its  classifications,  characteristics 
and  epidemiology.  Insomnia  assessment  and  diagnostic  issues  are  also  considered 
with  a  view  to  what  questions  each  of  these  methods  can  help  to  answer.  Thereafter 
the  three  main  perspectives  of  insomnia  and  some  theoretical  models  within  which  it 
is  possible  to  understand  the  emergence,  maintenance  and  exacerbation  of  insomnia 
are  outlined  and  evidence  supporting  and  /  or  disconfirming  these  perspectives  and 
models  are  presented.  By  taking  into  account  the  psychological  and  behavioural 
factors  presumed  to  be  involved  in  insomnia,  a  rationale  for  the  use  of  psychological 
treatments  is  proposed.  Psychological  interventions  for  insomnia  are  briefly  outlined 
and  treatment  outcome  studies  are  critically  reviewed  so  as  to  highlight  what  is  still 
to  be  done.  Furthermore,  variables  moderating  treatment  efficacy  are  discussed  and  a 
call  for  investigation  of  adherence  to  treatment  is  made.  Drawing  on  the  models  and 
current  limitations  in  insomnia  treatment  research,  and  the  recent  guidelines  on 
insomnia,  it  is  proposed  that  the  investigation  of  one  single  component  of  the 
behavioural  treatment  for  insomnia  stimulus  control,  namely  the  quarter  of  an  hour 
rule  (QHR),  can  be  employed  not  only  to  mitigate  sleep  difficulties  but,  importantly, 
to  shed  light  on  mechanisms  of  effects  and  the  minimum  dose  needed  to  achieve 
therapeutic  gains.  In  addition,  employing  only  one  single  element  permits  a  closer 
13 look  at  adherence  and  to  the  testing  of  an  objective  methodology  to  measure  and 
monitor  adherence  and  its  effects  on  therapy  outcomes. 
1.2  Insomnia 
Lay-person  definitions  of  insomnia  include  "not  being  able  to  sleep  well", 
"taking  ages  to  fall  asleep",  "spending  hours  awake  during  the  night"  and,  as  a 
result,  `feeling  very  tired  during  the  day  with  difficulties  concentrating",  `feeling 
lethargic  and  with  snappy  moods".  The  self-labelled  `insomniacs'  will  probably  go 
on  to  say  that  they  would  love  to  have  a  good  night's  sleep,  that  they  have  tried 
everything  (but  nothing  worked),  that  they  don't  want  drugs  or  that  drugs  are  not 
working  anymore.  Some  will  remember  how  easy  it  was  to  sleep  once,  and  how  good 
it  feels  when  they  have  the  occasional  good  night. 
Insomnia  is  so  widespread  that  most  people  have  an  idea  of  what  insomnia  is, 
although  the  `insomnia  ingredients'  vary  according  to  personal  (one's  own  or 
someone  else's)  experiences.  But  what  is  insomnia  really?  Perhaps,  as  proposed  by 
Espie  (1991,2002)  the  best  way  to  start  answering  this  question  is  to  understand 
what  normal  sleep  is  and  what  regulates  it. 
1.2.1  Basic  Facts  about  Sleep 
Sleep  is  not  a  unitary  state:  while  the  observer  can  only  see  the  two  opposite 
states,  that  is  wakefulness  and  sleep,  the  individual  experiences  different  types  of 
sleep  such  as  deep  and  light  sleep  and  dreaming.  Research  has  corroborated  the 
subjective  experience  of  sleep  as  a  non-unitary  state  by  the  measuring  of  the 
electrical  currents  of  the  brain. 
14 The  first  division  of  sleep  is  that  of  non-rapid  eye  movement  (NREM)  sleep  and 
REM  sleep.  As  illustrated  in  figure  1,  NREM  sleep  is  further  subdivided  into  four 
distinct  stages. 
Figure  1:  An  example  of  EEG  traces  during  NREM  and  REM  stages 
Stage  1 
Stage  2_L,  ý  ýýýrVlff  ý'ý 
Slow  Waves 
(stages  3&  4) 
r  ýtNyw, 
ý/y,  vM 
REM  sleep 
Stage  1  is  a  very  light  sleep  characterised  by  a  relatively  low-voltage  and  mixed 
frequency  activity  where  theta  rhythm  (3  to  7  cycles  per  second  -  cps)  and  vertex 
sharps  are  common.  Stage  2  represents  light  sleep  as  well  and  the  EEG  shows  a 
pattern  of  relatively  low  voltage  with  mixed  frequency  activity.  Two  specific  EEG 
patterns  enable  the  distinction  of  stage  2  from  stage  1:  the  sleep  spindles  (12-14  cps, 
with  a  duration  of  0.5  to  1.5  seconds)  and  k-complex  (a  well  delineated  sharp  wave 
of  duration  exceeding  0.5  seconds  which  is  immediately  followed  by  a  positive 
component  and  stands  out  from  the  ongoing  background  activity).  Each  epoch  (30 
seconds)  in  stage  2  comprises  up  to  20%  of  delta  waves  (delta  waves  have  high 
15 voltage,  i.  e.  amplitudes  greater  than  75  millivolts,  and  there  are  maximum  2  for  cps). 
Deep  sleep  is  seen  in  stage  3  and  4.  Stage  3  is  defined  by  the  presence  of  delta  waves 
in  a  percentage  between  20  and  50  per  each  epoch  of  EEG  recording.  Stage  4, 
finally,  is  characterised  by  delta  waves  in  more  than  50%  of  the  epoch.  REM  sleep  is 
characterized  by  EEG  activation:  relatively  low  voltage,  mixed  frequency  (typical  of 
relaxed  wakefulness)  at  the  scalp  level  coupled  to  rapid  eye  movement  and  motor 
atonia  (i.  e.  loss  of  muscle  tone).  Detailed  guidelines  and  criteria  for  staging  sleep  are 
provided  by  the  standard  sleep  staging  manual  (Rechtschaffen  and  Kales,  1968). 
Sleep  is,  then,  a  highly  organised  activity  and  it  follows  a  cyclic  pattern.  A  normal 
adult  enters  sleep  via  NREM  stages  (from  1  to  4);  this  sequence  is  then  reversed  from 
stage  4  to  2  leading  to  the  first  REM  episode.  This  first  cycle  of  sleep  takes  about  70 
to  120  minutes  and  on  average,  during  one  night,  four  to  five  of  these  cycles  happen. 
In  Table  1  generalisations  about  sleep  in  normal  and  primary  insomnia  adults  are 
provided.  These  PSG  values  for  sleep  continuity  and  sleep  architecture  measures 
were  estimated  by  Smith,  Nowakowski,  Soeffing,  Orff  and  Perlis  (2003)  from 
literature. 
Table  1-  Average  PSG  Sleep  variables  for  Healthy  Normal  Sleepers  and 
Primary  Insomnia 
can  Measures 
.'i  le  onto  ujý 
SOL  10  (minutes)  56  (minutes) 
WASO  10  (minutes)  45  (minutes) 
TST  420  (minutes)  352  (minutes) 
SE  >90%  79% 
Wake  5%  11% 
Stage  1  5%  10% 
Stage  2  60%  56% 
Stage  3&4  15%  12% 
Stage  REM  15%  22% 
The  question  is:  what  regulates  sleep? 
16 In  the  1970s  Borbely  and  his  colleagues  in  Zurich,  began  the  exploration  of  a  two- 
factor  theory  of  the  regulation  of  sleep  based  on  experimental  work  with  both 
animals  and  humans,  which  was  then  formulated  in  1984  (Daan,  Beersma  and 
Borbely,  1984).  In  brief,  they  proposed  that  two  `opponent  processes'  regulate  sleep: 
on  one  hand  a  homeostatic  sleep  drive,  which  is  constantly  active,  promotes  and 
maintains  sleep  (the  longer  one  is  without  sleep  the  greater  the  sleep  debt  and  as  a 
consequence  the  drive  to  sleep);  on  the  other  hand  wakefulness  is  fostered  by  a 
biological  clock  (regulated  by  a  circadian  timer),  active  during  the  day  and  inactive 
at  night  which  acts  as  a  kind  of  arousal  system  (Carskadon  and  Dement,  1981; 
Dement  and  Vaughan,  1999).  In  addition  environmental  and  social  factors  influence 
sleep  (e.  g.  shift  work)  (Webb,  1988). 
An  important  point  was  made  by  Espie  (2002):  normal  sleep  is  a  `passive'  state 
that  does  not  require  effort,  the  'good'  sleeper  falls  asleep  automatically  without 
forcefully  trying,  in  fact  without  trying  at  all. 
Having  discussed  normal  sleep,  its  regulation  and  `passivity'  it  is  easier  to  define 
and  understand  insomnia. 
1.2.2  Definition  and  Classification  of  Insomnia 
Broadly  speaking  insomnia  refers  to  difficulty  initiating  and/or  maintaining  sleep. 
A  more  specific  set  of  sleep  disorders,  all  of  which  have  in  common  a  complaint  of 
insomnia,  has  been  provided  by  classification  systems  such  as  the  Diagnostic  and 
Statistical  Manual  of  Mental  Disorders  (DSM)  and  the  International  Classification  of 
Sleep  Disorders  (ICSD).  Insomnia  can  be  broadly  subdivided  into  two  categories: 
primary  insomnia  (i.  e.  independent,  no  comorbid  symptoms)  and  secondary  insomnia 
17 (i.  e.  insomnia  is  instigated  by  other  sleep,  psychiatric  or  medical  conditions).  It  is 
noteworthy  that  determining  causality  is  often  difficult  (Smith,  Smith,  Nowakosky 
and  Perlis,  2003)  and  that  a  diagnosis  of  primary  insomnia  is  often  made  by 
exclusion  (Morin,  1993). 
Insomnia  is  also  characterized  by  its  duration:  in  the  DSM  insomnia  is  defined  as 
`acute'  if  it  lasts  for  less  than  a  month  and  it  is  accompanied  by  specific  events 
precipitating  the  sleep  problems  (e.  g.  pain,  bereavement).  Insomnia  is,  instead, 
considered  `chronic'  when  the  symptoms  last  longer  than  one  month  despite  the 
stressor  having  been  resolved  or  the  person  having  adjusted  to  it.  According  to  the 
ICSD-R,  instead,  insomnia  is  considered  chronic  if  it  lasts  for  at  least  six  months. 
Typically  if  the  individual  presents  with  secondary  insomnia  the  treatment  will 
focus  on  the  disorder  (for  example  depression)  deemed  to  give  rise  to  the  insomnia 
symptoms.  In  instances  of  acute  insomnia  the  treatment  choice,  if  treatment  is 
provided,  is  pharmacotherapy.  When  the  individual  presents  with  primary  insomnia 
symptoms,  instead,  behavioural  interventions  for  insomnia  are  provided,  if  available, 
as  either  standalone  treatment  or  in  addition  to  pharmacotherapy. 
The  present  research  investigates  psychological  interventions  for  insomnia,  hence 
attention  will  focus  on  insomnia  when  it  is  chronic  and  a  primary  disorder. 
In  short,  primary  insomnia  is  defined  by  DSM-IV  as  a  complaint  of  initiating 
and/or  maintaining  sleep  or  non-restorative  sleep  lasting  for  at  least  one  month 
associated  to  decreased  functioning  during  the  day  (e.  g.  lack  of  concentration, 
tiredness,  decreased  productivity)  (American  Psychiatric  Association,  2000).  Table 
2,  here  below,  provides  the  DSM-IV  diagnostic  criteria  for  primary  insomnia. 
18 Table  2-  DSM-IV  -  Diagnostic  Criteria  for  307.42  Primary  Insomnia 
A.  The  predominant  complaint  is  difficulty  initiating  or  maintaining 
sleep  or  non-restorative  sleep,  for  at  least  one  month. 
B.  The  sleep  disturbance  (or  associated  daytime  fatigue)  causes 
clinically  significant  distress  or  impairment  in  social,  occupational, 
or  other  important  areas  of  functioning. 
C.  The  sleep  disturbance  does  not  occur  exclusively  during  the  course 
of  narcolepsy,  breathing  related  sleep  disorder,  circadian  rhythm 
sleep  disorder,  or  a  parasomnia. 
D.  The  disturbance  does  not  occur  exclusively  during  the  course  of 
another  mental  disorder  (e.  g.  major  depressive  disorder, 
generalised  anxiety  disorder,  a  delirium). 
E.  The  disturbance  is  not  due  to  the  direct  physiological  effects  of 
a  substance  (e.  g.  a  drug  of  abuse,  a  medication)  or  a  general 
medical  condition. 
Primary  insomnia  as  defined  by  the  DSM-IV  subsumes  to  a  number  of  insomnia 
categories  in  the  ICSD.  The  category  most  closely  resembling  the  DSM-IV  definition 
of  primary  insomnia  is  that  of  psychophysiologic  insomnia.  According  to  the  ICSD- 
R  (American  Sleep  Disorder  Association,  1997)  psychophysiologic  insomnia  is  a 
disorder  of  somatized  tension  and  learned  sleep-preventing  associations  resulting  in  a 
complaint  of  insomnia  and  associated  decreased  functioning  during  wakefulness 
(table  3  reports  diagnostic  criteria). 
It  should  be  noted  that  this  definition,  as  compared  to  that  of  primary  insomnia,  is 
more  tied  up  with  the  underpinning  of  the  disorder  (i.  e.  how  insomnia  started  and  it  is 
maintained).  Somatized  tension  refers  to  somatic  hyperarousal,  either  perceived  or 
objectively  measured.  Learned  sleep-preventing  associations  refer  to  either  internal 
cognitions  (mainly  worry  about  the  inability  to  sleep)  or  external  stimuli  (conditioned 
19 association  of  sleeplessness  with  situations  and  behaviours  related  to  sleep  such  as 
lying  in  bed)  both  provoking  pre-sleep  arousal.  The  patient's  focused  attention  on 
sleep  is  of  paramount  importance  in  psychophysiologic  insomnia. 
Table  3-  ICSD-R  -  Diagnostic  Criteria:  Psychophysiologic  Insomnia  307.42-0 
a.  A  complaint  of  insomnia  is  present  and  is  combined  with  a  complaint  of 
decreased  functioning  during  wakefulness. 
b.  Indication  of  learned  sleep-preventing  associations  are  found  and  include  the 
following: 
1.  Trying  too  hard  to  sleep,  suggested  by  an  inability  to  fall  asleep  when 
desired,  but  ease  to  fall  asleep  during  other  relatively  monotonous 
pursuits,  such  as  watching  television  or  reading. 
2.  Conditioned  arousal  to  bedroom  or  sleep-related  activities,  indicated  by 
sleeping  poorly  at  home  but  sleeping  better  away  from  the  home  or 
when  not  carrying  out  bedtime  routines. 
c.  There  is  evidence  that  the  patient  has  increased  somatized  tension  (e.  g. 
agitation,  muscle  tension,  or  increased  vasoconstriction) 
d.  Polysomnographic  monitoring  demonstrates  all  of  the  following: 
1.  An  increased  sleep  latency 
2.  Reduced  sleep  efficiency 
3.  An  increased  number  and  duration  of  awakenings 
e.  No  other  medical  or  mental  disorders  accounts  for  the  sleep  disturbance. 
f.  Other  sleep  disorders  can  coexist  with  the  insomnia,  e.  g.  inadequate  sleep 
hygiene,  obstructive  sleep  apnoea  syndrome,  etc. 
Minimal  criteria:  A+B 
The  ICSD-R  has  recently  been  revised  and  a  new  version  has  been  published 
(ICSD-2,  American  Academy  of  Sleep  Medicine,  2005).  This  new  version,  informed 
by  current  research  and  guidelines,  incorporates  changes  with  regard  to  sleep 
disorders.  In  particular  psychophysiologic  insomnia,  is  renamed  psychophysiological 
20 insomnia  in  the  ICSD-2  and  described  as  a  complaint  of  primary  insomnia  with  the 
essential  features  of  heightened  arousal  and  sleep  preventing  associations  (appendix 
1  presents  the  revised  criteria).  It  is  noteworthy  that  although  the  characteristics 
pertaining  to  psychophysiological  insomnia  have  hardly  changed  from  one  version  to 
the  next,  in  the  latest  version  cognitive  activity  (in  the  form  of  intrusive,  ruminative 
presleep  cognitions,  often  related  to  the  inability  to  sleep  and  its  consequences)  are 
explicitly  mentioned. 
Having  clearly  defined  primary  insomnia  (as  per  DSM-IV)  and 
psychophysiological  insomnia  (as  per  ICSD-R,  ICSD-2),  attention  can  be  turned  to 
the  epidemiology  of  insomnia  worldwide. 
1.2.3  Epidemiology  of  Insomnia 
The  prevalence  of  primary  insomnia  in  the  adult  population,  as  evidenced  by 
epidemiologic  surveys,  is  around  10-15  %  increasing  to  around  20  %  in  older  adults 
with  a  'women  to  men'  ratio  of  roughly  3:  2  (Ancoli-Israel  and  Roth,  1999;  Foley, 
Monjan,  Brown,  Simonsick,  Wallace  et  al,  1995;  Ford  and  Kamerow,  1989;  Gallup 
Organisation,  1995;  Morgan,  2003;  Ohayon,  2002).  Although  there  are  variations  in 
percentage  of  insomnia  incidence,  it  is  a  worldwide  complaint  (Cirignotta,  Mondini, 
Zucconi,  Lenzi  and  Lugaresi,  1985;  Gislason  and  Almqvist,  1987;  Kim,  Uchiyama, 
Okawa,  Liu  and  Ogihara,  2000;  Leger,  Guilleminault,  Dreyfus,  Delahaye  and 
Paillard,  2000;  McGhie  and  Russell,  1962;  Ohahion  and  Partinen,  2002,  Ohahion  and 
Hong,  2002).  For  example,  an  epidemiological  survey  of  the  French  population 
found  that  29%  of  the  respondents  had  insomnia  symptoms  at  least  three  times  per 
week  during  the  previous  month  (Leger  et  al,  2000).  Cirignotta  and  colleagues 
21 (1985)  found  it  in  around  15%  of  the  population  of  San  Marino.  Similarly  a  survey  of 
the  South  Korean  general  population  found  insomnia  symptoms  at  least  three  times 
per  week  in  17%  of  those  surveyed  (Ohahion  and  Hong,  2002)  and  the  overall 
prevalence  of  insomnia  in  the  Japanese  general  population  has  been  reported  as  21  % 
(Kim,  Uchiyama,  Okawa,  Lin  and  Oshihara,  2000).  A  survey  carried  out  in  the  UK 
evidenced  that  sleep  problems  are  by  far  the  most'common  mental  health  complaint 
(Singleton,  Bumpstead,  O'Brien,  Lee,  Meltzer,  2001)  and  primary  insomnia  is  the 
most  common  of  all  sleep  complaints  (Bixler,  Kales,  Soldatos,  Kales,  and  Healy, 
1979).  It  is  noteworthy  that  around  2%  of  the  general  population  meet  criteria  for 
psychophysiological  insomnia  (American  Academy  of  Sleep  Medicine,  2005). 
Insomnia  is  often  dismissed  as  less  of  a  serious  problem  (Simon  and  vonKorff, 
1997)  and  often  ignored  at  the  clinical  level  despite  being  a  considerable  public 
health  problem  which  is  reported  by  around  20%  of  patients  seen  in  general  practice 
(Shocat,  Umphress,  Israel  and  Ancoli-Israel,  1999)  and  being  associated  with 
increased  economic  costs  both  in  health  care  and  industry  (Simon  et  al,  1997). 
Indeed,  insomnia  is  a  contributing  factor  to  reduced  productivity,  absenteeism,  and 
accidents  and,  once  established,  it  is  difficult  to  extinguish  (Brassington,  King  and 
Bliwise,  2000;  Katz  and  McHorney,  1998;  Mendelson,  1995;  Roth  and  Ancoli-Israel, 
1999). 
In  sum,  primary  insomnia  is  a  persistent,  common  and  difficult  to  treat  condition 
associated  with  reduced  daytime  functioning,  distress  and  sizeable  economic  costs. 
In  addition  insomnia  has  been  found  in  two  meta-analyses  to  be  a  key  risk  factor  in 
the  first  episode  and  recurrence  of  depression  (Cole  and  Dendukuri,  2003;  Riemann 
and  Voderholzer,  2003).  It  seems,  therefore,  important  to  understand  what 
22 mechanisms  underlie  the  development  and  maintenance  of  insomnia  and  effective 
ways  of  treating  it.  First  of  all,  however,  ways  of  assessing  insomnia  and  treatment 
outcomes  need  to  be  discussed. 
1.3  Assessment  of  Insomnia  and  Monitoring  Treatment  Efficacy 
The  main  methods  for  measuring  sleep  are  subjective  measures,  in  the  form  of 
retrospective  and  prospective  self-reports  and  objective  measures  in  the  form  of 
actigraphy  and  polysomnography  (PSG).  Each  of  these  will  be  briefly  described  and 
evaluated  so  as  to  outline  their  strengths  and  weaknesses. 
Typically,  the  sleep  data  collected  by  means  of  prospective  self-reports  and 
objective  measures  are  i)  sleep  onset  latency  (SOL)  that  is  the  time  taken  to  fall 
asleep  at  the  beginning  of  the  night;  ii)  wake  after  sleep  onset  (WASO)  that  is  the 
total  time  spent  awake  during  the  night  after  sleep  onset;  iii)  total  time  in  bed  (TIB) 
that  is  the  amount  of  time  spent  in  bed;  iv)  total  sleep  time  (TST,  TST=TIB  - 
[SOL+WASO])  that  is  the  amount  of  time  actually  spent  asleep  while  in  bed,  v)  sleep 
efficiency  (S.  E.,  S.  E.  =[TST/TTB]*100)  that  is  the  percentage  of  time  spent  asleep 
while  in  bed,  and  vi)  number  and  length  of  arousals  (only  objective  data).  It  should 
be  noted  that  WASO  can  comprise  all  awakenings  including  early  morning 
awakenings  or  it  can  be  subdivided  into  WASO  during  the  night  and  `early 
wakening'  that  is  the  amount  of  time  from  the  last  wakening  in  the  morning  until 
rising. 
23 1.3.1  Subjective  Measures 
The  two  most  commonly  used  self-report  measures  of  sleep  are  sleep 
questionnaires  (retrospective  self  reports)  and  sleep  diaries  (prospective  self-reports). 
1.3.1.1  Sleep  Questionnaires 
Sleep  questionnaires  have  sufficient  diagnostic  sensitivity  in  discriminating 
between  normal  and  poor  sleepers  and  they  provide  an  easy,  quick  and  inexpensive 
way  to  measure  sleep  patterns.  They  are,  therefore,  particularly  in  use  where  a  large 
number  of  people  are  to  be  screened  or  surveyed,  although  they  are  also  used  as  pre- 
and  post-  treatment  measures  of  the  individual's  perception  of  their  sleep  quality  and 
quantity.  For  example  The  Pittsburgh  Sleep  Quality  Index  (PSQI:  Buysse,  Reynolds, 
Monk,  Berman,  and  Kupfer;  1989)  was  expressly  designed  for  this  latter  purpose 
(Smith,  Nowakowski,  et  al,  2003). 
One  important  limitation  of  sleep  questionnaires  is  their  validity:  they  usually 
require  the  individual  to  provide  estimates  in  terms  of  average  which  are  most  likely 
influenced  by  the  particular  mood  of  the  individual  at  the  time  of  completion  and  the 
most  salient  or  recent  experience  of  sleep  (e.  g.  the  particularly  bad  night).  In 
addition,  an  average  figure  raises  validity  issues  given  that  in  insomnia  night-to-night 
variability  is  high  and,  importantly,  a  feature  of  insomnia:  most  researchers  and 
clinicians  will  have  come  across  questionnaires  with  replies  such  as  "it  varies"  or  "5 
minutes  to  4  hours",  to  the  questionnaire  item:  `average  time  to  fall  asleep  in  the  last 
month'. 
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measure  sleep  but  have  the  disadvantage  of  being  based  on  estimates  drawn  from 
memory  of  a  number  of  past  nights  and  of  giving  one  global  figure  for  each  sleep 
variable  under  scrutiny.  Sleep  diaries,  critically  outlined  below,  partly  avoid  these 
pitfalls. 
1.3.1.2  Sleep  Diary 
This  measurement  is  the  standard  of  practice  for  behavioural  sleep  medicine. 
Unlike  sleep  questionnaires,  the  sleep  diary  is  completed  each  morning  upon 
awakening  for  a  given  number  of  days  so  that  sleep  can  be  sampled  across  time. 
Therefore,  although  sleep  measures  are  taken  retrospectively  (i.  e.  the  previous  night), 
they  are  applied  prospectively  in  that  they  are  gathered  for  a  number  of  (future) 
consecutive  nights.  Similarly  to  retrospective  sleep  measures  the  individual  is 
required  to  estimate  variables  such  as  `time  to  fall  a  sleep'  and  `duration  of 
wakenings  during  the  night'.  However,  sleep  diaries  require  such  estimates  to  only 
one  time  point  (the  previous  night)  hence  the  response  biases  (e.  g.  using  averages) 
discussed  above  are  avoided.  Of  course  sleep  diaries  collect  subjective  judgements  of 
sleep  and,  therefore,  are  not  as  precise  as  objective  measures  (section  1.3.2  here 
below).  Nonetheless  a  very  important  feature  of  subjective  measures  is  that,  unlike 
PSG  or  actigraphy,  they  enable  the  gathering  of  information  about  the  perception 
both  of  sleep  disturbance  (i.  e.  the  complaint)  and  of  recovery  following  treatment. 
An  issue  with  the  diary  is  adherence  to  the  instruction  `fill  it  in  every  morning': 
people  might  fill  the  diary  in  later  on  during  the  day  or  even  worse  a  few  days  later. 
Another  issue  with  sleep  diaries,  worth  addressing  especially  for  research  purposes, 
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laboratories  regarding  the  sleep  parameters  to  be  gathered,  a  standardised  sleep  diary 
is  not  in  use  and  this  can  result  in  variations  in  the  characterisation  of  sleep 
continuity  across  studies.  These  problems  could  be  resolved  by  employing  simple 
ways  to  store  the  daily  sleep  diary  entries  (e.  g.  I-pod  type)  and  by  agreeing  on  a 
minimal  standard  form,  both  in  terms  of  sleep  parameters  to  be  collected  and 
wording  of  questions,  to  be  used  across  all  sleep  laboratories. 
As  it  has  been  shown  in  the  preceding  discussion  the  sleep  diary  is  an  inexpensive 
tool  for  measuring  sleep  continuity  and  sleep  quality  variables  night  after  night.  The 
fact  that  it  relies  on  the  individual's  report  of  the  previous  night  is  a  weakness  but 
also  a  major  strength  of  sleep  diaries.  On  one  hand  the  reported  values  are  not  free  of 
the  memory  biases  typical  of  retrospective  measures  but  on  the  other  hand  sleep 
diaries  capture  the  subjective  perception  of  the  sleep  difficulties.  Given  that  the 
essential  feature  of  insomnia  is  the  individual's  complaint  of  poor  sleep  (minimum 
three  days  per  week)  and  its  consequences  during  the  day,  it  can  be  argued  that  the 
sleep  diary  is  the  most  valid  tool  to  measure  this  feature  of  insomnia  and  it  is, 
therefore,  not  surprising  that  it  is  standard  practice  in  behavioural  sleep  medicine. 
Sleep  diaries  measure  sleep  continuity  and  collect  the  individual's  perception  of 
being  either  asleep  or  awake.  As  already  mentioned,  the  subjective  report  of  sleep 
argues  against  a  unitary  sleep  state  and  the  different  `layers'  of  sleep  can  be 
monitored  via  PSG,  an  objective  measurement  of  sleep  and  wakefulness. 
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In  this  section  polysomnography  and  actigraphy  will  be  described  and  critically 
evaluated. 
1.3.2.1  Polysomnography 
Polysomnography  (PSG)  permits  researchers  and  clinicians  to  measure  sleep 
objectively,  to  obtain  an  exact  temporal  (second-by-second)  resolution  of  sleep,  to 
have  direct  and  quantitative  measures  of  brain  and  muscle  activity  and  to 
differentiate  sleep  into  substates  (stages  1,2,3,4  and  REM)  which  are  not  detectable 
with  other  sleep  measurements  (Smith,  Nowakowski  et  al,  2003). 
Three  measures  are  sufficient  for  monitoring  and  scoring  sleep: 
electroencephalography  (EEG)  in  particular  the  recording  of  brain  wave  activity 
from  central  and  occipital  areas  of  the  scalp,  electrooculography  (EOG)  which 
measures  a  differential  of  electrical  potential,  generated  by  each  eye  movement, 
between  the  cornea  and  the  retina;  and  electromyography  (I3MG),  which  monitors 
muscle  tone  and  is  generally  recorded  at  the  chin  site.  These  electrical  currents  can 
be  represented  continuously  and  plotted  over  time  and  their  combination  permits  the 
detection  and  categorization  of  sleep  stages  and  wakefulness.  In  order  to  obtain 
reliable  PSG  data  the  electrodes  need  to  be  placed  accurately:  the  10-20  International 
System  (Jasper,  1958)  is  the  most  commonly  used  system  for  electrode  attachment. 
The  PSG  data  are  divided  into  sleep  stages  employing  criteria  for  staging  normal 
human  sleep  provided  in  the  Rechtschaffen  and  Kales'  (1968)  manual  (section  1.2.1 
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PSG  recording  device). 
An  important  issue  is  that  PSG  recording  usually  takes  place  in  sleep  laboratories 
and  several  studies  have  noted  that  PSG  sleep  differences  between  poor  and  normal 
sleepers  are  at  best  modest  (Means,  Edinger,  Glenn  and  Fins,  2003;  Sugarman,  Stem 
and  Walsh,  1985).  It  could  be  argued  that  in  laboratory  settings  the  conditioned  cues 
for  wakefulness  typical  of  the  poor  sleeper's  bedroom  are  absent.  Additionally  the 
laboratory  setting  may  provide  a  pre-bed  routine  that  obviates  to  sleep-disruptive 
habits  and  the  novelty  might  distract  the  individual  from  the  usual  pattern  of 
worrying  in  bed.  The  fact  that  poor  sleep  is  expected  can  paradoxically  promote  a 
good  night's  sleep  by  removing  sleep  anxiety  performance.  The  opposite  is  true  for 
the  normal  sleeper:  habitual  cues  for  sleep  are  absent,  the  usual  pre-bed  routine  is 
disrupted  and  they  might  question  their  ability  to  sleep  in  a  novel  environment. 
In  other  words,  it  can  be  argued  that  a  short  series  of  sleep  recordings  conducted 
in  laboratory  settings  might  not  be  representative  of  individuals'  typical  sleep.  For 
example,  Edinger  and  colleagues  conducted  a  series  of  PSG  studies  where  PSG 
recordings  were  conducted  both  at  participants'  homes  and  in  laboratory  settings. 
One  study  showed  that  individuals,  regardless  of  their  sleep  status,  acclimatise  more 
readily  to  PSG  recording  when  in  their  home  as  compared  to  the  laboratory  setting 
and  that  PSG  recording  at  home  enabled  capture  of  the  relatively  high  night-to-night 
variability  typical  of  people  with  insomnia  (Edinger,  Fins,  Sullivan,  Marsh,  Dailey, 
Hope,  Young,  Shaw,  Carlson  and  Vasilas,  1997).  In  a  subsequent  study  Edinger  and 
colleagues  found  that  people  with  insomnia  who  had  a  bed  partner  showed  sleep 
differences  with  regard  to  normal  sleepers  only  when  PSGs  were  recorded  at  home, 
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patterns  is  important  (Edinger,  Glenn,  Bastian,  Marsh,  Daile,  Hope,  Young,  Shaw 
and  Meeks,  2001). 
It  seems,  therefore,  worthwhile  to  measure  PSG  sleep  at  home  as  this  increases 
ecological  validity  in  comparison  with  laboratory  based  trials.  Simple  to  use,  non- 
intrusive,  relatively  cheap,  portable  EEG  systems  have  been  recently  devised  which 
make  it  feasible  to  conduct  home  PSG  so  as  to  monitor  objective  sleep  changes 
following  insomnia  interventions  whilst  the  individuals  sleep  in  the  `reality'  of  their 
own  usual  sleep  environment. 
It  is  noteworthy  that  subjective  measures  of  sleep  and  PSG  sleep  are  very  often 
mismatched  in  both  young  adults  and  the  elderly  (Carskadon,  Dement,  Mitler, 
Guilleminault,  Zarcone  and  Spiegel,  1976;  Mercer,  Bootzin  and  Lacks,  2002; 
Schramm,  Hohagen,  Backhaus,  Lis  and  Berger,  1995;  Webb  and  Schneider-Helmert, 
1988).  In  order  to  explain  such  discrepancies,  Borkovec  (1979)  suggested  that  when 
an  overly  active  reticular  system  (which  governs  arousal)  is  present  or  a 
neurotransmitter-dependant  sleep  system  fails  to  switch  on  then  PSG  confirms 
insomnia.  In  contrast,  when  reported  insomnia  is  not  confirmed  by  PSG  defined 
sleep  the  individual  has  an  overly  active  cognitive  processing  of  anxiety-laden 
thoughts.  It  could  be  argued  that,  in  the  latter  case,  sleep  staging  does  not  capture 
features  of  insomnia  such  as  alertness.  Alertness  in  the  form  of  EEG  fast  activity  can 
be  detected  by  performing  power  spectral  analysis  to  the  PSG  recorded  night  (Perlis, 
Smith,  Orff,  Andrews  and  Gill,  2001). 
Interestingly,  several  studies  highlighted  that  despite  positive  treatment  effects 
being  evidenced  by  sleep  diary  data,  there  were  only  very  small  treatment  effects  or 
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1993;  Engle-Friedman,  Bootzin,  Hazlewood  and  Tsao,  1992;  Morin,  Stone,  Trinkle, 
Mercer  and  Remsberg,  1993;  Schramm  et  al,  1995). 
Another  important  point,  related  to  the  difference  between  subjective  and 
objective  measures  of  sleep,  could  be  made  by  taking  into  account  Espie's  (1991) 
observation  that  the  subjective  complaint  normally  incorporates  an  element  of 
dissatisfaction  with  sleep  quality  variables  such  as  `not  feeling  refreshed  in  the 
morning',  or  `sleep  was  of  very  poor  quality'.  Such  complaints  are  not  invalidated  by 
an  absence  of  EEG  evidence  of  sleep  pattern  disruption:  indeed  not  being  sensitive  to 
sleep  quality  variables  weakens  the  role  of  PSG  as  a  measurement  criterion. 
1.3.2.2  Actigraphy 
Actigraphy  measures  movement  and  its  absence  i.  e.  this  measurement,  rather  than 
measuring  sleep  directly,  infers  sleep  by  the  absence  of  movement  (Sadeh  and 
Acebo,  2002).  The  movement  detector,  a  small  piezoelectric  accelerometer  that 
generates  voltages  when  there  is  movement,  is  housed  in  a  wristwatch-like  device. 
The  detected  movement  is  translated  into  digital  counts  accumulated  across  epoch 
intervals,  whose  length  can  range  from  2  seconds  to  15  minutes,  and  stored  in  the 
internal  memory  of  the  watch.  The  epoch  data  collected  are  transferred  to  a  computer 
that  has  the  set  up  and  the  reader  interface  and  each  epoch  is  evaluated  for  whether  it 
represents  sleep  or  wakefulness. 
Given  that  actigraphy  is  a  proxy  measure  of  sleep  its  validity  as  a  measurement  of 
sleep  variables  is  inferior  when  compared  to  that  of  sleep  diary  and  PSG.  Indeed  a 
problem  with  actigraphy  is  validity:  good  agreement  (r=0.94)  between  actigraphy 
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Kripke,  Cole,  Assmus  and  Langer,  2001),  but  epoch  by  epoch  wake  have  lower 
validity  most  probably  because  people,  especially  poor  sleepers,  tend  to  lie  still  in  an 
attempt  to  fall  asleep.  In  addition,  the  discrepancy  is  much  higher  when  the  sleep  of 
people  with  insomnia  is  assessed  (Chambers,  1994;  Hauri  and  Wisbey,  1992). 
Furthermore,  it  has  been  shown  that  there  are  gender  and  age  differences  in  actigraph 
estimates  of  sleep  (for  a  review  see  Sadeh  and  Acebo,  2002).  It  could  be  argued  that 
such  variability  decreases  the  usefulness  of  actigraphy  when  the  focus  of  research  is 
sleep.  Kushida,  Chang,  Gadkary,  Guilleminault,  Carrillo,  and  Dement,  (2001) 
compared  PSG,  actigraphy  and  sleep  diary  measures  for  one  night  in  one  hundred 
people  with  sleep  difficulties.  They  found  that  the  accuracy  of  actigraphy  declines  as 
sleep  diminishes:  actigraphy  was  excellent  in  detecting  sleep  (sensitivity  =  0.92)  but 
its  ability  to  detect  wakefulness  (specificity=  0.48)  was  rather  poor  and  the  ability  to 
detect  both  sleep  and  wakefulness  (accuracy  =  0.78)  was  low.  Pollack,  Tryon, 
Nagaraja  and  Dzwonczyk  (2001)  investigated  the  ability  of  actigraphy  to  predict 
PSG  defined  sleep  and  wakefulness  and  argued  that  actigraphy  is  not  an  accurate 
sleep-wake  detector,  although  it  may  be  useful  as  a  measure  of  rest/activity.  In 
particular,  Sadeh  and  Acebo  (2002,  p120)  cautioned  that  "actigraphy  is  not  the  best 
method  if  interest  is  in  the  precise  duration  of  sleep  onset"  because  the  largest 
discrepancies  between  actigraphy  and  PSG  measures  are  typically  around  sleep-wake 
and  wake-sleep  transitions. 
It  is  important  to  note  that  actigraphs  can  collect  other  measures  in  addition  to 
movement:  this  can  be  very  useful  if  actigraphy  is  employed  for  collecting  data  other 
than  sleep.  For  example  one  model  (Actiwatch-L  by  Cambridge  Neurotechnology, 
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light  sensor  that  monitors  light  intensity  range  measured  from  0  to  50,000  lux.  In  this 
way,  both  movement  and  light  are  detected  and  stored.  A  secondary  aim  of  the 
present  research  is  the  exploration  of  the  impact  of  adherence  on  insomnia  treatment 
outcomes:  this  extra  feature  of  actigraphy  can  be  exploited  to  objectively  monitor 
adherence  to  a  behavioural  instruction  asking  participants  to  read  (study  3,  ch.  5). 
In  sum,  there  is  not  an  absolute  `gold  standard  measure'  of  sleep.  While  sleep 
questionnaires  are  an  important  tool  to  quickly  gather  information  regarding  the 
perception  of  sleep  problems,  sleep  diaries  provide  nightly  information  regarding  the 
perception  of  sleep  continuity  and,  very  importantly,  the  subjective  complaint.  PSG 
measures  objective  sleep  continuity  and  sleep  architecture  and  enables  power 
spectral  analysis.  However,  given  that  PSG  recordings  are  costly  and  time  consuming 
they  are  not  really  feasible  as  a  measurement  of  many  consecutive  nights.  For  this 
reason  actigraphy  is  employed  when  the  measurement  of  sleep  over  time  is  to  be 
collected  objectively;  even  though  it  presents  the  important  problem  of  validity 
discussed  above. 
It  can  be  concluded  that  subjective  and  objective  measures  of  sleep  might  be 
complementary  and,  most  importantly,  the  questions  one  is  trying  to  answer  and  the 
issues  and  hypotheses  under  investigation  (e.  g.  endorsed  beliefs  about  sleep,  EEG 
activity  during  sleep)  should  inform  which  are  the  best  to  use. 
The  next  section  introduces  insomnia  aetiological  systems  and  related  research. 
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The  aim  of  this  section  is  to  critically  outline  the  major  perspectives  on  insomnia 
(i.  e.  physiological,  behavioural  and  cognitive)  and  related  research.  In  addition 
'purist'  models  within  a  given  perspective  and  models  integrating  different 
perspectives  are  discussed. 
Whilst  there  is  limited  information  regarding  mechanisms  underlying 
pathophysiology  and  genetic  or  heritability  factors  in  insomnia  (Richardson  and 
Roth,  2001;  Yves,  Morin,  Cervena,  Carlander,  Beset  and  Billiard,  2003),  most 
insomnia  models  agree  on  the  hypothesis  that  insomnia  is  a  disorder  of  arousal:  the 
person  complaining  of  insomnia  has  a  level  of  arousal  inhibiting  sleep  onset  at 
bedtime  and/or  during  the  night.  The  debate  regarding  the  origin  (physiological, 
psychological  and/or  environmental)  of  such  hyperarousal  is,  however,  ongoing. 
1.4.1  Physiological  Perspective  of  Insomnia 
This  perspective  proposes  that  physiological  arousal  and  sleep  are  incompatible 
and  that  individuals  with  chronic  insomnia  experience  sleep  difficulties  because  of  a 
high  level  of  physiological  arousal  either  in  general  or  around  bedtime  and  during  the 
night. 
In  the  nervous  system  arousal  can  be  maintained  by  a  failure  of  central  nervous 
system  (CNS)  processes  to  promote  sleep  (homeostatic  sleep  drive)  and/or  to  inhibit 
wakefulness  (biological  clock)  (Daan  et  al,  1984).  There  is  evidence  of  heightened 
cortical  arousal  during  the  sleep  of  people  with  insomnia.  For  example,  Merica,  Blois 
and  Gaillard's  (1998)  PSG  study  found  increased  beta  power  (beta  waves  are 
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Similar  results  were  obtained  by  Perlis,  Kehr,  Smith,  Andrew,  Orff  and  Giles  (2001): 
high  frequency  EEG  activity  during  the  light  sleep  stages  (stages  1  and  2)  was 
increased  in  individuals  with  primary  insomnia  as  compared  both  to  controls  and 
individuals  with  insomnia  secondary  to  major  depression. 
High  levels  of  autonomic  activity  associated  with  tension  and  problems  in 
physiological  relaxation  (e.  g.  muscle  tension,  respiration  rate)  can  be  another  form  of 
arousal  that,  less  directly,  inhibits  sleep.  For  example  Monroe  (1967)  conducted  an 
important  study  with  16  normal  and  16  poor  sleepers  and  found  that  poor  sleepers 
exhibited  heightened  autonomic  arousal  both  during  and  prior  to  sleep  (evidenced  by 
higher  body  temperature,  body  movements  per  hour,  vasoconstriction  per  minute, 
perspiration  rate  and  skin  conductance).  Other  studies,  however,  did  not  find 
differences  between  normal  and  poor  sleepers  in  autonomic  variables  (for  a  review 
see  Bootzin  and  Nicassio,  1978;  Borkovec,  1982).  More  recently,  Bonnet  and 
colleagues  assessed  physiological  arousal  employing  a  measure  of  oxygen 
consumption  (V02)  and  found  that  the  insomnia  group,  as  compared  to  controls, 
displayed  higher  metabolic  rate  (autonomic  arousal)  both  during  the  day  and  at  night 
(Bonnet  and  Arand,  1995,1997;  Bonnet,  McNulty  and  Arand,  1993).  A  limitation  of 
these  studies  is  that  physical  fitness  and  caloric  intake  greatly  influence  body  oxygen 
consumption,  hence  the  observed  differences  could  have  been  due,  for  example,  to 
the  insomnia  group  being  less  physically  fit  than  the  control  group. 
In  sum,  although  there  are  findings  that  physiological  hyperarousal  (autonomic 
and/or  cortical)  correlates  with  insomnia,  research  has  not  unequivocally  supported 
the  physiological  perspective.  It  is  noteworthy  that  this  perspective  informs  on  the 
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development  and  exacerbation  of  insomnia.  Although  research  evidence  of 
physiological  arousal  is  often  used  to  provide  support  for  aspects  of  some  theoretical 
models  of  insomnia,  a  formal  model  of  insomnia  within  the  physiological  perspective 
has  not  been  proposed. 
The  behavioural  perspective,  discussed  in  the  next  section,  attempts  to  provide  an 
analysis  of  the  maintenance  and  exacerbation  of  insomnia. 
1.4.2  Environmental/Behavioural  Perspective  of  Insomnia 
According  to  the  behavioural  perspective,  acute  insomnia  might  be  precipitated  by 
a  number  of  psychosocial  events  but  chronic  insomnia  has  its  source  in  the 
environment.  The  source  of  the  individual's  recurrent  difficulties  with  sleep  is  not 
considered  to  be  physiological  or  psychological  in  origin,  rather  the  individual's 
arousal  is  caused  by  situation  and  temporal  factors  or  the  interaction  between  the 
individual  and  their  environment. 
This  perspective  posits  that  the  environment  may  elicit  arousal  responses  by  either 
failing  to  predict  sleep  at  the  right  time  for  sleeping  or  predicting  wakefulness  at  the 
wrong  times.  It  is  suggested  that  sleep  disruptive  habits  (e.  g.  extending  the  time  spent 
in  bed,  napping)  and  conditioned  responses  (e.  g.  lying  in  bed  elicits  wakefulness 
rather  than  sleep)  interfere  with  sleep  drive  and  serve  as  environmental  inhibitors  of 
sleep  (Bootzin  and  Epstein,  2000;  Edinger  and  Wohlgemuth,  1999;  Morin,  Savard 
and  Blais,  2000;  Spielman,  Saskin  and  Thorpy,  1987). 
However,  results  from  the  couple  of  studies  investigating,  directly  or  indirectly, 
conditioning  in  insomnia  call  into  question  the  conceptual  basis  of  the  behavioural 
35 perspective  of  insomnia.  Kazarian,  Howe  and  Csapo  (1979)  found  support  for  the 
hypothesis  that  poor  sleepers  engage  in  sleep  incompatible  behaviour  (both  in  the 
form  of  overt  behaviour  such  as  reading  and  covert  such  as  thinking).  However,  two 
other  studies  found  that  normal  sleepers,  similarly  to  poor  sleepers,  engaged  in  sleep 
incompatible  activity  in  the  bedroom  and  that  the  two  groups  did  not  differ  in  pre- 
sleep  activities  (Harvey,  2000a;  Haynes,  Adams,  West,  Kamens  and  Safranek,  1982). 
The  findings  that  poor  and  normal  sleepers  endorse  similar  behaviour  at  bedtime  do 
not  automatically  rule  out  the  role  of  conditioning  in  insomnia:  it  could  be,  for 
example,  that  the  concept  of  `preparedness'  applies  to  poor  sleepers  but  not  to 
normal  sleepers  with  regard  to  sleep  incompatible  behaviours  and  sleep.  In  learning 
theory,  the  concept  of  `preparedness'  refers  to  the  observation  that  depending  on  the 
organism's  make-up  and  social  modelling,  the  organism  is  prepared  (predisposed)  to 
learn  some  associations  more  readily  than  others  (Seligman,  1971;  Hygge  and 
Ohman,  1978).  Learned  taste  aversion  studies,  for  example,  suggest  that  there  is  a 
biological  preparedness  to  learn  certain  relations  more  readily  than  others  and  similar 
effects  occur  in  operant  learning  with  some  responses  more  readily  strengthened  by 
some  reinforcers  than  others  (Bolles,  1970;  Shettleworth,  1972;  Bernstein,  1978).  As 
discussed  in  section  1.4.2.2,  predisposition  is  one  of  the  three  main  factors  theorised 
to  play  a  major  role  in  insomnia  (Spielman  et  al,  1987).  Additional  research,  perhaps 
employing  prospective  rather  than  retrospective  measures,  is  much  warranted  to 
validate  this  hypothesis. 
Two  behavioural  models  of  insomnia  (stimulus  control  and  the  3  factor  model  of 
insomnia)  have  gained  extreme  popularity.  Perhaps,  especially  with  regard  to 
36 stimulus  control,  this  is  mainly  due  to  the  positive  outcomes  repeatedly  obtained  with 
stimulus  control  therapy  for  insomnia  and  sleep  restriction. 
1.4.2.1  Stimulus  Control  (Bootzin.  1972.  Bootzin  and  Nicassio.  1978) 
Bootzin  (1972)  conceptualised  sleep  and  insomnia  in  terms  of  learning  theory  and 
developed  stimulus  control  therapy  for  insomnia.  Stimulus  control  is  based  on 
operant  conditioning  concepts:  stimuli  can  elicit  a  number  of  responses  depending  on 
the  conditioning  history.  Stimulus  control  can  be  defined  as  the  degree  to  which  an 
antecedent  stimulus  (or  class  of  stimuli)  determines  the  probability  that  the  organism 
gives  the  conditioned  response  i.  e.  the  antecedent  stimulus  has  some  control  over  that 
particular  response.  Briefly,  applying  stimulus  control  concepts  to  sleep,  falling 
asleep  (operant)  is  emitted  so  as  to  produce  sleep  (reinforcement)  and  stimuli 
associated  with  sleep  become  discriminative  stimuli  for  the  occurrence  of  sleep 
(Bootzin  and  Nicassio,  1978).  Stimuli  associated  with  sleep  can  be  temporal  (i.  e. 
bedtime)  and/  or  environmental  (i.  e.  bedroom). 
Fig  2  -Operant  Analysis  of  Sleep 
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In  normal  sleet)  stimuli  such  as  one's  bed  are  associated  to  sleep 
As  shown  in  figure  2,  this  model  proposes  that  in  normal  sleep  the  bedroom 
environment  provides  stimuli  signalling  sleep  and  such  stimuli  elicit  falling  asleep. 
37 Bootzin  and  colleagues  proposed  that  in  the  case  of  insomnia  the  discriminative 
stimuli  for  sleep  are  not  established  (e.  g.  lack  of  association  sleep-bedroom)  or 
stimuli  for  activities  that  are  not  compatible  with  sleep  (e.  g.  television)  are  present. 
Situational  triggers  (sleep-preventing  activities  such  as  watching  TV,  reading, 
problem  solving  and  bed  aversion)  may  elicit  arousal  responses  by  becoming  a  cue 
for  wakefulness  or  by  failing  to  predict  sleep.  Espie  (2002)  suggested  that  poor 
stimulus  control  can  inhibit  bedtime  de-arousal  responses  that  in  turn  disrupt  both  the 
homeostatic  sleep  drive  and  the  wakefulness-sleep  circadian  cycle. 
Evidence  for  this  model  is  provided  by  the  success  of  the  therapy  intervention 
(section  1.7.2)  derived  by  the  stimulus  control  analysis  of  insomnia  rather  than  by 
testing  directly  the  conditioning  aspects  theorised  to  be  responsible  for  insomnia.  As 
critically  presented  in  sections  1.6.2  and  1.7.2,  many  studies  found  that  stimulus 
control  therapy  for  insomnia  markedly  decreased  SOL  and  WASO  by  50  to  80%  as 
compared  to  pre-treatment  values  and  this  findings  have  been  taken  as  evidence  for 
the  plausibility  of  this  model.  Notwithstanding  its  efficacy,  the  mechanisms  by  which 
stimulus  control  achieves  its  effects  are  unclear  and  it  cannot  be  ruled  out  that  the 
therapy  works  for  reasons  other  than  re-establishing  stimulus  control.  This  point  has 
been  emphasised  by  Salkovskis  (2002)  who  argued  that  treatment  evidence  does  not 
shed  light  on  the  underlying  mechanisms  of  effect.  Indeed,  as  already  discussed  in 
the  previous  section,  only  a  few  studies  have  investigated  pre-bed  activities  in  normal 
and  poor  sleepers  and  no  differences  have  been  observed.  Contrary  to  conventional 
wisdom  (ICSD-R),  it  has,  recently,  been  reported  that  people  with  insomnia  sleep 
worse  when  they  are  away  from  home  and  it  has  been  argued  that  this  finding  runs 
contrary  to  the  hypothesis  of  conditioning  to  the  bedroom  environment  (Vallieres, 
38 Belanger,  Bastien,  Espie,  Morin,  2005).  However,  it  could  also  be  argued  that,  in  the 
case  of  insomnia,  falling  asleep  is  not  under  the  stimulus  control  of  any  bedroom 
environment  (either  one's  own  or  a  hotel  room),  which  coupled  to  other  factors  (e.  g. 
drinking  more,  uncomfortable  mattress)  increases  the  sleep  problem.  It  could  also  be 
that  any  bedroom  environment  sustains  wakefulness,  rather  than  falling  asleep,  in 
people  with  insomnia. 
This  model  explains  how  insomnia  is  maintained  and  exacerbated  but  it  lacks 
explanatory  power  with  regards  to  the  emergence  of  insomnia.  The  Spielman  model, 
to  which  attention  is  now  turned,  while  emphasising  conditioning  as  the  main  factor 
maintaining  insomnia,  attempts  to  explain  the  emergence  of  insomnia. 
1.4.2.2  The  Three  Factor  Model  of  Insomnia  (Spielman,  Caruso,  and  Glovinsky 
198_7 
Departing  from  an  exclusively  environmental/behavioural  framework  Spielman, 
Caruso  and  Glovinsky  (1987)  proposed  a  stress  diathesis  model  of  insomnia  with  an 
additional  behavioural  component.  In  brief,  this  model  hypothesises  that  insomnia 
occurs  acutely  in  relation  to  both  trait  and  state  (predisposing  and  precipitating) 
factors.  In  its  early  stages  maintaining  factors  are  developed  and  if  not  extinguished 
such  maintaining  factors  will  give  rise  to  chronic  insomnia. 
Figure  3  shows  the  factors  responsible  for  the  emergence,  exacerbation  and 
maintenance  of  insomnia  over  time.  The  individual  may  be  predisposed  to  develop 
insomnia  due  to  trait  characteristics  such  as  personality  characteristics,  physiological 
arousal  (Perlis,  Giles,  Mendelson  and  Bootzin,  1997;  Kales  and  Kales,  1984; 
Stepanski,  2000)  and  genetic  predisposition  (Bastien  and  Morin,  2000).  However, 
39 precipitating  events  (e.  g.  situational  stress,  bereavement,  pain)  need  to  occur  for  the 
individual  to  experience  acute  insomnia,  and  factors  adopted  in  an  attempt  to  cope 
with  insomnia  symptoms  (e.  g.  napping,  extending  the  sleep  opportunity  window)  are 
proposed  to  play  a  major  role  in  chronic  insomnia. 
Fig.  3-  The  Three  Factor  Model  of  Insomnia  (Spielman  et  al,  1987) 
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Similarly  to  the  stimulus  control  model,  the  three  factor  model  is  hased  on  operant 
conditioning  and  does  not  take  into  account  the  possibility  that  classical  conditioning 
plays  a  role  in  the  maintenance  of  insomnia. 
As  already  mentioned,  both  the  stimulus  control  and  the  three  factor  models  derive 
evidence  from  the  efficacy  of  behavioural  treatment  of  insomnia.  However,  their 
central  tenets  have  never  been  tested  empirically. 
Neither  of  these  models  of  insomnia  nor  the  behavioural  perspective  in  general, 
take  cognition  into  consideration,  yet  a  common  complaint  of  people  with  insomnia 
is  that  of  'an  overactive  mind'  during  the  night.  Attention  is,  therefore.  now  turned  to 
a  perspective  addressing  this  reported  feature  of  insomnia. 
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13  Perpetuating 1.4.3  Cognitive  Perspective  on  Insomnia 
According  to  the  cognitive  perspective  of  insomnia  cognitive  and/or  emotional 
hyperarousal  predisposes,  precipitates  and  maintains  insomnia.  In  brief,  mental 
alertness  (e.  g.  thinking,  planning)  may  interfere  with  sleep  and,  sleeping  difficulties 
can  become  a  source  of  cognition  with  consequent  effects  upon  self-perception:  the 
individual  ruminates  about  not  sleeping  and  its  consequences.  Cognitive  arousal, 
therefore,  can  manifest  itself  not  only  in  the  form  of  planning/thinking  at  night  but 
also  in  the  form  of  rumination,  the  individual's  beliefs  about  their  insomnia  and/or 
the  attribution  of  negative  daytime  events  to  insomnia  (Espie,  1991;  Harvey,  2002a, 
Morin,  1993).  This  preoccupation  with  sleep  becomes  a  source  of  cognitive  arousal 
and  consequently  exacerbates  insomnia  in  a  continuous  negative  loop  where  faulty 
cognitions  about  sleep  (e.  g.  amount  of  sleep  needed,  effects  of  sleep  loss)  fuel  worry 
and  worry  jeopardises  sleep  (Espie,  2002;  Morin,  1993). 
Research  findings  lend  support  to  this  perspective:  people  with  insomnia  were 
found  to  complain  of  cognitive  arousal  (e.  g.  inability  to  `switch  off  their  mind')  more 
than  of  physiological  arousal  (Nicassio,  Mendlowitz,  Fussel  and  Petras,  1985)  and  of 
higher  levels  of  presleep  rumination  as  compared  to  normal  sleepers  (Espie,  Brooks 
and  Lindsay,  1989;  Harvey,  2000c;  Lichstein  and  Rosenthal,  1980).  For  example 
Lichstein  and  Rosenthal  (1980)  found  that  55%  of  their  296  people  with  insomnia 
sample,  regarded  their  sleep  problems  as  arising  from  cognitive  arousal  and  only  5% 
as  arising  from  somatic  arousal.  Espie  and  collaborators  found  that  two  thirds  (42 
people)  of  their  sample  regarded  cognitive  intrusion  as  an  important  source  of  their 
sleep  problems  (Espie,  Lindsay,  Brooks,  Hood  and  Turvey,  1989).  These  findings 
have  been  replicated  by  Harvey  (2000b).  Nicassio  et  al  (1985)  found,  in  their  sample 
41 comprising  both  college  students  and  adults  with  sleep  problems,  that  the  correlation 
between  pre-sleep  cognitive  arousal  and  sleep  onset  latencies  was  higher  than  that 
with  pre-sleep  somatic  arousal.  However,  Sanavio  (1988)  found  hardly  any 
correlation  (0.09)  between  measures  of  pre-sleep  cognitions  and  self-reported  SOL. 
It  is  noteworthy  that  poor  sleepers'  cognitive  activity  at  bedtime  is  generally 
emotionally-laden:  poor  sleepers  typically  report  more  negative  thoughts  regarding 
their  sleep  and  its  impact  on  their  lives  than  controls  (e.  g.  Espie,  1991;  Edinger,  Fins 
et  al,  2000;  Kuisk,  Bertelson  and  Walsh,  1989).  Bedtime  is  a  period  during  which 
competing  external  stimulation  is  minimal  and  it  is  not,  therefore,  surprising  that  it 
becomes  the  time  for  focusing  upon  problems.  It  has  been  proposed  (Kales  and 
Kales,  1984)  that  people  with  insomnia  internalise  stress  during  the  day  which  then 
re-emerges  at  sleep  time.  Indeed,  Nelson  and  Harvey  (2003)  explored  the  amount 
(employing  a  press-holder  counter  device)  and  content  of  pre-sleep  imagery  and 
found  that  poor  sleepers,  as  compared  to  normal  sleepers,  reported  fewer  images. 
However,  unlike  those  of  normal  sleepers,  such  images  were  unpleasant  (and  related 
to  topics  such  as  intimate  relationships  and  sleep);  furthermore,  SOL  and  amount  of 
negative  images  were  positively  correlated. 
In  addition,  research  findings,  employing  self-report  questionnaires  (e.  g.  Edinger 
et  al,  2000;  Harvey,  2000b;  Morin,  1993)  or  audiotape  recordings  of  pre-sleep 
thoughts  (Wicklow  and  Espie,  2000)  suggest  that  insomniacs  hold  greater 
dysfunctional  beliefs  and  attitudes  about  sleep  than  normal  sleepers  (e.  g.  `I  need  8 
hours  of  sleep  to  function  well  the  next  day').  Indeed  people  with  insomnia 
experience  anxiety  about  being  able  to  sleep  (sleep  performance  anxiety):  they  try  to 
42 control  the  `deviant'  performance  via  coping  efforts  which  might  actually  have  the 
opposite  effect  of  increasing  SOL  and  WASO. 
Another  line  of  evidence  for  a  cognitive  model  has  been  provided  by  studies 
where  emotional  and  cognitive  arousals  have  been  manipulated  (DeValck,  Cluydts 
and  Pirrera,  2004;  Gross  and  Borkovec,  1982).  For  example,  Gross  and  Borkovec 
(1982)  found  that  individuals  who  were  told  they  had  to  give  a  speech  (manipulation 
of  sleep  cognition)  had  nap  onset  latencies  almost  twice  as  long  than  those  who  were 
not  told  so.  In  contrast,  however,  Haynes,  Adams  and  Franzen  (1981)  found  that  a 
pre-sleep  arithmetic  mental  task  shortened  SOL  in  people  with  insomnia.  Although 
this  finding  suggests  that  mentation  does  not  impact  on  sleep,  it  can  also  be  argued 
that  the  fairly  simple  task  employed  by  Haynes  and  colleagues  inhibited  self- 
generated  and  emotionally-laden  mental  activity,  hence  enabling  cognitive  de- 
arousal. 
Cognition  and  affect,  therefore,  seem  to  interact  in  insomnia  and  it  is  possible  that 
failure  to  find  associations  between  sleep  and  cognitive  arousal  in  some  studies  may 
have  depended  on  the  type  of  cognitions  (and  whether  they  were  affect-laden)  under 
examination. 
It  is  important  to  consider  that  reinforcement  contingencies  are  not  always 
negative:  thinking  and  planning  can  be  enjoyable  and  valued  by  the  individual  and  if 
this  is  the  case  avoiding  mentation  in  bed  might  be  difficult.  In  addition  a  distinction 
between  difficulty  sleeping  because  of  thinking  and  thinking  because  of  wakefulness 
must  be  made:  taking  into  account  that  research  has  not  always  found  an  association 
between  sleep  latency  and  cognitive  alertness  it  has  been  suggested  that  cognitive 
43 arousal  may  be  epiphenomenal  to  wakefulness  (Espie,  1991;  Morin,  1993,  Perlis, 
Giles,  Mendelson,  Bootzin  and  Wyatt,  1997). 
Nevertheless  a  sizeable  amount  of  evidence  for  cognitive  arousal  in  insomnia  has 
been  gathered  and  it  should  be  noted  that  this  perspective,  as  compared  to  the 
physiological  and  behavioural  ones,  has  provoked  a  lot  of  research,  most  probably 
fuelled  by  patients'  reports  of  `a  racing  mind'  and  the  popularity  of  cognitive  theories 
and  therapies  for  psychopathologies  and  psychological  distress  in  general. 
In  the  next  section  a  cognitive  model  of  insomnia  that  acknowledges  and  gives 
equal  weight  to  (faulty)  cognition  both  at  night  and  during  the  day  is  presented. 
1.4.3.1  Cognitive  Model  of  the  Maintenance  of  Insomnia  (Harvey.  2002a) 
Harvey's  (2002a)  cognitive  model  of  insomnia  draws  on  contemporary 
experimental  cognitive  approaches  to  psychopathologies  in  general  and  anxiety 
disorder  in  particular.  This  model  argues  that  selective  attention  and  the  processes 
hindering  the  automatic  corrections  of  distortion  of  perception  typically  seen  in 
anxiety  disorders  maintain  insomnia. 
According  to  this  model  (depicted  in  figure  4)  insomnia  is  fuelled  by  worry  and 
rumination  about  sleep  and  the  daytime  consequences  of  little  sleep.  This  negatively 
valenced  cognitive  activity  triggers  autonomic  arousal.  The  `fight  or  flight'  state 
produces  selective  attention  towards  threat-cues  related  to  the  initiation  of  sleep  and 
the  individual  monitors  body  sensations  and  environmental  stimuli  (Neitzer-Semler 
and  Harvey,  2004).  In  turn,  monitoring  internal  and  external  events  that  could  disrupt 
sleep  increases  both  cognitive  and  physiologic  arousal  so  that  the  individual  is  more 
likely  to  find  evidence  of  arousal,  which  reinforces  monitoring  behaviour.  In 
44 addition,  selective  attention  and  monitoring  the  consequences  of  poor  sleep  can  lead 
to  detecting  daytime  deficits  and  to  distorted  perception  of  the  causes  of  such 
deficits.  This  process  ultimately  leads  to  the  endorsement  of  counterproductive  safety 
behaviour  (e.  g.  avoiding  demanding  work  and  social  activities),  which.  in  turn. 
increases  worry  regarding  lack  of  sleep  (Harvey,  2002a). 
Fig.  4-  Cognitive  Model  of  the  Maintenance  of  Insomnia  (Harvey,  2(N)2a) 
In  Bed  /  During  the  day 
Excessne  negatively  toned 
cogniGvc  activ  it) 
Arousal  and  distress 
klecti,  c  attention  and  nr.  nitoriý  , 
Distorted  perception  of  deficit 
I  Beliefs 
tiufcly  belwioun 
Krr" 
Exads 
ba 
Leads  ToG 
Real  Deficit 
A  key  point  of  this  model  is  that  insomnia  is  maintained  by  cognitive  processes 
and  not  by  deficits  in  the  sleep/wake  cycle.  This  model  makes  a  novel  cont  1-1  hilt  ion  to 
the  cognitive  perspective  in  that  it  introduces  the  concepts  of  selective  attention, 
distorted  perception  and  safety  behaviours  and,  very  importantly  it  places  equal 
weight  upon  cognitive  activity  at  night  and  during  the  day. 
Research  findings  supporting  the  concept  of  negatively  toned  cognitive  activity  at 
bedtime  has  been  reviewed  in  the  preceding  section  and  lends  support  to  this  model. 
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found  that  clock  monitoring  increased  SOL  in  both  normal  and  poor  sleepers.  While 
this  finding  is  evidence  that  looking  at  the  clock  impacts  negatively  on  SOL,  it  does 
not  `prove'  that  clock  monitoring  is  a  typical  behaviour  engaged  by  people  with 
insomnia.  From  a  conditioning  perspective,  on  the  other  hand,  it  could  be  argued  that 
clock  monitoring  is  a  sleep-incompatible  behaviour  hence  not  eliciting  falling  asleep. 
More  recently  Neitzer-Semler  and  Harvey  (2004)  found  that  people  with  insomnia, 
as  compared  to  normal  sleepers,  reported  more  monitoring  for  sleep  related  threat- 
cues,  negative  thinking  and  the  endorsement  of  safety  behaviours. 
Although  clinicians  and  sleep  researchers  alike  have  experience  of  people  with 
insomnia  reporting  `shying  away'  from  "demanding  and  social"  activities  because 
they  think  they  will  not  be  able  to  cope  due  to  lack  of  sleep,  a  systematic 
investigation  of  such  social  avoidance  has  yet  to  come.  Nonetheless  this  is  an 
important  issue  because  research  have  highlighted  that  maintaining  appropriate  levels 
of  physical  activities  (e.  g.  recreation,  domestic  maintenance,  walking)  affords 
protection  against  insomnia  (Morgan,  2003). 
This  model  has  implications  for  insomnia  therapy:  instead  of  focusing  directly  on 
increasing  amount  of  sleep  and  decreasing  SOL  and  WASO,  therapy  should  aim  at  i) 
decreasing  selective  attention  and  monitoring  for  sleep  related  threat  cues;  ii) 
correcting  distorted  perceptions  about  lack  of  sleep  and  its  consequences  and  iii) 
eliminating  the  endorsement  of  safety  behaviours. 
None  of  the  models  discussed  in  the  previous  sections  stand  alone  as  a 
comprehensive  theoretical  model  of  the  emergence,  exacerbation  and  maintenance  of 
46 insomnia:  each  explains  part  of  the  empirical  findings  regarding  physiological, 
behavioural  and  cognitive  relation  with  insomnia.  These  frameworks  are  obviously 
not  mutually  exclusive  and,  as  the  next  section  highlights,  some  sleep  scholars  have 
proposed  models  of  insomnia  integrating  the  physiological,  environmental  and 
cognitive  perspectives. 
1.4.4  Integrative  Models  of  Insomnia 
Several  integrative  models  of  insomnia  have  been  put  forward  over  the  past 
decades  and  furthered  insight  into  factors  likely  to  be  implicated  in  the  maintenance 
and  exacerbation  of  insomnia.  In  this  section,  however,  only  four  integrative  models 
will  be  critically  appraised.  Kales  and  Kales'  (1984)  model  has  been  selected  because 
it  incorporates  psychodynamic  concepts  and  explicitly  points  out  secondary  gains 
which  may  hinder  the  person's  desire  to  overcome  insomnia.  Morin's  (1993)  model 
takes  into  account  individual  and  environmental  factors  and  argues  that  the 
consequences  of  insomnia  can  become  the  cause  in  a  bi-directional  loop.  Perlis  et 
al's  (1997)  model  introduces  the  concept  of  classical  conditioning  in  insomnia  and 
provides  a  rationale  of  how  this  can  activate  cortical  arousal  producing  enhanced 
sensory  and  information  processing  in  the  quiet  hours  of  sleep.  Espie's  (2002)  model 
stands  out  because,  differently  from  the  general  consensus  that  insomnia  is  linked  to 
hyperarousal,  it  proposes  that  mechanisms  inhibiting  de-arousal  are  responsible  for 
the  inability  to  fall  asleep. 
47 1.4.4.1  Insomnia  as  a  Psychobehavioural  Disorder  (Kales  and  Kales.  1984) 
Kales  and  Kales  (1984),  building  on  their  experience  of  evaluating  and  treating 
individuals  with  insomnia,  proposed  that  insomnia  is  a  psychobehavioural  disorder 
(characterised  by  excessive  somatic  symptomatology  despite  being  functional  in 
nature)  and  as  such  it  is  best  understood  by  using  the  biopsychosocial  model  of 
illness.  Similarly  to  other  psychobehavioural  disorders,  insomnia  affects  and  is 
affected  by  a  number  of  facets  of  the  person's  life:  personality  factors,  the  illness 
itself,  the  family,  the  physician-patient  interaction  and  society. 
Supported  by  research  evidence  and  strongly  rooted  in  psychodynamic  theories, 
Kales  and  Kales  proposed  that  a  tendency  to  internalise  emotions  and  to  have  certain 
vulnerabilities  rooted  in  childhood  (i.  e.  emotional  deprivation  in  childhood  leading 
them  to  a  feeling  of  inadequacy,  insecurity  and  dependency  in  adulthood)  can  cause 
the  emergence  and  maintenance  of  insomnia.  It  is  therefore  understandable  that  the 
insomniac  may  develop  feelings  of  entitlement  and  expect  to  be  nurtured  and  cared 
for  by  others  (Healy,  Kales,  Monroe  et  al,  1981  as  cited  in  Kales  and  Kales,  1984; 
Coursey,  Buchsbaum  and  Frankel,  1975;  Kales,  Kales  and  Bixler,  1976). 
In  other  words  the  internalisation  of  psychological  conflicts  is  a  source  of  chronic 
emotional  arousal,  which  produces  physiological  activation,  which  in  turn  causes 
insomnia.  In  support  of  their  model,  Kales  and  Kales  (1984)  cited  two  studies 
involving  more  than  500  participants  employing  the  Minnesota  Multiphasic 
Personality  Inventory.  It  was  found  that  the  predominant  personality  characteristic  of 
people  with  insomnia,  as  compared  to  controls,  was  a  strong  tendency  to  internalise 
psychological  conflicts  rather  then  to  express  them  openly.  It  can  be  argued  that 
internalisation  of  conflicts  gives  rise  to  constant  worry  and  frustration  and, 
48 interestingly,  people  with  insomnia  scored  higher  than  normal  sleepers  in  personality 
factors  related  to  trait  worry  (Dorsey  and  Bootzin,  1997).  In  addition,  Kales  and 
Kales  (1984)  proposed  that  the  initial  sleep  difficulty  can  give  rise  to  a  fear  of 
sleeplessness  as  well  as  an  expectation  of  poor  sleep,  both  contributing  to  further 
emotional  and  psychological  arousal  and  consequently  maintenance  and  exacerbation 
of  insomnia. 
An  important  point  often  overlooked  is  that  insomnia  symptoms  can  generate 
secondary  gains  such  as  sympathy  and  attention  (Kales  et  al,  1976).  The  social 
environment  may  contribute  to  the  persistence  of  insomnia  by  providing  benefits  that 
hinder  willingness  to  rehabilitation.  In  this  way,  insomnia  itself  may  have  a 
reinforcing  effect  by  offering  the  individual  a  way  to  manipulate  their  environment 
and  avoid  unwanted  aspects  of  daily  life. 
1.4.4.2  An  Integrative  Model  of  Insomnia  (Morin.  1993) 
In  1993  Morin,  putting  together  research  findings  and  clinical  experience, 
proposed  an  integrative  model  of  insomnia  based  on  social  learning  theory,  in 
particular  the  stimulus-organism-response-consequence  model  (see  Haynes  and 
O'Brien,  1990).  Morin  (1993)  reasoned  that  the  main  mediating  feature  of  insomnia 
must  be  hyperarousal  because  arousal  regulates  the  balance  between  wakefulness  and 
sleep  and  excessive  arousal  is  incompatible  with  sleep.  Depending  on  the  individual, 
hyperarousal  can  manifest  itself  in  the  motoric,  cognitive-affective  and  /or 
physiological  (both  central  and/or  autonomic  systems)  domains. 
In  addition  sleeplessness  can  exacerbate  hyperarousal  in  a  vicious  loop.  A  variety 
of  stimulus  conditions  (e.  g.  associations  about  bedtime  routines  and  worry  about  not 
49 being  able  of  falling  asleep)  can  elevate  arousal  above  a  critical  threshold  and 
interrupt  the  natural  sequence  of  relaxation,  drowsiness  and  falling  asleep.  Morin 
suggested  that  people  prone  to  insomnia  might  be  more  prone  to  conditioning.  As 
proposed  in  section  1.4.2,  people  with  insomnia  might  display  a  biological 
preparedness  to  learn  certain  associations  but  this  hypothesis  has  not  been 
empirically  tested.  Furthermore  events  during  the  day  may  influence  the  inability  to 
sleep:  internalisation  of  psychological  conflicts,  as  proposed  by  Kales  and  Kales  in 
1984,  may  fuel  arousal  at  bedtime  and  strengthen  the  underlying  conditioning 
process. 
Typical  responses  to  sleeplessness  include  worry  over  sleep  loss,  rumination 
about  daytime  events,  muscle  tension  and  restlessness.  In  addition  the  person  tries 
harder  to  fall  asleep  which  increases  performance  anxiety.  Next  day  consequences 
(perceived  or  real)  involve  fatigue,  mood  disturbances  and  performance  impairments 
and  these,  in  turns,  fuels  the  memory  of  the  bad  night  and  can,  over  time,  produce  a 
sense  of  helplessness.  In  order  to  cope  with  insomnia  people  develop  maladaptive 
behaviours  such  as  napping  which,  while  temporarily  minimising  sleep  loss, 
overtime  interfere  with  the  synchronising  effect  of  regular  sleep-wake  rhythm. 
Similarly  to  the  three  factor  model  (Spielman  et  al,  1987),  Morin's  (1993)  model 
proposes  that  chronic  insomnia  is  generally  preceded  by  situational  insomnia, 
brought  on  by  stressful  life  events,  that  failed  to  improve  once  stressors  disappeared. 
This  model  highlights  that  the  consequences  of  insomnia  can  become  the  causes 
and  vice-versa:  there  is  a  bi-directional  influence  among  these  controlling  variables 
(figure  5).  This  is  a  strength  of  Morin's  model  in  that  it  has  explanatory  power  of  the 
50 persistence  of  insomnia  complaints  and  of  the  fact  that  insomnia  is  unlikely  to  remit 
spontaneously. 
Fig.  5-  An  Integrative  Model  of  Insomnia  (Morin,  1993) 
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There  is  evidence  (albeit  not  unequivocal)  for  the  components  of  this  model.  In 
previous  sections  evidence  for  cognitive,  emotional  and  physiological  arousal  in 
insomnia  have  been  discussed  and  causality  has  been  questioned.  The  hypothesis  that 
people  with  insomnia,  as  compared  to  controls,  endorse  dysfunctional  cognitions 
regarding  sleep  and  consequences  of  lack  of  sleep  has  been  evaluated  and  many 
examples  of  research  findings  supporting  this  hypothesis  have  been  provided.  It  has 
also  been  pointed  out  that  there  is  scarce  direct  testing  of  the  hypothesis  that  people 
with  insomnia  endorse  more  maladaptive  behaviour  than  normal  sleepers.  Finally, 
although  most  insomnia  patients  complain  of  daily  deficits  (Morin  and  Espie,  2003) 
objective  evaluation  of  daily  functioning  has  found  only  mild  impairments  (Riedel 
and  Lichstein,  2000). 
51 Morin  points  out  that  this  theoretical  framework  has  several  implications  for  the 
management  of  chronic  insomnia.  First,  learned  behavioural  and  cognitive  responses 
play  a  major  role  in  maintaining  insomnia,  thus,  treatment  should  focus  on 
maladaptive  sleep  habits  and  dysfunctional  sleep  cognitions.  Given  that  teaching  to 
control  sleep  might  exacerbate  performance  anxiety  and,  consequently,  ability  to 
sleep,  this  model  posits  training  people  with  insomnia  to  control  temporal, 
contextual,  behavioural  and  cognitive  factors  that  facilitate  sleep  rather  than  to 
control  sleep  itself. 
1.4.4.3  The  NeurocoQnitive  Model  of  Insomnia  (Perlis  et  al.  1997) 
The  neurocognitive  model  (Perlis  et  al,  1997)  can  be  viewed  as  an  extension  of 
the  behavioural  model  proposed  by  Spielman  et  al  (1987).  As  illustrated  in  figure  6, 
this  model  acknowledges  that  cognitive  factors  might  be  mediating  the  occurrence 
and  severity  of  insomnia  in  its  acute  phase  and  that  cognitive  activity  might  extend 
wakefulness.  However,  it  argues  that  chronic  insomnia  is  a  `reversible'  central 
nervous  system  disorder  due  to  operant  and  classical  conditioning  (Perlis,  Smith  and 
Pegeon,  2005)  and  that  dysfunctional  beliefs  and  worry  are  epiphenomena  to  (that  is 
a  by-product  of)  insomnia  rather  than  a  cause  of  insomnia.  As  discussed  previously 
this  possibility  has  been  raised  by  other  researchers  (e.  g.  Morin,  1993,  Espie,  2002). 
Perlis  and  colleagues  reasoned  that  wakefulness  in  bed  might  elicit  arousal  and 
that  the  continuing  pairing  of  bed  environment  and  wakefulness  might  be  classically 
conditioning  the  individual  to  be  aroused  by  the  bedroom  itself.  Such  conditioned 
arousal  might  perpetuate  insomnia  even  when  sleep  incompatible  or  maladaptive 
behaviours  (e.  g.  watching  TV  in  bed,  staying  in  bed  for  long  periods)  are  removed. 
52 Fig.  6:  The  Neurocognitive  Model  of  Insomnia  (Perlis  et  al,  1997) 
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The  neurocognitive  model  took  its  lead  from  previous  work  (e.  g.  Mendelson  et  al, 
1986)  on  the  perception  of  being  awake  while  actually  being  asleep  according  to 
EEG  sleep  staging.  It  argues  that  cortical  arousal  is  the  result  of  classical 
conditioning  and  it  is  observable  in  people  with  primary  insomnia  as  a  high- 
frequency  EEG  activity  (such  as  Beta  activity,  14-45  Hertz)  prior  to  falling  asleep 
and  during  NREM  sleep.  Beta  activity  allows  for  higher  levels  of  sensory  and 
information  processing  making  the  individual  more  sensitive  to  environmental 
53 stimuli.  Being  more  sensitive  to  stimuli  interferes  with  the  ability  to  `let  go  of  the 
surrounding'  and  initiate  sleep  and  can,  hence,  explain  longer  SOL. 
Likewise  increased  information  processing  during  PSG-defined  sleep  is  proposed 
to  interfere  with  the  person's  ability  to  distinguish  sleep  from  wakefulness  and, 
therefore,  can  help  in  explaining  the  individual's  complaint  of  hardly  having  slept  all 
night  despite  PSG  evidence  of  sleep. 
Fast  EEG  activity  studies  lend  support  to  this  model.  Indeed,  studies  have  shown 
that  Beta  EEG  is  elevated  in  people  with  insomnia  as  compared  to  normal  sleepers 
(Freedman,  1986;  Lamarche  and  Ogilvie,  1997;  Merica  et  al,  1998;  Merica  and 
Gaillard,  1992;  Perlis,  Smith,  Orff  et  al,  2001),  it  is  positively  associated  with  sleep 
state  misperception  (degree  of  discrepancy  between  subjective  and  objective 
measures  of  sleep)  (Mercer  et  al,  2002),  and  varies  with  successful  CBT  treatment 
for  insomnia  (Krystal,  Edinger,  Wohlgemuth  and  Marsh,  2002).  In  addition  Beta 
activity  has  been  found  to  be  negatively  associated  to  perception  of  sleep  quality 
(Hall,  Buysse,  Nowell,  Nofzinger,  Houck  et  al,  2000;  Nofzinger,  Price,  Metzer, 
Buysse,  Villemagne  et  al,  2000;  Perlis,  Merica  et  al,  2001).  It  is  important  to  note 
that  the  evidence  that  increased  high  frequency  activity  appeared  to  be  in  the  Beta 
and  Gamma  bands  of  the  EEG  suggests  that  the  primary  source  potential  for  the 
signal  is  EEG  (i.  e.  cortical  arousal),  rather  than  EMG  (i.  e.  somatic  arousal)  which 
supports  the  suggestion  that  cortical  and  somatic  arousals  are  distinct  phenomena. 
Although  the  findings  from  these  studies  reveal  cortical  arousal  the  possibility  that  it 
is  a  consequence  of  cognitive  arousal  (e.  g.  being  more  alert  because  of  scanning  the 
environment  for  events  threatening  sleep)  rather  than  being  classically  conditioned 
cannot  be  ruled  out. 
54 1.4.4.4  Psychobiological  Inhibition  Model  of  Insomnia  (Espie.  2002) 
The  models  of  insomnia  discussed  in  the  previous  sections  focus  on  hyperarousal. 
Espie  (2002),  by  contrast,  proposed  that  insomnia  is  associated  to  the  individual's 
inability  to  de-arouse.  His  psychobiological  inhibition  model  examined  insomnia 
from  a  different  angle  than  the  one  traditionally  taken.  Rather  than  considering 
insomnia  as  the  result  of  hyperarousal  and  its  sleep  inhibiting  effects  (inhibition  of 
the  `falling  asleep'  system),  Espie  conceptualised  insomnia  as  the  malfunction  of 
mechanisms  and  processes  inhibiting  wakefulness  (inhibition  of  the  'wake-off' 
system).  According  to  this  model,  and  typical  of  neurobiological  systems,  good  sleep 
is  the  natural  state  for  the  individual  with  both  functional  plasticity  (accommodating 
night-to-night  variations)  and  automaticity.  Espie  (2002)  proposed  automaticity  of 
`sleep  homeostasis'  and  `circadian  timing'  (for  details  see  Dijk  and  Czeisler,  1995)  to 
be  the  controlling  feature  of  good  sleep.  Importantly,  the  concept  of  automaticity 
encapsulates  the  idea  that  good  sleep  is  a  `passive'  state  that  does  not  require  effort. 
As  depicted  in  figure  7,  good  sleep  is  maintained  by  four  interacting  components: 
sleep-stimulus  control,  physiological  de-arousal,  cognitive  de-arousal  and  daytime 
facilitation.  In  normal  sleep  both  physiological  and  mental  cues  of  sleep  readiness  are 
accurately  interpreted  and  cues  in  the  home  environment  reinforce  cognitive  and 
physiological  de-arousal  so  that  the  individual  enters  sleep  effortlessly.  In  insomnia, 
instead,  cognitive  phenomena  (preoccupation  with  sleep,  intention  to  sleep  and  effort 
to  sleep)  inhibit  such  de-arousal  processes  and  make  sleep  difficult  both  at  the 
beginning  and  during  the  night  (for  a  formal  conceptualisation  of  the  attention- 
intention-effort  pathway  to  insomnia  see  Espie,  Broomfield,  MacMahon,  Macphee 
and  Taylor;  2006). 
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This  model  helps  explain  the  transition  from  acute  to  chronic  insomnia:  attempts 
to  re-gain  normal  sleep  (e.  g.  focussing  on  ways  to  sleep  well,  going  to  tied  earlier  if 
the  night  before  was  bad)  are  likely  to  give  rise  to  homeostatic  dysregulation, 
circadian  timing  problems  and  conditioned  arousal. 
Perlis  et  al  (2005)  pointed  out  that  considering  hyper-arousal  and  de-arousal  as 
two  separate  concepts  enables  us  to  define  insomnia  more  clearly  and  to  search  for 
its  neurobiological  basis.  In  addition  such  differentiation  permits  to  better  understand 
mechanisms  of  effect  in  insomnia  treatment  programmes.  Empirical  research  on  the 
distinction  of  these  two  concepts  is,  therefore,  warranted. 
This  model  suggests  that  the  efficacy  of  multicomponent  cognitive-behavioural 
therapies  (CBT)  (outlined  and  discussed  in  the  next  session)  may  rely  on  the  de- 
activation  of  inhibitory  mechanisms  of  de  arousal.  Sleep  hygiene  might  remove  some 
potential  inhibitors  of  physiological  de-arousal.  Sleep  scheduling  (temporal 
instruction  of  stimulus  control  therapy  and  sleep  restriction),  re-adjusts  the  balance 
between  the  homeostatic  sleep  drive  and  the  biological  clock.  and  might  also  de- 
activate  inhibition  processes  of  cognitive  de-arousal.  In  other  words,  when  falling 
56 asleep  is  difficult,  giving  up  trying  to  sleep  enables  to  decrease  mental  effort  and 
consequently  to  fall  asleep.  Performing  an  activity  rather  than  lying  in  bed  awake  is 
likely  to  shift  cognition  from  sleep  related  concerns  to  the  activity  itself.  Relaxation 
techniques  are  likely  to  facilitate  both  cognitive  and  physiological  de-arousal. 
Addressing,  challenging,  and  substituting  dysfunctional  sleep  related  thoughts  is 
likely  to  decrease  worry  about  not  sleeping  and  its  consequences  permitting  cognitive 
de-arousal. 
The  theoretical  concepts  and  related  evidence  for  the  development.  maintenance 
and  exacerbation  of  insomnia  inform  insomnia  therapy  to  which  attention  is  now 
turned. 
1.5  Therapeutic  Approaches  to  the  Treatment  of  Insomnia 
In  this  section  the  principal  therapies  for  insomnia  (table  4),  informed  hý  one  or 
the  integration  of  the  perspectives  discussed  in  the  preceding  section,  are  briefly 
outlined. 
Table  4-  Insomnia  Therapy  according  to  Underlying  Perspective 
Therapy  Perspectives:  Physiological  Behavioural  Cognitive 
Pharmacotherapy 
Sleep  Hygiene  v  tý 
Progressive  Muscle  Relaxation  v 
Diaphragmatic  Breathing  V 
Biofeedback  Assisted  Relaxation  V 
Stimulus  Control  v 
Sleep  Restriction  V 
Paradoxical  Intention  V 
Imagery  v 
Suppression  v 
Cognitive  Restructuring 
CBT  vVv 
57 Given  that  the  experiments  devised  and  carried  out  in  the  present  research  relate 
to  stimulus  control  therapy,  in  addition  to  being  presented  here,  stimulus  control  is 
explained  in  details  and  critically  appraised  in  subsequent  sections. 
1.5.1  Treatments  Related  to  the  Physiological  Perspective 
1.5.1.1  Pharmacotherapy 
Pharmacotherapy  derives  from  the  physiological  perspective  and  it  is  the  most 
popular  approach  for  treating  insomnia  patients  in  primary  care  (Dement,  1994  as 
cited  in  Edinger  and  Wohlgemuth,  1999).  It  is  noteworthy  that  Greater  Glasgow 
remains  amongst  the  highest  prescribing  areas  in  Scotland  per  head  of  weighted 
population  during  1999  according  to  ISD  Primary  Care  Unit  statistics.  Although 
pharmacotherapy  has  been  shown  to  produce  short-term  sleep  improvements,  there  is 
little  evidence  of  its  long-term  efficacy  (Kramer,  2000)  and  prolonged  use  of 
hypnotics  is  not  recommended  due  to  risks  of  dependence,  sedative  side  effects, 
misuse  and  associated  morbidity  (Russell  and  Lader,  1992). 
Perlis,  Pigeon  and  Riemann  (2006,  submitted)  summarised  the  findings  of  four 
meta-analyses  on  the  use  of  pharmacotherapy  (hypnotics  and  off  label  treatment  with 
sedating  antidepressant)  and  concluded  that  there  is  no  firm  evidence  of  the  efficacy 
of  pharmacotherapy  for  the  treatment  of  persistent  insomnia.  Furthermore,  they 
warned  that,  in  the  elderly,  treatment  benefits  are  outweighed  by  the  risks.  Their 
summary  is  in  agreement  with  the  NIH  Statement  produced  in  2005  regarding 
treatment  of  insomnia  (National  Institute  of  Health,  2005). 
58 Kripke  (2000)  argued  that  prescription  should  be  limited  to  short  courses  and 
substituted  by  cognitive  behavioural  treatment  (CBT).  Indeed,  more  recently  NICE 
(2004)  recommended  GPs  to  consider  non-medicine  as  the  first  line  of  insomnia 
treatment  and  to  prescribe  hypnotic  drugs  only  in  the  most  severe  cases  of  insomnia 
and  only  for  short  periods.  Importantly,  a  pragmatic  randomised  controlled  trial 
evidenced  the  efficacy  and  cost  effectiveness  of  CBT  for  insomnia  (CBT-I)  in 
primary  care  patients  presenting  with  a  history  of  long  term  hypnotic  drug  use 
(Morgan,  Dixon,  Mathers,  Thompson  and  Tomeny,  2003).  Similarly  to  Morin, 
Colecchi,  Ling,  and  Sood's  (1995)  results,  Morgan  et  al's  (2003)  study  showed  that 
CBT-I  facilitated  hypnotic  drug  use  decrease.  Another  important  finding  of  Morgan 
et  al's  (2003)  study  was  that  following  CBT-I,  participants'  sleep  and  quality  of  life 
were  improved  as  compared  to  participants  who  continued  with  their  usual  treatment 
(i.  e.  hypnotic  drugs). 
Given  that  research  findings  and  guidelines  suggest  that  pharmacotherapy  for 
persistent  insomnia  is  not  the  best  line  of  treatment  (Kramer,  2000),  it  is  not 
surprising  that  a  variety  of  behavioural  and  cognitive  therapies  for  insomnia  have 
been  devised. 
1.5.1.2  Sleep  Hygiene 
Sleep  hygiene  is  typically  regarded  as  a  behavioural  strategy  which,  being 
educational  in  nature,  sits  well  within  a  cognitive  framework.  Nonetheless,  its  aim  is 
to  ensure  that  agents  heightening  physiological  arousal  are  avoided  in  the  hours 
before  bedtime  and  during  sleep.  In  fact,  sleep  hygiene  most  often  involves  providing 
the  patient  with  a  list  of  behaviour  (e.  g.  ingesting  too  much  caffeine,  smoking, 
59 alcohol  consumption)  that  may  influence  sleep  quantity  and  quality.  Although  sleep 
hygiene  is  very  popular,  research  findings  evidenced  that  it  is  not  efficacious  as  a 
standalone  insomnia  treatment  (Morin,  Culbert  and  Schwartz,  1994). 
1.5.1.3  Relaxation 
A  number  of  relaxation  techniques  have  been  devised,  each  targeting  a  particular 
physiological  system.  The  rationale  being  that  a  person  with  physiological  arousal 
will  find  it  difficult  to  fall  asleep,  hence  if  relaxation  is  induced  sleep  will  follow.  For 
example  `progressive  muscle  relaxation'  aims  at  decreasing  muscle  tension  (Haynes, 
Woodward,  Moran  and  Alexander,  1974).  Diaphragmatic  breathing  aims  at  moving 
the  patient  from  thorax  to  abdomen  breathing  (i.  e.  deeper  and  slower).  Biofeedback 
assisted  relaxation  aims  at  inducing  muscle  relaxation  by  frontalis  EMG  biofeedback 
(see  Bootzin  and  Nicassio,  1978  for  a  review).  It  should  be  noted  that  the  efficacy  of 
relaxation  in  improving  sleep  does  not  lend  support,  per  se,  to  the  physiological 
framework.  Indeed  research  found  that  sleep  improvements  following  relaxation 
were  not  coupled  to  post  treatment  changes  on  physiological  measures  (e.  g.  heart 
rate,  respiration)  (Hauri,  1981;  Borkovec,  Grayson,  O'Brien,  Weerts,  1979). 
1.5.2  Treatments  related  to  the  behavioural  perspective 
1.5.2.1  Sleep  restriction 
As  discussed  previously,  poor  sleepers  tend  to  extend  the  sleep  window 
opportunity  (going  to  bed  earlier  and  staying  in  bed  longer,  especially  if  the  night 
before  was  a  bad  night)  in  an  effort  to  provide  more  opportunity  to  sleep:  this 
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and  colleagues  (1987),  drawing  on  the  idea  that  homeostatic  sleep  drive  and  accurate 
circadian  timing  regulate  sleep  and  that  the  individual's  coping  strategies  disrupt 
these  process,  devised  a  therapy  named  'sleep  restriction'. 
Sleep  restriction  aims  at  increasing  S.  E.  by  restricting  the  amount  of  time  spent  in 
bed  (so  as  to  approximate  it  to  the  actual  time  spent  asleep)  and  at  regularising  sleep 
patterns  by  going  to  bed  and  getting  up  at  the  same  time  each  day.  Once  S.  E.  is 
improved  (i.  e.  S.  E.  >_85%)  the  time  in  bed  is  extended  by  15  minutes  per  night  per 
week  until  the  patient's  S.  E.  starts  to  decline  again.  Morin  (2005)  proposed  that  sleep 
restriction  improves  sleep  continuity  due  to  a  mild  sleep  deprivation  and  a  reduction 
of  sleep  performance  anxiety.  Morin  et  al's  (1994)  meta-analysis  found  sleep 
restriction  to  improve  both  SOL  and  WASO. 
1.5.2.2  Stimulus  Control  Therapy  for  Insomnia 
By  applying  the  conditioning  conceptualisation  of  insomnia  already  discussed 
(section  1.4.2.1)  a  stimulus  control  therapy  for  insomnia  was  devised  (Bootzin,  1972; 
Bootzin  and  Nicassio,  1978).  Given  that  stimulus  control  is  the  most  efficacious 
single  therapy  for  insomnia,  and  the  present  research  focus  on  one  of  its  elements, 
the  stimulus  control  treatment  and  associated  efficacy  studies  are  discussed  in  details 
in  section  1.7.  In  brief  the  stimulus  control  package  aims  at  bringing  the  act  of 
falling  asleep  quickly  under  the  stimulus  control  of  the  bedroom  environment  by 
training  the  person  with  insomnia  to  re-associate  temporal  (bedtime)  and 
environmental  (bedroom)  cues  for  sleep  with  rapid  sleep  onset. 
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sleep  restriction  and  stimulus  control  are  most  often  used  together:  for  example, 
Espie  and  colleagues  call  this  combination  `sleep  scheduling'  (e.  g.  Espie,  Inglis, 
Tessier  and  Harvey,  2001)  in  their  CBT  intervention. 
1.5.3  Cognitive  Treatments  for  Insomnia 
As  discussed  in  previous  sections  there  is  ample  evidence  that  individuals  with 
insomnia  report  heightened  cognitive  arousal  at  bedtime.  The  basic  premise  of 
cognitive  therapy  is  that  appraisal  of  sleeplessness  can  trigger  negative  cognitions, 
emotions  and  beliefs  about  lack  of  sleep  and  its  consequences  that  are  incompatible 
with  sleep.  A  number  of  cognitive  treatments  for  insomnia  aiming  to  produce  sleep 
by  altering  faulty  beliefs  and  attitudes  about  sleep  have  been  devised.  For  example 
`paradoxical  intention'  aims  at  increasing  the  chance  of  falling  asleep  quickly  by 
obviating  the  performance  anxiety  that  develops  because  of  trying  to  control  sleep.  It 
directs  the  individual  to  try  at  any  cost  not  to  fall  asleep:  it  is  a  "let  it  be  attitude"  and 
it  is  the  only  cognitive  technique  that  does  not  directly  try  to  decrease  cognitive 
activity.  `Imagery',  in  contrast,  attempts  to  distract  the  individual  from  thinking 
about  sleep  related  topics.  `Suppression'  aims  at  blocking  out  the  thought  content 
itself.  Cognitive  restructuring  teaches  the  individual  to  rationally  re-appraise  their 
thought  contents  and  to  de-catastrophise  the  consequences  of  a  bad  night's  sleep. 
These  techniques  might  all  be  cognitive  but  they  focus  upon  different  solutions  to  the 
mental  problem  and  represent  variants  of  a  cognitive  model  of  insomnia. 
Interestingly,  given  the  amount  of  research  and  related  theoretical  debate  regarding 
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outcome  studies  are  not  based  solely  on  cognitive  therapy. 
1.5.4  Multifaceted  Cognitive  Behavioural  Therapy 
The  different  interventions  described  so  far  are  obviously  not  incompatible  with 
each  other.  Indeed  they  can  be  combined  and  in  recent  years  treatment  packages, 
each  including  several  single  therapies  for  insomnia,  have  become  the  standard 
practice  (Morin,  2005).  Cognitive  Behaviour  Therapy  (CBT)  for  insomnia  typically 
includes  stimulus  control,  sleep  restriction,  cognitive  restructuring  and  sleep  hygiene. 
The  CBT  package  might  also  include  other  single  therapies  such  as  relaxation, 
paradoxical  intention  and  imagery. 
In  sum,  a  number  of  psychological  therapies  for  insomnia  have  been  devised  and 
in  recent  years  insomnia  therapy  has  typically  been  delivered  in  a  multicomponent 
package  (CBT).  Having  briefly  outlined  the  principal  insomnia  therapies  it  is 
important  to  turn  attention  to  evidence  of  treatment  efficacy.  Meta-analytic  reviews 
pertaining  to  behavioural  and  psychological  therapies  for  insomnia  permit  evaluation 
of  treatments  across  studies  and  to  identify  therapies  standing  out  as  most 
efficacious. 
1.6  Treatment  Outcome  Evidence 
This  section  presents  a  summary  of  the  evidence  currently  available  in  support  of 
non-pharmacological  interventions  for  insomnia.  Findings  from  meta-analyses  are 
summarised  and  discussed  and  a  brief  overview  of  recent  clinical  trials  is  provided 
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meta-analytic  procedures  are  briefly  explained. 
1.6.1  Meta-Analytic  Procedures 
Meta-analytic  procedures  are  an  important  tool  as  they  permit  the  systematic 
evaluation  of  treatment  outcome  across  multiple  studies.  Statistics  such  as  t  tests  or  F 
tests  are  not  appropriate  for  such  comparisons  as  the  values  obtained  with  these  tests 
are  partially  a  function  of  the  sample  size.  In  other  words,  studies  with  equivalent 
differences  between  treatment  and  control  conditions  can  have  very  different  t  and  F 
values  depending  on  the  sample  sizes.  In  contrast,  estimates  of  effect  size  provide  a 
standard  metric  for  assessing  treatment  effectiveness  across  multiple  trials  because 
they  are  not  influenced  by  sample  sizes.  The  most  common  estimate  of  effect  size  is 
Cohen's  d  (Cohen,  1988).  Cohen's  d  is  a  measure  of  effect  that  may  be  thought  of  as 
determining  how  many  standard  deviations  separate  the  means  of  two  groups.  Cohen 
(1988)  hesitantly  defined  an  effect  size  of  0.20  as  a  small  effect,  0.50  as  a  medium 
effect  and  0.80  as  a  large  effect  and  acknowledged  the  danger  of  using  terms  such  as 
`small',  `medium'  and  `large'  out  of  context  ("there  is  a  certain  risk  in  offering 
conventional  operational  definitions  for  those  terms  for  use  in  power  analysis  in  as 
diverse  a  field  of  inquiry  as  behavioural  science",  p.  25). 
1.6.2  Meta-Analytic  Findings 
Outcomes  of  studies  evaluating  non-pharmacological  interventions  for  insomnia 
have  been  summarised  in  six  meta-analyses  (Irwin,  Cole  and  Nicassio,  2006;  Morin 
et  al,  1994;  Montgomery  and  Dennis,  2004;  Murtagh  and  Greenwood  1995;  Pallesen, 
64 Nordhus  and  Kvale,  1998;  Smith,  Perlis,  Park,  Smith,  Pennington,  et  at,  2002).  In 
figure  8  the  effect  sizes  reported  by  each  of  these  meta-analyses  are  reported. 
Fig:  8-  Effect  Sizes  for  Sleep  Parameters  Obtained  with 
Psychological  Interventions  as  reported  in  5  Meta-Analyses 
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In  1994,  Morin  et  al  reviewed  59  studies  (involving  more  than  2000  participants) 
on  the  psychological  treatment  of  insomnia  so  as  to  assess  the  size  of  changes 
occurring  with  CBT.  With  regard  to  SOL  the  effect  size  was  0.88  (i.  e.  on  average  the 
treated  person  was  0.88  standard  deviation  better  than  the  untreated  people)  and  the 
average  treated  individual  was  falling  asleep  faster  than  81(/(-  of  those  who  did  not 
receive  treatment.  With  regard  to  WASO  the  effect  size  was  0.65  and  the  treated 
person  had  WASO  shorter  than  74%  of  those  who  did  not  receive  treatment.  TST 
effect  size  was  found  to  be  0.42.  The  absolute  values  of  improvement  rate  were  27.7 
minutes  for  SOL  (43%  improvement),  32.7  minutes  for  WASO  (46%  improvement) 
and  28.5  minutes  for  TST  (8c/c  improvement).  Only  the  effects  for  SO  L  and  WASO 
were  statistically  significant.  The  modest  improvement  in  TST  might  be  due  to  the 
initial  impact  of  stimulus  control  and  sleep  restriction.  Finally  comparison  of  various 
treatment  modalities  showed  that  stimulus  control  and  sleep  restriction  (although 
65 the  authors  advised  to  be  caution  regarding  the  latter  therapy  as  only  a  few  studies 
were  available)  were  the  most  effective  single  therapies  for  both  SOL  (improvement 
of  32  minutes)  and  WASO  (improvement  of  40  minutes)  while  sleep  hygiene  was  not 
effective  as  standalone  therapy. 
Murtagh  and  Greenwood's  (1995)  meta-analysis  evaluated  66  studies  (involving 
about  1500  participants)  so  as  to  assess  the  size  of  changes  occurring  with  CBT  on 
three  variables:  SOL,  number  of  wakenings  after  sleep  onset  (NoA)  and  TST.  These 
authors  made  the  decision  to  include  unpublished  manuscripts  they  could  get  hold  of. 
They  reasoned  that,  typically,  only  studies  reporting  significance  are  published  and 
this  (unwritten)  publishing  policy  might  lead  to  effect  sizes  being  inflated.  However, 
they  found  effect  sizes  to  be  similar  to  those  found  by  Morin  et  al  (1994):  0.87  for 
SOL,  0.63  for  NoA  and  0.49  for  TST.  The  absolute  values  of  improvement  rate  were 
24  minutes  for  SOL  (39%  improvement),  -1.2  for  NoA  (73%  improvement)  and  32 
minutes  for  TST  (9%  improvement).  Stimulus  control  global  effect  size  was  higher 
than  that  of  any  other  therapy  and  SOL  improvement  was  32  minutes.  Similarly  to 
Morin  et  al's  (1994)  meta-analysis  findings,  stimulus  control  appeared  to  provide 
the  greatest  improvement  in  general. 
These  two  meta-analyses  also  examined  follow-up  data:  the  improvements 
obtained  were  maintained  and  for  certain  variables  (SOL  and  TST)  changes  from 
baseline  values  actually  increased. 
In  1998  Pallesen  et  al  evaluated  the  outcome  of  thirteen  studies  examining  the 
effects  of  CBT-I  in  the  older  population.  Significant  effects  were  found  for  SOL 
(effect  size  was  0.41),  NoA  (effect  size  0.25),  WASO  (effect  size  0.61)  and  TST 
66 (effect  size  0.15).  The  effect  sizes  were  higher  at  follow-ups.  It  was,  therefore, 
concluded  that  CBT-I  is  also  indicated  in  the  older  population. 
By  contrast,  Montgomery  and  Dennis'  (2004)  summary  of  outcomes  for  CBT-I  in 
the  older  population  provided  by  six  studies  yielded  positive  results  only  for  WASO 
and  TST.  They  found  that  CBT  had  a  modest  impact  on  WASO  (decrease  of  22 
minutes)  and  on  TST  (increase  of  14.6  minutes)  and  practically  no  effect  on  SOL. 
They  concluded  that  CBT-I  is  indicated  for  WASO  in  the  older  population. 
In  2006  Irwin  and  colleagues  carried  out  a  further  meta-analysis  evaluating  the 
impact  of  behavioural  interventions  for  insomnia  in  older  adults.  Evaluation  of  23 
randomised  controlled  trials  showed  significant  effects  on  sleep  quality  (effect  size  of 
0.76),  SOL  (effect  size  of  0.52)  and  WASO  (effect  size  of  0.64).  Behavioural 
therapies  (stimulus  control  and  sleep  restriction)  effect  sizes  were  found  to  be  in  the 
region  of  0.91  for  sleep  quality,  0.59  for  SOL  and  0.82  for  WASO. 
Finally,  Smith  and  colleagues  in  2002  published  a  comparative  meta-analysis  of 
pharmacotherapy  and  behavioural  therapies  for  chronic  insomnia.  With  regard  to  the 
impact  of  behavioural  therapies  on  sleep  the  following  effect  sizes  and  absolute 
changes  were  found.  The  effect  size  for  both  SOL  and  WASO  was  1.0,  for  TST  was 
0.46  and  for  sleep  quality  rating  was  1.44.  Behavioural  therapies  fared  better  than 
pharmacotherapy  for  all  values  but  TST.  However,  this  outcome  might  be  due  to 
sleep  restriction  curtailing  amount  of  sleep.  Absolute  values  of  improvement  rate 
were  23.3  minutes  (43%  improvement)  for  SOL,  38.4  minutes  (55.9%  improvement) 
for  WASO,  19.6  minutes  (5.9%  improvement)  for  TST  and  0.96  (28.4% 
improvement)  for  sleep  quality  ratings. 
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treatments  for  insomnia  produce  reliable  and  robust  changes  in  a  number  of  sleep 
continuity  parameters  and  that  these  improvement  hold  at  follow-ups.  It  is  important 
to  note  that  stimulus  control  was  found  to  produce  equivalent  (or  better)  outcomes 
than  multicomponent  CBT  and  other  single  therapies  for  insomnia. 
1.6.3  Clinical  studies 
Clinical  trials  have  evidenced  that  CBT  is  clinically  effective  for  persistent 
insomnia  presenting  in  general  practice  (Espie,  Inglis  and  Harvey,  2001;  Morgan, 
Thompson,  Dixon,  Tomeny  and  Mathers,  2003),  therapeutic  gains  are  maintained  at 
follow  up  and  CBT  can  provide  a  cost  effective  alternative  to  pharmacotherapy  in  the 
treatment  of  insomnia  (Morgan,  Dixon,  Mathers,  Thompson  and  Tomeny,  2004). 
Taking  into  account  these  findings  it  is  not  surprising  that  Espie  (1999)  argued  that 
cognitive-behavioural  treatment  therapies  might  be  the  treatment  of  choice  for 
chronic  primary  insomnia  rather  than  pharmacotherapy. 
It  is  noteworthy  that,  although  the  majority  of  people  treated  improve  their  sleep, 
only  a  small  percentage  of  them  (around  25  %)  return  within  the  normal  sleep 
parameters.  The  majority  still  experience  some  (albeit  less  severe)  sleep  problems 
(Espie,  Inglis,  Tessier  and  Harvey,  2001;  Morin,  Colecchi,  Stone,  Sood  and  Brink, 
1999). 
1.6.4  Is  CBT  the  Treatment  of  Choice? 
The  meta-analyses  and  clinical  studies  discussed  above  provide  convergent 
evidence  regarding  the  efficacy  and  effectiveness  of  CBT-I  in  reducing  sleep 
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of  the  AASM  (Chesson,  Ferber,  Fry,  Grigg-Damberger,  Hartse  et  al,  1999;  Morin, 
Hauri,  Espie,  Spielman,  Buysse  and  Bootzin,  1999)  reached  similar  conclusions, 
albeit  a  note  of  caution  was  stated  because  none  of  the  published  studies  was 
awarded  `A  level'.  `A  level'  methodology  requires  a  placebo  control  while  non- 
pharmacological  studies  of  insomnia  typically  have  a  waiting-list  control  group. 
Indeed,  only  a  few  studies  have  used  attention-placebo  conditions  (e.  g.  Lichstein, 
Riedel,  Wilson  et  at,  2001;  Backhaus,  Hohagen,  Voderholzer,  Riemann,  2001)  while 
majority  of  clinical  trials  have  used  waiting  list  control  groups.  Without  a  placebo 
control  it  is  difficult  to  attribute,  unequivocally,  treatment  effects  to  any  specific 
elements  of  the  therapy  itself  (e.  g.  relaxation,  re-conditioning)  rather  than  to  factors 
such  as  the  measurement  process  (e.  g.  self-monitoring)  or  factors  such  as  social 
desirability  (Crowne  and  Marlow,  1960),  therapist  attention  or  patient's  expectation. 
It  is  noteworthy  that  stimulus  control  was  the  only  therapy  being  warranted  a  full 
Grade  B  recommendation.  In  addition  it  should  be  noted  that  effect  sizes  for  SOL 
and  WASO  reported  for  stimulus  control  have  ranged  between  0.70  and  1.16  while 
for  CBT  from  0.92  to  1.05  (Morin  et  at,  1994;  Murtagh  et  al,  1995)  and  that  best 
outcomes  from  CBT  have  been  found  when  stimulus  control  (and  sleep  restriction) 
were  part  of  the  package. 
1.6.5  Considerations  Regarding  Treatment  Outcome  Findings 
To  conclude  this  section  the  following  main  points  are  to  be  considered. 
First,  although  CBT  has  become  in  recent  years  the  standard  non  pharmacological 
therapy  for  insomnia,  stimulus  control  has  yielded  strong  effects  as  evidenced  by  the 
69 meta-analytic  reviews  just  discussed.  Significantly,  the  Standards  of  Practice 
Committee  of  the  AASM  (1999)  recommended  stimulus  control  as  the  gold  standard 
treatment  for  insomnia. 
Second,  despite  ample  evidence  supporting  the  efficacy  of  psychological  and 
behavioural  treatments  for  insomnia,  there  is  still  scarce  information  regarding  the 
specificity  of  these  treatment  modalities  and  the  active  mechanisms  responsible  for 
sleep  improvements  (Morin,  Bastien  and  Savard,  2003).  Not  surprisingly,  given  that 
stimulus  control  for  insomnia  fared  better  than  other  single  therapies,  one  such 
investigation  found  that  the  most  critical  ingredients  associated  with  long-term  sleep 
improvements  were  stimulus  control  and  sleep  restriction  (Harvey,  Inglis  and  Espie, 
2002). 
It  seems,  therefore,  timely  to  investigate  what  the  critical  components  of  CBT  are 
and,  furthermore,  what  elements  of  each  single  therapy  are  essential.  One  way  to 
carry  out  such  investigation  is  by  a  dismantling  strategy  to  isolate  individual 
components  (Currie,  Wilson,  Pontefract  and  deLaplante,  2000). 
An  important  pitfall  in  insomnia  research  is  the  dose-response  curve.  While  it  has 
been  amply  investigated  in  pharmacological  research  this  has  not  been  the  case  with 
regard  to  psychological  treatment.  That  is,  behavioural  therapists  have  generally 
failed  to  explore  what  "dose"  of  CBT  is  needed  to  achieve  minimally  acceptable 
sleep  improvement  (Edinger  and  Means,  2005).  Lichstein  and  Riedel  (1994),  after 
performing  a  review  of  treatments  of  insomnia,  pointed  out  that  there  appears  to  be 
wide  potential  for  brief  interventions  and  limited  therapist  participation.  For 
example,  Edinger  and  Sampson  (2003)  have  found  that  2  sessions  of  CBT  produced 
significant  improvements  in  insomnia  symptoms.  More  recently,  Edinger  and 
70 colleagues  have  explored  the  dose-response  effects  of  behaviour  therapy  for 
insomnia.  They  assessed  the  optimal  dose  of  CBT  for  treating  WASO  by 
administering  it  in  1,2,4  and  8  bi-weekly  sessions  and  found  that  the  1  and  4  session 
protocols  had  greater  efficacy  than  the  other  two  conditions.  Specifically  a  50% 
reduction  WASO  in  58%  of  participants  was  achieved  by  the  4  session  condition,  in 
44%  of  participants  by  the  1  session  condition  and  only  23%  in  the  8  session 
condition  (Edinger,  Wohlgemuth,  Radtke  and  Marsh,  2004).  This  is  a  much  needed 
and  welcomed  line  of  research:  it  helps  in  establishing  the  optimum  dose  of  therapy 
required  to  achieve  a  given  level  of  improvement  and  providing  intervention 
guidelines  accordingly. 
Whilst  significant  progress  has  been  made,  the  field  is  not,  as  yet,  at  a  point  where 
the  patients  can  be  offered  a  maximally  effective  psychological  treatment.  This  is 
indicated  by  the  significant  percentage  (20-30%)  of  patients  who  do  not  improve 
following  CBT  and  by  the  average  overall  improvement  (see  the  six  meta-analyses 
just  reviewed)  among  those  who  do  respond  being  only  around  40  to  60%.  Although 
this  degree  of  change  is  statistically  significant,  it  is  not  enough  to  convincingly 
move  the  average  patient  into  a  state  where  they  could  be  classified  as,  and  they 
would  call  themselves,  normal  sleepers. 
Given  these  premises  it  seems  very  important  to  examine  systematically  from  first 
principles  (almost  at  a  microscopic  level)  the  single  components  of  individual 
therapies  that  are  delivered  as  part  of  the  multicomponent  package  CBT-I.  This  has 
theoretical  and  more  pragmatic  values.  Testing  one  element  at  a  time  helps  to  shed 
light  on  the  theoretical  underpinning  of  the  therapy  (why  it  works).  Likewise 
examining  single  elements  of  insomnia  packages  would  enable  the  extraction  of  the 
71 essential  and  most  therapeutic  ingredients  and  ultimately  enable  the  provision  of 
optimum  service  while  containing  health  costs. 
Stimulus  control  appears  to  be  a  good  candidate  for  a  detailed  examination  of 
single  elements.  Not  only  has  it  been  favoured  by  outcome  findings  and  been 
recommended  as  the  gold  standard  therapy  for  insomnia;  it  is  also  easy  to  administer 
and  positive  outcomes  are  typically  obtained  in  a  few  weeks. 
1.7  Stimulus  Control:  a  Detailed  Description  and  Critical  Appraisal 
This  section  is  in  three  parts.  First,  the  six  elements  comprising  stimulus  control 
are  analysed  so  as  to  assess  what  the  theoretical  bases  underpinning  these  elements 
are.  Second,  previous  research  on  stimulus  control  therapy  for  insomnia  is  outlined 
and  evaluated.  Third,  by  taking  into  consideration  both  theory  and  research  evidence, 
the  element  of  stimulus  control  therapy  deemed  to  epitomise  stimulus  control  is 
identified. 
1.7.1  Stimulus  Control  Therapy:  its  Elements 
As  already  discussed  stimulus  control  therapy  is  based  on  learning  theory,  in 
particular  operant  conditioning  and  stimulus  control  (section  1.4.2.1).  Briefly, 
stimulus  control  theory  holds  that  in  chronic  insomnia,  sleep  incompatible  behaviour 
diminishes  or  extinguishes  the  discriminative  properties  for  sleep  of  the  bedroom 
environment. 
The  aim  of  therapy,  therefore,  is  for  the  patient  to  be  in  their  bed  only  when  asleep 
so  that  the  bedroom  environment  acquires  discriminative  properties  eliciting  the 
physiological  response  and  attitude  consistent  with  a  discriminative  stimulus.  In 
72 other  words,  the  bedroom  environment  (discriminative  stimulus)  would  signal  the 
imminence  of  sleep  (reinforcer)  and  the  person  should  follow  asleep  quickly 
(operant).  Subsequent  sleep  experiences  will  reinforce  this  process. 
It  is  important  to  note  that  stimulus  control  therapy  for  insomnia  comprises  both 
elements  of  strict  stimulus  control  and  elements  of  temporal  harmonisation  of  the 
sleep-wake  schedule.  In  particular,  by  inspecting  table  5,  it  becomes  apparent  that 
instructions  2,3,  and  4  are  situational  in  that  they  aim  at  ensuring  that  the  bed  is  used 
only  for  sleep  and  that  the  patient  does  not  spend  time  in  bed  awake.  The  other 
instructions  (1,5  and  6)  are  temporal  in  nature:  they  ensure  a  stable  sleep-wake 
rhythm. 
Table  5-  Components  of  the  Stimulus  Control  Therapy  for  Insomnia 
1.  Lie  down  intending  to  sleep  ONLY  when  you  are  sleepy. 
2.  Do  not  use  your  bed  for  anything  except  sleep:  that  is  do  not  read,  watch  TV,  eat  or 
worry  in  bed.  Sexual  activity  is  the  only  exception  to  this  rule.  On  such  occasion  the 
instructions  are  to  be  followed  afterward,  when  you  intend  to  sleep. 
3.  If  you  find  yourself  unable  to  fall  asleep,  get  up  and  go  to  another  room.  Stay  up  as  long 
as  you  wish  and  then  return  to  the  bedroom  to  sleep.  Although  we  do  not  want  you  to 
watch  the  clock,  we  want  you  to  get  out  of  bed  if  you  do  not  fall  asleep  immediately. 
Remember  that  the  goal  is  to  associate  your  bed  with  falling  asleep  quickly.  If  you  are 
in  bed  more  than  about  10-15  minutes  without  falling  asleep  and  have  not  gotten  up, 
you  are  not  following  this  instruction, 
4.  If  you  still  cannot  fall  asleep,  repeat  step  3.  Do  this  as  often  as  it  is  necessary  throughout 
the  night. 
5.  Set  your  alarm  and  get  up  at  the  same  time  every  morning  irrespective  of  how  much 
sleep  you  got  during  the  night.  This  will  help  your  body  acquire  a  consistent  sleep 
rhythm. 
6.  Do  not  nap  during  the  day. 
73 It  could  be  argued  that  while  situational  elements  sit  well  within  a  stimulus 
control  framework,  temporal  elements  do  not.  This  suggests  that  the  mechanism  of 
effects  of  at  least  half  of  the  stimulus  control  package  for  insomnia  is  likely  to  be  due 
to  factors  other  than  those  of  operant  learning  theory.  This  reasoning  restricts  the 
choice  of  the  best  candidate  to  synthesise  stimulus  control  to  only  two  elements: 
`using  the  bed  only  for  sleeping'  (instruction  2)  and  `getting  out  of  bed  if  not  asleep 
quickly'  (instruction  3  and  4).  Both  instructions  aim  at  the  same  target:  `be  in  bed 
only  when  asleep'.  In  this  way  the  association  between  bedroom  and  sleep  is  created 
and  strengthened  while  associations  between  bedroom  and  wakefulness  avoided. 
However,  it  is  felt  that  instruction  2  does  not  explicitly  tell  the  patient  what  to  do  if, 
once  intending  to  sleep,  sleep  does  not  come.  Instruction  3,  by  contrast,  prescribes 
what  to  do  (i.  e.  go  to  another  room)  if  not  asleep:  in  so  doing  it  automatically 
prevents  sleep-incompatible  activities  being  performed  in  bed  and  ensures  that  the 
bed  is  used  only  for  sleeping.  The  instruction  "If  you  find  yourself  unable  to  fall 
asleep,  get  up  and  go  to  another  room"  can  be  proposed,  therefore,  as  the  element  of 
stimulus  control  that  better  encapsulates  the  stimulus  control  essence. 
It  should  be  noted  that  instruction  3  requires  the  person  to  get  out  of  bed  if  not 
asleep  within  10-15  minutes.  However,  as  pointed  out  by  Espie  (1991)  this  10-15 
minutes  limit  is  arbitrary.  Indeed,  in  his  first  application  of  stimulus  control  to 
insomnia  Bootzin  (1972)  left  this  rule  vague:  `if  unable  to  sleep  get  up'  so  as  to  avoid 
the  patient  initiating  a  habit  of  clock  watching.  Espie  and  colleagues  (Espie  et  al, 
1989)  used  a  20  minutes  period  for  initial  sleep  latency  because  in  their  clinical 
experience  only  few  successfully  treated  people  achieved  post-treatment  sleep  onset 
latency  of  ten  minutes.  They  argued  that  ten  minutes  might  be  too  strict  a  threshold 
74 when  compared  to  the  sleep  pattern  of  normal  sleepers  for  whom  taking  ten  minutes 
to  fall  asleep  might  not  be  considered  problematic. 
As  shown  in  figure  9,  the  amount  of  time  lying  awake  in  bed  prior  to  "getting  up 
and  going  to  another  room"  varies  from  study  to  study  (a  few  minutes  to  25  minutes 
range). 
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Figure:  9-  Time  frame  for  the  Stimulus  Control  instruction 
'get  up  and  go  to  another  room' 
A  few  10  15-20  20  20-25  20-30 
Minutes 
A  few  minutes/reasonable  time:  Bootzin,  1972;  Toler,  1978:  Norton  et  al,  1979:  Haynes  et  al,  1975 
10  minutes:  Bootzin  et  al,  1991:  Bootzin  et  al,  2000:  Lacks,  et  al,  1983a:  Lacks  et  al.  19836: 
Puder  et  al,  1983;  Turner  et  al,  1979ä.  b:  Zwart  et  al,  1979: 
15-20  minutes:  Bootzin  et  al,  2000:  Morin  et  al,  1988:  Morin  et  al.  1990:  Morin  et  al. 
1994:  Morin,  Colecchi  et  al,  1999:  Morin,  Hauri  et  al,  1999. 
20  minutes:  Morin  et  al,  1995:  Sanavio  et  al,  1990:  Espie  et  al,  1989;  Espie  et  al,  1999 
20-25  minutes:  Jacob  et  al,  1993 
20-30  minutes:  Hoelscher  et  al,  1988 
Ultimately  the  aim  of  therapy  is  to  move  the  patient  to  normalcy:  it  is,  therefore, 
important  to  explore  the  length  of  normal  sleepers'  SOL  so  as  to  determine  the 
optimum  timeframe  for  this  stimulus  control  instruction.  The  average  PSG  measured 
SOL  for  normal  young  adults  is  around  10  minutes  (see  table  1  p.  4),  but  it  seems 
important  to  examine  SOL  also  in  terms  of  sensitivity  and  specificity  so  as  to 
establish  what  duration  best  represents  SOL  in  normal  sleep.  This  issue  is  addressed 
in  the  first  study  of  the  present  research  (chapter  3). 
75 1.7.2  Stimulus  Control  Therapy:  Outcome  Studies 
Bootzin  (1972)  first  used  stimulus  control  in  a  single  case  study  and  within  three 
weeks  of  stimulus  control  treatment  the  number  of  times  the  patient  had  to  get  out  of 
his  bed  at  sleep  onset  were  dramatically  reduced.  Importantly,  as  depicted  in  figure 
10,  improvement  was  maintained  at  six  weeks  follow  up  and  confirmed  by  the 
individual's  wife.  The  improvement  was  very  encouraging  and  warranted  more 
systematic  and  controlled  research. 
Fig.  10  -  Frequency  of  nightly  rising  during  treatment  and 
follow-up  (Bootzin,  1972) 
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Bootzin  (1975)  (as  reported  in  Bootzin  and  Nicassio's  review,  1978)  allocated  a 
sample  of  66  participants,  with  severe  and  persistent  insomnia,  to:  stimulus  control, 
relaxation,  self-relaxation  placebo  or  waiting  list  control  groups.  Participants  self- 
reported  severe  insomnia  although  the  length  of  insomnia  was  not  stated.  Stimulus 
control  reduced  SOL  by  67  minutes,  while  relaxation  reduced  it  by  30  minutes.  In 
addition  57%  of  those  receiving  stimulus  control  averaged  less  than  25  minutes  to 
fall  asleep  as  compared  to  29%  of  those  in  the  relaxation  group  and  22%  of  those  in 
the  two  untreated  groups. 
76 Following  these  first  two  insomnia  treatment  studies  employing  stimulus  control 
many  investigations  have  shown  that  stimulus  control  is  effective  in  reducing  SOL 
and  WASO  and  increasing  TST. 
For  example,  Haynes  et  al's  (1975)  found  stimulus  control  therapy  to  be 
associated  with  shorter  SOL  (average  reduction  of  40  minutes)  in  all  four  single 
cases  by  the  end  of  treatment.  There  were  also  improvements  for  all  four  participants 
in  terms  of  TST  and  feeling  rested  after  sleep,  and  three  of  them  reported  fewer 
wakenings.  In  addition,  in  three  out  of  four  cases,  improvements  were  maintained  at 
a  nine-month  follow  up  (telephone  contact).  In  view  of  previous  findings  that  poor 
and  normal  sleepers  engage  in  similar  sleep-incompatible  behaviours  in  the  pre-bed 
period  (Haynes,  Follingstad  and  McGowan,  1974),  they  proposed  that  stimulus 
control  increases  sleep  continuity  by  conditioning  low  levels  of  physiological  arousal 
to  bedroom  stimuli.  Reading,  talking  working  in  bed  may  increase  arousal  and  thus 
make  sleep  more  difficult.  It  is  important  to  note  that  their  design  ABAB  (baseline, 
stimulus  control,  back  to  baseline,  stimulus  control)  did  not  show  a  reversal  effect 
after  the  first  treatment  phase;  it  could,  however,  be  argued  that  rather  than  a  return 
to  baseline  it  represented  a  maintenance  phase.  Therefore  the  re-introduction  of 
stimulus  control  treatment  in  the  following  phase  was  of  little  experimental  value 
(Espie,  1991). 
Lawrence  and  Tokarz  (1976,  as  reported  in  Bootzin  and  Nicassio,  1978)  recruited 
a  student  population  with  moderate  SOL  and  assigned  them  to  individual  stimulus 
control,  small  group  stimulus  control,  progressive  relaxation  training  or 
desensitisation  placebo.  Both  stimulus  control  groups  reduced  mean  SOL  to  less  than 
20  minutes  and  improvement  was  considerably  better  than  relaxation  (75%  vs  30% 
77 improvement  SOL  improvement  at  post-treatment).  Unfortunately  no  follow-up  data 
is  available. 
Hughes  and  Hughes  (1978)  assigned  36  media  recruited  people  with  insomnia  for 
at  least  4  months  to  one  of  four  groups:  stimulus  control,  relaxation,  EMG  feedback 
or  pseudo-feedback.  Two  weeks  baseline  and  two  weeks  post-treatment  sleep  diary 
were  collected.  A  drawback  of  this  study  is  that  treatment  length  varied  considerably 
from  eight  weeks  for  EMG  feedback,  to  four  weeks  for  relaxation  and  to  only  two 
weeks  for  stimulus  control.  All  groups  improved  and  no  differences  were  found  in 
efficacy  among  treatments.  Interestingly  stimulus  control  produced  SOL 
improvements  very  rapidly  (two  weeks).  Similarly  to  other  researchers  they  proposed 
that  the  equivalence  in  treatment  outcome  might  be  due  to  a  cognitively  mediated 
process  common  to  all  treatments.  Follow-up  data  suggested  that  results  were 
maintained  but,  unfortunately,  given  that  data  was  available  for  only  33%  of 
participants  (12  out  of  36),  it  was  impossible  to  differentiate  between  treatments. 
Turner  and  Asher's  (1979b)  treatment  study  employed  a  multiple  baseline  design 
with  six  severe  insomniacs.  After  one-week  baseline,  three  participants  received 
eight  weeks  of  stimulus  control  and  the  other  three  participants  four  weeks  of  quasi- 
desensitisation  placebo  treatment  followed  by  four  weeks  of  stimulus  control.  The 
placebo  treatment  had  little  impact  on  SOL,  while  stimulus  control  reduced  SOL  in 
both  when  treatment  lasted  eight  and  four  weeks.  Interestingly  the  authors  reported 
that  five  out  of  the  six  participants  achieved  SOL  shorter  than  thirty  minutes  within 
four  weeks  of  stimulus  control  therapy.  The  sleep  diary  data  were  corroborated  by 
reports  of  spouses  or  roommates.  Turner  and  Asher  also  collected  participants' 
suggestions  regarding  stimulus  control  efficacy.  All  six  individuals  suggested  that 
78 stimulus  control  worked  by  "breaking  up  lying  in  bed  and  thinking";  in  other  words 
it  provided  a  way  of  controlling  bedtime  cognitions  by  simply  getting  out  of  bed. 
These  comments  suggest  that  stimulus  control  decreases  anxiety  regarding 
sleeplessness. 
Turner  and  Ascher  (1979a)  devised  a  well  controlled  comparative  study  and 
showed  that  stimulus  control,  similarly  to  progressive  muscle  relaxation  and 
paradoxical  intention,  improved  the  sleep  of  severe  insomniacs  while  control 
conditions  (desensitisation  placebo  and  waiting-list)  did  not.  Each  group  comprised 
ten  media  recruited  participants  who  received  four  weekly  therapy  sessions  following 
a  baseline  week.  All  three  active  groups  reduced  SOL  (from  more  than  an  hour  to 
less  than  thirty  minutes)  and  number  of  awakenings  after  four  weeks  of  therapy. 
Stimulus  control  was  not  found  to  be  superior  to  relaxation  or  paradoxical  intention 
but  it  produced  the  greatest  absolute  SOL  reduction.  Three  shortcomings  to  this  study 
should  be  noted.  First  there  was  no  follow-up  and  it  could  be  that  gains  might  have 
been  kept  differentially  across  treatments.  Second,  there  was  no  indication  of  what 
point  in  treatment  therapeutic  effects  started  to  emerge.  Third  uncontrolled  use  of 
sleep  medication  was  allowed:  both  increment  and  reduction  of  sleep  medication 
might  have  contributed  to  the  post-treatment  results. 
Lacks,  Bertelson,  Gans  and  Kunkel  (1983a)  replicated  Turner  and  Asher's 
(1979a)  study  and  they  also  investigated  the  interaction  between  insomnia  severity 
and  treatment.  Sixty-four  media  and  GPs  recruited  participants  divided,  upon 
completion  of  one  week  sleep  diary,  into  three  groups:  mild  (SOL  15-44  minutes), 
moderate  (SOL  45-75  minutes)  and  severe  (SOL  76-152  minutes)  insomnia  and 
randomly  allocated  within  groups  to  each  of  the  treatments.  Participants  received 
79 therapy  for  four  weekly  sessions  in  small  groups.  Differently  from  Turner  and 
Ascher's  (1979a)  study,  SOL  measures  showed  that  stimulus  control  outcomes  were 
considerably  superior  not  only  to  no-treatment  and  placebo,  but  also  to  paradoxical 
intention  and  relaxation  at  each  assessment  point  after  week  one.  They  also  found  a 
modest  positive  correlation  between  insomnia  severity  and  degree  of  improvement 
and  they  concluded  that  stimulus  control  is  the  most  effective  treatment  choice 
regardless  of  insomnia  severity. 
Lacks,  Bertelson,  Sugerman  and  Kunkel  (1983b)  compared  the  effect  of  stimulus 
control  with  quasi  desensitisation  placebo  on  WASO.  Fifteen  participants,  all 
presenting  with  sleep  maintenance  insomnia  (average  75  minutes),  were  recruited  via 
media  advertisements  and  letters  to  GPs.  After  one  week  baseline  they  were  given 
treatment  in  small  groups  during  (four  weekly  sessions  of  60-90  minutes).  WASO 
was  reduced  from  60  to  25  minutes  in  the  stimulus  control  group  and  from  88  to  51 
minutes  in  the  placebo  group  (note  that  both  groups  reduced  WASO  by  thirty-five 
minutes).  The  two  treatments  did  not  differ  from  one  another  and  both  treatments 
maintained  these  gains  at  three  months  follow-up.  Two  important  points  can  be  made 
from  this  study:  first  that  stimulus  control  is  efficacious  in  reducing  WASO  as  well 
as  SOL  and  number  of  awakenings.  Second  the  quasi-desensitisation  placebo 
treatment  may  actually  have  an  active  component:  specifically  the  mental  rehearsal 
of  pre-bedtime  routine  and  imagery  is  likely  to  preclude  intrusive  cognitions  and  in 
this  way  facilitating  returning  to  sleep. 
The  studies  reviewed  so  far  assessed  stimulus  control  efficacy  in  students  and 
adults.  Anderson  and  colleagues  tested  stimulus  control  efficacy  in  improving  sleep 
80 in  older  adults.  Stimulus  control  improved  WASO  and  S.  E.  but  not  SOL  in  their 
group  of  older  adults  (Anderson,  Zendell,  Rosa,  Rubinstein,  Herrera  et  al,  1988). 
Sanavio  et  al  (1990)  allocated  40  insomniacs  to  one  of  four  experimental 
(cognitive,  biofeedback,  stimulus  control  coupled  to  relaxation  and  no  treatment) 
groups.  Each  group  received  six  intervention  sessions.  The  three  active  groups  all 
reduced  both  SOL  and  WASO  as  compared  to  no  improvements  in  the  control  group. 
However,  only  cognitive  therapy  resulted  in  an  increase  in  TST.  These  authors 
provided  three  years  follow  up  data  (23  participants  out  of  30  provided  data)  showing 
that  further  reductions  in  both  SOL  and  WASO  were  achieved  for  all  three  active 
treatments.  In  particular  WASO  was  reduced  from  roughly  an  hour  at  baseline  to 
about  15  minutes  three  years  after  the  six  weeks  treatment. 
Puder,  Lacks,  Bertelson  and  Storandt  (1983)  found  that  stimulus  control  was 
efficacious  in  improving  SOL  in  older  adults  when  a  clinical  psychologist 
administered  therapy  in  small  groups  in  four  weekly  sessions.  A  cohort  of  sixteen 
older  adults  was  assigned  to  either  immediate  or  delayed  (following  ten  weeks 
baseline)  stimulus  control.  Both  groups,  once  stimulus  control  was  administered, 
reduced  their  sleep  latency  by  around  fifty  per  cent  and  such  reduction  was 
maintained  at  two  months  follow-up. 
Stimulus  control  efficacy  in  reducing  sleep  difficulties  in  `older'  people  (average 
age  57)  was  also  investigated  by  Morin  and  Azrin  (1987).  Twenty-seven  media 
recruited  people  meeting  criteria  for  insomnia  were  randomly  allocated  to  stimulus 
control,  imagery  training  and  no  treatment  control.  Following  one-week  baseline 
participants  attended  four  weekly  one-hour  therapy  sessions  conducted  in  small 
groups.  The  stimulus  control  group  achieved  a  statistically  significant  reduction  of 
81 WASO  (by  65%)  as  compared  to  the  other  two  groups.  At  12-months  follow  up, 
however,  stimulus  control  and  imagery  displayed  almost  identical  WASO  (around  25 
minutes).  They  argued  that  psychological  therapy  for  insomnia  is  indicated  to 
decrease  WASO  in  older  adults  too. 
Morin  and  Azrin  (1988)  conducted  another  study,  similar  to  that  of  the  previous 
year  with  regard  to  number  of  participant  and  treatments,  collecting  data  both  via 
sleep  diary  and  a  switch-activated  clock  to  record,  objectively,  WASO  and  SOL. 
Both  active  treatments,  but  not  the  waiting-list  control  group,  reduced  WASO  and 
stimulus  control  produced  an  increase  in  TST  of  65  minutes  on  average.  Therapeutic 
gains  were  maintained  at  12  months  follow-up.  SOL  data  were  also  reported  and 
showed  improvement  both  at  the  end  of  treatment  and  at  follow-up  for  stimulus 
control  (56,40  and  23  minutes  respectively),  at  a  lesser  extent  for  imagery  training 
(38,26,25)  but,  interestingly,  also  for  the  waiting  list  control  (52,31). 
Espie,  Lindsay  et  al  (1989)  recruited  eighty-four  GPs  referred  outpatient  adults, 
seventy  participants  were  allocated  to  either  stimulus  control,  relaxation,  paradoxical 
intention,  desensitisation  placebo  or  no  treatment.  The  remaining  fourteen  were 
allocated  to  a  tailored  intervention.  Sleep  diaries,  incorporating  both  measures  of 
sleep  quantity  and  quality,  were  completed  for,  two  weeks  baseline  and  eight  weeks 
intervention.  It  is  noteworthy  that  the  stimulus  control  group  almost  halved  SOL 
during  the  first  week  of  treatment  and  by  the  eighth  week  SOL  was  31  minutes  (pre 
to  post  change  of  62%).  In  line  with  Lacks  et  al's  (1983a)  findings  stimulus  control 
produced  significant  improvements  in  short  time.  By  the  end  of  the  eighth  week 
paradoxical  intention  reduced  SOL  to  36  minutes  (51%  pre  to  post  change).  In 
contrast,  relaxation  effects  were  similar  to  placebo.  With  regard  to  sleep  quality, 
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wakening  in  the  morning  and  sleep  enjoyment,  stimulus  control  produced  no 
measurable  impact  upon  these  variables.  To  summarize,  stimulus  control  produced 
quick  and  effective  improvements  in  SOL,  and  the  treatment  achieved  clinical 
significance:  indeed  every  patient  improved,  two-thirds  reduced  SOL  by  greater  than 
half  and  a  higher  percentage  of  participants  had  sleep  onset  latencies  of  30  minutes 
or  less  at  follow-up.  As  pointed  out  by  the  authors  the  instruction  to  go  to  bed  only 
when  sleepy/tired  might  have  guaranteed,  per  se,  shorter  SOL. 
It  is  noteworthy  that  the  efficacy  of  stimulus  control  in  improving  sleep  has  been 
typically  tested  by  employing  only  subjective  measures  (sleep  diary).  To  the  author's 
knowledge  only  two  studies  looked  at  subjective  and  objective  sleep  improvements 
following  stimulus  control.  In  Anderson  et  al's  (1988)  study  stimulus  control 
improved  subjective  estimates  of  WASO  and  S.  E  but  S.  E.  was  the  only  PSG  sleep 
parameter  improved.  Similarly,  Engle-Friedman  et  al  (1992)  found  that  stimulus 
control  improved  subjectively  measured  sleep  parameters  and  was  the  most  effective 
condition  in  improving  sleep  when  compared  to  relaxation  and  control.  However 
such  subjective  changes  were  not  corroborated  by  polysomnographic  data.  It  should 
be  noted  that  lack  of  PSG  changes  following  CBT-I  treatments  are  not  uncommon 
(Krystal,  Edinger,  Wohlgemuth,  and  Michaels,  2002). 
The  studies  reviewed  so  far  highlight  that  stimulus  control  is  efficacious  in 
reducing  estimates  of  SOL,  WASO  and  NoA  per  night  and,  in  general,  it  has  yielded 
greater  therapeutic  effects  when  compared  to  other  treatments.  Furthermore 
therapeutic  effects  have  generally  been  achieved  very  rapidly  (Espie,  Lindsay  et  al, 
1989;  Hughes  and  Hughes,  1978).  In  addition  it  has  been  found  to  be  efficacious 
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ups. 
The  mechanisms  of  effects  of  stimulus  control  are,  however,  less  clear  and 
participants'  comments  on  the  possible  ways  in  which  this  therapy  works  are 
suggestive  of  `breaking  a  pattern  of  lying  in  bed  thinking',  'being  able  of  stop 
thinking  by  getting  out  of  bed'.  In  addition  the  findings  of  four  studies  cast  doubts  on 
the  stimulus  paradigm  by  either  using  only  some  instructions  or  by  using  a  paradigm 
that  seems  to  run  counter  to  the  whole  conditioning  aspect. 
Tokarz  and  Lawrence  (1974)  (as  reviewed  in  Bootzin  and  Nicassio,  1978) 
separated  temporal  components  aimed  at  regularising  the  sleeping  pattern  according 
to  the  constraints  of  time  (sleep  scheduling)  and  stimulus  components  aimed  at 
making  the  bedroom  environment  function  as  a  discriminative  stimulus  for  falling 
asleep  (e.  g.  not  watching  TV  in  bed)  of  stimulus  control.  Results  showed  these  two 
factors  to  yield  equivalent  efficacy  in  reducing  SOL  (from  50  minutes  at  baseline  to 
around  10  at  post-treatment)  in  their  student  sample  when  therapy  was  delivered  in 
small  groups  once  a  week  over  four  weeks.  This  is  an  important  finding  as  it  suggests 
that  only  half  of  the  stimulus  control  instructions  (either  temporal  or  situational 
instructions)  are  sufficient  to  produce  remarkable  improvements.  It  is,  therefore, 
surprising,  that  only  a  couple  of  studies  have  been  carried  out  to  replicate  and  explain 
these  findings  especially  given  that  stimulus  control  is  the  core  of  CBT,  the  most 
delivered  insomnia  therapy  in  the  last  25  years. 
Another  important  study  with  regard  to  the  mechanisms  of  effect  of  stimulus 
control  was  carried  out  by  Zwart  and  Lisman  in  1979.  They  assigned  47 
undergraduate  students,  all  reporting  SOL  greater  than  30  minutes,  to  five  different 
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instructions,  `non-contingent  control'  (that  is  getting  out  of  bed  a  fixed  number  of 
times  at  fixed  intervals),  `countercontrol'  (that  is  sit  up  in  bed  and  do  something  if 
unable  to  sleep  within  10  minutes)  and  `waiting  list'.  Each  group,  other  than  the 
waiting  list  one,  met  4  times  on  a  weekly  basis  for  30  minutes.  Figure  11  shows  SOL 
at  baseline  and  at  the  end  of  treatment  (4  weeks)  for  the  five  conditions:  interestingly 
the  whole  stimulus  control  package,  temporal  control  instructions  and  countercontrol 
instructions  form  three  parallel  lines  suggesting  equivalence  of  improvement 
(confirmed  by  statistical  analyses). 
Fig.  11  -Mean  SOL  for  Groups  at  Baseline  and  End  of  Treatment 
(Zwart  and  Lis  man,  1979) 
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In  line  with  Tokarz  and  Laurence's  (1974)  findings,  `temporal  control' 
instructions  were  effective  and  sufficient  to  decrease  insomnia  symptoms.  This 
finding  made  the  authors  suggest  that  stimulus  control  may  function  both  for 
reconditioning  of  responses  to  the  environment  but  also  via  improved  harmonisation 
of  the  circadian  cycle.  Of  particular  importance  was  the  finding  that  `counter  control 
instructions'  were  as  effective  as  the  stimulus  control  package.  This  finding  shed 
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counter  control  ensured  disruption  of  bedtime  as  cues  for  mental  arousal.  In  other 
words  `doing  something'  acts  as  a  distractor:  the  person  who  cannot  sleep  is 
occupied  and  does  not  focus  on  lying  there  not  sleeping. 
Alperson  and  Biglan  (1979)  investigated  the  efficacy  of  self-administered  (in  the 
form  of  manual  with  minimal  therapist  contact)  treatment  of  insomnia.  After  two 
weeks  baseline,  twenty  two  media-recruited  insomniacs  aged  less  than  fifty-five 
years  old,  were  assigned  to  one  of  three  groups:  relaxation  and  stimulus  control, 
relaxation  and  `counter-control'  or  self-monitored.  A  further  group,  comprising 
seven  insomniacs  aged  over  fifty-five  received  relaxation  plus  stimulus  control.  It 
was  found  that  both  the  stimulus  control  and  the  counter-control  groups  decreased 
sleep  latency  significantly  better  than  the  self-monitor  group,  and,  similarly  to  Zwart 
and  Lisman's  (1979)  findings  there  were  no  differences  between  the  stimulus  control 
and  the  counter  control  groups.  However  it  is  not  possible  to  rule  out  the  possibility 
that  the  procedure  most  impacting  on  SOL  reduction  was  relaxation  (which  was 
taught  in  both  conditions).  It  is  worth  noticing  that  the  older  group  responded 
significantly  less  well  than  the  younger  one.  This  latter  finding  could  be  due  to 
stimulus  control  being  less  efficacious  with  older  adults.  However,  given  that  other 
studies  have  shown  stimulus  control  to  improve  sleep  in  this  population  (e.  g.  Morin 
and  Azrin,  1987,1988;  Puder  et  al,  1983),  this  explanation  seems  unlikely.  Different 
outcomes  between  the  studies  could  be  due  to  delivery  modality:  self-administered 
therapy  might  work  less  well  than  therapist  led  administration  with  older 
participants.  It  could  also  be  that  older  participants  found  it  difficult  getting  out  of 
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stimulus  control. 
Indeed,  when  counter-stimulus  control  was  administered  to  older  adults,  a 
statistically  significant  reduction  in  WASO  was  obtained  (Davies,  Lacks,  Storandt 
and  Bertelson,  1986). 
In  sum  these  four  studies,  in  line  with  the  stimulus  control  studies  discussed 
previously,  evidenced  the  efficacy  of  stimulus  control.  In  addition,  and  very 
importantly,  Tokarz  and  Lawrence's  (1974)  and  Zwart  and  Lisman's  (1979)  studies 
also  highlighted  that  stimulus  control  may  function  via  at  least  two  separate 
mechanisms:  a  stimulus  control  paradigm  (situational  components  of  stimulus 
control)  and  an  `improved  harmonisation  of  the  individual's  circadian  cycle' 
(temporal  instructions)  rather  than  solely  via  reconditioning  of  responses  to  the 
environment  (Espie,  1991,  p.  55).  Furthermore,  the  findings  that  counter-stimulus 
control  instructions  improved  sleep  call  into  question  the  conceptual  basis  of 
stimulus  control.  Should  the  mechanism  of  effects  be  the  strengthening  of  an 
association  between  bedroom  environment  and  sleep,  then  asking  people  to  stay  in 
bed  awake  (and  perform  activities  in  bed)  should  weaken  even  further  such 
association.  Taking  this  point  into  consideration  it  could  be  argued  that  counter- 
stimulus  control  produced  sleep  improvements  because  of  its  temporal  instructions. 
1.7.3  `Get  up  and  go  to  another  room  if  not  asleep':  a  feasible  therapy? 
The  stimulus  control  studies  discussed  in  the  previous  section  evidenced  the 
efficacy  of  stimulus  control  therapy  for  insomnia:  importantly,  stimulus  control  has 
been  consistently  found  to  be  as  efficacious  as  other  therapies  or  to  produce  stronger 
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therapy.  However,  participants'  comments  suggested  that  positive  outcomes  might 
not  be  due  only  to  bringing  back  falling  asleep  under  the  stimulus  control  of  the 
bedroom.  Three  studies  (Alperson  and  Biglan,  1979;  Davies  et  al,  1986;  Zwart  and 
Lisman,  1979)  showed  that  both  the  original  stimulus  control  and  counter-stimulus 
control  improved  sleep.  These  findings  would  suggest  caution  about  considering 
conditioning  as  the  only  mechanism  underpinning  stimulus  control  efficacy. 
In  section  1.7.1  it  has  also  been  argued  that  stimulus  control  therapy  for  insomnia 
comprises  two  different  sets  of  instructions:  one  set  aiming  at  re-establishing 
temporal  harmonisation  of  the  sleep-wake  schedule  and  the  other  one  aiming  at 
bringing  falling  asleep  under  the  stimulus  control  of  the  bedroom  (situational 
elements).  Indeed,  two  studies  evidenced  that  therapeutic  effects  can  be  obtained 
when  only  situational  or  only  temporal  instructions  are  delivered  (Tokarz  and 
Lawrence,  1974;  Zwart  and  Lisman,  1979). 
The  results  of  these  four  studies,  coupled  to  the  findings  that  both  poor  and 
normal  sleepers  endorsed  similar  sleep  incompatible  behaviours  at  bedtime  (e.  g. 
Harvey,  2000a;  Haynes  et  al,  1982),  highlight  the  importance  of  carrying  out  further 
research  on  the  situational  aspect  of  stimulus  control.  As  already  mentioned,  it  is 
surprising  that  this  line  of  investigation  has  not  been  pursued  and  it  seems  timely  to 
address  this. 
Given  that  situational  elements  of  stimulus  control  have  been  shown  to  produce 
sleep  improvements  and  that  the  instruction  `If  you  find  yourself  unable  to  fall 
asleep,  get  up  and  go  to  another  room'  seemed  to  epitomise  the  essence  of  stimulus 
control  theory  (section  1.7.1),  it  seems  reasonable  to  propose  a  simplified  stimulus 
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sleep. 
Before  concluding  this  chapter  it  is  important  to  highlight  moderating  variables, 
that  is  variables  that  can  influence  treatment  outcomes. 
1.8  Treatment  Response  and  Moderating  Variables 
Meta-analyses  have  evidenced  that  behavioural  therapies  for  insomnia  improve 
sleep  in  around  70-80%  of  treated  individuals  -  that  is  around  20-30%  of  people 
undergo  insomnia  treatment  without  benefiting  from  it.  This  finding  raises  an 
important  question:  what  factors  inhibit  or  moderate  negatively  sleep  improvements 
in  some  of  the  treated  individuals? 
Chambers  (1992)  suggested  that  non-adherence  might  be  the  single  greatest 
drawback  to  the  success  of  behavioural  treatment  for  insomnia,  and  attention  is  now 
turned  to  this  moderating  variable.  Thereafter  therapy  credibility  and  expectancy  of 
improvement  are  discussed.  Finally  the  importance  of  the  individual's  readiness  to 
change  is  highlighted. 
1.8.1  Treatment  Adherence 
In  the  provision  of  health,  the  term  adherence  refers  to  the  implementation  of 
medical  and  treatment  advice  (Spilker,  1991)  and  it  has  been  highlighted  that  non- 
adherence  with  treatment  instructions  can  mask  treatment  effects  (Frangakis  and 
Baker,  2001). 
Sleep  researchers  are  becoming  increasingly  aware  that  adherence  is  an  extremely 
important  construct  in  therapeutic  interventions  (Bouchard,  Bastien  and  Morin, 
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Lichstein,  2001;  Vincent  and  Hameed,  2003),  yet  very  little  systematic  research  on 
its  impact  on  therapeutic  gains  have  been  carried  out  and  no  standardized 
methodology  for  measuring  adherence  exists. 
The  few  times  adherence  has  been  measured,  measurement  has  relied  on 
subjective  (mainly  examination  of  sleep  diaries)  or  important  others'  reports  (Morin, 
Colecchi  et  al  1999;  Bouchard  et  al,  2003).  For  example,  Bouchard  and  colleagues 
(2003)  used  sleep  diaries  to  measure  adherence  during  8  weeks  CBT  treatment. 
Seven  daily  criteria  reflecting  stimulus  control  and  sleep  restriction  were  extracted 
from  the  sleep  diaries  and  rated.  It  was  found  that  participants  complied  with  at  least 
6  criteria  each  day.  Harvey  et  al  (2002)  asked  patients  (both  responders  and  non- 
responders  to  treatment)  to  rate  their  use  of  the  behavioural  treatment  components  of 
CBT-I  1  year  after  treatment  was  completed.  Although  the  component  sleep 
scheduling  (a  combination  of  stimulus  control  and  sleep  restriction)  was  used  by  less 
than  50%  of  patients  at  one  year  follow-up,  it  was  found  to  be  the  strongest  and  most 
consistent  predictor  of  SOL  and  WASO  reduction. 
The  possibility  that  stimulus  control  could  present  a  challenge  in  terms  of 
adherence  has  also  been  evidenced  by  Schramm  and  colleagues.  Their  insomnia 
sample  was  asked,  at  the  end  of  therapy,  about  their  use  of  CBT  modules  and 
responses  showed  that  stimulus  control  was  rarely  practised  (Schramm  et  al,  1995). 
Similarly,  Chambers  (1992)  found  that  only  about  30%,  of  a  sample  of  103  insomnia 
patients,  strictly  followed  treatment  recommendations.  In  contrast,  Riedel  and 
Lichstein  (2001)  found,  in  their  sample  of  older  adults,  that  adherence  to  sleep 
restriction  instructions  was  `reasonably  good';  interestingly,  consistency  in  sleep 
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reduction  did  not. 
These  studies  investigated  adherence  to  CBT  and,  therefore,  do  not  permit 
assessment  of  whether  participants  applied  all  components  of  stimulus  control.  In 
this  regard  it  has  been  suggested  that  the  instruction  `get  out  of  bed  if  unable  to 
sleep',  particularly  when  elderly  people  are  involved,  can  be  difficult  to  comply  with 
(Bootzin  and  Epstein,  2000).  Indeed,  Lichstein  and  Morin  (2000)  argued  that  the 
component  of  stimulus  control  `get  out  of  your  bed  if  not  asleep  in  20  minutes'  is 
particularly  difficult  to  be  followed  by  older  adults  because  of  mobility  issues  and  the 
reluctance  to  leave  the  bed  during  winter  months:  non  adherence  with  this  instruction 
might  help  explain  findings  that  stimulus  control  for  insomnia  is  less  efficacious  with 
older  adults. 
As  already  mentioned  these  studies  relied  either  on  adherence  being  inferred  by 
sleep  diary  entries  or  on  retrospective  (end  of  studies  and  follow-ups)  estimates  of 
adherence.  This  can  be  misleading  as  reports  of  adherence  can  be  affected  by  the 
researcher's  expectation  or  the  participant's  desire  to  conform  or  please  the  therapist 
raising  the  possibility  that  conclusions  on  the  effects  and  active  therapeutic 
ingredients  of  an  intervention  could  be  compromised  (Buysse,  2003). 
One  instrument,  namely  actigraphy,  already  used  in  sleep  studies,  could  lend  itself 
to  monitoring  adherence  objectively.  Carney,  Lajos  and  Waters  (2003)  proposed  that 
using  actigraphy  to  verify  adherence  to  treatment  instructions  could  be  very 
important.  In  their  elegant  study  they  found  that  participants  who  were  told  that 
actiwatches  would  provide  information  on  application  of  sleep  instructions  (bed  and 
wake  time)  adhered  more  than  those  who  were  not  informed  that  the  'watch'  would 
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followed  only  for  2  nights;  it  is  therefore  possible  that  the  undergraduates  complied 
with  instructions  only  because  of  the  short  time  they  were  required  to  do  so.  In 
addition  the  group  was  composed  of  normal  sleepers.  It  might  be  that  poor  sleepers 
would  find  it  more  difficult  to  follow  instructions.  Nonetheless,  this  study 
highlighted  an  objective  method  to  evaluate  adherence  which  is  worth  pursuing.  In 
study  two  and  three  of  the  present  research  the  possibility  to  use  actigraphy  to 
measure  adherence  objectively  is  explored. 
It  is  important  to  pay  attention  to  two  other  factors,  namely  credibility  of 
treatment  and  expectancy  of  improvement  following  treatment,  because  they  can 
impact  on  treatment  outcomes  (Kazdin,  1979).  For  example,  if  the  individual  does 
not  believe  that  therapy  will  help  improve  sleep,  they  might  be  less  likely  to  adhere 
to  the  treatment  modality. 
1.8.2  Credibility  and  Expectancy 
Assessing  credibility  of  treatment  and  expectancy  of  positive  treatment  outcomes 
enables  the  investigators  to  check  that  these  two  variables  are  not  responsible  for  any 
differences  in  observed  outcome  between  the  compared  conditions.  Expectancy  and 
credibility  have  been  found  to  be  influenced  by  the  amount  of  information  given  and 
the  kind  of  language  used  (Kazdin  and  Krouse,  1983),  and  to  correlate  with  therapy 
outcome  (Chambless,  Tran  and  Glass,  1997;  Borkovec  and  Costello,  1993).  Riedel 
and  Lichstein  (2001)  found  that  some  of  their  patients  did  not  adhere  to  spending  less 
time  in  bed  (sleep  restriction)  because  this  seemed  counterintuitive  to  what  one  ought 
to  do  when  having  insomnia. 
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It  can  be  argued  that  independently  of  the  efficacy  of  a  given  treatment,  the 
individual  must  be  ready  (that  is  motivated  and  willing)  to  learn  and  apply  therapy 
instructions  (Edinger  and  Means,  2005).  In  other  words,  if  the  individual  is  not 
"ready  to  change",  even  the  most  efficacious  treatments  will  not  produce  positive 
therapeutic  outcomes.  As  suggested  by  Morin  and  Espie  (2003)  the  'stages  of 
change'  model  put  forward  by  Prochaska,  DiClemente  and  Norcross  (1992)  is  a 
useful  tool  to  assess  readiness  and  motivation  to  change  (figure  12).  It  is  noteworthy 
that  Morgan  et  al's  (2003)  study  highlighted  that  higher  expectations  of  change 
predicted  better  treatment  outcomes. 
Fig.  12  -  Assessment  of  Readiness  to  Implement  Insomnia  Therapy  using 
the  Process  of  Change  Model 
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For  example,  secondary  gains  (e.  g.  sympathy,  relief  from  demanding  tasks)  might 
influence  readiness  to  change  (Kales  and  Kales,  1984). 
93 1.9  Summary  of  the  Introduction 
The  preceding  sections  critically  reviewed  the  literature  pertaining  to  insomnia,  its 
non-pharmacological  treatment  and  variables  that  can  hinder  treatment  efficacy. 
Several  distinct  findings  can  be  extracted  from  the  literature. 
First,  although  there  is  empirical  evidence  supporting  the  physiological, 
behavioural  and  cognitive  perspectives  of  insomnia  none  seems  to  be  exhaustive. 
Single  factor  theories  are  attractive  for  their  simplicity  but  recent  research  suggests 
that  insomnia  is  multi-dimensional  in  that  physiological,  psychological,  behavioural 
and  social  domains  interacts  in  the  emergence,  maintenance  and  exacerbation  of 
insomnia. 
Second,  in  the  last  20  years  CBT-I,  which  comprises  several  single  therapies,  has 
been  the  most  popular  non-pharmacological  treatment  for  insomnia  and  behavioural 
sleep  medicine  is  continually  providing  further  evidence  of  its  efficacy.  Nonetheless 
its  mode  of  action  is  less  clear,  in  other  words  we  know  it  works  but  we  don't  quite 
know  what  the  mechanisms  of  effect  are.  Furthermore,  whether  all  CBT-I 
components  are  essential  to  positive  treatment  outcomes  is  unknown. 
Third,  meta-analyses  have  highlighted  that  stimulus  control  for  insomnia  is  the 
most  efficacious  single  component  therapy  for  insomnia.  It  is  also  the  only  therapy 
recognised  as  the  golden  standard  treatment  for  insomnia  by  the  American  Academy 
of  Sleep  Medicine  and  a  core  component  of  CBT  packages.  Nonetheless, its 
mechanisms  of  effect  are  unclear.  Despite  stimulus  control  being  based  on  the  notion 
that  in  insomnia  falling  asleep  is  not  under  the  stimulus  control  of  the  bedroom 
(because  sleep  incompatible  behaviours  are  in  the  bedroom  and/or  sleep  inducing 
stimuli  are  not  established),  research  findings  raised  doubts  about  this  hypothesis. 
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poor  sleepers,  hence  suggesting  that  behaviour  incompatible  with  sleep  might  not 
play,  per  se,  an  essential  role.  Furthermore,  a  counter-stimulus  control  paradigm, 
requiring  participants  to  spend  time  awake  sitting  up  in  bed,  was  found  to  improve 
sleep.  This  finding  argues  against  situational  conditioning.  In  addition,  participants' 
comments  suggested  that  stimulus  control  breaks  a  pattern  of  lying  awake  in  bed 
thinking.  Finally,  a  detailed  examination  of  the  elements  of  stimulus  control 
highlighted  that  it  comprises  both  situational  (aiming  at  re-establishing  good  stimulus 
control)  and  temporal  instructions  (aiming  at  re-harmonising  sleep  and  wakefulness). 
Fourth,  although  research  has  consistently  found  stimulus  control  to  improve 
sleep,  most  studies  relied  only  on  subjective  estimates  of  sleep.  Indeed,  the  two 
studies  employing  objective  measurements  (PSG)  of  sleep  failed  to  find  changes  in 
the  sleep  parameters  under  investigation. 
Fifth,  it  has  been  shown  that,  although  insomnia  treatments  produce  sleep 
improvements  in  around  70-80%  of  the  population,  not  everyone  responds  to 
treatment.  The  possibility  that  this  is  in  part  due  to  non-adherence  has  been  raised  but 
systematic  research  on  adherence  and  its  impact  on  treatment  outcomes  is  lacking. 
Furthermore,  in  the  few  instances  in  which  adherence  has  been  investigated,  its 
measurement  was  provided  by  retrospective  and  subjective  tools  (e.  g.  sleep  diary, 
participants'  comments).  This  finding  highlighted  the  importance  of  measuring 
adherence  systematically  and  objectively. 
The  next  chapter  details  the  present  research,  which  comprises  three  studies 
designed  to  investigate  the  issues  just  highlighted  above. 
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Overview  of  the  Present  Research 
2.1  Rationale 
The  literature  reviewed  in  the  previous  chapter  highlighted  that  CBT  is  an 
efficacious  treatment  for  insomnia  comprising  several  discrete  therapies  each  of 
which,  in  turn,  encompasses  several  elements.  The  fact  that  it  is  multicomponent 
makes  it  difficult  to  assess  if  all  its  components  are  critical  to  therapeutic  gains  and  to 
identify  mechanisms  of  treatment  effect.  The  assessment  of  what  elements  are 
critical  to  positive  outcomes  is  important  because  of  the  need  to  provide  cost- 
effective  care.  Understanding  the  mechanisms  of  effect  underpinning  insomnia 
treatment  is  also  important  because  it  may  help  to  shed  light  on  factors  that  maintain 
and/or  exacerbate  insomnia.  This,  in  turn,  could  lead  to  possible  ways  of  preventing 
acute  insomnia  from  becoming  chronic,  and  so  maximise  the  effectiveness  of 
insomnia  treatment  packages. 
However,  most  research  on  insomnia  therapy  has  been  `macroscopic'  in  nature 
focussing  on  the  efficacy  and  effectiveness  of  complex  multicomponent  packages, 
with  a  tendency,  if  anything,  to  add  modules  rather  than  striving  to  obtain  maximum 
effect  with  minimum  intervention.  It  seems  important,  therefore,  to  address  this  issue 
by  looking  not  just  at  single  therapies  within  CBT  but  also  `microscopically'  at 
single  elements  of  these  therapies.  A  good  analogy  would  be:  having  built  a  fine 
house  it  is  as  if  we  have  neglected  to  pay  sufficient  attention  to  what  its  foundations 
and  cornerstones  are.  The  present  research  was  devised  to  look  into  this  matter. 
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emerged  as  a  core  component  of  CBT,  the  most  efficacious  single  therapy  and  the 
only  therapy  recognised  as  the  gold  standard  treatment  for  insomnia  by  the  American 
Academy  of  Sleep  Medicine.  Notwithstanding  its  efficacy,  previous  research 
findings  cast  doubts  on  whether  all  its  elements  are  critical  to  positive  outcomes  and 
on  the  mechanisms  of  effect  of  stimulus  control.  For  this  reason  stimulus  control 
was  examined  in  more  detail.  Analysis  of  its  six  component  parts  suggested  that  the 
instruction  `if  you  are  not  asleep  within  a  reasonable  time  get  up  and  go  to  another 
room  and  return  to  bed  only  when  sleepy  again'  captures  the  essence  of  learning 
theory  posited  to  underlie  stimulus  control  therapy  and,  in  this  sense,  may  be  a 
cornerstone  element  worth  of  close  examination. 
Interestingly,  the  duration  of  waking  time  before  applying  this  instruction  was 
found  to  be  somewhat  arbitrary  in  that  it  varied  from  study  to  study.  If  this 
instruction  is  to  return  the  individual  into  the  normal  range  then  what  constitutes 
normalcy  with  regard  to  SOL  needs  to  be  clear  and  study  one  was  devised  to  address 
this  issue. 
Furthermore,  findings  that  poor  and  normal  sleepers  endorse  similar  sleep 
incompatible  behaviours  at  bedtime  questioned  conditioning  as  the  sole  mechanism 
underpinning  stimulus  control.  This  possibility  was  strengthened  by  findings  that  a 
counter-stimulus  control  paradigm  produced  positive  outcomes. 
The  literature  review  also  highlighted  that  the  impact  of  stimulus  control  on  PSG 
defined  sleep  seeming  largely  unknown.  It  should  be  appreciated  that  it  is  only  in  the 
past  10-15  years  that  PSG  measures  have  started  to  be  employed  in  efficacy  studies 
and  that  results  are  equivocal:  some  studies  have  evidenced  PSG  defined  sleep 
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majority  of  outcome  studies  employing  PSG  are  CBT  trials  perhaps  because  most 
single  therapy  studies  were  carried  out  in  the  1970s  and  early  1980s  when,  due  to 
technology  constraints,  PSG  recording  was  more  cumbersome  than  nowadays.  One 
stimulus  control  study  employing  PSG  measures  found  only  S.  E.  improvements 
(Anderson  et  al,  1988).  It  seems,  therefore,  important  to  attempt  to  address  the  need 
for  objective  data  on  sleep  changes  following  therapy.  In  particular,  given  that 
stimulus  control  for  insomnia  attempts  to  condition  falling  asleep  to  the  bedroom 
environment,  home  PSG  seems  a  more  logical  choice  than  PSG  recorded  in 
laboratory  settings. 
In  addition,  examination  of  previous  research  revealed  that  not  everyone  responds 
to  insomnia  treatment.  Several  researchers  have  argued  that  poor  treatment  response 
is  likely  to  be  related  to  adherence,  yet  adherence  has  been  rarely  investigated.  In 
addition  the  few  studies  that  examined  adherence  have  done  so  subjectively  or  have 
inferred  it  from  sleep  diary  entries.  It  was  reasoned  that  in  the  case  of  a  single 
element  therapy,  whose  implementation  requires  overt  behaviour  (i.  e.  get  up  and 
read),  actigraphy  could  be  employed  to  measure  adherence  objectively. 
The  present  research,  therefore,  represents  an  investigation  into  the  impact  of  a 
single  element  therapy,  named  the  Quarter  of  an  Hour  Rule  (QHR),  on  subjective  and 
objective  (PSG)  sleep  in  people  presenting  with  insomnia  in  primary  care  or  self- 
referred  as  having  insomnia.  Additionally,  whether  conditioning  to  the  bedroom 
environment  is  the  sole  mechanism  of  effect  of  stimulus  control  therapy  for  insomnia 
was  explored.  Finally,  the  relationship  between  treatment  outcome  and  adherence 
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objectively  were  examined. 
2.2  Aims 
The  principal  aim  of  the  present  research  was  to  examine  the  impact  of  the  QHR 
on  sleep  parameters  of  individuals  with  psychophysiological  insomnia.  Both 
subjective  (sleep  diaries)  and  objective  measures  (home  PSGs)  of  sleep  were 
gathered.  The  second  aim  was  to  investigate  its  mechanisms  of  effect.  The  third 
objective  was  to  explore  the  relationship  between  therapy  outcomes  and  adherence 
and  the  feasibility  of  employing  actigraphy  to  measure  adherence  objectively. 
This  research  comprises  three  studies.  Two  preliminary  studies  were  completed  to 
inform  the  randomised  controlled  experimental  trial  (study  three).  The  first  aim  of 
study  one  (chapter  three)  was  to  determine  what  constitutes  normalcy  with  regard  to 
SOL  so  as  to  have  a  `reasoned'  duration  of  time  to  wait  before  applying  the  QHR. 
The  results  of  study  one  informed  the  second  and  the  third  studies. 
Prior  to  conducting  a  randomised  controlled  experimental  study,  it  was  deemed 
important  to  carry out  a  few  single  case  studies  to  test  if  the  QHR  would  impact  on 
sleep.  The  first  aim  of  study  two  (chapter  four)  was,  therefore,  to  assess  the  effect  of 
the  QHR  on  subjective  and  objective  sleep  of  three  individuals  presenting  with 
insomnia.  In  particular,  the  validity  of  home  portable  EEG  equipment,  whose  set  up 
could  be  performed  by  the  participants  themselves,  was  tested.  Another  aim  of  study 
two  was  to  investigate  adherence  to  the  QHR  both  subjectively  via  adherence  diaries 
and  objectively  using  actigraphy.  The  results  of  this  explorative  study  informed  on 
the  feasibility  of  the  QHR  as  a  standalone  therapy.  Data  gathered  from  study  two  also 
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measurements  of  sleep  and  adherence. 
The  first  aim  of  the  randomised  controlled  experimental  trial  (study  three,  chapter 
five)  was  to  investigate  the  impact  of  the  QHR  on  subjective  and  objective  sleep  of 
GP  referred  and  self-referred  people  with  insomnia.  The  second  aim  was  to  explore 
possible  mechanisms  of  effect  of  the  QHR  by  requiring  to  apply  the  QHR  in  two 
different  locations  out  of  bed  (QHRout)  and  in  bed  (QHRin).  In  addition,  a  battery  of 
sleep  related  questionnaires  measuring  sleep  related  behaviours,  cognitions  and 
arousability  were  administered.  As  in  study  two,  another  aim  of  this  research  was  to 
investigate  the  impact  of  adherence  on  treatment  effects.  Adherence  with  the  QHR 
treatments  was  measured  daily  subjectively,  via  an  adherence  diary,  and  objectively 
by  means  of  actigraphs  incorporating  a  light  detector. 
Each  of  these  studies  are  described  and  discussed  in  the  following  chapters. 
2.3  Ethical  Approval  and  Ethical  Issues 
Ethical  approval  for  the  present  research  and  two  amendments  to  the  original 
approved  protocol  were  granted  by  the  Greater  Glasgow  NHS  Primary  Care  Trust. 
Copies  of  the  original  and  the  amendments  were  forwarded  to  the  University  Ethics 
Committee  as  is  standard  practice  (appendix  2). 
It  should  be  noted  that  based  on  prior  work  in  this  area  (e.  g.  Bootzin,  1972;  Zwart 
and  Lisman,  1979;  Davies  at  al,  1986)  it  was  assumed  that  the  QHR  intervention 
would  be  either  beneficial  or  would  carry  no  adverse  effects. 
With  regard  to  home  PSG,  the  procedure  was  well  tolerated  and  minimal 
discomfort  was  reported.  Participants  were  given  a  mobile  telephone  contact  number 
100 so  as  to  have  access  to  the  researcher  during  the  PSG  nights.  Participants  were 
encouraged  to  contact  the  researcher  if  they  had  questions  or  problems  related  to  the 
PSG  recording  equipment  or  if  emergencies  requiring  the  removal  of  PSG  equipment 
arose.  Only  one  participant  phoned,  soon  after  the  researcher  left  her  home,  as  she 
thought  she  might  have  switched  the  EEG  recording  equipment  off. 
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A  Cross-Sectional  Comparison  of  Sleep  Behaviour  in 
Normal  and  Poor  Sleepers 
This  study  was  carried  out  so  as  to  assess  normal  and  poor  sleepers'  SOL  with  the 
aim  of  determining  the  duration  of  SOL  in  normal  sleep.  In  addition,  the  portion  of 
the  sleep  opportunity  window  that  should  be  considered  in  calculating  TIB  was  also 
explored  with  the  aim  of  wording  the  sleep  diary  so  as  to  best  capture  sleep 
continuity  variables.  The  findings  of  this  study  informed  methodology  for  study  two 
and  study  three  (chapters  four  and  five  respectively)  with  regard  to  component 
therapy  (called  the  QHR). 
3.1  Rationale 
Research  typically  focuses  on  the  `abnormal'  and  on  therapies  to  decrease 
'disease'.  Ideally,  however,  the  ultimate  goal  of  therapy  is  not  just  to  achieve 
symptom  control  but  also  to  return  the  individual  to  normalcy.  It  seems  very 
important,  therefore,  also  to  study  normal  sleep  behaviour  to  inform  both  theory  and 
treatment. 
In  the  present  context,  decisions  concerning  the  amount  of  time  to  wait  before 
applying  the  instruction  `get  up  and  go  to  another  room'  (table  5,  instruction  3 
section  1.7.1)  would  be  somewhat  arbitrary  without  data  on  what  latency  constitutes 
SOL  in  normal  sleep.  Whereas  to  the  author's  knowledge  what  constitutes  normal 
subjective  SOL  has  never  been  formally  assessed  in  its  own  right,  such  data  can  be 
inferred  from  the  literature  comparing  normal  and  poor  sleepers.  For  example,  Means 
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Fins  and  Sullivan  (1999)  of  23  minutes. 
Likewise,  it  is  also  important  to  standardise  research  and  clinical  practice  by 
employing  a  `reasoned'  definition  of  sleep  efficiency.  Sleep  diaries  routinely  used  in 
research  include  sleep  continuity  variables  (e.  g.  SOL,  WASO),  however,  sleep 
behaviour  at  bedtime  and  in  the  morning  is  not  always  measured  in  a  uniform 
manner.  For  example,  it  is  possible  to  measure  TIB  in  several  ways:  TIB  can  be 
defined  as  the  time  elapsed  from  `intention  to  sleep'  to  `woke  up'  (i.  e.  the  narrowest 
sleep  window  opportunity),  or  it  can  be  calculated  as  the  time  between  `retiring  to 
bed'  to  `out  of  bed'  (i.  e.  the  widest  sleep  opportunity).  Providing  TIB  is  measured 
consistently  (i.  e.  it  is  measured  identically  across  conditions  and  at  the  considered 
time  points)  this  does  not  represent  an  issue  within  each  single  study.  However  when 
studies  carried  out  by  different  researchers  are  compared,  the  way  in  which  TIB  is 
measured  might  be  in  part  responsible  for  differences  in  treatment  outcomes. 
Importantly,  if  the  sequences  of  behaviour,  at  sleep  time  (Ti)  and  in  the  morning 
upon  awakening  (T2)  (fig.  13),  differ  between  normal  and  poor  sleepers  then  when 
calculating  TIB  T1  and/or  T2  would  acquire  importance  for  theory  (potentially 
helping  explaining  some  aspects  of  insomnia)  and,  consequently,  for  therapy. 
Fig.  13:  Sequence  of  Behaviour  at  Sleep  Time  and  in  the  Morning 
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The  first  aim  of  this  study  was  to  investigate  the  duration  of  subjective  SOL  that  is 
typical  of  normal  sleep.  In  particular  what  duration  would  be  the  best  cut-off  to 
include  normal  sleepers  and  to  exclude  poor  sleepers  (sensitivity/specificity)  was 
examined. 
The  second  aim  was  to  investigate  sleep  behaviour  at  bedtime  and  in  the  morning 
in  normal  and  poor  sleepers.  Based  on  the  stimulus  control  argument  that  in  insomnia 
sleep  incompatible  behaviours  are  present,  it  was  hypothesised  that  poor  and  normal 
sleepers  would  differ  with  regard  to  the  periods  of  time  spent  awake  in  bed,  both  at 
bedtime  pre-sleep  and  in  the  morning  after  wakening.  The  first  prediction  was  that 
Ti  would  be  greater  for  poor  sleepers  than  normal  sleepers.  The  second  prediction 
was  that  T2  would  be  greater  for  poor  sleepers  than  normal  sleepers. 
In  addition,  information  regarding  reasons  for  waking  up  in  the  morning  and 
behaviour  endorsed  when  sleep  did  not  come  easily  was  collected. 
3.3  Methods 
3.3.1  Design 
This  was  a  cross  sectional  comparison  to  examine  sleep  behaviour  in  normal  and 
poor  sleepers.  The  areas  of  interest  regarded  the  sleep  pattern  at  SOL,  Ti  and  T2 
(measured  in  minutes).  There  was  one  between  subjects  factor  of  `Group'  with  two 
levels  (normal  sleeper  and  poor  sleeper). 
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One  hundred  potential  participants  were  approached.  These  were  acquaintances  and/ 
or  colleagues  of  the  researcher,  with  English  as  their  first  language,  aged  20  to  60 
years.  Fourteen  individuals  decided  not  to  participate  and  six  participants  did  not 
return  the  forms.  A  total  of  eighty  volunteers  took  part  in  the  survey  (45  females  and 
35  males).  The  majority  was  employed  either  full  or  part  time  (77%),  while  a  small 
percentage  was  retired  (9%)  or  in  full  time  university  education  (14%).  They  all  self- 
reported  as  free  from  psychological  or  neurological  disorders.  To  analyse  the  data  in 
relation  to  sleep  problems,  participants  were  divided  into  two  groups  according  to 
their  total  score  in  the  PSQI  (Buysse  et  al,  1989).  Demographic  and  PSQI 
characteristics  are  reported  in  table  6  (section  3.4.1). 
3.3.3  Materials  and  Apparatus 
3.3.3.1  Diary 
Sleep  parameters  were  gathered  by  means  of  sleep  diaries  (adapted  from  Morin 
and  Espie's  (2003)  sleep  diary),  which  participants  completed  each  morning  upon 
rising  for  one  week  (appendix  3).  Via  the  sleep  diary,  daily  information  on  'sleep 
continuity'  such  as  SOL,  WASO,  which  indicated  and  /  or  confirmed  the  disorder 
(i.  e.  insomnia)  were  gathered.  The  sleep  diary  is  routinely  used  to  gather  sleep- 
continuity  measures  in  sleep  research  (Espie,  1991;  Morin,  1993). 
The  sleep  diary,  however,  can  also  be  used  to  gather  sleep  behaviour  information 
such  as  pre-bed  routine.  This  investigation  concentrated  on  sleep  behaviour  at  night 
(when  retiring  to  bed)  and  in  the  morning  by  explicitly  differentiating  the  'retiring  to 
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section  3.1).  Additionally,  the  diary  included  three  questions  so  as  to  gather 
information  about:  i)  endorsed  behaviour  when  `sleep  does  not  come  easily'  at  sleep 
onset,  ii)  endorsed  behaviour  when  `sleep  does  not  come  easily'  during  the  night  and 
iii)  reasons  for  waking  up  in  the  morning. 
Similar  to  Monk,  Buysse,  Rose,  Hall  and  Kupfer's  (2000)  study,  information 
regarding  restedness  and  alertness  on  awakening  was  collected.  Participants  judged 
their  quality  of  sleep,  restedness  and  alertness  in  the  morning  on  a  rating  scale  (0= 
not  at  all,  .., 
4=very  much). 
3.3.3.2  Sleep  Questionnaire 
The  Pittsburgh  Sleep  Quality  Index  (PSQI:  Buysse  et  al,  1989)  is  a 
retrospective  self-rated  questionnaire  comprising  19  items  assessing  the  individual's 
sleeping  habits  and  sleep  quality  during  the  past  month  (appendix  4).  The  PSQI 
produces  seven  component  scores  (each  producing  a  score  between  0  and  3),  the  sum 
of  which  provide  a  global  index  of  sleep  quality.  A  score  above  5  on  the  global  index 
(score  ranging  from  0-21)  identifies  significant  sleep  disturbance  with  high 
sensitivity  and  specificity  (Buysse  et  al,  1989;  Backhaus,  Junghanns,  Broocks, 
Riemann  and  Hohagen,  2002).  Test-retest  reliability  for  the  PSQI  global  score,  over  a 
one-month  period,  was  found  to  be  0.85  in  the  original  study  (Buysse  et  al,  1989)  and 
Carpenter  and  Andrykowski  (1998)  reported  good  internal  consistency  in  a  mixed 
sample  of  medical  patients  with  normal  and  poor  sleep  (Cronbach's  a=0.80). 
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The  primary  sleep  diary  variables  were  `Duration  of  SOL',  Ti  and  T2  as  previously 
defined.  In  order  to  validate  the  cross  sectional  investigation,  however,  the  sleep 
parameters  indicating  a  disorder  of  insomnia  were  first  studied. 
Data  were  analysed  using  a  statistical  package  (SPSS  for  Windows  version  11.5). 
3.3.5  Procedure 
Potential  participants  were  informed  that  the  study  investigated  whether  people 
who  sleep  well  act  differently  from  those  who  do  not  sleep  well  both  during  typical 
nights  and  when  sleep  does  not  come  so  easily.  People,  who  expressed  an  interest  in 
participating,  were  told  that  they  were  required  to  fill  in  a  sleep  questionnaire  (PSQI) 
and,  thereafter,  to  complete  sleep  diary  every  morning  for  one  week.  Both  the  PSQI 
and  the  sleep  diary  were  to  be  forwarded  to  the  researcher  in  the  provided  envelope 
at  the  end  of  the  week.  As  the  diary  and  the  PSQI  did  not  have  an  ID  number,  they 
were  stapled  together. 
The  PSQI  takes  around  10  minutes  to  complete  and  the  sleep  diary  around  5 
minutes  per  day,  thus  requiring  around  45  minutes  of  participants'  time  to  complete 
the  investigation. 
3.4  Results 
3.4.1  Participant  Characteristics 
Table  6  presents  information  regarding  number  of  participants  in  each  group,  their 
gender,  age,  and  the  mean  and  standard  deviation  (SD)  for  PSQI  total  scores. 
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----------------------------------------------------------------------------------  -  -  ---------- 
Normal  sleeper 
- 
Poor  sleeper 
----  -- 
Total 
Participants  il)  l  NO 
Female/Male  29/21  16/  14  45/35 
Age  band: 
(20-30  years)  22  10  32 
(31-40  years)  13  9  22 
(41-50  years)  8  6  14 
(51-60  years)  7  5  12 
PSQI  total  score  (SD)  2.5  (1.0)  10.0(1.9) 
As  expected,  given  that  the  normal  and  poor  sleeper  groups  were  formed  by 
splitting  the  participants  into  two  groups  depending  on  their  PSQI  score  (Buysse  et 
al,  1989),  an  independent  t-test  confirmed  that  the  2  groups  differed  significantly  in 
terms  of  their  quality  of  sleep  level  Jt(78)=  -23.53,  p=O.  OOOl  J.  There  were  no 
significant  differences  in  age  group  Ix2(3)=O.  90,  p=0.821  or  gender  IX2(  1  )=O.  16. 
p=0.68  J. 
3.4.2  Sleep  Continuity  and  Sleep  Quality  Data 
Sleep  continuity  variables  are  generally  used  to  confirm  sleep  status  initially. 
As  shown  in  table  7,  diary  sleep  data  demonstrated  differences  between  normal 
and  poor  sleepers.  In  order  to  assess  if  these  differences  were  statistically  significant 
separate  Mann-Whitney  U  tests  were  conducted  on  SOL,  WASO  and  TST  with 
group  (normal  sleeper  vs.  poor  sleeper)  as  the  between  subjects  factor.  The  choice  of 
a  non-parametric  test  was  nude  because  visual  inspection  o1'  the  data  suggc"ted  that 
the  scores  were  not  normally  distributed.  This  was  confirmed  by  examination  of 
kurtosis  and  skewness  (values  higher  than  1.9). 
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(0-4)  for  the  Normal  Sleeper  and  Poor  Sleeper  Groups 
Normal  Sleeper  (N=50)  Poor  Sleeper  (N=30) 
SOL  9.38(7.69)  47.22(31) 
WASO  8.72(8.87)  53.73(58) 
TST  442(43)  342(85) 
TIB  Intention  to  sleep'  to  'wok  en  up')  460(43)  444(66) 
TI  ('retiring  to  bed'  to  'intention  to  sleep  )  14(14)  17(14) 
T2  'waken  up'  to  'out  of  bed'  )  29(20)  57(42) 
Quality  of  Sleep  3.04(0.48)  1.60(0.72) 
Restedness  2.91(0.50)  1.58(0.63) 
Alertness  2.91(0.59)  1.79(0.80) 
Mann  Whitney  analyses  revealed  that  there  were  highly  significant  differences 
with  regard  to  SOL  (U=101.000,  N1=50,  N,  =30,  P=  0.0001  two  tailed),  WASO  IU= 
219.50,  Ni=50.  N2=30,  P=  0.0001  two  tailed)  and  TST  (U=182.000.  Ni=50.  Ný=30, 
P=  0.0001  two  tailed).  Specifically,  participants  in  the  poor  sleeper  group  took 
longer  to  fall  asleep,  were  awake  for  longer  during  the  night  and  slept  less  than 
normal  sleepers.  These  results,  therefore,  confirmed  the  initial  differentiation  of  the 
two  groups  on  the  basis  of  their  PSQI  scores. 
Each  morning  participants  reported  the  quality  of  the  previous  night's  sleep,  and 
their  level  of  alertness  and  restedness  upon  awakening.  Examination  of'  able  7 
indicates  that  ratings  of  quality  of  sleep,  restedness  and  alertness  on  final  waking  of 
normal  sleepers  differed  from  those  of  the  poor  sleeper  group.  The  data  net  criteria 
for  parametric  tests  and  independent  t-tests  confirmed  that  normal  sleepers  reported 
better  quality  of  sleep,  felt  more  rested  and  alert  upon  awakening  than  poor  sleepers 
[t(78)=  10.70,  p<0.00I;  t(78)=10.30,  p<0.001;  t(78)=7.12,  p<O.  00I  respectivelyl. 
Interestingly,  on  occasions  when  normal  sleepers  could  not  fall  asleep  easily  they 
tended  to  'just  lie  there  waiting  for  sleep'  (84%  of  times).  Although  poor  sleepers 
09 reported  `lying  there'  as  their  most  endorsed  behaviour  when  they  could  not  sleep 
(66%),  they  often  reported  `watching  TV'  and/or  `reading  a  book'  and/or  `listening 
to  the  radio'  and/or  `thinking  about  how  to  sleep'. 
3.4.3  Upper  Limit  of  Sleep  Onset  for  Normal  Sleepers 
To  establish  the  upper  limit  of  normal  sleep  behaviour  at  sleep  onset,  data  from 
the  normal  sleeper  group  were  examined  in  terms  of  sensitivity  and  specificity. 
Sensitivity  refers  to  the  probability  that  a  person  having  a  given  characteristic  will  be 
correctly  identified  as  having  such  characteristic.  Specificity  is  the  probability  that  a 
person  without  that  characteristic  will  be  properly  classified  as  not  having  it. 
Analysis  of  sensitivity  and  specificity  data  indicated  that  SOL  of  5  minutes 
correctly  identified  only  38%  (19  individuals)  of  normal  sleepers  and  correctly 
excluded  100%  (30  individuals)  of  poor  sleepers,  SOL  of  10  minutes  correctly 
identified  72%  (36  individuals)  of  normal  sleepers  and  correctly  excluded  90%  (27 
individuals)  of  poor  sleepers,  SOL  of  15  minutes  correctly  identified  92%  (46 
individuals)  of  normal  sleepers  and  correctly  excluded  86.7%  (26  individuals)  of 
poor  sleeper  and  SOL  of  20  minutes  correctly  identified  92%  (46  individuals)  of 
normal  sleepers  and  correctly  excluded  76.7%  (23  individuals)  of  poor  sleepers. 
As  depicted  in  figure  14,  these  results  indicate  that  a  SOL  of  15  minutes  is  the  best 
cut-off  to  include  normal  sleepers  and  exclude  poor  sleepers. 
In  light  of  these  findings,  it  seems  plausible  to  consider  a  quarter  of  an  hour  as  the 
upper  limit  of  normal  sleep  behaviour  at  sleep  onset  and,  to  specify  such  time  when 
instruction  3  of  stimulus  control  is  delivered  (table  3,  section  1.7.1). 
110 Fig.  14:  Box  and  Whiskers  Plot  indicating  that  a  quarter  of  an  hour  is 
the  best  cut-off  for  normal  sleep  onset  behaviour 
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3.4.4  Sleep  Behaviour  at  Bedtime  and  in  the  Morning 
Data  for  TI  and  T2  were  also  not  normally  distributed  hence  non-parametric 
statistical  analyses  were  carried  out.  Separate  Mann-Whitney  U  tests  were  conducted 
on  these  variables.  There  was  no  significant  difference  between  the  two  groups  for 
TI  (U=656.500,  N1=50,  N,  =30,  P=0.35  n.  s.  )  indicating  that  the  amount  of  time  spent 
in  bed  prior  to  switching  off  the  light  with  the  intention  to  sleep,  did  not  differ 
between  normal  and  poor  sleepers. 
In  contrast,  there  was  a  significant  difference  between  the  two  groups  with  regard 
to  T2  (U=443.500,  N1=50,  N2=30,  P=0.002  two  tailed)  suggesting  that  the  aniotint  of 
time  spent  lying  in  bed  once  awake  in  the  morning  was  greater  for  poor  sleepers. 
This  finding  highlighted  the  importance  of  considering  this  portion  of  sleep 
opportunity  window  when  calculating  TIB. 3.4.5  Reasons  for  Waking  Up  in  the  Morning 
With  regard  to  reasons  given  for  waking  up,  normal  sleepers  reported  using  some 
form  of  wake  up  call  (e.  g.  an  alarm  clock,  their  partner  or  flatmate)  on  70%  of 
weekdays,  and  38%  of  weekends.  They  `just  woke  up'  on  16%  and  because  of  noise 
on  14%  of  weekdays  and  50%  and  12%  respectively  of  week-ends.  Poor  sleepers,  by 
contrast,  indicated  that  they  woke  up  on  majority  of  days  (76%)  because  of  light, 
noise,  or  `for  no  reason'  and  attempted  to  sleep  again  till  the  time  to  get  up  for  work 
or  their  daily  activities  both  on  weekdays  and  weekends. 
3.5  Discussion 
In  this  section  results  obtained  in  the  survey  will  be  discussed  with  particular 
attention  to  the  design  of  study  two  (exploratory  single  case  study,  chapter  4)  and 
study  three  (experimental  study,  chapter  5). 
3.5.1  Summary  of  the  Results 
The  first  aim  of  this  cross  sectional  study  was  to  assess  the  duration  of  SOL  typical 
of  normal  sleep  behaviour.  Results  indicated  that  15  minutes  was  the  best  cut-off  to 
discriminate  normal  SOL.  The  second  aim  was  to  investigate  whether  or  not  sleep 
behaviour  at  bedtime  and  in  the  morning  differed  between  normal  and  poor  sleepers. 
The  first  prediction,  that  the  amount  of  time  spent  in  bed  before  switching  off  the 
light  with  the  intention  to  sleep  would  be  greater  for  poor  sleepers  compared  to 
normal  sleepers,  was  not  supported.  The  second  prediction,  that  poor  sleepers  would 
spend  a  longer  time  in  bed  in  the  mornings  than  normal  sleepers,  was  supported. 
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and  behaviour  endorsed  when  sleep  did  not  come  easily  was  collected.  This 
information  suggests  that  normal  sleepers  during  weekdays  tended  to  use  a  form  of 
`wake  up'  call  in  order  to  get  up  in  the  morning  while  poor  sleepers  tended  to  wake 
up  for  no  apparent  reasons  or  because  of  noise.  Additionally,  in  the  few  occasions 
when  normal  sleepers  could  not  fall  asleep  easily  they  tended  to  lie  in  bed  waiting  for 
sleep  to  come  while  poor  sleepers  tended  to  endorse  a  variety  of  behaviour  (e.  g.  lie  in 
bed,  watching  TV,  read,  get  a  juice). 
3.5.2  -  Interpretation  of  the  Results 
Importantly  for  insomnia  therapy  instructions,  this  study  highlighted  that  15 
minutes  provides  the  best  sensitivity-specificity  cut-off  to  discriminate  normal  SOL 
from  SOL  of  poor  sleepers.  For  example,  as  already  pointed  out  in  the  introduction, 
the  amount  of  time  to  wait  before  applying  the  stimulus  control  instruction  'get  out 
of  your  bed  and  go  to  another  room'  is  rather  arbitrary  varying  from  a  few  minutes 
(Haynes  et  al,  1975)  to  20-30  minutes  (Hoelscher  et  al,  1988).  The  present  finding 
suggests  that  15  minutes  may  be  the  most  appropriate  amount  of  time  to  return  the 
poor  sleeper  to  normalcy. 
The  first  prediction,  that  the  amount  of  time  spent  in  bed  before  switching  off  the 
light  with  the  intention  to  sleep  would  be  greater  for  poor  sleepers  as  compared  to 
normal  sleepers,  was  not  supported.  However,  on  reflection,  this  finding  may  not  be 
surprising,  given  that  some  previous  research  has  shown  that  poor  and  normal 
sleepers  endorse  similar  pre-sleep  activities  (Haynes  et  al,  1982).  In  poor  sleepers, 
considering  TIB  from  the  intention  to  sleep  could  result  in  heightened  arousal  due  to 
113 the  pairing  of  being  in  bed  with  being  awake  and  frustrated/worried.  Accordingly 
from  a  learning  theory  perspective,  any  time  spent  awake  should  be  avoided  so  as  to 
re-establish  appropriate  stimulus  control. 
The  present  results  seem  to  suggest  that  both  normal  and  poor  sleepers  do  spend  a 
similar  amount  of  time  in  bed  prior  to  attempting  to  sleep.  However,  it  could  be 
speculated  that  the  reason  for  spending  time  awake  in  bed  prior  to  attempting  to  sleep 
differed  depending  on  the  group.  In  particular  it  might  be  that  normal  sleepers  decide 
to  switch  off  the  light  so  as  to  sleep  when  they  feel  sleepy,  while  poor  sleepers  might 
make  such  decision  on  the  basis  of  external  cues  (e.  g.  clock,  partner)  rather  than  to 
internal  cues  for  sleep.  This  possibility  has  been  raised  in  a  recent  paper  on  the 
attention-intention-effort  pathway  to  insomnia  (Espie  et  al,  2006).  Espie  et  al  (2006) 
proposed  that  normal  sleepers  read  in  bed  and  attempt  to  stay  awake  (but  they 
cannot),  while  poor  sleepers  read  because  they  cannot  fall  asleep/cannot  stay  asleep. 
In  other  words,  normal  sleepers  intend  to  read  in  bed  but  sleep  takes  over  while  poor 
sleepers  unsuccessfully  intend  to  fall  asleep  and  because  of  wakefulness  they  start  to 
read.  Although  this  is  a  possibility,  it  was  not  tested  in  this  study. 
The  second  prediction,  that  time  spent  in  bed  from  waking  up  to  getting  out  of  bed 
would  be  greater  in  poor  sleepers  than  in  normal  sleepers,  was  supported.  This  result 
highlights  the  importance  of  considering  the  period  between  waking  up  and  getting 
up  when  calculating  TIB.  Whereas  normal  sleepers  once  they  woke  up  tended  to  get 
out  of  their  bed,  poor  sleepers  seemed  to  lie  there,  presumably,  in  the  hope  of  getting 
some  more  sleep.  This  finding  is  potentially  important  with  regard  to  stimulus 
control  theory  at  WASO.  The  poor  sleeper,  by  staying  in  bed  when  awake  in  the 
morning,  might  weaken  the  association  between  the  bed  and  sleep. 
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alarm  clock  replicate  Monk  et  al's  (2000)  findings.  They  suggested  that  this  finding 
coupled  to  the  fact  that  normal  sleepers  tended  to  sleep  longer  at  weekends  (when 
they  could  wake  up  at  leisure),  was  an  indication  of  sleep  debt.  It  could  be  argued 
that  normal  sleepers  maintain  a  healthy  tension  between  sleep  drive  and  sleep 
behaviour,  that  is  having  a  modicum  of  sleep  debt  helping  to  maintain  sleep 
homeostasis.  Poor  sleepers,  in  contrast,  reported  waking  up  because  of  environmental 
noises  or  for  no  apparent  reasons.  However,  this  finding  cannot  be  taken  as  an 
indication  that  they  do  not  have  a  sleep  debt.  Indeed,  they  felt  less  rested  and  less 
alert  in  the  morning  than  normal  sleepers  and  they  tried  to  satisfy  their  need  for  more 
sleep  by  staying  in  bed  and  `trying  to  fall  back  to  sleep'  once  they  woke  up. 
3.5.3  Considerations  for  Study  Two 
These  findings  inform  the  methodology  for  study  two  and  three. 
First,  the  results  indicated  that  a  window  of  15  minutes  gives  ample  opportunity  to 
fall  asleep  and  may  be  the  optimal  cut-off  when  normalcy  in  sleep  onset  is 
considered  desirable.  It  seems  reasonable,  therefore,  to  ask  people  complaining  of 
insomnia  to  apply  the  stimulus  control  instruction  `get  out  of  your  bed  and  go  into 
another  room  if  not  asleep  within  a  quarter  of  an  hour'.  Bearing  in  mind  that  the 
ultimate  goal  of  therapy  is  reinstating  the  person  with  insomnia  as  a  normal  sleeper, 
by  setting  the  limit  of  being  in  bed  awake  to  quarter  of  an  hour,  the  goal  of  sleep 
normalcy  in  the  treatment  programme  is  reinforced.  It  was  decided  to  focus  on  a 
quarter  of  an  hour  rather  than  15  minutes,  so  as  to  move  away  from  the  concept  of 
`being  absolutely  precise'. 
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period  between  wake  and  rise)  so  as  to  capture  early  wakening.  Importantly,  with 
regard  to  stimulus  control  therapy,  considering  this  period  is  important  in  order  to 
make  sure  that  the  stimulus  control  instruction  is  applied  every  time  the  person  is  in 
bed  but  not  asleep.  Therefore,  the  sleep  diary  employed  in  study  two  and  three 
explicitly  asked  `What  time  did  you  rise  from  bed  this  morning'. 
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Could  a  Single  Element  of  the  Stimulus  Control 
Package  Improve  Sleep?  An  Exploratory  Study 
This  chapter  reports  three  single  case  studies,  conducted  to  examine  the 
feasibility  of  a  single  element  therapy  to  improve  sleep  of  people  with  insomnia,  and 
data  on  adherence  gathered  subjectively  and  objectively. 
4.1  Rationale 
In  the  introduction  it  was  reasoned  that,  despite  CBT-I  being  consistently  found  to 
improve  sleep  of  people  with  insomnia,  its  mechanisms  of  effect  and  whether  all 
components  are  critical  to  positive  outcomes  are  unclear.  Furthermore,  although 
stimulus  control  is  central  to  diagnostic  conceptualisation  of  psychophysiological 
insomnia  (ICSD-R),  a  core  component  of  CBT-I  and,  also,  the  best  evidenced  non- 
pharmacological  intervention,  whether  re-conditioning  is  the  mechanism  responsible 
for  sleep  improvements  is  uncertain.  In  addition  research  findings  highlighted  that 
administering  only  some  of  the  components  of  the  stimulus  control  package 
produced  outcomes  equivalent  to  those  obtained  by  the  whole  package. 
These  findings  highlighted  the  importance  of  de-constructing  stimulus  control. 
Following  a  detailed  analysis  of  its  components,  one  element  (spending  night-time 
wakeful  periods  out  of  the  bedroom)  was  deemed  to  best  epitomise  the  stimulus 
control  essence  and,  therefore,  merit  of  analysis  in  its  own  right.  In  study  one  a 
quarter  of  an  hour  was  identified  as  the  best  amount  of  time  to  represent  SOL  of 
117 normal  sleepers,  hence  this  single  element  therapy  was  named  the  quarter  of  an  hour 
rule  (QHR).  The  present  exploratory  study  comprises  three  single  cases  and  was 
conducted  to  assess  the  impact  of  the  QHR  on  sleep  of  people  with  insomnia. 
The  literature  reviewed  in  chapter  one  also  highlighted  the  need  to  measure 
stimulus  control  efficacy  objectively  because  its  efficacy  in  reducing  insomnia  has 
typically  been  measured  only  subjectively.  Given  that  home  PSG  has  the  advantage 
of  increasing  ecological  validity  and  that  stimulus  control  hypotheses  conditioning  to 
the  bedroom  environment,  PSGs  were  recorded  in  participants'  homes.  In  particular, 
this  study  explored  the  feasibility  of  a  novel  program,  (Biosleep),  requiring  recording 
EEG  only  at  Fz  and  either  Al  or  A2.  If  this  program  proved  to  be  valid,  then  it  could 
be  readily  used  for  home  PSG  studies  because  participants  could  set  up  EEG 
recording  by  themselves  once  trained  to  do  so. 
Finally,  given  that  adherence  has  been  suggested  to  be  an  important  factor  in 
treatment  outcomes  but  it  has  been  rarely  studied  systematically,  this  study  examined 
adherence  by  measuring  it  both  subjectively  and  objectively. 
4.2  Aims  and  Hypotheses 
The  first  aim  of  the  present  study  was  to  investigate  the  impact  of  the  QHR  on 
sleep  parameters.  In  line  with  most  research  regarding  the  efficacy  of  cognitive  and 
behavioural  treatments  for  insomnia,  this  study  employed  subjective  sleep  measures 
in  the  form  of  sleep  diary  and  the  diagnostic  tool  PSQI  (Buysse  et  al,  1989). 
Based  on  previous  research  showing  that  stimulus  control  improved  sleep 
parameters  (e.  g.  Bootzin,  1972,1975;  Haynes  et  al,  1975;  Puder  at  al,  1983)  and 
produced  clinically  significant  changes  (e.  g.  Sanavio,  1990),  it  was  predicted  that: 
118 i)  Participants'  subjective  SOL  and  WASO  would  be  reduced  and  S.  E.  would  be 
increased  following  intervention;  ii)  The  QHR  would  produce  clinically  significant 
improvements. 
In  addition  to  diary  data  objective  sleep  continuity  parameters  were  also 
recorded  so  as  to  explore  if  meaningful  PSG  data  could  be  obtained  by  `Biosleep'  a 
software  package  requiring  recordings  only  at  one  site. 
Another  aim  of  the  present  study  was  to  assess  daily  adherence  with  the  QHR  and 
to  gather  comments  related  to  its  implementation.  The  feasibility  of  employing 
actigraphy  to  measure  adherence  objectively  was  explored. 
4.3  Methods 
4.3.1  Design 
The  study  comprised  3  single  cases:  P1,  P2  and  P3.  Single  case  studies  have  been 
widely  used  by  cognitive-behavioural  researchers  and  this  methodology  is  of  great 
importance  in  the  preliminary  assessment  of  clinical  techniques  and  innovations 
(Morley,  1987).  Each  single  case  was  an  A-B  design  (A=baseline  of  21-22  days,  B= 
treatment  of  23  days).  Treatment  phase  length  was  decided  on  the  basis  of  previous 
findings  that  sleep  improvements  were  observed  within  two  to  three  weeks  after 
stimulus  control  implementation  (e.  g.  Bootzin,  1972;  Espie,  Brooks  et  al,  1989; 
Sloan,  Hauri,  Bootzin,  Morin,  Stevenson  and  Shapiro,  1993;  Zwart  and  Lisman, 
1979).  The  data  collected  during  baseline,  via  participants'  responses  to  a  nightly 
sleep  diary,  served  as  a  point  of  comparison  to  evaluate  i)  changes  in  sleep  patterns 
and  ii)  therapeutic  gains  following  treatment. 
119 4.3.2  Participants 
A  campus  e-mail  recruitment  procedure  was  introduced  to  identify  individuals 
with  sleep  difficulties  for  an  experimental  study  on  insomnia.  The  researcher 
evaluated  interested  individuals'  eligibility  via  a  screening  interview  according  to 
DSM-IV  (APA,  1994)  and  ICSD-R  (ASDA,  1997)  diagnostic  criteria. 
Inclusion  criteria  were:  difficulty  in  initiating  and/or  maintaining  sleep  (SOI; 
and/or  WASO  greater  than  30  minutes)  occurring  at  least  three  nights  per  week  for  at 
least  six  months  (consistent  with  Lichstein,  Durrence,  Taylor,  Bush  and  Riedel, 
2003)  and  perceived  as  causing  distress  or  deterioration  in  daytime  functioning,  and  a 
PSQI  (Buysse  et  al,  1989)  score  greater  than  5.  Exclusion  criteria  were  a  score 
greater  than  14  on  either  of  the  two  subscales  of  the  HADS  (Zigmond  and  Snaith, 
1983),  major  medical  and/or  psychiatric  disorder  (self  reported),  psychotropic  drug 
use  over  the  last  year,  sleep  medication  use  during  the  last  month,  alcohol  and/or 
drug  abuse,  report  of  symptoms  suggestive  of  sleep  apnoea,  periodic  leg  movement 
(PLMS)  or  restless  legs  syndrome  (RLS). 
Of  an  initial  eighteen  potential  participants  who  were  screened,  4  met  all 
diagnostic  criteria.  However,  one  participant  was  excluded  because  diary  baseline 
SOL,  WASO,  TST  and  S.  E.  values  were  in  the  normative  range  for  good  sleepers 
(flow  chart  as  per  Consort  guidelines  in  fig.  17).  The  present  study,  therefore, 
includes  3  participants. 
120 4.3.3  Materials  and  Apparatus 
4.3.3.1  Sleet)  Diarv 
Subjective  sleep  continuity  parameters  were  gathered  by  means  of  sleep  diaries 
(adapted  from  Morin  and  Espie's  (2003)  sleep  diary),  which  participants  completed 
each  morning  upon  arising  during  baseline  and  intervention  phases.  Via  the  sleep 
diary,  daily  information  on  SOL,  WASO,  bed-time,  rising  time,  alcohol 
consumption,  sleep  medication  and  daytime  napping  were  obtained  (appendix  5).  In 
addition  information  regarding  quality  of  sleep,  restfulness  and  alertness  upon  rising 
(5-point  Likert  scale)  were  collected.  The  variables  retained  from  the  sleep  diaries 
were  S.  E.,  SOL  and  WASO.  WASO  was  defined  as  the  summation  of  the  time  spent 
awake  after  sleep  onset  and,  therefore,  comprised  duration  of  all  awakenings 
including  early  morning  awakenings. 
4.3.3.2  Sleep  Assessment  and  Anxiety  and  Depression  Questionnaire 
4.3.3.2a  The  Pittsburgh  Sleep  Quality  Index 
The  Pittsburgh  Sleep  Quality  Index  (PSQI:  Buysse,  et  al,  1989)  was  used  as  a 
global  measure  of  sleep  quality  (section  3.3.3.2,  appendix  4).  In  this  study  the  global 
index  was  used  in  the  analysis  of  treatment  outcome  as  well  as  for  individual 
assessment  of  clinical  significance. 
4.3.3.2b  The  Screening  Interview 
The  screening  interview  was  a  standard  protocol  (Espie,  2000;  Morin  and  Espie, 
2003)  based  on  the  ICSD-R  and  DSM-IV  criteria  for  chronic  insomnia.  This  was 
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(chronicity,  number  of  nights  with  sleep  difficulties,  SOL  and  WASO),  daytime 
functioning,  use  of  sleeping  tablets,  mood,  sleep-disruptive  medical  conditions  and 
other  sleep  disorders  were  assessed. 
4.3.3.2c  The  Hospital  Anxiety  and  Depression  Scale 
The  Hospital  Anxiety  and  Depression  Scale  (HADS:  Zigmond  and  Snaith,  1983) 
is  a  self-report  questionnaire  measured  on  a4  point  Likert  scale  (0-3):  7  items 
measure  depression  and  7  items  measure  anxiety  (appendix  6).  In  particular  a  score 
between  0  and  7  is  considered  as  normal,  8  to  10  as  mild,  11  to  14  as  moderate  and 
15  to  21  as  severe.  Internal  consistency  and  test-retest  reliability  were  found  to  be 
good  (Cronbach  alpha=  0.89  for  both  sub-scales,  test-retest  correlation  =  0.72, 
p<0.001)  (Dunbar,  Ford,  Hunt  and  Der,  2000;  ). 
4.3.3.3  Objective  Measurement  of  Sleep 
4.3.3.3a  Ambulatory  Electroencephalogram/Polygraph  Recording  Device 
The  Ambulatory  EEG/PSG  recording  device  employed  in  this  study  was  Trackit 
(Lifelines  Ltd,  UK).  It  is  a  multi  channel  ambulatory  electroencephalograph, 
comprising  of  24-channel  EEG  amplifier  and  an  8-polychannel  acquisition  board. 
The  device  is  powered  by  3  batteries,  it  is  the  size  of  a  small  hand-bag  and  weighs 
approximately  750  grams  (fig.  15a).  The  Patient  Connection  Unit  is  a  block  of 
moulded  plastic  with  touch-proof  sockets  and  a  shielded  cable,  which  connects  the 
EEG  recording  electrodes  attached  to  the  individual  to  the  Trackit  unit.  The  Trackit 
122 set  up  software  is  used  to  program  the  Trackit  recorder  for  an  ambulatory  recording 
session. 
The  EEG  data  are  stored  on  an  internal  ATA  flash  card  in  the  form  of'  an  t:  Utý 
(European  Data  Format)  file,  which  enables  subsequent  review  by  any  1; )F- 
compatible  EEG  software  package. 
4.3.3.3b  Analysis  of  the  Electroencephalographic  Recording 
The  EEG  data  in  the  fonn  of  EDF  files  were  analysed  by  employing  BioSleep 
software  (Oxford  Bio  Signal  Ltd).  Biosleep  is  a  computer  program  which  uses  a 
neural  network  (Roberts  and  Tarassenko,  1992;  Pardey,  Roberts,  "I'arissenko  and 
Stradling,  1996)  to  quantify  sleep  and  wakefulness  on  a  second-by  second  basis, 
using  a  single  channel  of  recorded  EEG.  In  particular  the  EOG  signal  is  proposed  to 
contain  both  eye  movement  and  EEG  signal. 
Biosleep  first  indirectly  performs  frequency  analysis  of  the  El'G,  then  it  pre'ents 
this  analysis  as  input  to  a  neural  network  which  has  been  trained  to  recognise 
combinations  of  three  different  types  of  EEG  activity:  wakefulness,  REM  or  light 
sleep  and  deep  sleep.  Figure  15b  shows  an  example  of  BioSleep  Hypnogram. 
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For  each  one-second  epoch, 
Biosleep  assigns  a  probability  value 
to  each  of  these  three  processes  so 
as  to  extract  the  probability  that  one 
particular  process  was  dominant  in 
the  brain  during  a  particular  one- 
second  epoch. 
Biosleep's  analysis  of  the  frequency  content  of  the  EEG  uses  a  technique  known 
as  autoregressive  modelling.  It  constructs  its  model  using  the  kind  of  least-square 
technique  employed  in  regression  analysis. 
It  is  important  to  note  that  Biosleep  is  a  simple  and  user  friendly  package, 
however  it  provides  pseudo  R&K.  A  study  by  McGrogan,  Braithwaite  and 
Tarassenko  (2001)  showed  that  over  the  nine  nights  recordings  of  sleep  EEG  the 
correlation  between  the  pseudo-  R&K  obtained  with  Biosleep  and  R&K  stages  from 
a  consensus  of  three  human  experts  was  72.2%. 
4.3.3.4  Measures  of  Adherence 
Adherence  was  measured  both  subjectively  via  adherence  diary  and  objectively  via 
actigraphy.  In  particular,  with  regard  to  objective  adherence,  it  was  reasoned  that 
implementation  of  the  QHR  required  movement  (e.  g.  going  to  another  room,  reading 
or  having  a  juice)  and  therefore,  actigraphy  could  be  a  useful  tool. 
124 4.3.3.4a  Actigraphy 
The  Actiwatch  (Cambridge  Neurotechnology  Ltd)  is  a  lightweight  wristwatch-like 
electronic  device  that  measures  and  records  physical  movements  by  the  means  of  a 
piezo-electric  accelerometer  that  is  set  up  to  record  the  intensity,  amount  and 
duration  of  movement  (figure  16).  The  corresponding  voltage  produced  is  converted 
and  stored  as  an  activity  count  in  the  Actiwatch  memory  unit.  The  data  collected  are 
then  analysed  via  a  software  package  produced  by  Cambridge  Neurotechnology  Ltd. 
Fiji.  16:  Actiwatch  Given  that  the  Ql-lR  required 
participants  to  `get  out  of  your  bed  ii 
,,  )t  aslcep  within  it  quarter  of  an  hour' 
one  minute  epochs  recorded  by  the 
:  \CTW  were  considered.  It'  there  was 
L  ontinued  movement  for  at  least  16 
minutes,  the  QHR  should  have  been 
applied. 
4.3.3.66  Adherence  Diary 
Adherence  with  the  QHR  was  measured  daily,  from  the  first  night  of 
implementation,  via  a  small  'intervention  diary'  devised  by  the  researcher  by 
adapting  Lichstein's  CBT  adherence  checklist  (personal  communication,  2003).  This 
served  to  collect  data  regarding  whether,  for  each  night  of  intervention,  the  QI  IR  had 
to:  a)  be  applied  to  fall  asleep  and/or  during  the  night  if  awake,  h)  how  many  times, 
c)  after  how  long  it  was  applied  (if  at  all)  and  d)  how  difficult  it  was  to  apply  it 
(measured  on  a  Likert  type  scale:  1-10  with  1=not  difficult  at  all  and  10=  extremely 
difficult)  (appendix  7).  In  order  to  minimise  social  desirability  issues  (e.  g.  pleasing 
125 the  researcher)  participants  were  told  that  their  responses  would  help  the  researcher 
to  understand  the  extent  to  which  people  found  it  difficult  to  implement  the  QHR. 
4.3.3.6c  Adherence  Score 
An  adherence  score  was  calculated  using  the  following  formula: 
Number  of  Times  QHR  was  adhered  to 
Adherence  Score= 
Number  of  Times  Implementation  was  Required 
4.3.3.5  The  Quarter  of  an  Hour  Rule  Intervention 
The  intervention  was  named  The  quarter  of  an  hour  rule'(QI-IR)  and  was  extracted 
from  the  original  protocol  proposed  by  Bootzin  in  1972.  The  QIIR  stated: 
If  you  are  NOT  asleep  within  a  quarter  of  an  hour, 
Then  get  up  and  do  the  chosen  activity  in  the  chosen  room. 
Go  back  to  your  bed  when  you  feel  ready  to  sleep  again. 
The  activity  to  perform  and  the  room  to  go  to  were  decided  by  the  participant  durin" 
the  delivery  of  the  QHR  intervention.  The  words  when  you  feel  sleepy  again'  of  the 
original  protocol  (Bootzin,  1972)  were  changed  into  when  you  feel  ready  to  sleep 
again'  to  reduce  the  impact  of  the  implicit  instruction  of  monitoring  an  internal  sta(c 
for  sleep. 
Participants  were  requested  to  follow  the  instruction  again  if,  once  returned  to  their 
bed  they  were  not  asleep  within  a  quarter  of  an  hour  or  if  they  woke  np  during  the 
night  and  could  not  fall  to  back  to  sleep  within  a  quarter  of  an  hour. 
126 It  was  made  clear  that  clock  watching,  so  as  to  decide  when  a  quarter  of  an  hour 
had  elapsed,  was  to  be  avoided  as  this  might  keep  them  awake  and  to  get  up  if  they 
felt  that  they  had  been  lying  in  bed  for  about  a  quarter  of  an  hour.  The  intervention 
was  delivered  individually,  by  the  researcher,  following  a  written  protocol  (appendix 
12)  and  it  took  only  30  minutes.  A  flow-chart  instruction  sheet  was  given  to 
participants  to  help  them  follow  the  QHR  when  at  home  (appendix  8). 
4.3.4  Procedure 
People  who  replied  to  the  recruitment  email  showing  an  interest  in  the  study  were 
sent  an  information  pack  (appendix  9)  and  they  were  invited  to  contact  the  researcher 
if  they  wanted  to  participate. 
Fig.  17  -  Flow-chart  of  Participants  to  the  study 
Screening  interview  (N=18) 
Not  meeting  criteria 
Meeting  criteria. 
(N=  14)  (N=  4) 
Baseline:  3  weeks 
3  weeks  of  Sleep  Diary  and  2  PSG  measurements 
Sleep  Diary  data  suggested) 
Normal  sleep  Treatment  :  Three  weeks  (N) 
Day 1: 
QHR  delivered 
Sleep  Continuity/quality: 
3  wks  sleep  diary 
Adherence  to  QHR: 
3  wks  actigraphy 
3  wks  adherence  diary 
Telephone  contacts: 
Day  3&  Day  14 
PSG  measurement: 
Last  2  nights  of  treatmcnt 
Questionnaires 
127 Once  potential  participants  replied,  they  were  invited  to  meet  with  the  researcher 
(on  an  individual  basis)  and  sign  a  consent  form.  Eligibility  was  then  assessed  via 
structured  interview  (chapter  3  in  Morin  and  Espie,  2003),  the  PSQI  (Buysse  et  al, 
1989)  and  the  HADS  (Zigmond  and  Snaith,  1983).  Assessment  lasted  around  forty- 
five  minutes.  Participants  not  meeting  criteria  were  debriefed  and  thanked  for  their 
interest  and  time  but  did  not  continue  with  the  study.  Participants  meeting  criteria 
were  trained  in  the  correct  use  of  the  EEG/PSG  recording  equipment  (Trackit, 
section  4.3.3.3a),  had  a  practice  session  and  were  handed  in  a  written  memo 
(appendix  11).  The  practice  session  ensured  that  participants  had  understood  how  to 
set  up  Trackit  properly  and  that  they  felt  comfortable  using  it.  Participants  were  then 
provided  with  the  sleep  diary  to  be  filled  in  each  morning  upon  rising  for  three  weeks 
and  the  EEG/PSG  recording  equipment.  The  training/practice  session  lasted  around 
forty-five  minutes.  The  researcher  collected  the  EEG/PSG  recording  equipment  three 
days  after  this  meeting. 
Three  weeks  after  baseline,  participants  met,  on  an  individual  basis,  with  the 
researcher  who  delivered  the  QHR  intervention  following  a  written  version  so  as  to 
avoid  confounding  in  therapy  outcome  due  to  different  wordings  (appendix  12). 
Participants  were  given  an  easy  to  follow  memo  about  the  QHR  (appendix  8),  were 
instructed  to  keep  completing  the  sleep  diaries  and,  in  addition,  the  `adherence  with 
the  QHR  diary'  (appendix  7)  for  a  further  three  weeks.  Finally,  it  was  explained  that 
the  actiwatch  detected  movement  and  would  provide  the  research  with  information 
regarding  when  they  were  active  or  resting.  They  were  asked  to  wear  the  actiwatch 
all  the  time  (unless  they  were  getting  in  contact  with  water)  during  the  three  week 
128 intervention  and  were  given  a  memo  about  actiwatch  use  (appendix  13).  The 
intervention  session  lasted  around  thirty  minutes. 
During  the  three  weeks  intervention  there  were  two  informal  contacts  (the  third 
and  the  fourteenth  day  of  the  intervention)  over  the  phone,  lasting  no  more  than  10 
minutes  each,  during  which  the  QHR  was  reinforced.  Two  days  prior  to  the  end  of 
the  intervention  period  the  researcher  gave  participants  the  EEG  recording  equipment 
and  reminded  them  how  to  use  it.  The  morning  after  the  second  EEG  night, 
participants  met  with  the  researcher  and  filled  in  the  PSQI.  The  researcher  collected 
comments  (verbatim)  about  their  sleep  and  how  they  felt  about  the  intervention. 
Participants  returned  the  EEG  recording  equipment,  the  sleep  and  adherence  diary 
and  the  Actiwatch.  They  were  fully  debriefed  and  their  sleep  results  were  sent  to 
them  within  a  month.  This  session  lasted  around  forty-five  minutes. 
4.3.5  Data  Analysis 
Efficacy  of  the  QHR  was  explored  via  subjective  (sleep  diary)  and  objective 
(PSG  recording)  measures  of  SOL  and  WASO.  Daily  sleep  diary  data  were  first 
analysed  by  visual  inspection  of  graphic  representations,  a  standard  method  used  in 
single  case  studies  (Franklin,  Gorman,  Beasley  and  Allison,  1996).  Thereafter 
Interrupted  Time  Series  Analyses  (ITSACORR,  Crosbie,  1993)  were  conducted  to 
determine  whether  visually  observed  changes  between  baseline  and  post  intervention 
were  statistically  significant.  Time  series  analysis  permits  identification,  across 
adjacent  (baseline  and  treatment)  phases  in  an  experimental  design,  of  level  change 
(abrupt  change  in  the  mean  level  of  the  data)  and  slope  change  (gradual  change)  once 
the  treatment  is  introduced. 
129 In  accordance  with  Lichstein  and  Fischer's  (1985)  and  Kazdin's  (1980)  proposal, 
the  following  indices  of  clinical  significance  of  results  (therapeutic  gains  obtained  at 
outcome)  were  employed:  i)  SOL  and  WASO  shorter  than  31  minutes  and  SE  greater 
than  85%,  ii)  PSQI  global  score  equal  to  or  less  than  5  (which  measure  provided 
collateral  validation  of  measures  obtained  via  sleep  diaries)  and  iii)  individual  subject 
variable  effect  sizes.  These  were  calculated  by  dividing  the  pre-post  treatment 
change  by  the  pooled  standard  deviation.  A  positive  effect  size  indicated  a  reduction 
in  insomnia  symptomology. 
No  inferential  statistics  were  calculated  for  objective  sleep  data  or  adherence. 
Objective  sleep  continuity  data  were  compared  to  subjective  data.  As  already 
mentioned,  Biosleep  provides  pseudo  R&K  and  sleep  architecture  values  were 
reported.  Adherence  scores  and  participants'  comments  regarding  applying  the 
QHR  were  reported. 
4.4  Results 
4.4.1  Participants'  Characteristics 
Participant  P1  was  a  25  years  old  male  complaining  of  both  sleep  onset  and  sleep 
maintenance  difficulties  since  the  age  of  sixteen.  He  could  not  relate  the  onset  of 
sleep  difficulties  to  any  particular  event.  He  had  a  higher  degree,  was  working  full 
time,  and  shared  a  flat  with  two  friends.  He  did  not  have  a  regular  bed  partner. 
Participant  P2  was  a  female  third  year  accountancy  undergraduate  student,  22 
years  of  age,  who  complained  of  having  had  sleep  onset  and  sleep  maintenance 
130 difficulties  for  eighteen  months  (grandmother  died).  She  was  sharing  a  flat  with  two 
people  and  did  not  have  a  regular  bed  partner. 
Participant  P3  was  a  45  years  old  final  year  history  undergraduate  student, 
married  and-  with  no  children.  His  sleeping  difficulties  started  in  his  mid-twenties 
probably  due  to  shift  work.  His  sleep  difficulties  had  not  disappeared  despite  having 
left  the  army  (and  shift  work)  for  over  15  years.  He  complained  of  difficulties  falling 
asleep. 
Participant  P4  was  a  male  support  worker  aged  32,  who  complained  of  both  sleep 
onset  and  sleep  maintenance  difficulties  and,  particularly,  of  not  feeling  refreshed  in 
the  morning  (non-restorative  sleep).  His  sleep  difficulties  started  when  he  was  a 
teenager  and  his  family  moved  from  south  of  England  to  Scotland  and  he  was  teased 
at  school  for  his  accent.  Criteria  of  psychophysiologic  insomnia  were  met  at  intake, 
however,  analysis  of  the  three  weeks  baseline  showed  that  all  sleep  parameters  were 
within  the  norms  for  good  sleepers  (hence  not  confirming  intake  diagnosis).  For  this 
reason  he  was  excluded  from  the  study.  He  was  fully  debriefed,  and  the  good 
sleeping  guide  prepared  by  Espie,  together  with  a  sleep  relaxation  tape,  were  given  to 
the  participant. 
4.4.2  Sleep  Pattern  Changes:  Visual  Inspection  of  Sleep  Diary  Data  and  ITSA 
4.4.2.1  Complaint  of  difficulty  of  fallin  asleep  (SOL) 
Figure  18  presents  SOL  data  for  P1,  P2  and  P3.  Baseline  values  reflect  typical 
sleep  pattern  variations  inherent  in  insomnia  with  no  indication  of  spontaneous 
improvement.  Mean  values  for  each  phase  are  presented  in  table  8. 
131 Following  intervention  with  the  QHR,  Pl's  mean  SOL  reduced  by  24%  (table  8) 
although  visual  inspection  of  figure  18a  does  not  reveal  a  clear  pattern  of  change.  By 
contrast  P2's  SOL  reduced  by  35%  and  in  particular  only  3  out  of  the  23  treatment 
nights  were  in  the  clinical  range  (greater  than  31  minutes)  compared  with  8  in  the  22 
baseline  nights.  Visual  inspection  suggests  reduced  variability  in  sleep  pattern.  ITSA 
revealed  a  trend  with  regard  to  change  in  slope  [t(39)=  -1.75,  p=0.08]  from  baseline 
to  treatment  for  P1.  With  regard  to  P3,  this  participant  never  applied  the  QHR during 
the  21  intervention  nights  and  it  is  not,  therefore,  surprising  that  no  changes  were 
observed  between  baseline  and  intervention  periods. 
Fig.  18:  Daily SOL  at  Baseline  and  Intervention 
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132 4.4.2.2  Complaint  of  difficulty  of  staying  asleep  (WASO) 
Figure  19  presents  WASO  data  for  P1,  P2  and  P3.  Baseline  values,  again,  reflect 
typical  sleep  pattern  variations  inherent  in  insomnia  with  no  indication  of 
spontaneous  improvement.  Mean  values  for  each  phase  are  presented  in  table  8. 
Fig  19:  Daily  WASO  at  Baseline  and  Intervention 
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Fig  19b:  P2's  dally  WASO  for  baseline  and  Intervention 
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Visual  inspection  of  fig.  19a  suggests  decrease  in  WASO  for  P1  confirmed  by 
mean  reduction  of  28  minutes  (67%,  table  8),  in  particular  14  out  of  the  21  nights  of 
baseline  were  in  the  clinical  range  (greater  than  31  minutes),  but  none  of  the  23  post- 
intervention  nights  were.  Reduction  in  WASO  for  P2  was  less  marked  (37%) 
nonetheless  5  of  the  23  post-intervention  nights  were  in  the  clinical  range  compared 
with  9  out  of  the  22  baseline  nights.  It  should  be  noted  that  she  was  camping  at  a 
133 concert  site  during  nights  10,11  and  12  of  the  intervention  phase  and  people  were 
coming  and  going  all  night.  ITSA  confirmed  a  significant  overall  change 
[F(2,39)=4.61,  p=0.02]  and  a  significant  change  in  slope  [t(39)=  -2.06,  p=0.05]  from 
baseline  to  treatment  for  participant  P1. 
4.4.3  Clinical  Significance 
Clinical  significance  was  evaluated  on  three  indices:  end  state  scores  for  SOL, 
WASO,  S.  E.  and  PSQI  global  score  change  and  effect  sizes.  In  particular  clinical 
significance  was  measured  on  two  criteria:  a  post-treatment  change  over  baseline 
greater  than  50%  (Lichstein  and  Fischer,  1985)  and/or  the  individual  has  moved  from 
the  dysfunctional  to  the  functional  range  (Kazdin,  1977). 
As  depicted  in  table  8,  Pl's  WASO  and  S.  E.  and  P2's  SOL  and  WASO  returned 
within  the  normative  average  range  following  intervention.  In  addition,  outcome 
measure  on  the  PSQI  showed  a  significant  improvement  following  QHR  intervention 
for  both  participants.  Although  their  PSQI  scores  did  not  quite  fall  below  the 
recognised  threshold  for  sleep  disturbance  (55)  scores  were  reduced  by  50%:  from 
13  to  6  (P1)  and  from  14  to  7  (P2)  respectively.  It  is  noteworthy  that  a  significant 
improvement  was  found  for  the  PSQI  component  score  `subjective  sleep  quality', 
which  changed,  following  intervention,  to  `fairly  good'  for  both  P1  and  P2  (table  8). 
Finally,  SOL  effect  sizes  were  in  the  small  to  medium  range,  and  WASO  and  S.  E. 
effect  sizes  in  the  medium  to  large  range  for  both  participants.  With  regard  to  P3,  he 
did  not  show  positive  changes  in  the  above  mentioned  values  following  treatment. 
His  PSQI  score  changed  from  9  to  8  and  his  PSQI  component  score  'subjective  sleep 
quality'  changed  from  `fairly  bad'  to  `fairly  good'. 
134 la)  Mean  (SD)  for  SOL  WASO  and  SE  at  baseline  and  post-  intervention, 
post-treatment  changes  and  effect  sizes 
Baseline  Post-Interv  Pre  to  Post  Change  Treatment 
Value  17f  EtTect  Size 
PI  47.1(33.4)  35.6(25.3)  -  11.5  24.4  0.39 
P2  45.0(50.3)  29.1(40.6)  -  15.9  35.3  0.35 
P3  74.5(  8.3)  73.4(  4.0)  -  1.1  1.5  0.17 
P1  42.9(19.0)  14.3(14.4)  -  28.6  66.6  1.69 
P2  40.2(36.3)  25.2(35.4)  -  15.0  37.3  0.42 
P3  4.5(6.5)  13.4(20.6)  +  8.9*  66.4  *-0.58* 
WASO  worsen  ed  in  the  intervention  period 
S.  E.  (%) 
P1  75(11)  86(11)  II  14.6 
P2  64(16)  74(14)  10  15.6 
P3  84(03)  82(05)  -  2*  2.4* 
*  this  value  shows  a  deterioration  of  sleep  variables  from  baseline  to  F 
Ib)  PSQI  at  1'`  day  baseline  and  23  `d  day  post-intervention 
O.  y1) 
0.67 
-  O.  75* 
t-trea(Illellt 
PSQI  global  score  PSQI  `subjective  sleep  quality'  component 
Baseline  Post-Interv  Baseline  Post-Interv 
P1  13  6  Fairly  bad  Fairly  good 
P2  14  7  Very  bad  Fairly  good 
P3  98  Fairly  bad  Fairly  good 
4.4.4  Objective  Sleep  Continuity  Data 
Table  9  presents  the  sleep  continuity  and  sleep  architecture  data  recorded  during 
the  second  night  of  baseline  and  the  last  night  of  treatment. 
Inspection  of  table  9  shows  that  Participant  Pi's  objective  SOL  and  WASO  were 
shorter  the  last  night  of  treatment  than  at  baseline,  participant  P2's  SQL  decreased 
and  participant  P3's  SOL  and  WASO  increased.  The  objective  and  subjective  data  do 
not  show  any  clear  association.  It  is  noteworthy  that  pseudo  R&K  values  for  REM 
1  35 are  extremely  high  as  compared  to  those  reported  in  the  literature  (p.  16)  for  hoth 
normal  and  poor  sleepers. 
Table  9-  Sleep  Continuity  Variables  gathered  by  PSG  at  Baseline  (night  2) 
and  during  the  Last  Night  of  Treatment  Phase  (and  correspondent  diary  values) 
BASELINE  END  OF  TREATMENT 
PSG  Diary  Pseudo  R&K  PSG  Diary  Pseudo  R&K 
Participant  Pl 
S.  E.  0.92  0.61  0.98  0.97 
WASO  29  60  70 
SOL  9  40  1  15 
%  REM  54.9%  85.2% 
%  Stage  1  12.2%  12.6% 
%  Stage  2  20.3%  22% 
%  Stage  3&4  12.6%  0.0% 
Participant  P2 
S.  E.  0.95  0.88  0.92  0.97 
WASO  9  0  30  0 
SOL  10  30  1  20 
%  REM  39.5%  40.2x% 
%  Stage  1  3.8%  20.7% 
(/  Stage  2  11.1%  12.8% 
%  Stage  3&4  45.6%  26.2(7( 
Participant  P3 
S.  E.  0.98  0.71  0.93  0.79 
WASO  4  35  25  15 
SOL  0  80  23  80 
%  REM  54%  58% 
%  Stage  1  13%  15% 
%  Stage  2  20%  17% 
%  Stage  3&4  13%  10% 
4.4.5  Adherence  with  the  Quarter  of  an  Hour  Rule 
Participant  P1  reported  (daily  adherence  diary)  applying  the  QHR  at  SOL  93%%c  of' 
the  times  (14  of  15)  he  was  not  asleep  within  a  quarter  of  an  hour.  Data  gathered  via 
actigraphy  showed  that  there  was  movement  on  13  occasions.  With  regard  to  WASO 
participant  P1  stated  that  he  never  had  to  apply  the  rule.  However,  actigrahhv 
recorded  seven  periods  of  movements  greater  than  16  minutes  suggesting  that  he 
should  have  applied  the  rule  at  least  7  times  during  the  intervention  phase. 
136 P2  applied  the  QHR  70%  of  the  times  (12  of  17)  she  was  not  asleep  within  a 
quarter  of  an  hour  at  SOL  and  data  gathered  via  actigraphy  confirmed  that  there  was 
movement  at  SOL  in  12  occasions.  With  regard  to  WASO,  participant  P2  applied  the 
rule  only  29%  of  the  times  (2  out  of  7)  she  did  not  return  to  fall  asleep  within  15 
minutes  and  actigraphy  detected  movement  on  7  occasions. 
Participant  P3  never  applied  the  rule. 
4.4.6  Adherence  Comments 
PI  commented  that  he  wanted  to  "really  give  it  a  try",  noticed  the  intervention 
helped  his  sleep  and  this,  in  turn,  made  him  "more  determined  to  follow  the  rule  ". 
he  enjoyed  "reading  my  book"  instead  of  "turning  in  my  bed  wondering  whether  I 
will  fall  asleep  and  thinking  about  everything  until  eventually  I  fall  asleep  ". 
P2  felt  that  by  staying  in  bed,  even  if  awake,  she  could  not  be  blamed  for  her  poor 
sleep  "It  shows  I  am  really  trying  to  sleep  it  is  not  my  fault  if  I  can  not".  For  the 
same  reason  it  was  hard  for  her  to  stay  up  till  she  felt  ready  to  sleep  again  "I  feel 
obliged  to  go  back  and  try  hard  to  sleep".  Having  the  QHR  to  apply  enabled  her  to 
"get  rid  of  the  blame"  and,  therefore,  to  "stop  trying  harder  and  harder  and  getting 
more  frustrated'. 
P3  did  not  apply  the  rule.  When  the  researcher  met  the  participant  to  debrief  him, 
he  said  that  he  had  realised  that  "family  and  friends  know  I  don't  sleep" and  "I  can 
get  on  with  my  study  and  things  at  my  own  pace".  He  told  the  researcher  that  not 
sleeping  much  at  night  and  then  having  a  nap  actually  suited  him  ok. 
137 4.5  Discussion 
In  this  section  results  are  discussed  in  relation  of  the  feasibility  of  employing  the 
QHR  as  a  stand  alone  therapy  and  in  relation  to  design  improvements  for  the  main 
study  (study  three).  A  more  general  discussion  is  provided  when  results  of  the  main 
study  are  analysed  and  general  issues  raised. 
4.5.1  Summary  of  the  Results 
The  primary  aim  of  this  study  was  to  explore  if  the  QHR  would  reduce 
symptomatic  sleep  complaint  at  a  meaningful  clinical  level.  In  addition,  this  study 
explored  the  possibility  of  acquiring  meaningful  PSG  data  by  recording  at  one  site 
only.  Finally  this  study  assessed  daily  adherence  and  participants'  comments 
regarding  the  implementation  of  the  QHR.  The  feasibility  of  actigraphy  to  measure 
adherence  objectively  was  also  explored. 
Two  specific  predictions  were  made.  The  first  prediction  was  that,  following  the 
QHR,  participants'  estimates  of  SOL  and  WASO  would  be  reduced  and  S.  E. 
increased.  This  prediction  was  partially  supported.  Inspection  of  SOL  and  WASO 
mean  and  raw  score  values  suggested  that  the  QHR  was  associated  with  positive 
improvements  in  the  two  participants  (P1  and  P2)  who  applied  the  QHR. 
Conservative  time  series  analyses  evidenced  statistically  significant  changes  in 
WASO,  and  a  trend  toward  significance  for  SOL  for  participant  P1.  Objective 
measures  of  sleep  did  not  show  a  clear  trend:  P1's  SOL  and  WASO  and  P2's  SOL 
were  reduced. 
138 The  second  prediction  was  that  the  QHR  would  produce  clinically  significant 
improvements.  This  prediction  was  also  supported.  WASO  of  participants  P1  and  P2, 
P2's  SOL  and  P1's  S.  E.  fell  within  the  normative  range  at  post-treatment  and  their 
PSQI  global  scores  were  reduced  by  50%,  approaching  normal  range. 
Another  aim  of  this  study  was  to  collect  adherence  information.  Results 
suggested  that  better  adherence  (participant  P1  reported  following  the  QHR  most  of 
the  time)  was  associated  with  more  convincing  data  evidencing  change  (including 
ITSA).  It  is  noteworthy  that  participant  P2  obtained  therapeutic  gains  despite  partial 
adherence  to  the  protocol.  Importantly  participant  P3  never  adhered  to  the  QHR  and, 
indeed,  his  sleep  did  not  improve. 
With  regard  to  objective  measures  of  sleep  acquired  via  Trackit  and  analysed  via 
a  novel  program  requiring  EEG  recording  at  one  site  only,  no  clear  patterns  were 
found.  Importantly,  sleep  architecture  data  differed  greatly  from  those  reported  in 
EEG  literature  for  both  normal  and  poor  sleepers. 
4.5.2  Interpretation  of  the  Results 
As  reported  in  the  previous  section,  following  the  QHR  sleep  difficulties  were 
decreased  in  two  out  of  three  participants.  With  regard  to  the  participant  whose  sleep 
did  not  improve,  it  is  noteworthy  that  he  never  adhered  to  the  QHR.  Interestingly, 
these  results  are  comparable  to  those  obtained  in  previous  studies  of  the  full  stimulus 
control  treatment  and  of  multicomponent  CBT  (Morin  et  al,  1994). 
Effect  size  calculations  indicated  that  treatment  gains  were  in  the  small  to 
moderate  range  for  SOL  and  in  the  moderate  to  large  range  for  WASO.  Previous 
studies  have  reported  larger  effect  sizes  for  SOL  (Morin  et  al,  1994;  Morin  et  al, 
139 1999;  Murtagh  and  Greenwood,  1995)  but  initial  insomnia  severity  in  the  present 
study  was  moderate  thus  limiting  power.  Indeed,  a  positive  relationship  between 
SOL  and  WASO  reductions  and  initial  insomnia  severity  in  clinical  samples  has  been 
found  in  previous  studies  (Espie  et  al,  2001;  Lacks  et  al,  1983a). 
Importantly,  for  the  two  participants  who  applied  the  intervention,  improvements 
were  also  clinically  significant  with  sleep  parameters  and  PSQI  scores  reduced  by 
50%  or  returned  to  normalcy.  Furthermore  both  participants  PI  and  P2  reported 
greater  satisfaction  with  their  sleep.  This  is  an  important  finding  as  perception  that 
one's  quality  of  sleep  has  improved,  rather  than  insomnia  symptoms  simply  being 
less,  might  be  critical  to  reduce  the  psychological  distress  often  accompanying 
insomnia  (Morin  et  al,  1994).  Subjective  distress  may  be  the  primary  motivation 
prompting  people  with  insomnia  to  seek  treatment  (Stepanski,  Koshorek,  Zorick, 
Glinn,  Rohers,  and  Roth  1989). 
In  sum,  three  weeks  after  the  delivery  of  the  QHR  (a  single  session  intervention 
requiring  30  minutes  to  be  delivered)  positive  effects,  on  both  quality  of  sleep  and 
sleep  parameters,  were  obtained. 
Adherence  data  are  important  both  from  a  clinical  (adherence-response 
relationship)  and  theoretical  (mechanisms  of  effect)  point  of  view.  An  interesting 
finding,  which  highlights  the  need  to  research  the  issue  systematically,  regards  the 
adherence-response  relationship.  Chambers  (1992)  proposed  that  adherence  might  be 
the  most  important  factor  in  treatment  success:  indeed,  better  adherence  (P1)  was 
associated  with  more  convincing  data  evidencing  change  (including  ITSA). 
However,  despite  partial  adherence  to  the  protocol,  therapeutic  gains  were  also 
obtained  by  participant  P2.  This  was  an  unexpected  result:  in  light  of  Bootzin  and 
140 Epstein's  (2000)  suggestion  that,  for  stimulus  control  to  work,  participants  must 
follow  the  instructions  `fastidiously'  (p.  175),  it  was  assumed  that  the  QHR  was  to  be 
followed  consistently  and  rigorously  to  produce  sleep  changes.  Perhaps  factors  other 
than  adherence  (e.  g.  feeling  in  control)  played  a  role. 
Participant  P1's  comments  suggest  that  the  QHR  might  help  the  individual  to  feel 
differently  about  the  time  spent  awake:  rather  than  a  frustrating  period  it  becomes 
acceptable,  even  enjoyable.  Speculatively,  it  could  be  argued  that  the  QHR,  by 
preventing  the  individual  from  using  the  time  awake  worrying,  enabled  him  to  reach 
the  `right  conditions'  to  fall  asleep.  On  the  other  hand,  it  is  possible  that  the  QHR 
`broke'  the  association  bedroom-wakefulness  (i.  e.  sleep  improvements  were  due  to 
good  stimulus  control)  but  that  the  participant  interpreted  sleep  improvement  in  a 
cognitive  way. 
Participant  P2  waited  longer  than  fifteen  minutes  before  applying  the  QHR  most 
times  (67%)  and  her  comments,  not  only  highlight  one  of  the  causes  of  non- 
adherence,  but  are  also  an  example  of  `effortful  sleep'  typical  of  insomnia  yet  so 
atypical  of  `normal  sleepers'  (Espie,  2002).  However,  her  sleep  improved  and  it 
could  be,  tentatively,  suggested  that  the  QHR  by  removing  her  responsibility  for  not 
being  able  to  sleep  (she  would  have  tried  harder  but  the  QHR  did  not  allow  her) 
enabled  her  to  `do  nothing'  and  hence  fall  asleep.  As  proposed  by  Espie  (2002)  good 
sleepers  do  not  try  or  do  something  to  fall  asleep:  they  just  seem  to  do  it. 
Overall  these  comments  are  in  line  with  Zwart  and  Lisman's  (1979)  proposal  that 
stimulus  control  might  work  by  disrupting  cognitive  activity  at  bedtime:  be  it 
thinking,  planning,  trying  to  sleep.  Indeed,  the  six  participants  in  Turner  and 
Ascher's  (1979a,  b)  studies  pointed  out  that  stimulus  control  provided  them  with  a 
141 means  of'avoiding  thinking  while  lying  in  bed.  Although  this  is  an  interesting 
proposal  further,  direct  testing,  of  this  hypothesis  should  be  devised. 
This  study  suggested  that  home  PSG  was  well  tolerated  as  participants 
commented  on  Trackit  being  easy  to  carry  around  (e.  g.  going  to  the  bathroom, 
watching  TV  in  the  sitting  room,  making  a  cup  of  tea)  and  that  the  recording 
equipment  minimally  disrupted  their  usual  sleep.  However,  Biosleep  output 
displayed  very  high  percentage  of  REM  sleep  and  little  percentage  of  Stg  2  sleep  as 
compared  to  PSG  scored  according  to  R&K  guidelines.  This  finding  argues  against 
recording  EEG  at  only  one  site  and  analysing  data  employing  Biosleep  because 
output  does  not  seem  valid. 
In  sum,  this  exploratory  study  highlighted  that  the  QHR,  requiring  only  30 
minutes  to  be  explained,  might  be  a  promising  therapy  for  insomnia.  In  addition 
home  PSG  was  well  tolerated  and  participants  reported  that  they  were  able  to  apply 
the  QHR. 
4.5.3  Considerations  for  the  main  study 
As  summarised  and  discussed  in  the  previous  section  the  results  of  this 
preliminary  study  are  encouraging:  one  single  session  followed  by  a  couple  of 
telephone  contact  were  sufficient  to  decrease  sleep  difficulties  and  outcomes  were 
clinically  significant.  The  two  participants,  who  applied  the  QHR,  responded  quickly 
to  treatment,  reported  good  adherence  and  that  home  PSG  was  minimally  intrusive. 
Furthermore  this  study  highlighted  changes  to  the  methodology  so  as  to  better 
calibrate  the  main  study.  In  particular  the  following  points  were  noted. 
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quickly  and  at  modest  cost  and  it  is,  therefore,  well  suited  to  test  novel  interventions. 
Indeed,  the  present  single  case  study  suggested  that  the  QHR,  a  novel  intervention 
requiring  minimal  contact  with  the  therapist,  decreases  sleep  difficulties.  However, 
without  a  contrast  intervention  it  is  hard  to  assess  whether  any  therapeutic  gains  are 
attributable  to  the  QHR  itself  or  to  other  factors  such  as  passage  of  time  or  contacts 
with  a  therapist  or  the  measurement  process  itself  (i.  e.  monitoring  one's  sleep).  The 
randomised  controlled  trials,  which  compare  two  or  more  treatments  (one  of  which 
can  be  no-treatment)  can  help  to  address  this  issue.  It  seems,  therefore,  advisable,  to 
carry  out  the  next  study  employing  this  methodology. 
Second,  although  participants  to  the  present  study  met  criteria  for 
psychophysiological  insomnia,  they  were  self-referred.  In  order  to  explore  the 
generalisability  of  the  QHR  outcomes  the  main  study  involved  GPs'  and  consultants' 
referred  participants. 
Third,  in  order  to  shed  light  on  whether  the  mechanisms  of  effects  of  the  QHR  are 
purely  due  to  environmental  conditioning  and  the  re-establishment  of  good  stimulus 
control,  a  counter  control  intervention  (Zwart  and  Lisman,  1979)  could  be  employed. 
For  this  reason  a  counter  QHR  instructing  participants  to  apply  the  QHR  in  bed  was 
devised  and  its  outcomes  contrasted  to  those  of  the  canonical  QHR. 
Fourth,  although  actigraphy  may  have  a  value  in  monitoring  adherence,  the 
present  study  highlighted  that  actigraphy  can  only  indicate  if  the  person  is  moving 
but  does  not  evidence  whether  the  QHR  is  actually  adhered  to.  It  was  reasoned  that  if 
the  QHR  asked  participants  to  read  if  not  asleep,  then  actigraphy  with  the  added 
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main  study  objective  adherence  was,  therefore,  measured  with  actigraphy  plus  light. 
Fifth,  the  pilot  study  highlighted  that  home  PSG  is  feasible  and  well  tolerated  but 
that  Biosleep  has  limited  validation:  it  produces  pseudo  R&K  and  data  seems 
implausible  (note  the  REM  for  example).  In  the  main  study  home  PSG  was  carried 
out  according  to  insomnia  PSG  recording  criteria  so  as  to  enable  traditional  R&K 
scoring  and  interpretation  of  the  collected  EEG  data. 
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Study  Three 
Impact  of  the  quarter  of  an  hour  rule  intervention,  implemented 
in  bed  and  out  of  bed,  on  sleep  parameters 
5.1  Rationale 
The  results  obtained  with  the  single  case  studies  in  the  preliminary  study  (study 
two,  chapter  4)  suggested  that  the  QHR  might  be  a  promising  therapy  for  insomnia 
and,  therefore,  worth  exploring  in  a  more  systematic  way.  In  addition,  taking  into 
account  the  methodological  shortcomings  highlighted  by  the  preliminary  study,  a 
number  of  changes  were  made  with  regard  to  sleep  measurements,  objective 
measurement  of  adherence  and  procedure.  Furthermore,  sleep  related  questionnaires 
were  introduced  in  order  to  shed  light  on  the  mechanism  of  effects  of  the  QHR.  The 
QHR  was  administered  in  two  different  formats  and  a  control  group  was  added. 
Briefly,  this  study  comprised  three  groups  (QHR  in  bed,  QHR  out  of  bed  and 
Control).  Similarly  to  the  preliminary  study  sleep  parameters  were  measured 
subjectively  and  objectively;  however,  unlike  study  two,  home  PSG  measurements 
were  performed  employing  traditional  recording  sites  as  per  R&K  (Rechtschaffen 
and  Kales,  1968).  As  in  study  two  objective  and  subjective  measures  of  adherence 
were  also  collected;  however  the  objective  measure  of  adherence  incorporated  both 
detection  of  movement  and  light.  Finally,  a  battery  of  sleep  related  questionnaires, 
tapping  into  sleep  related  cognitions,  behaviours  and  arousability  at  bed  time,  was 
administered  at  baseline  and  at  the  end  of  the  intervention. 
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The  first  aim  of  study  three  was  to  assess  whether  the  QHR,  proposed  to  capture 
the  essence  of  the  stimulus  control  therapy  for  insomnia,  could  be  employed  to 
reduce  sleep  difficulties  in  a  clinical  population. 
The  second  aim  of  the  present  research  was  to  explore  possible  mechanisms  of 
effect  of  the  QHR.  This  exploration  was  carried  out  by  devising  two  QHR 
interventions:  one  to  be  implemented  out  of  bed  (QHRout)  and  one  to  be 
implemented  in  bed  (QHRin).  Additionally,  sleep  related  questionnaires  measuring 
sleep  behaviours  and  cognitive  activity  at  bed  time  were  employed. 
The  third  aim  was  to  investigate  the  relationship  between  adherence  and 
treatment  response  and  to  look  into  the  feasibility  of  an  objective  measurement  of 
adherence. 
Specifically  the  following  predictions  were  made: 
.  First,  resting  on  the  same  bases  discussed  in  the  rationale  of  study  two,  it  was 
predicted  that  participants'  self  reported  SOL  and  WASO  would  be  reduced  and  TST 
and  S.  E.  increased  following  the  QHRout  intervention. 
The  second  prediction  rested  on  evidence  presented  in  the  introduction  (Alperson 
and  Biglan,  1979;  Zwart  and  Lisman,  1979;  Davies  et  al,  1986)  that  a  procedure 
named  `countercontrol'  improved  sleep.  Specifically,  it  was  predicted  that  self- 
reported  SOL  and  WASO  would  decrease  and  TST  and  S.  E.  would  increase 
following  the  QHRin  intervention. 
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interventions,  the  control  group  condition  would  not  impact  on  SOL,  WASO,  S.  E.  or 
TST. 
Fourth,  it  was  predicted  that  the  outcome  measure  PSQI  (Buysse  et  al,  1989)  at 
the  end  of  the  intervention  would  be  reduced,  as  compared  to  baseline,  in  both  QHR 
groups.  No  changes  in  PSQI  were  expected  for  the  control  group. 
Fifth,  improvements  in  reported  qualitative  measures  of  sleep  (i.  e.  quality  of 
sleep,  restedness  and  alertness  upon  awakening  in  the  morning)  were  expected 
following  intervention  only  for  the  active  treatment  groups. 
Sixth,  in  view  of  evidence  that  stimulus  control  produces  clinically  significant 
changes  (e.  g.  Bootzin,  1972;  Sanavio  et  al,  1990)  and  the  results  of  the  pilot  study,  it 
was  predicted  that  participants  in  the  active  treatment  groups  would  meet  criteria  for 
clinically  significant  changes  as  compared  to  the  control  group.  However,  no 
predictions  were  made  with  regard  to  the  differential  magnitude  of  improvements 
obtained  with  the  two  different  administrations  of  the  QHR. 
No  firm  predictions  were  made  with  regard  to  sleep  related  cognitions  (e.  g.  sleep 
effort,  sleep  beliefs)  and  arousability  at  bedtime  measured  via  questionnaires.  As 
discussed  in  the  introduction  a  number  of  authors  (e.  g.  Espie,  1991,  Turner  and 
Ascher,  1979a,  b;  Zwart  and  Lisman,  1979)  have  suggested  that  stimulus  control 
reduced  sleep  difficulties  not  only  by  re-conditioning  mechanisms  but  also  by 
decreasing  cognitive  interference.  If  this  was  the  case  then  a  decrease  in  cognitive 
activity  would  be  expected.  In  contrast,  if  the  mechanisms  of  effect  were  solely 
related  to  re-conditioning  then  no  differences  in  sleep  related  cognitions  should  be 
found. 
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regard  to  objective  changes  following  non-pharmacological  insomnia  interventions 
(Stepanski,  2000)  no  firm  predictions  were  made  with  regard  to  changes  in  PSG 
defined  sleep. 
Seventh,  it  was  predicted  that  sleep  continuity  parameters  measured  via  PSG  and 
via  sleep  diary  would  be  positively  correlated.  This  prediction  rests  on  evidence  (e.  g. 
Carskadon  et  at,  1976;  Schramm  et  at,  1995)  that  sleep  diary  and  PSG  are  correlated 
although  sleep  continuity  parameters  seem  to  be  inflated  as  compared  to  objective 
ones. 
The  eighth  prediction  rested  on  claims  that  adherence  might  be  an  important 
aspect  of  treatment  response  (section  1.81):  specifically  it  was  predicted  that  greater 
adherence  to  treatment  would  be  associated  with  better  outcomes. 
The  third  study  set  out  to  test  these  eight  predictions  and  to  shed  light  on  the  two 
research  questions. 
5.3  Methods 
5.3.1  Design 
This  was  a  randomised  experimental  controlled  trial  (Clinical  Registration  N. 
NCT00170391)  investigating  the  efficacy  of  the  QHR  carried  out  in  bed  (QHRin) 
and  out  of  bed  (QHRout)  as  compared  with  a  sleep  self-monitoring  group  (control), 
using  parallel  measurements  of  objective  and  subjective  sleep  parameters,  taken  at 
baseline  and  post-treatment.  The  impact  of  the  QHR  interventions  on  a  number  of 
cognitive  factors  was  investigated  by  employing  six,  well-validated  questionnaires. 
They  are  commonly  used  in  sleep  research  (section  5.3.3.2a  provides  a  detailed 
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investigated  both  subjectively  (adherence  diary)  and  objectively  (actigraphy  plus 
light).  Randomisation  was  performed  by  the  statistics  department  at  Glasgow 
University:  a  random  sequence,  controlling  for  participants'  gender,  was  generated 
by  SPSS. 
This  quasi-experiment  with  a  mixed  design  had  one  between  subject  factor 
`Group'  with  three  levels  ('QHRout',  'QHRin'  and  `control')  and  one  within  subject 
factor  `Time'  with  two  levels  ('baseline'  and  `end  of  treatment'). 
Table:  10  -  Dependent  Variables  for  PSQI,  Sleep  Continuity,  Sleep  Quality, 
Questionnaires  and  Adherence  with  the  QHR 
Subjective  Objective 
Diary  Questionnaire  PSG  ACTW.  L 
PSQI 
PSQI  Total  Score  --  ￿  --  -- 
Sleep  Continuity 
SOL  (minutes)  ￿  --  ￿  -- 
WASO  (minutes)  ￿  _  ￿ 
S.  E.  (%)  ￿  _  ￿  -. 
TST  (minutes)  ￿  --  ￿ 
Number  of  Arousals  --  --  ￿ 
Sleep  Quality 
Quality  of  Sleep  (0-4)  ￿  _  -- 
Restedness  (0-4)  ￿  --  -- 
Alertness  (0-4)  ￿  _  _  -- 
Stage  1&2  (%)  --  --  ￿  -- 
Stage  3&4  (%)  --  -  ￿ 
REM  (%)  --  --  ￿  -- 
Sleep  related  Cognitions 
Q1:  Total  Sleep  Behaviour  --  ￿  -- 
Q2:  Glasgow  Sleep  Effort  --  ￿  --  -- 
Q3a:  Physical  Tension  --  ￿  --  -- 
Q3b:  Sleep  Pattern  Problem  -  ￿  --  -- 
Q3c:  Cognitive  Arousal  --  ￿  -- 
Q3d:  Sleep  Effort  --  ￿  --  -- 
Q4a:  Problem  Solving  --  ￿  -- 
Q4b:  Sleep  &  Wakefulness  --  ￿  --  -- 
Q4c:  Somatic  &  Sensory  Engagement  --  ￿  _  -- 
Q5a:  Cognitive  Arousal  --  ￿  -- 
Q5b:  Somatic  Arousal  --  ￿  --  -- 
Q6a:  Immediate  Consequence  of  Insomnia  --  ￿  --  -- 
Q6b:  Long-term  Consequence  of  Insomnia  --  ￿  _  -- 
Q6c:  Need  for  Control  over  Insomnia  -  ￿  --  -- 
Adherence  with  the  QHR 
Adherence  score  at  SOL  (0-10)  ￿  --  --  ￿ 
Adherence  score  at  WASO  (0-10)  ￿  --  --  ￿ 
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basis  of  participants'  responses  to  a  nightly  sleep  diary)  and  objectively  (on  the  basis 
of  PSG  recordings).  The  sleep  continuity  dependent  variables  (DVs),  sleep  quality 
DVs,  battery  of  questionnaires  DVs,  adherence  with  the  QHR  DVs  and  whether  they 
were  objectively  or  subjectively  collected  are  listed  in  table  10. 
5.3.2  Participants 
Eighty-three  individuals  were  screened.  They  were  recruited  via  GP  practices,  a 
sleep  clinic  at  the  Southern  General  Hospital  and  via  a  media  advertisement.  People 
who  responded  to  the  media  advertisement  were  invited  to  speak  to  their  GP  and  ask 
to  be  referred.  Participants'  insomnia  was  assessed  according  to  DSM-IV  (APA, 
1994)  and  ICSD-R  (ASDA,  1997)  diagnostic  guidelines  first  during  a  telephone 
interview  and  then  during  a  face-to-face  interview. 
Inclusion  and  exclusion  criteria  were  identical  to  those  applied  in  the  preliminary 
study  (study  two,  section  4.3.2).  Thirty-nine  possible  participants  were  excluded, 
after  assessment,  due  to  the  following:  aged  over  75  (n=4),  drug  use  (n=1),  alcohol 
use  (n=5),  suspected  sleep  apnoea  (n=9),  suspected  PLMS/RLS  (n=4),  pain  (n=4), 
shift-work  (n=2),  suspected  sleep  terrors  (n=1),  PTSD  (n=2),  physical  illnesses  (n=5) 
and  nightmares  (n=2). 
A  cohort  of  44  participants  entered  the  study,  however,  one  participant  withdrew 
from  the  study  after  ten  baseline  days  due  to  personal  circumstances.  The  first  PSG 
night  confirmed  that  the  44  individuals  included  in  the  study  did  not  present  with 
sleep  disorders  other  than  insomnia. 
Six  participants  completed  the  study  for  all  phases  but  the  last  PSG  recordings  (5 
participants  informed  the  researcher  that  they  could  not  undergo  the  two  PSG  nights 
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recording  and,  therefore,  the  researcher  decided  not  to  perform  PSG  assessment).  In 
addition,  one  participant  did  not  complete  the  diary  during  the  treatment  phase  and 
one  participant's  diary  was  lost  in  the  post.  Finally,  four  participants  did  not  return 
the  end  of  treatment  battery  of  questionnaires. 
In  summary  baseline  and  treatment  diary  data  and  PSQI  scores  were  gathered 
from  41  participants,  baseline  and  end  of  treatment  PSG  data  from  37  participants, 
complete  sleep  continuity  and  sleep  quality  data  (diary  and  PSG)  were  obtained  from 
35  participants.  Baseline  and  end  of  treatment  questionnaires  were  available  for  39 
participants  (flow  chart  as  per  Consort  guidelines  in  fig.  25). 
Demographic  and  clinical  characteristics  of  participants  in  each  group  are 
summarised  in  table  11.  In  brief,  participants'  mean  age  was  47.5  years,  there  were 
29  females  and  15  males,  25  were  living  with  a  partner  and  19  were  living  alone,  28 
were  in  full  employment,  4  were  in  full  time  education  and  12  were  retired.  They 
were  all  educated  at  college  level  or  above. 
5.3.3  Materials  and  Apparatus 
5.3.3.1  Screening  Interview 
The  screening  interview  was  identical  to  that  used  in  study  two  (section  4.3.3.2b). 
Although  reliance  on  self-report  for  screening  out  sleep  disorders  other  than 
insomnia  is  prone  to  error  (Hoffestein  and  Szalai,  1993)  it  provides  a  cost-effective 
way  to  initially  screen  each  potential  participant  reducing,  therefore,  the  number  of 
(costly) PSGs  to  be  carried  out. 
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5.3.3.2a  Sleep  Diary 
The  sleep  diary  was  the  same  as  that  used  in  study  two  (section  4.3.3.1  and 
appendix  5).  As  in  study  two  the  variables  retained  from  the  sleep  diaries  were  SOL, 
WASO,  S.  E.  and,  in  addition,  TST. 
5.3.3.2b  Sleep  Related  Questionnaires 
As  in  study  two  the  PSQI  (Buysse,  et  al,  1989)  and  the  HADS  (Zigmond  and 
Snaith,  1983)  were  administered  (sections  4.3.3.2a  and  4.3.3.2c  and  appendixes  4 
and  6  respectively). 
In  addition  psychological  measures  associated  with  sleep  were  collected  by 
means  of  a  battery  comprising  six,  well  validated,  sleep  related  questionnaires  that 
focus  on  symptoms,  interpretation,  cognitions  and  behaviour  that  may  accompany 
sleep  complaints. 
Sleep  Behaviour  Self  Rating  Scale  -  Revised  (SBSRS-R  Kohn  and  Espie,  2005) 
is  an  experimental  measure  of  the  behavioural  pattern  around  bedtime  and  it  is  a 
revised  form  of  the  original  one  produced  in  1979  (Kazarian,  Howe  and  Csapo, 
1979).  The  revised  version  comprises  14  statements  (appendix  14)  rated  on  a5  point 
Likert  scale  (`Never',  `Rarely',  `Sometimes',  `Often',  `Very  Often').  The  total  score 
ranges  from  14  to  70.  It  was  developed  to  assess  sleep  incompatible  behaviour 
associated  with  a  person's  bed/bedroom  and  it  is  the  only  published  scale  to  quantify 
the  stimulus  control  paradigm.  Test-retest  correlation  was  r=0.88  indicating 
acceptable  reliability;  internal  consistency  and  discriminant  validity  were  also 
acceptable  (Cronbach  alpha=0.69,  K-R  20  =0.70). 
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composed  of  7  statements  measured  on  a  3-point  Likert  scale  (`Very  Much',  `To 
Some  Extent',  `Not  at  all')  and  the  total  score  ranges  from  0  to  14  (appendix  15).  It 
measures  elements  of  effortful  preoccupation  with  sleep  (e.  g.  worrying  over  sleep 
and  failure  to  sleep,  need  to  control  one's  sleep).  It  has  acceptable  internal 
consistency  (Cronbach  alpha=0.77). 
Sleep  Disturbance  Questionnaire  (SDQ,  Espie  et  al,  1989,2000)  comprises  12 
statements  (appendix  16).  Using  a5  point  Likert  scale  (`Never  True',  `Seldom  True', 
`Sometimes  True',  'Often  True',  `Very  often  True')  participants  had  to  indicate  what 
factors  they  perceived  to  be  the  sources  of  their  sleep  problem  (e.  g.  `I  get  too  "worked  up" 
at  not  sleeping').  This  questionnaire  differentiates  four  sleep  interfering  factors.  In 
particular  items  1,5  and  9  give  a  total  score  for  `physical  tension',  items  3,7  and  11 
for  `sleep  pattern  problems',  items  2,6  and  10  for  `cognitive  arousal'  and  items  4,8 
and  12  for  `sleep  effort'.  Each  of  these  4  factors'  total  score  ranges  from  3  to  15.  It 
has  good  internal  consistency  (Cronbach  alpha=0.82). 
Glasgow  Content  of  Thoughts  Inventory  (GCTI,  Harvey  and  Espie,  2004) 
comprises  25  items  scored  on  a4  point  Likert  scale  ('Never',  'Sometimes,  ',  `Often' 
and  `Always')  (appendix  17).  It  measures  the  types  of  thoughts  people  have  while 
trying  to  get  to  sleep  and  gathers  a  score  for  three  different  constructs:  `cognitive 
intrusions  relating  to  active  problem  solving'  (items  1,3,8,12,14,15,19,21  and  23 
with  a  total  score  range  from  9  to  36),  `cognitive  intrusions  relating  to  sleep  and 
wakefulness'  (items  5,6,7,9,11,18,22,24  and  25  with  a  total  score  range  from  9 
to  36)  and  `cognitive  intrusions  relating  to  somatic  and  sensory  engagement'  (items 
2,4,10,13,17  and  20  with  a  total  score  range  from  7  to  28).  Internal  consistency  is 
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correlation  coefficient  was  found  to  be  highly  satisfactory  (ICC=0.87,  p<0.001) 
Pre-Sleep  Arousal  Scale  (PSAS,  Nicassio  et  al,  1985).  The  PSAS  is  a  sixteen 
item  questionnaire  using  a  5-point  rating  scale  (not  at  all,  slightly,  moderately,  a  lot, 
extremely)  assessing  the  intensity  of  pre-sleep  somatic  and  cognitive  aspects  of 
arousal  (appendix  18).  Higher  scores  indicate  greater  arousal.  Eight  items  assess 
cognitive  arousal  (e.  g.  `thoughts  keep  running  through  your  head')  and  eight  assess 
somatic  arousal  (e.  g.  `a  tight  tense  feeling  in  your  muscles')  that  can  be  experienced 
in  the  pre-sleep  period.  Scores  of  the  two  sub-scales  (each  scale  ranges  from  8  to  40) 
are  computed  separately  by  summing  across  cognitive  and  somatic  arousal  items. 
This  scale  is  a  helpful  screening  measure  to  discriminate  poor  from  good  sleepers. 
Somatic  and  cognitive  sub-scales  were  shown  to  be  internally  consistent  and  stable 
over  time  (Cronbach  alphas  ranged  from  0.68  on  the  cognitive  subscale  to  0.88  on 
the  somatic  subscale;  3  week  test-retest  correlations  ranged  from  0.72  on  the 
cognitive  to  0.76  on  the  somatic  subscales).  Mean  scores  of  people  with  insomnia 
were  significantly  higher  than  those  of  normal  sleepers  on  scores  for  both  subscales. 
On  the  cognitive  subscales  means  for  those  with  and  without  insomnia  were 
M=15.2(5.3)  and  M=11.34(3.4),  respectively. 
Dysfunctional  Beliefs  and  Attitudes  about  Sleep  -10  (DBAS-10,  Espie,  Inglis, 
Harvey  and  Tessier,  2000)  is  a  10  item  scale  rated  on  a  visual  analogue  scale 
concerning  sleep-related  beliefs  (e.  g.  needing  8  hours  of  sleep  per  night)  (appendix 
19).  It  is  based  on  the  original  30  item  scale  (Morin  et  al,  1993)  but  limited  to  items 
shown  to  be  sensitive  to  change  after  CBT.  It  has  acceptable  internal  consistency 
(Cronbach  alpha=0.69).  It  measures  the  types  of  beliefs  people  hold  regarding 
154 insomnia  and  yields  a  score  for  three  different  constructs:  `beliefs  about  the 
immediate  negative  consequences  of  insomnia'  (items  1,2,6,7  and  9  with  a  total 
score  ranging  from  0  to  50),  `beliefs  about  the  long  term  negative  consequences  of 
insomnia'  (items  3,5  and  8  with  a  total  score  ranging  from  0  to  30)  and  `beliefs 
about  need  for  control  over  insomnia  (items  4  and  10  with  a  total  score  ranging  from 
0  to  20).  Its  validity  has  been  recently  supported  (Edinger,  Wohigemuth  et  al,  2001). 
Credibility/Expectancy  Questionnaire  (modified).  The  original  questionnaire 
was  developed  by  Devilly  and  Borkovec  (2000)  and  comprised  six  items  using  a  9- 
point  rating  scale  (not  at  all,  ..,  very).  It  measures  rationale  credibility  (items  1,2,3 
and  5)  and  treatment  expectancy  (items  4  and  6).  The  credibility  factor  was  found  to 
possess  high  internal  consistency  (Cronbach  alphas  ranged  from  0.81  to  0.86),  inter- 
item  correlations  across  studies  ranged  between  0.62  and  0.78  and  test-retest 
reliability  was  0.75.  In  the  present  study  only  the  four  items  of  the  credibility 
subscale  were  used.  Furthermore  the  words'  `trauma  symptoms'  were  changed  to 
`sleep  difficulties'.  In  the  present  study  the  four  items  were  measured  on  a  4-point 
scale  (not  at  all,  somewhat,  quite,  very)  (appendix  20). 
5.3.3.3  Objectively  Measured  Sleek 
Data  for  objective  sleep  measures  were  obtained  using  PSG.  These  included  data 
obtained  from  EEG,  EOG  and  EMG  (section  5.3.3.3a).  The  objective  measures  of 
sleep  were  acquired  via  an  ambulatory  recording  device  (section  5.3.3.3b)  and 
downloaded  to  a  proprietary  software  package  (section  5.3.3.3c).  They  were  then 
manually  scored  according  to  R&K  manual  (section  5.3.3.3c). 
155 5.3.3.3a  Objectively  Measured  Sleep 
EEG  was  recorded  at  4  scalp  sites  (C3,  C4,  Ol 
, 
02)  according  to  the  10-20 
international  electrode  system  (Jasper,  1958)  (fig.  20)  using  an  ambulatory 
EEG/polygraphy  recorder  referenced  to  Cz. 
Fig.  20  -  The  10-20  Electrode  Placement 
International  System 
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(LOC,  ROC).  System  reference  (the 
mean  amplitude  between  Cz  and  the 
recording  sites)  was  used  for  recording. 
Neutral  was  taken  from  Ez.  The  data 
were  later  re-referenced  off  line  to  the 
opposite  mastoid  bone  (Al.  A2). 
The  montage,  therefore,  included  2  EOG  referenced  to  the  left  and  right  mastoid 
(LOC/A2  and  ROC/A  1),  4  EEG  referenced  to  both  mastoids  (C3/A2,  C4/A  1,  O1  /A2, 
02/AI)  and  a  bipolar  mentalis  EMG.  EOGs  and  EEGs  were  high  pass  filter  at  0.3  1  lz 
and  low  pass  filtered  at  70Hz.  EMGs  were  high  pass  filtered  at  2  Hz  and  low  pass 
filtered  at  120  HZ.  Electrode  impedance  was  kept  below  5k12. 
The  researcher  had  been  trained  in  correct  electrode  attachment  and  electrode 
removal  by  Mrs  Popadopoulos  the  chief  EEG  technician  of  the  department  of 
Neurology  at  the  Southern  General  Hospital  in  Glasgow. 
5.3.3.3b  Ambulatory  Electroencephalogrant/Polygrcrph  Recording  Device 
The  ambulatory  EEG/polygraphy  recording  device  was,  the  Trackit  (Lifcline.  s, 
Ltd),  the  same  as  that  employed  in  study  two  (4.3.3.3a). 
156 5.3.3.3c  Analysis  of  the  Polygraphic  Recording 
Stellate  Sleep  System  (Stellate  Ltd,  Canada)  is  a  software  package  enabling  the 
acquisition  and  storage  of  EEG  data  in  a  central  database.  It  offers  tools  facilitating 
manual  scoring  of  the  recorded  EEG  (e.  g.  spindle  detector  tool,  autonnatised  division 
of  the  EDF  file  in  30  second  epochs).  An  example  of  the  sleep  hypnogram  and  sleep 
report  produced  by  Stellate  is  depicted  in  figure  21.  The  EEG  acquired  via  Trackit 
was  stored  in  EDF  format.  The  EDF  file  was,  subsequently,  uploaded  in  Stellate 
Reviewer  and  manually  scored  by  an  expert  PSG  technician  according  to  R&K 
(Rechtschaffen  and  Kales.  1968)  guidelines.  Thereafter,  Stellate  summarised  the 
scored  file  in  sleep  reports  which  contain,  among  others,  SOL,  WASO,  'I'ST,  S.  E?., 
sleep  stages  and  micro/mini  arousals  data. 
Fig.  21  -  An  example  of  a  PSG  scored  record  and  relative  sleep  report.  The  PSG  recording  is  manually 
scored  and  staging  for  each  epoch  is  memorised  in  Stellate  and  thereafter  a  Sleep  Report  is  gcncraii  d  by 
the  Stellate  Software 
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The  PSG  recordings  were  blind  scored  in  30-second  epochs  from  lights  off  to 
lights  on  according  to  R&K's  (Rechtschaffen  and  Kales,  1968)  standardised  criteria 
by  Ms  Manon  Lamy  (Sleep  Laboratory  Coordinator,  Universite'  Laval,  QC).  Lights 
off  and  lights  on  were  extracted  by  the  `eventit'  feature  of  Trackit:  basically 
participants  pressed  a  button  on  Trackit  when  they  switched  off  the  light  and  in  the 
morning  when  they  got  up.  The  time  of  button  pressing  was  recorded  by  Trackit  and 
retrieved  by  the  experimenter  at  a  later  stage.  The  C3,  EMG  and  EOG  areas  were 
used  for  scoring.  However,  for  correct  detection  of  the  waking  stage  (EEG  alpha 
activities),  the  02  area  was  used  as  well.  If  C3  and/or  02  recordings  were  difficult  to 
score  due  to  artifact  contaminations,  C4  and/or  01  were  used  as  alternatives.  TIB 
was  calculated  from  lights  off  to  lights  on.  EEG  defined  sleep  onset  was  scored  as 
the  occurrence  of  3  consecutives  epochs  of  stage  1,  or  1  epoch  of  stage  2,3,4,  or 
REM. 
Thus  sleep  continuity  variables  were  as  follows:  SOL  was  the  amount  of  time 
elapsed  in  minutes  from  lights  off  to  sleep  onset,  WASO  was  the  sum  of  wake  time 
in  minutes  from  sleep  onset  to  the  last  REM  or  NREM  sleep  episode,  TST  was  the 
sum  of  NREM  and  REM  sleep  in  minutes.  The  epochs  contaminated  by  body 
movements  for  longer  than  half  the  epoch  (i.  e.  16-30  sec)  were  scored  as  movement 
time.  Micro-and  mini-  arousals  were  computed  visually  according  to  the  criteria  of 
the  American  Sleep  Disorders  Associations  (ASDA,  1992). 
158 5.3.3.4  Subjective  Measurement  of  Adherence 
As  in  study  two,  adherence  to  the  QHR  was  measured  daily.  In  particular 
measurement  of  adherence  to  the  QHRout  diary  was  identical  to  that  employed  in  the 
pilot  study  and  gathered  information  such  as  the  need  to  apply  the  QHR  and  whether 
it  was  applied  or  not  (section  4.3.3.6  and  appendix  7).  The  only  difference  between 
the  adherence  diary  for  the  QHRout  and  QHRin  (appendix  21)  concerned  the 
location  where  the  rule  was  to  be  applied  (e.  g.  `Did  you  go  to  another  room'?  '  and 
`Did  you  sit  up  in  bed?  '  respectively). 
5.3.3.5  Objective  Measurement  of  Adherence 
In  the  next  two  subsections  actigraphy  and  the  algorithm  devised,  by  the 
researcher,  to  obtain  an  adherence  score  for  objectively  measured  adherence  are 
presented. 
5.3.3.5a  Actigraphv 
The  Actiwatch-Light  (ACTW-L  -  Cambridge  Neurotechnology  Ltd)  is  similar  tu 
the  Actiwatch  used  in  study  two  (section  4.3.3.4  and  figure  17).  However.  as  shown 
on  the  left  (fig.  22),  the  event  button  is  replaced  by  a 
light  detector.  In  this  way  in  addition  to  collecting 
movement  information,  the  ACTW-L  measures  light 
intensity  via  a  lux  sensor. 
Data  collected  using  the  ACTW-L  were  analysed  via  a  software  package 
produced  by  Cambridge  Neurotechnology  Ltd  (Actiwatch  sleep  2002).  As  shown  in 
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Fig.  22:  ACT\V-I. figure  23,  this  software  produces  an  automated  measure  of  sleep  continuity  and  light 
during  the  recorded  period.  A  string  of  numbers  represents  the  amount  of  movement 
and  the  amount  of  lux  (light)  for  each  one-minute-  epoch. 
Fig.  23  -  On  the  left  side  the  Sleep  analysis  of  the  data  gathered  with  ACTW-L  is  presented:  the  black 
lines  represent  movement  and  the  yellow  lines  represent  light.  On  the  left  side  the  epoch  by  epoch  output 
with  activity  and  light  is  presented.  ￿￿R  IC.  R 
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5.3.3.5b  -  Adherence  Algorithm  and  Adherence  Score 
Given  the  interest  in  adherence  to  the  rule  during  the  night,  only  the  data  gathered 
during  the  period  from  `switching  off  the  light  with  the  intention  to  sleep'  -  to  `rising 
from  bed'  was  considered.  As  depicted  in  fig.  23,  Actiwatch  Sleep  produces  3 
columns  for  each  epoch:  one  with  time,  one  with  movement  data  and  one  with  light 
data. 
A  rule-based  algorithm  was  devised  comprising  binary  digit  notation  to  yield  an 
index  of  movement  and  an  index  of  light.  These  two  indices  were  then  linked  to 
provide  an  overall  adherence  score.  Specifically,  each  sixty-second  epoch  of  the 
night  was  examined  for  movement  and  light  sufficient  to  read  (Iux>6).  In  order  to 
determine  adherence  with  the  QHR  the  following  steps  were  applied: 
160 1.  Three  columns  (M=movement,  L--light  and  A=adherence)  were  created 
adjacently  to  those  reporting  movement  and  light  values. 
2.  In  column  M  all  epochs  were  given  a  score  (0=  no  movement;  1=  movement). 
3.  If  one  or  two  epochs  of  no  movement  (M=0)  were  observed  between  two  epochs 
of  movement  (M=1),  they  were  considered  as  movement  and  given  a  score  of  1. 
In  this  way  a  column  with  a  mix  of  zeros  and  ones  was  produced  for  movement. 
4.  In  column  L  all  light  epochs  were  given  a  score  (0=  not  enough  light  to  read  i.  e. 
lux-<6;  1=  enough  light  to  read  i.  e.  lux>6). 
5.  For  each  period  of  more  than  15  consecutive  movement  epoch  (M=1  for  15 
consecutive  epochs),  the  light  scores  (column  L)  were  examined.  If  following 
movement  only  epochs  (i.  e.  M=1,  L=0)  light  was  also  detected  (i.  e.  M=1  and 
L=1)  then  adherence  with  the  QHR  was  successful;  if  no  light  was  detected  (i.  e. 
M=1  and  L=O)  then  the  QHR  was  not  implemented  (i.  e.  no  adherence). 
This  rule  based  algorithm  permitted  the  researcher  to  count  objectively  the 
number  of  times  the  behavioural  intervention  `QHR'  should  have  been  implemented, 
the  number  of  times  the  QHR  was  actually  adhered  to  and  the  length  of  time  elapsed 
before  the  instruction  was  implemented. 
As  in  study  two  the  adherence  score  was  calculated  using  the  following  formula: 
Number  of  Times  QHR  was  adhered  to 
Adherence  Score= 
Number  of  Times  Implementation  was  Required 
Similarly  to  Riedel,  Lichstein,  Peterson,  Epperson,  Means  and  Aguillard'  (1998) 
study  if  a  participant  fell  asleep  within  a  quarter  of  an  hour  (i.  e.  no  need  to  apply  the 
QHR)  a  score  of  100%  was  given. 
161 5.3.3.6  Material  for  the  intervention 
5.3.3.6a  The  Single  Component  Interventions:  QHR  out  of  bed  &  QHR  in  bed 
The  Single  Component  Intervention,  named  `the  quarter  of  an  hour  rule'  (QHR), 
was  adapted  from  the  situational  component  of  stimulus  control  intervention 
(Bootzin,  1972)  `if  you  are  not  asleep  within  reasonable  time  get  up  and  do 
something  in  another  room  until  you  feel  sleepy.  Repeat  the  instruction  as  many 
times  as  it  is  necessary.  '  In  order  to  test  the  hypotheses,  it  varied  regarding  the 
location  where  it  had  to  be  applied  (fig.  24). 
Fig.  24  -  The  QHR  out  of  bed  and  The  QHR  in  bed 
QHR  out  of  bed  -  (QHRout) 
If  you  are  not  asleep  within  a 
QUARTER  OF  AN  HOUR 
Get  out  of  your  bed, 
go  to  the  designated  room, 
read. 
Go  back  to  bed  when 
ready  to  sleep  again  / 
QHR  in  bed  -  (QHRin) 
If  you  are  not  asleep  within  a 
QUARTER  OF  AN  HOUR 
Sit  up  in  your  bed, 
read 
lie  down  when 
ready  to  sleep  again 
As  shown  in  figure  24,  if  not  asleep  within  a  quarter  of  an  hour  then  the  QHRout 
asked  participants  to  `get  out  of  bed,  go  to  the  designated  room  and  read.  Return  to 
bed  when  you  feel  ready  to  sleep'.  The  QHRin,  in  contrast,  asked  participants  to  `sit 
up  in  bed  and  read.  Lie  down  when  you  are  ready  to  sleep  again'.  The  QHR 
162 interventions  were  delivered  individually  by  the  researcher  and,  in  order  to  enhance 
treatment  fidelity,  structured  written  protocols  were  followed.  In  this  way  it  was 
ensured  that  delivery  of  the  QHRout  and  QHRin  interventions  were  consistent  across 
participants  (appendixes  22a  and  22b  respectively).  A  flow-chart  type  instruction 
sheet  was  handed  to  participants  to  help  them  follow  the  rule  (appendixes  23a  and 
23b  respectively). 
5.3.3.6b  Self-monitoring:  the  Control  Group 
The  control  group  self  monitored  their  sleep  by  completing  the  sleep  diary  for  the 
whole  duration  of  the  study  (five  weeks).  In  order  to  ensure  that  outcomes  were  due 
to  specific  therapeutic  ingredients  rather  than  the  measurement  process  (sleep  self- 
monitoring)  or  other  non-  specific  factors  (e.  g.  patient's  expectations,  therapist's 
attention)  the  number  and  length  of  contacts  between  the  control  group  and  the 
researcher  were  identical  to  those  with  participants  randomised  to  the  active 
intervention  groups.  Importantly,  the  control  group  was  not  given  sleep  hygiene 
instructions  or  any  other  insomnia  treatment:  during  contacts  the  researcher  asked 
general  questions  such  as  "how  was  your  sleep  yesterday?  "  or  "did  you  remember  to 
fill  in  the  sleep  diary?  ". 
5.3.4  -  Data  Processing 
Preliminary  calculations  (e.  g.  TIB,  S.  E.,  global  adherence  score)  were  performed 
by  inputting  raw  data  in  a  spreadsheet  (Microsoft  Excel)  and  results  were  then  used 
for  statistical  analyses.  All  data  analyses  (parametric  and  non-parametric  tests  of 
163 differences  and  correlations)  were  performed  employing  the  statistical  software 
package  SPSS  11.5  for  Windows  (Microsoft). 
In  the  mixed  model  ANOVAs,  `Group'  (QHRin  vs.  QHRout  vs.  Control)  was  the 
between  subjects  factor  and  time  of  measurement  `Time'  (Baseline  vs.  End  of 
Treatment)  was  the  repeated  measure.  The  alpha  level  was  set  at  0.05  (Sterling, 
Rosenbaum  and  Weinkam,  1995)  and  a  p-value  between  0.051  and  1.0  was 
considered  as  a  non-significant  trend.  In  instances  where  non-significant  results  were 
obtained,  the  test  power  to  detect  significant  difference  was  inspected  and  reported. 
A  statistically  significant  main  effect  for  `Group'  was  followed  by  pairwise 
Bonferroni  corrected  comparisons  (p=0.05/3=0.017).  Likewise  a  significant  `Group' 
by  `Time'  interaction  was  followed  by  pairwise  Bonferroni  corrected  comparisons 
(p=  0.05/6=  0.008)  to  examine  the  time  effect  within  each  group  individually  and  the 
differences  between  groups  at  end  of  treatment. 
Bonferroni  corrections  for  each  set  of  analyses  were  employed  to  control  for  type 
I  error.  It  is  appreciated  that  the  Bonferroni  correction  is  conservative  and,  therefore, 
while  controlling  for  type  I  error  it  inflates  type  II  error.  A  less  conservative  post-hoc 
test,  such  as  the  Tukey  HSD,  would  be  more  appropriate  to  balance  type  I  and  type  II 
errors.  However,  this  test  assumes  that  each  group  has  an  equal  number  of  cases 
(Urdan,  2001).  The  present  study  employed  unequal  sample  size  groups  and, 
therefore,  the  Tukey  HSD  was  not  deemed  to  be  the  best  post-hoc  test  to  use.  Fisher 
LSD,  a  post-hoc  test  less  conservative  and  indeed  often  criticised  for  not  sufficiently 
controlling  for  Type  I  error,  also  requires  equal  size  samples  (Keppel  and  Wickens, 
2004).  It  was  decided,  therefore,  also  to  report  uncorrected  t-test  values  for  those 
164 pairwise  comparisons  that  had  obtained  a  p:  50.05  value  but  which  were  non- 
significant  once  Bonferroni  correction  was  applied. 
Cohen's  effect  sizes  (Cohen,  1988)  were  calculated  using  the  formula  (for  an 
explanation  of  effect  sizes  see  section  1.6.1): 
ES= 
Ml-M2 
(SD12+SD22)/2  M,  (SDI)=  Mean  (SD)  Group, 
M2  (SD2)=  Mean  (SD)  Group2 
5.3.5  -  Procedure 
As  depicted  in  figure  25  participant  recruitment  utilised  three  avenues:  General 
Practioners'  (GPs)  referral,  sleep  clinic  referred  patients  and  media  advertisement. 
The  researcher  contacted,  by  letter,  42  surgeries  in  Greater  Glasgow  explaining  the 
study  and  inviting  GPs  to  refer  suitable  patients  (appendix  24).  This  first  contact  was 
followed  by  a  telephone  contact  within  one  month  and,  if  requested,  a  visit  to  the 
surgery.  The  surgeries  to  be  contacted  were  decided  on  the  basis  of  number  of  GPs 
per  surgery  (N>2).  GPs  referred  possible  participants  on  the  basis  of  a  quick  `fitting 
criteria  for  the  study'  checklist  (appendix  25).  With  regard  to  recruitment  via  sleep 
clinic  referrals,  a  letter  asking  permission  to  contact  the  referred  patient  was  sent  to 
the  referrer  (appendix  26).  Individuals  who  responded  to  a  media  advertisement  were 
asked  to  speak  to  their  GP  with  a  view  to  being  referred  to  the  study.  There  are  no 
available  data  on  number  of  people  who  responded  to  the  advertisement  and,  when 
prompted  to  do  so,  asked  their  GPs  to  be  referred  to  the  study. 
Referred  individuals  were  sent  an  information  pack  (appendix  27)  by  post  and 
were  asked  to  reply  if  interested  in  the  study.  Eighty-three  individuals  agreed  to  be 
contacted. 
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166 The  telephone  screening  interview  lasted  around  thirty  minutes.  Those  presenting 
with  suspected  sleep  disorders  other  than  primary  insomnia  or  not  meeting  other 
criteria  (e.  g.  age,  medication  used)  were  thanked  for  their  interest,  the  `good  sleep 
guide'  (appendix  28)  was  forwarded  to  them  but  they  did  not  participate  further  in 
the  study. 
Individuals  who,  as  per  preliminary  assessment,  seemed  to  fit  criteria  were  asked 
to  come  to  the  sleep  research  laboratory  for  an  in  depth  face  to  face  interview  who 
lasted  around  one  hour.  Those  meeting  DSM-IV/ICSD-R  diagnostic  criteria  for 
primary/psychophysiologic  insomnia  were  advised  of  the  study  procedure  in  detail.  If 
they  agreed  to  participate,  they  were,  once  again,  informed  of  their  right  to  withdraw 
at  any  time  without  having  to  explain  their  decision  and  were  asked  to  read  and  sign 
a  consent  form  (appendix  29).  They  were  reminded  that,  as  stated  in  the  information 
leaflet,  they  might  not  be  assigned  to  a  treatment  group  and  that  they  would  be 
informed  by  phone  of  whether  they  had  been  randomised  to  a  treatment  or  control 
group.  Participants,  then,  completed  the  battery  of  questionnaires  and  the  PSQI  and 
the  date  to  start  the  baseline  phase,  commencing  with  two  home  PSG  recordings,  was 
agreed.  The  first  night  was  an  adaptation  night,  as  routinely  conducted  in  PSG 
studies  (e.  g.  Bonnet  and  Arand,  1997),  it  provided  objective  screening  information 
but  the  data  collected  were  not  utilised  for  outcome  analyses. 
It  is  important  to  highlight  that  the  researcher  followed  a  'safety  procedure' 
during  home  visits  (appendix  30).  This  was  a  revised  form  of  the  home  visit 
procedure  in  place  at  that  time  at  the  Section  of  Psychological  Medicine  at  the 
University  of  Glasgow. 
167 On  the  first  PSG  night,  the  researcher  went  to  the  participant's  house  at  the 
agreed  time,  explained  how  to  fill  in  the  sleep  diaries,  how  the  electrodes  were  going 
to  be  attached  and  removed  and  what  to  do  with  the  ambulatory  PSG  recorder  at 
bedtime  and  in  the  morning.  Participants  were  provided  with  a  mobile  number  to 
contact  the  researcher  during  the  night  should  they  have  any  question  or  problem. 
Thereafter  the  PSG  was  set  up  for  the  nightly  measurement.  This  procedure  lasted 
around  1%z  hours.  The  following  morning  the  researcher  returned  to  the  participant's 
house  to  remove  electrodes.  This  contact  lasted  around  half  an  hour.  The  second 
night  and  following  morning  procedures  were  identical  to  those  of  the  first  night  and 
the  associated  morning. 
After  the  baseline  period  (2  weeks)  the  researcher  met  again  with  the  participant. 
If  the  participant  had  been  assigned  to  either  the  QHRout  or  the  QHRin  then  the 
appropriate  intervention  was  delivered  and  the  researcher  checked  that  the  participant 
had  clearly  understood  how  to  implement  the  intervention.  An  easy  to  follow  QHR 
memo  was  provided  (appendices  8  and  23).  Use  of  Actiwatch  and  adherence  diary 
(appendices  7  and  21)  was  explained  and  the  participant  was  reminded  to  keep  filling 
the  sleep  diary  in.  In  order  to  avoid  inflating  adherence  by  making  the  participant 
aware  of  the  purpose  of  actigraphy,  they  were  told  that  the  actiwatch  monitored 
movement  and  rest  and  could  give  an  indication  of  rest-wake  patterns  during  day  and 
night.  This  meeting  lasted  around  45  minutes  and  the  delivery  of  the  intervention 
took  no  more  than  30  minutes. 
If  the  participant  had  been  assigned  to  the  control  group  the  researcher  met  with 
them,  collected  the  2-week  baseline  diaries  and  asked  a  few  general  questions 
168 regarding  their  sleep.  They  were  then  reminded  to  keep  filling  the  sleep  diary  in  for 
the  next  three  weeks. 
Four,  5-10  minute,  telephone  contacts  were  made  during  the  treatment  period  so 
as  to  ensure  that  the  QHR  was  implemented  correctly  each  night.  The  participants  in 
the  control  group  were  also  contacted  four  times,  and  the  telephone  conversation 
regarded  correct  completion  of  the  sleep  diary.  Participants  were  contacted  on  the 
2n",  4th,  9th  and  15th  day  of  the  intervention  period  (fig.  25). 
During  the  last  two  days  of  the  treatment  period  PSG  recordings  were  repeated. 
Participants  were  asked  to  fill  in  the  PSQI  and  the  battery  of  questionnaires  on  the 
morning  after  the  last  PSG  recording.  In  instances  where  participants  had  to  go  to 
work  early  and  did  not  have  time  to  fill  in  the  questionnaires,  they  completed  them 
later  in  the  day  and  posted  them  by  the  next  morning. 
As  already  discussed  in  study  2  length  of  treatment  phase  was  decided  based  on 
previous  findings  that  sleep  improvements  were  observed  within  two  to  three  weeks 
after  stimulus  control  implementation  (e.  g.  Bootzin,  1972;  Espie,  Brooks  et  al,  1989; 
Sloan  et  al,  1993;  Zwart  and  Lisman,  1979). 
5.4  Results 
This  section  comprises  descriptive  and  inferential  statistics,  for  subjective  and 
objective  data.  First,  participants'  clinical  and  demographic  characteristics  are 
reported.  Second,  the  results  of  analyses  carried  out  on  the  subjective  sleep 
continuity,  sleep  quality,  clinical  significance  and  sleep  related  cognitions 
questionnaires  are  provided.  Third,  the  results  of  statistical  analyses  on  the 
objectively  gathered  sleep  quantity  and  sleep  architecture  data  are  reported.  Fourth, 
169 results  of  the  comparison  of  the  subjective  and  objective  data  are  given.  Finally,  the 
results  of  the  subjective  and  objective  measurements  of  adherence  and  their 
associations  to  sleep  parameters  are  presented. 
5.4.1-  Participants'  Characteristics 
Table  11  presents,  for  each  of  the  3  groups,  information  regarding  the  number  of 
participants,  their  gender,  if  they  were  living  with  a  partner  or  alone,  their 
employment  status  and  the  type  of  insomnia  they  presented  with  [mixed,  sleep  onset 
(SOL)  or  sleep  maintenance  (WASO)].  All  participants  were  educated  at  college 
level  or  above.  In  addition  mean  (SD)  age  of  participants,  PSQI  total  score,  length  of 
the  insomnia  complaint,  HADS  anxiety  and  depression  scores  are  reported. 
Table  11:  Summary  Data  for  participants  randomised  to  the 
QHRin,  QHRout  and  Control  (SD  in  brackets) 
Sociodemovayhic 
Age  (yrs)  Mean  (SD) 
Age  Range 
Gender  (number  of  f/m) 
Living  with  Partner/Alone 
Employment  Status 
Full  Time/Student/Retired 
Steep 
QHRin  (n=15)  QHRout  (n=17) 
48.3  (14.7)  45.5  (14.1) 
21-70  18-64 
11/4  11/6 
6/9  11/6 
10/1/4  12/2!  3 
Mean  (SD)  PSQI  total  score  12.8  (1.4) 
Mean  (SD)  Insomnia  Duration  (years) 11.5  (7.6) 
Insomnia  Type:  Mixed/SOU  WASO  11/1/5 
Psycholozical 
Mean  (SD)  HADS  Anxiety  8.1(2.8) 
Mean  (SD)  HADS  Depression  4.6  (2.5) 
13.4(l.  9) 
10.2  (7.8) 
10/2/5 
9.5  (3.7) 
5.5  (2.9) 
Control  (n=12) 
48.9  (14.9) 
24-72 
8/4 
8/4 
6￿1/5 
12.0  (2.6) 
10.9  (9.2) 
610/6 
7.5  (4.0) 
5.7  (3.7) 
170 One-way  ANOVA  revealed  that  there  were  no  statistically  significant  between 
groups  differences  in  age  [F(2,41)=0.24,  n.  s.  ],  duration  of  insomnia  [F(2,41)=0.11, 
n.  s.  ],  PSQI  total  score  [F(2,41)=1.79,  n.  s.  ],  HADS  anxiety  [F(2,41)=1.22,  n.  s.  ]  or 
HADS  depression  [F(2,41)=0.50,  n.  s.  ]  (all  p,  >0.1). 
5.4.2  -  Subjective  Sleep  Continuity  Data  and  PSQI  total  Score 
In  this  section  sleep  continuity  parameters  (SOL,  WASO,  TST  and  S.  E.  )  gathered 
via  sleep  diary  and  the  PSQI  total  score  are  reported  descriptively  and  then  formally 
analysed.  Before  analysing  each  of  these  variables  some  points  common  to  all 
variables  are  addressed. 
Diary  entries  for  both  baseline  and  intervention  periods  were  completed  by  41 
participants.  The  baseline  mean  values  correspond  to  the  mean  of  the  two-week 
baseline  daily  data  for  each  participant.  In  order  to  assess  that  there  were  no 
differences  between  the  mean  values  of  week  1  and  those  of  week  2,  mixed 
ANOVAs  were  carried  out  for  each  of  the  sleep  continuity  variables  and  no 
statistically  significant  differences  were  found  (all  ps>O.  1).  The  end  of  treatment 
mean  values  correspond  to  the  mean  values  of  the  daily  data  for  the  third  week  of 
treatment.  Inspection  of  sleep  diary  data  suggested  that  they  were  not  normally 
distributed  and,  indeed,  the  Shapiro-Wilk  test  of  normality  confirmed  this.  Therefore, 
logarithmic  transformations  (base  10)  were  performed  on  SOL,  WASO,  TST  and 
S.  E.  data.  For  clarity,  however,  the  reported  means  in  tables  and  figures  correspond 
to  non-transformed  data. 
One-way  ANOVAs  were  performed  on  the  baseline  mean  SOL,  WASO,  TST  and 
S.  E.  values  and  the  mean  PSQI  total  score  (table  12)  to  examine  if  there  were 
171 statistically  significant  differences  in  sleep  continuity  parameters  among  the  groups 
prior  to  the  treatment  phase.  No  significant  differences  were  found  for  SOL 
[F(2,38)=0.12,  n.  s.  ],  WASO  [F(2,38)=2.60,  n.  s.  ],  TST  [F(2,38)=0.58,  n.  s.  ],  S.  E. 
[F(2,38)=0.36,  n.  s.  ]  or  PSQI  [F(2,38)=  2.56,  n.  s]  (all  p,  >.  1). 
As  already  discussed  in  section  5.3.4,  if  the  mixed  ANOVAs  showed  significant 
main  effects  or  interactions  then  pairwise  t-tests,  with  Bonferroni  correction,  were 
carried  out  to  assess  where  the  differences  were  located.  In  particular,  as  the  one-way 
ANOVAs  showed  no  significant  differences  between  the  3  groups  at  baseline, 
independent  t-tests  were  carried  out  only  on  the  end  of  treatment  mean  values.  Paired 
t-tests  (baseline  vs.  end  of  treatment)  were  applied  for  within  subjects  differences. 
Prior  to  reporting  descriptive  and  inferential  analyses  it  is  important  to  provide 
data  regarding  the  credibility  of  treatment. 
5.4.2.1  Credibility  of  the  OHR Treatment 
Credibility  questionnaires  were  completed  by  13  participants  in  each  of  the  2 
treatment  groups  (QHRin  and  QHRout)  to  rule  out  the  possibility  that  outcomes  were 
influenced  by  a  treatment  being  more  plausible  than  the  other.  The  mean  credibility 
score  for  the  QHRin  was  2.88  (0.55)  and  for  the  QHRout  was  2.98  (0.39).  An 
independent  t-test  showed  that  the  two  groups'  credibility  scores  were  not 
statistically  different  [t(26)=  -0.55,  n.  s.  ). 
5.4.2.2  Descriptive  Sleep  Continuity  Data  gathered  via  Sleep  Diary 
Table  12  presents  mean  (SD)  data  for  sleep  continuity  variables  (SOL,  WASO, 
TST  and  S.  E.  )  and  PSQI  at  baseline  and  the  third  week  of  treatment  for  the  QHRin, 
172 QHRout  and  Control  groups.  In  order  to  assess  if  the  differences,  suggested  by 
inspection  of  table  12,  between  and  within  groups  were  statistically  significant, 
inferential  statistics  were  computed.  The  next  sub-sections  report  the  results  for  each 
of  the  sleep  continuity  variables  examined  (ANOVAs  results  in  appendix  33). 
Table  12:  Mean  and  SD  for  Subjective  Sleep  Continuity  Variables  and  PSQI 
at  Baseline  and  End  of  Treat  ment  for  the  QH  Rin,  QHRout  and  Control  Groups 
OHRin  (N=14)  OHRout  (N=15)  Control  (N=12) 
SOL  Baseline  61.5  (50.4)  58.2  (57.1)*  49.1  (31.0) 
SOL  End  Treatment  51.9  (58.7)*  30.1(34.3)*  64.1(52.7) 
WASO  Baseline  113.5  (89.5)  98.4  (59.2)*  111.54  (57.3) 
WASO  End  Treatment  63.5  (54.1)  45.7  (36.9)*  113.0  (67.1) 
TST  Baseline  314.6  (94.7)  342.6  (73.1)  321.3  (78.9) 
TST  End  Treatment  "  383.0  (76.7)  408.7  (36.7)  324.1  (72.7)* 
S.  E.  Baseline  0.64  (0.18)  0.69  (0.14)  0.66  (0.15) 
S.  E.  End  Treatment  0.77  (0.16)  0.83  (0.09)*  0.65  (0.13) 
PSQI  (SD)  Baseline  12.6  (1.3)  13.7  (1.8)  12.0  (2.7) 
PSQI  (SD)  End  of  Treatment  8.8  (2.9)  8.1(2.9)  12.0  (2.1) 
Note:  *  Shapiro-Wilk  test  of  normalit  y  indicated  that  data  are  not  normally  distributed 
5.4.2.3  Sleep  Onset  Latency 
In  figure  26  the  mean  SOL  values  for  each  group  at  baseline  and  end  of  treatment 
are  presented  graphically.  A  mixed  model  ANOVA  was  carried  out  on  the  log 
transformed  mean  SOL  data.  There  was  a  significant  main  effect  for  time 
[F(1,38)=7.11,  p=0.01]  showing  that  the  mean  value  at  baseline  [M=  56.16(47.5)] 
was  statistically  significantly  higher  than  that  at  the  end  of  treatment 
[M=47.56(50.0)].  No  significant  main  effect  for  group  [F(2,38)=0.81,  n.  s.  ]  was  found 
but  a  significant  interaction  effect  was  found  between  group  and  time  [F(2,38)=4.36, 
173 pß.  02].  Employing  the  Bonferroni  post-hoc  correction  (p=0.006),  only  the 
difference  between  baseline  and  end  of  treatment  mean  times  for  the  QHRout  group 
was  significant  [t(14)=3.99,  p=0.001]. 
Fig.  26  -  Mean  SOL  at  Baseline  and  End  of  Treatment  for  the 
QHFän,  QHRout  and  Control  Groups 
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As  depicted  in  figure  26  this  result  confirmed  that  following  the  QHR  out  of  bed 
intervention  the  QHRout  group's  mean  SOL  was  decreased.  Regarding  the 
uncorrected  t-tests,  the  only  significant  result  was  that  between  the  QHRout  and  the 
Control  groups  at  end  of  treatment  [t(25)=-2.14,  p=0.041. 
5.4.2.4  Wake  after  Sleep  Onset 
In  figure  27  the  mean  WASO  values  for  each  group  at  baseline  and  end  of 
treatment  are  presented  graphically.  A  mixed  ANOVA  revealed  no  significant  main 
effect  for  group  but  a  significant  main  effect  for  time  was  found  [F(1,38)=20.4, 
p<0.0005]  showing  that  the  mean  value  at  baseline  [M=  107.39(69.2)]  was 
statistically  significantly  higher  than  that  at  the  end  of  treatment  [M=71.48(58.8)].  A 
significant  interaction  effect  [F(2,38)=4.56,  p=0.02]  was  explored  with  Bonferroni 
post-hoc  correction.  The  difference  between  the  baseline  mean  time  and  that  at  the 
end  of  treatment  for  the  QHRout  group  was  significant  [t(14)=5.26,  p<0.0005]  as 
174 was  the  difference  between  the  mean  time  between  the  QHRout  and  the  Control 
groups  at  the  end  of  treatment  [t(25)=3.63,  p=0.001]. 
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These  results  indicate  that  following  intervention  WASO  was  decreased  in  the 
QHRout  group  and  that  it  was  significantly  lower  than  that  of  the  Control  group  at 
the  end  of  the  intervention.  Regarding  the  uncorrected  t-tests,  statistically  significant 
differences  were  found  between  baseline  and  end  of  treatment  for  the  QHRin 
[t(13)=2.49,  p=0.03]  and  between  the  QHRin  and  the  Control  groups  at  end  of 
treatment  [t(24)=-2.34,  p=0.03]. 
5.4.2.5  Total  Sleep  Time 
In  figure  28  the  mean  TST  values  for  each  group  at  baseline  and  end  of  treatment 
are  presented  graphically.  A  mixed  ANOVA  revealed  no  significant  main  effect  for 
group  but  a  significant  main  effect  for  time  was  found  [F(1,38)=13.89,  p=0.001] 
showing  that  the  mean  TST  value  at  baseline  [M=  328(81.6)]  was  statistically 
significantly  lower  than  that  at  end  of  treatment  [M=374(71.1)].  Probably  because 
the  power  to  detect  significant  differences  was  low  (power=0.53),  the  interaction 
between  group  and  time  showed  only  a  non-significant  trend  [F(2,38)=2.89,  p=0.07]. 
Fig.  27  -  Mean  WASO  at  Baseline  and  End  of  Treatment  for  the  OHFÜn,  OHRout 
and  Control  Groups 
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Inspection  of  figure  28  suggests  that  the  QHRin  and  the  QHRout  groups  slept 
longer  following  the  intervention  increased  from  baseline  to  treatment  while  the 
control  group's  TST  did  not  change. 
5.4.2.6  Sleep  Efficiency 
Figure  29  presents  S.  E.  values  for  each  group  at  baseline  and  end  of  treatment. 
No  significant  main  effect  of  group  was  found  but  a  main  effect  of  time 
[F(1,38)=24.79,  p<0.00051  was  found.  Mean  S.  E.  value  at  baseline  [M=  0.67(0.16)] 
was  statistically  significantly  lower  than  that  at  the  end  of  treatment  [M=0.77(0.15)]. 
In  addition,  a  significant  interaction  effect  [F(2,38)=8.13,  p=0.001]  was  explored 
employing  the  Bonferroni  post-hoc  test.  This  indicated  differences  between  S.  E. 
means  at  baseline  and  at  end  of  treatment  for  the  QHRout  [t(14)=-5.52,  p<0.0005] 
and  for  the  QHRin  [t(13)=-3.68,  p=0.003]  groups.  Furthermore,  the  difference 
between  the  QHRout  and  the  Control  groups  at  the  end  of  treatment  [t(25)=3.27, 
p=0.003]  was  also  significant.  Regarding  uncorrected  t-tests,  the  only  significant 
difference  was  between  QHRin  and  Control  groups  at  end  of  treatment  [t(24)=2.51, 
p=0.02]. 
176 Fig.  29-  Mean  S.  E.  at  Baseline  and  End  of  Treatment  for  the  QHRin,  QHRout  and 
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These  results  indicate  that  S.  E.  increased  following  both  QHR  interventions  and 
that  the  S.  E.  at  the  end  of  treatment  was  higher  in  QHRout  than  the  Control  group. 
5.4.2.7  Pittsburgh  Sleep  Quality  Index  Total  Score 
In  figure  30  the  mean  PSQI  total  score  values  for  each  group  at  baseline  and  end 
of  treatment  are  presented  graphically. 
Fig.  30  -  Mean  PSQI  Total  Score  at  Baseline  and  End  of  Intervention  for  the 
QHRin,  QHRout  and  Control  Croups 
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There  was  no  significant  main  effect  for  group  [F(2,38)=2.00,  n.  s.  ]  but  a  significant 
main  effect  for  time  [F(1,38)=46.04,  p<0.0005]  was  found.  This  indicated  that  the 
PSQI  at  the  end  of  treatment  [M=9.54(3.1)]  was  lower  than  that  at  baseline 
[M=12.83(2.0)].  A  significant  interaction  effect  [F(2,38)=13.38,  p<0.0005]  was 
explored  with  Bonferroni  correction.  Pair-wise  comparisons  indicated  that  at  end  of 
177 treatment  the  mean  PSQI  values  of  the  QHRin  and  the  QHRout  groups  were 
statistically  significantly  lower  that  that  of  the  Control  group  [t(24)=-3.54,  p=0.003 
and  t(25)=-3.95,  p=0.001  respectively].  In  addition,  the  mean  PSQI  values  at  end  of 
treatment  as  compared  to  baseline  were  lower  for  both  the  QHRin  [t(13)=4.19, 
pß.  001]  and  the  QHRout  [t(14)=6.68,  p<0.0005]. 
5.4.2.8  Summary  of  subjectively  measured  sleep  continuity  parameters 
The  analyses  reported  in  the  sub-sections  above  suggest  the  QHR  interventions 
produced  statistically  significant  differences  in  some  of  the  sleep  parameters 
gathered  via  sleep  diary  while  no  changes  were  found  between  baseline  and  end  of 
treatment  for  the  Control  group.  In  addition,  while  no  statistically  significant 
differences  were  found  at  baseline  between  the  3  groups,  differences  between  the 
Control  group  and  the  QHRout  and/or  the  QHRin  were  found  at  end  of  treatment. 
Furthermore,  the  QHR  interventions  produced  highly  statistically  significant  changes 
on  the  PSQI  total  scores  within  groups  compared  to  the  control  group.  However  no 
differences  were  found  between  the  two  treatment  groups  QHRin  and  QHRout  for 
any  of  the  sleep  continuity  or  PSQI  mean  values.  These  results  will  be  critically 
examined  in  the  discussion  section. 
The  aims  of  insomnia  treatments  are  not  only  to  improve  sleep  continuity  but  also 
to  improve  the  perception  of  quality  of  sleep  and  feelings  upon  awakening.  The  next 
section  is  concerned  with  subjective  estimates  of  sleep  quality. 
178 5.4.3  Sleep  Quality  Data 
In  this  section  estimates  of  sleep  quality  factors  are  reported  and  analysed.  Each 
morning  participants  reported  the  quality  of  the  previous  night's  sleep,  and  their  level 
of  alertness  and  restedness  upon  awakening.  First  the  descriptive  data  are  presented 
and,  thereafter,  the  results  of  separate  mixed  ANOVAs  on  each  of  these  three 
dependent  variables  are  reported. 
One-way  ANOVAs  on  the  baseline  means  of  quality  of  sleep,  alertness  and 
restedness  (table  16)  revealed  no  significant  differences  for  quality  of  sleep 
[F(2,38)=.  111,  n.  s.  ],  restedness  [F(2,38)=.  79,  n.  s.  ]  or  alertness.  [F(2,38)=.  15,  n.  s.  ] 
(all  p,  >O.  1)  between  the  groups. 
5.4.3.1  Descriptive  Sleep  Quality  Data 
The  Mean  Score  and  SD  for  each  group  during  baseline  and  during  the  last  week 
of  treatment  are  reported  in  table  13. 
Table:  13-  Mean  (SD)  scores  for  Quality  of  Sleep,  Restedness  and  Alertness 
baseline  and  end  of  treatment  for  the  QHRin,  QHRout  and 
QHRin  N=14 
Q"a1:  t  of  ciP  Pp_,  s1ertnesý  RactnilnPSS 
Baseline  2.01(.  48)  2.09  (.  71)  1.93  (.  71) 
End  of  Treatment  2.48  (.  73)  2.25  (.  87)  2.26  (.  83) 
QHRout  N=15 
Baseline  1.97  (.  62)  1.99  (.  79)  1.63  (.  64) 
End  of  Treatment  2.29  (.  47)  2.21(.  55)  2.12  (.  51) 
Control  N=12 
Baseline  1.70  (.  57)  2.16  (.  98)  1.69  (.  67) 
End  of  Treatment  1.70  (.  68)  1.90  (1.0)  1.57  (.  76) 
179 Inspection  of  table  13  suggests  that  there  were  differences  between  and  within 
groups  and  inferential  statistics  were  performed  to  assess  if  such  differences  were 
statistically  significant. 
5.4.3.2  Sleep  Quality 
In  figure  31a  the  mean  Sleep  Quality  values  for  each  group  at  baseline  and  end  of 
treatment  are  presented  graphically. 
A  significant  main  effect  of  group  was  found  [F(2,38)=3.80,  p=0.03].  The  sleep 
quality  means  were  M=2.25(0.6)  for  the  QHRin,  M=2.13(0.9)  for  QHRout  and 
M=1.70(0.6)  for  the  Control.  Employing  Bonferroni  post-hoc  pairwise  comparisons 
no  significant  differences  between  the  groups'  means  were  found.  There  was  also  a 
significant  main  effect  for  time  [F(1,38)=9.82,  p<0.0005]  indicating  that  quality  of 
sleep  at  the  end  of  treatment  [M=2.18(0.7)]  was  higher  than  that  at  baseline 
[M=1.90(0.6)].  The  group  by  time  interaction  was  not  significant  perhaps  because 
power  was  low  (power=0.49).  However,  a  trend  [F(2,38)=2.60,  p=0.09]  suggested 
that  at  the  end  of  treatment  the  QHRin  and  the  QHRout  groups  reported  that  the 
quality  of  their  sleep  was  better  compared  to  baseline  while  the  control  group's  score 
remained  virtually  the  same. 
5.4.3.3  Restedness  Upon  Awakening 
In  figure  31b  the  mean  restedness  values  for  each  group  at  baseline  and  end  of 
treatment  are  presented  graphically. 
There  was  no  significant  main  effect  of  group  [F(2,38)=1.74,  n.  s]  but  a  significant 
main  effect  of  time  [F(1,38)=6.95,  p=0.01]  was  found  indicating  that  the  level  of 
180 restedness  at  the  end  of  treatment  [M=2.01(0.7)]  was  higher  than  that  at  baseline 
[M=1.75(0.7)].  In  addition  the  group  by  time  interaction  was  significant 
[F(2,38)=4.07,  p=0.02].  However,  employing  the  Bonferroni  post-hoc  test  none  of 
the  pairwise  comparisons  was  significant.  Regarding  uncorrected  t-tests  significant 
differences  were  detected  for  QHRin  baseline  vs.  end  of  treatment  [t(13)=-2.29, 
p=0.04],  QHRout  baseline  vs.  end  of  treatment  [t(14)=-3.05,  p=0.009],  QHRin  vs. 
Control  at  end  of  treatment  [t(24)=2.16,  p=0.04]  and  QHRout  vs.  Control  at  end  of 
treatment  [t(25)=2.16,  p=0.04].  These  differences  indicate  that  both  QHR 
interventions  increased  the  level  of  restedness  compared  to  baseline  and  that  by  the 
end  of  the  intervention  both  QHR  groups'  estimate  of  restedness  was  higher  than 
that  of  the  Control  group. 
5.4.3.4  Alertness  Upon  Awakening 
In  figure  31c  the  mean  alertness  values  for  each  group  at  baseline  and  end  of 
treatment  are  presented  graphically. 
No  significant  time  effect  [F(1,38)=.  24,  n.  s.  ]  or  group  effect  [F(2,38)=.  10,  n.  s.  ] 
were  found.  Perhaps  due  to  low  power  (power=0.55),  only  a  non-significant  group 
by  time  interaction  trend  [F(2,38)=2.89,  p=0.07]  was  found.  It  suggested  that  the 
QHRin  and  QHRout  groups  estimated  greater  alertness  at  the  end  of  treatment  as 
compared  to  baseline  while  the  control  group's  estimate  of  alertness  was  lower  at  the 
end  of  treatment  as  compared  to  baseline. 
Interestingly,  figure  31  shows  almost  parallel  lines  for  the  QHRin  and  QHRout 
suggesting  that  the  intervention  produced  similar  changes  in  direction  and  intensity 
181 in  the  three  sleep  quality  variables  under  examination.  This  raises  the  possibility  that 
these  questionnaires  were  measuring  one  single  construct. 
Fig.  31  -  Mean  scores  for  the  variables  'Quality  of  Sleep',  'Restedness'  and 
`Alertness`  at  baseline  and  end  of  treatment  for  the  three  groups 
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In  order  to  assess  if  this  was  the  case  a  Pearson  product  correlation  was  Carried 
out  on  the  first  baseline  week  of  participants  in  study  three  and  on  the  week  of 
participants  in  study  one  (total  N=121).  Significant  positive  correlations  between 
'quality  of  sleep'  and  'restedness'  (r=.  875,  p<.  0005),  'restedness'  and  'alertness' 
(r=.  877,  p<.  0005)  and  'quality  of  sleep'  and  'alertness'  (r=.  809,  p<.  OOO5)  were 
found.  Squaring  these  values  resulted  in  R2=7(/.  IZ2=761/  and  It'=65'%  respecti%eIv 
indicating  that  there  was  substantial  shared  variance  across  this  set  OI'  qualitative 
ratings. 
i81 5.4.3.5  Summary  of  the  Sleep  Quality  Results 
The  results  presented  above  indicate  that  both  QHR  groups  reported  improved 
sleep  quality,  restedness  and  alertness  following  the  intervention  while  the  control 
group's  estimates  did  not  change. 
Having  analysed  the  impact  of  the  QHR  interventions  on  both  sleep  continuity 
and  sleep  quality  variables,  which  suggested  that  the  QHR  is  efficacious  in  producing 
improvements,  attention  is  now  turned  to  the  clinical  significance  of  the  QHRin  and 
the  QHRout. 
5.4.4  Clinical  Changes  Associated  to  the  QHRin  and  the  QHRout 
In  this  section  the  clinical  significance  of  the  QHR  treatment  is  addressed.  Kazdin 
(1977)  regarded  change  in  therapy  as  clinically  significant  when  the  individual 
moved  from  the  dysfunctional  to  the  functional  range  of  normalcy.  In  addition, 
Lichstein  and  Fischer  (1985)  regarded  a  change  over  baseline  greater  than  50%  as  a 
useful  clinical  outcome  measure.  These  two  outcome  measures  were  used  to  assess 
the  clinical  significance  of  the  QHRin  and  QHRout  interventions.  They  were  applied 
to  the  sleep  continuity  variables  SOL  and  WASO  and  to  the  PSQI  total  score. 
5.4.4.1  Clinical  Significance 
Table  14  presents  the  percentage  of  participants  in  each  group  (QHRin,  QHRout 
and  Control)  achieving  a  mean  reduction  of  clinical  significance  (Kazdin,  1977, 
Lichstein  et  al,  1985)  for  SOL,  WASO  and  PSQI  and  associated  effect  sizes. 
183 Table:  14  -  Percentage  of  Participants  in  Each  Treatment  Condition  achieving 
Mean  Reduction  of  Clinical  Significance  According  to  2  Criteria'`'  and  Effect  Sizes'`-]' 
5Vl  Reduction  Returned  to  Nurmatc} 
SOL 
QHRin  14  2I  'Y(  33%  0.2 
Q11kout  15  47(4  33%  0.6 
Control  12  17%  11%  0.3 
WASO 
QHRin  14  57%  33%  0.7 
QIlRout  15  53%  33%  1.1 
Control  12  0%  0%  0.0 
PSQI 
QHRin  14  29%  7%  1.7 
QHRout  15  33%  13%-  2.3 
Control  12  0%  0170  1).  1) 
'`'Criteria  proposed  by  Kazdin,  1977:  Lichst  ein  cl  al,  1985 
»'  Effect  size  c  alculated  base  line  to  end  of  intervention 
As  reported  in  table  14  the  QHRin  and  the  QHRout  produced  clinically  significant 
changes  in  30  to  50%  of  the  participants.  The  effect  sizes  were  in  the  small  toi 
medium  range  for  SOL,  in  the  medium  to  large  range  for  WASO  and  in  the  large 
range  for  the  PSQI.  The  effect  sizes  for  both  TST  (0.8  for  QI  Win,  1.  I  for  OI  Innut 
and  0.0  for  Control)  and  S.  E.  (0.8  for  QHRin,  0.8  for  QllRout  and  t).  O  fror  Control) 
were  in  the  large  range.  Importantly  43%  of'  participants  in  the  QIIRin,  0012(A  f 
QHRout  and  only  8%  of  controls  achieved  a  S.  F.?  851/ 
. 
Interestingly,  the  magnitude  of'  change  achieved  with  the  QHRout  was  superior  to 
that  achieved  with  the  QHRin  as  evidenced  by  effect  sizes. 
5.4.4.2  Therapeutic  effects  at  week  one,  two  and  three 
In  order  to  explore  when  the  QHR  started  to  impact  on  slop.  Ihc  mcan  chanrc 
scores  over  baseline  at  week  1,  week  2  and  week  3  were  considered.  Week  I,  week  2 
and  week  3  represent  the  ºnean  of  the  sleep  diary  data  gathered  during,  thy'  first, 
184 second  and  third  week  of  intervention  respectively.  In  the  following  sections  non- 
parametric  analyses  (Kruskal-Wallis)  were  carried  out  on  the  change  score  values  to 
assess  after  how  many  intervention  days  statistically  significant  differences  between 
groups  emerged. 
5.4.4.2a  Response  Curve  for  Sleep  Onset  Latency 
In  figure  32  the  mean  SOL  changes  over  the  baseline  mean  values  at  week  1,2, 
and  3  for  each  group  are  presented  graphically. 
Fig.  32  -  SOL  Mean  Change  Values  over  the  Baseline  Mean  Value  at 
Intervention  (week  1,2  and  3)  for  the  3  Groups 
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Statistically  significant  differences  between  the  groups  were  found  for  SOL  mean 
change  values  over  baseline  at  week  1  [x2(2)=  9.700,  p=0.008],  week  2  [x2(2)= 
6.756,  p=0.03]  and  week  3  [x2(2)=  9.213,  p=0.01].  Bonferroni  corrected  Mann- 
Whitney  comparisons  between  groups  were  performed  for  each  week  comparison. 
No  statistically  significant  differences  were  found  between  the  two  treatment  groups 
(QHRin  and  QHRout)  at  week  1,  week  2  or  week  3.  With  regard  to  week  1, 
statistically  significant  differences  were  found  between  the  QHRin  and  the  Control 
groups  [U=36.00,  N1=14,  N3=12,  p=0.01]  and  the  QHRout  and  the  control  groups 
[U=31.00,  N2=15,  N3=12,  p=0.003]  indicating  that  already  during  the  first  week  of 
intervention  the  two  treatment  groups  took  less  time  to  fall  asleep  than  the  control 
185 group.  With  regard  to  week  2  and  3,  statistically  significant  differences  were  found 
between  QHRout  and  the  control  [U=39.500,  N2=15,  N3=12,  p=0.01  and  U=26.000, 
N2=15,  N3=12,  p=0.001  respectively]  showing  that  during  the  second  and  third 
weeks  of  intervention  the  QHRout  took  less  time  to  fall  asleep  as  compared  to  the 
control  group.  It  is  important  to  note  that  these  results  are  due  to  the  QHRout  group 
reducing  their  SOL  and  the  control  group  increasing  theirs. 
5.4.4.2b  Response  Curve  for  Wake  After  Sleep  Onset 
The  graphic  representation  of  the  mean  WASO  changes  over  the  baseline  mean 
values  at  week  1,2,  and  3  for  each  group  (fig.  33)  suggests  no  change  for  the  control 
group  but  positive  changes  from  the  first  week  of  intervention  for  the  QHRin  and  the 
QHRout. 
Fig.  33  -  WASO  Mean  Change  Values  over  the  Baseline  Mean  Value  at 
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Statistically  significant  differences  between  the  groups  were  found  for  WASO 
mean  change  scores  over  baseline  at  week  1  [X2(2)=  11.050,  p=0.004],  week  2 
[x2(2)=  9.678,  p=0.008]  and  week  3  [x2(2)=  9.075,  p=0.01].  Bonferroni  corrected 
comparisons  showed  no  statistically  significant  differences  between  the  QHRin  and 
the  QHRout  at  week  1,  week  2  or  week  3.  With  regard  to  week  1,  statistically 
significant  differences  were  found  between  the  QHRin  and  the  Control  groups 
[U=29.000,  N1=14,  N3=12,  p=0.004]  and  the  QHRout  and  the  Control  groups 
186 [U=31.00,  N2=15,  N3=12,  p=0.003]  indicating  that  already  during  the  first  week  of 
intervention  the  two  treatment  groups  spent  less  time  awake  during  the  night  as 
compared  to  the  control  group.  These  improvements  were  maintained  during  week  2 
and  3  [QHRout  and  the  control  group  U=44.000,  N2=15,  N3=12,  p=0.02  and 
U=24.000,  N1=15,  N3=12,  p=0.001  respectively  and  QHRin  and  the  control  group 
U=26.000,  N1=14,  N3=12,  p=0.002  and  U=46.000,  N2=14,  N3=12,  p=0.05 
respectively]  (uncorrected  t-tests  for  week  3). 
5.4.4.2c  Response  Curve  for  Total  Sleep  Time 
Inspection  of  figure  34  suggests  that  the  mean  TST  over  the  baseline  mean  values 
at  week  1,2,  and  3  differed  only  for  the  QHRin  and  the  QHRout. 
Fig.  34-TST  Mean  Change  Values  over  the  Baseline  Mean  Value  at 
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Statistically  significant  differences  between  the  groups  were  found  for  the  TST 
mean  change  values  over  baseline  at  week  1  [X2(2)=  7.503,  p=0.02],  week  2  [x2(2)= 
10.000,  p=0.07]  and  a  non,  significant  trend  at  week  3  [x2(2)=  5.704,  p=0.06]. 
Applying  Bonferroni  corrected  comparisons  no  statistically  significant  differences 
were  found  between  the  QHRin  and  the  QHRout  at  week  1,2  or  3.  With  regard  to 
week  1,  a  statistically  significant  difference  was  found  between  the  QHRout  and  the 
control  groups  [U=37.00,  N2=15,  N3=12,  p=0.009]  indicating  that  already  during  the 
first  week  of  intervention  the  QHRout  slept  longer  as  compared  to  the  control  group. 
187 The  difference  between  the  QHRin  and  the  control  group  approached  significant 
difference  [U=42.000,  N1=14,  N3=12,  p=0.03].  With  regard  to  week  2,  a  statistically 
significant  difference  was  found  between  the  QHRout  and  the  control  group 
[U=28.000,  N2=15,  N3=12,  p=0.002].  In  addition  the  difference  between  the  QHRin 
and  the  control  groups  approached  significance  [U=38.000,  N1=14,  N3=12,  p=0.018]. 
With  regard  to  week  3a  non-significant  trend  was  found  and  inspection  of  figure  34 
suggests  that  during  the  third  week  of  intervention  the  QHRout  and  QHRin  slept 
longer  than  the  control  group. 
5.4.4.2d  Response  Curve  for  Sleep  Efficiency 
In  figure  35  the  mean  S.  E.  changes  over  the  baseline  mean  values  at  week  1,2, 
and  3  for  each  group  are  presented  graphically. 
Fig.  35  -  S.  E.  Mean  Change  Values  over  the  Baseline  Mean  Value  at 
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Statistically  significant  differences  between  the  groups  were  found  for  the  S.  E. 
mean  change  values  over  baseline  at  week  1  [X2(2)=  11.40,  p=0.003],  week  2  [X2(2)= 
14.40,  p=0.001]  and  week  3  [x2(2)=  11.64,  p=0.003].  Bonferroni  corrected 
comparisons  showed  no  statistically  significant  differences  between  the  QHRin  and 
the  QHRout  at  week  1,2  or  3.  With  regard  to  week  1,  statistically  significant 
differences  were  found  between  the  QHRin  and  the  control  group  [U=35.000,  N1=14, 
N3=12,  p=0.01]  and  the  QHRout  and  the  control  group  [U=21.500,  N2=15,  N3=12, 
188 p<0.0005]  indicating  that  already  during  the  first  week  of  intervention  S.  E.  mean 
change  values  of  the  QHRin  and  the  QHRout  were  greater  that  that  of  the  control 
group.  With  regard  to  week  2,  a  statistically  significant  difference  was  found 
between  the  QHRin  and  the  control  group  [U=26.500,  N1=14,  N3=12,  p=0.002]  and 
the  QHRout  and  the  control  group  [U=18.000,  N2=15,  N3=12,  p<0.0005]  showing 
that  during  the  second  week  of  intervention  the  QHRout  and  the  QHRin  had  higher 
mean  S.  E.  values  as  compared  to  the  control  group.  With  regard  to  week  3,  a  trend 
between  the  QHRin  and  the  control  group  [U=45.000,  NI=14,  N3=12,  p=0.05]  and  a 
statistically  significant  difference  between  the  QHRout  and  the  control  groups 
[U=14.500,  N2=15,  N3=12,  p<0.0005]  were  found. 
5.4.4.2e  Summary  of  the  Response  Curve  Findings 
The  response  curve  results  obtained  by  performing  statistical  analyses  on  the 
mean  change  scores  suggested  that  the  QHR  interventions  produced  statistically 
significant  differences  in  most  of  the  sleep  parameters  already  during  the  first  week 
of  treatment  as  compared  to  the  control  group.  These  results  are  critically  examined 
in  the  discussion  section. 
Having  shown  that  the  QHR  interventions  improved  subjectively  estimated  sleep 
continuity  and  quality,  that  it  produced  clinical  significance  changes  and  that  these 
changes  presented  within  the  first  week  of  treatment,  attention  is  now  turned  to  the 
possibility  that  the  QHR  intervention  is  associated  to  changes  in  sleep  related 
cognitions  and  to  arousability  at  bed  time. 
189 5.4.5  Sleep  Related  Questionnaires 
In  this  section  sleep  related  cognition  and  physical  and  mental  arousal  at  bedtime, 
gathered  via  a  battery  of  six,  well  validated  questionnaires,  are  reported  descriptively 
and  then  formally  analysed.  This  analysis  can  help  to  shed  light  on  whether  the  QHR 
had  an  impact  on  cognition  and  arousal  as  well  as  sleep  parameters.  Before  analysing 
each  of  the  questionnaires  some  common  points  may  be  made.  One-way  ANOVAs 
were  performed  on  the  baseline  mean  scores  for  each  scale,  or  questionnaire  sub- 
scales  where  appropriate,  to  examine  if  there  were  statistically  significant  differences 
among  the  groups  prior  to  the  treatment  phase.  The  only  significant  differences 
indicated  that  at  baseline  the  somatic  and  sensory  engagement  of  the  QHRin  was 
lesser  than  those  of  the  QHRout  and  of  the  control  group.  The  results  of  one-way 
ANOVAs  are  reported  in  appendix  31. 
5.4.5.1  Descriptive  Data  of  sleep  related  cognitions  and  bed-time  arousal 
The  Mean  Score  and  SD  for  each  group  at  baseline  and  end  of  treatment  are 
reported  in  table  15.  The  next  subsections  report  results  for  each  of  the 
questionnaires  completed  by  participants. 
5.4.5.2  01:  Sleep  Behaviour  Self  Rating  Scale  -R 
With  regard  to  the  SBSRS-R  scale  no  significant  main  effects  for  time 
[F(1,36)=0.18,  n.  s.  ]  or  group  [F(2,36)=4.89,  p=0.01]  or  significant  interaction 
[F(2,36)=2.48,  n.  s]  were  found.  It  should  be  noted  that  power  to  detect  differences 
was  very  low  (power  =  0.25) 
190 Table  15  -  Mean(SD)  scores  at  baseline  and  end  of  treatment  for  the  battery  of 
questionnaires  for  the  QHRin,  QHRout  and  Control  groups 
QHRin(N=13)  QHRout  (N=17)  Control  (N=9) 
Baseline  Intervention  Baseline  Intervention  Baseline  Intervention 
Q1  29.8(6.8)  30.0(5.3)  29.8(5.5)  27.8(4.6)  31.3(5.9)  32.4(6.2) 
Q2  7.5(3.6)  5.3(2.8)  8.6(2.4)  6.5(2.4)  8.1((3.4)  7.9(2.8) 
Q3a  11.1(3.9)  9.9(4.1)  12.4(2.6)  11.7(2.6)  11.8(1.8)  12.1(1.3) 
Q3b  7.6(2.6)  6.1(2.2)  9.2(23)  8.5(4.1)  10.8(3.2)  9.7(2.8) 
Q3c  8.9(3.1)  5.1(1.8)  10.6(2.1)  7.9(2.2)  9.2(2.2)  7.1(2.2) 
Q3d  9.4(2.4)  6.2(1.7)  9.3(1.9)  6.3(1.8)  8.4(1.6)  8.2(2.2) 
Q4a  18.6(5.9)  17.9(6.5)  21.2(4.4)  18.6(5.3)  21.1(3.4)  22.1(2.9) 
Q4b  20.1(5.4)  18.7(6.2)  23.1(33)  19.5(5.0)  22.4(5.9)  245(4.2) 
Q4c  12.1(2.5)  12.0(3.1)  14.6(2.6)  11.6(2.3)  14.9(1.7)  15.7(3.3) 
Q5a  133(4.3)  11.6(3.8)  13.2(4.1)  113(3.7)  14.2(6.6)  14.1(5.8) 
Q5b  21.1(7.6)  19.1(7.9)  24.7(5.3)  21.8(6.7)  26.5(3.4)  25.2(4.7) 
Q6a  11.8(3.8)  11.1(3.9)  13.6(2.7)  12.9(2.4)  13.2(2.6)  11.6(3.7) 
Q6b  16.4(4.7)  16.8(4.2)  18.1(4.9)  18.7(3.2)  17.0(4.8)  16.4(4.5) 
Q6c  24.6(4.2)  23.6(6.9)  26.3(7.0)  24.6(5.9)  27.6(7.0)  26.7(8.0) 
Q1=  SBSRS-R, 
Q2=GSES, 
Q3=  SDQ.  It  comprises  4  subscales,  measuring: 
Q3a=  cognitive  arousal.  Q3b=  physical  tension,  Q3c=  sleep  effort,  Q3d-  sleep  pattern  problems 
Q4=  GCTI.  It  comprises  3  subscales  measuring  cognitive  intrusions  relating  to 
Q4a=  active  problem  solving,  Q4b=  sleep  and  wakefulness  Q4c=somatic  and  sensory  engagement 
Q5=  PSAS.  It  comprises  2  subscales  measuring  Q5a=  cognitive  arousal,  Q5b=  somatic  arousal 
Q6=  DBAS-10.  It  comprises  3  subscales  measuring  beliefs  about  insomnia.  In  particular 
Q6a=need  for  control  over  insomnia  Q6b=  long  term  &  Q6c=  short  term  negative  consequences 
5.4.5.3  02:  Glasgow  Sleep  Effort  Scale 
In  figure  36  the  mean  total  GSES  scores  for  each  group  at  baseline  and  end  of 
treatment  are  presented  graphically. 
Fig.  36  -  Mean  Total  Score  for  f12  (GSI  )  for  the  Three  Groups  at  Baseline  and 
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191 No  main  effects  of  group  [F(2,36)=0.32,  n.  s.  ]  was  found  but  a  significant  main 
effect  of  time  [F(1,36)=12.93,  p=0.001]  was  found  showing  that  the  total  score  was 
higher  at  baseline  [M=  8.1(3.0)]  than  at  end  of  treatment  [M=  6.4(2.7)].  This  result 
indicated  a  decrease  in  sleep  effort  at  the  end  of  treatment.  No  significant  interaction 
[F(2,36)=2.00,  n.  s.  ]  was  found  but  power  to  detect  differences  was  low 
(power=0.38). 
5.4.5.4  03:  Sleep  Disturbance  Questionnaire 
The  SDQ  comprises  four  sub-scales  which  were  analysed  separately  as  they 
measure  different  constructs. 
5.4.5.4a:  Cognitive  Arousal 
With  regard  to  the  dimension  `cognitive  arousal'  of  the  SDQ  no  significant  main 
effects  of  time  [F(1,36)=  3.00,  p=0.09]  or  group  [F(2,36)=1.31,  n.  s.  ]  or  significant 
interactions  [F(2,36)=1.90,  n.  s.  ]  were  found.  The  power  to  detect  differences  was  low 
(power  =0.39,0.26  and  0.37  for  Time,  Group  and  interaction  respectively). 
5.4.5.4b:  Physical  Tension 
With  regard  to  the  dimension  `physical  tension'  of  the  SDQ  a  significant  main 
effect  of  group  [F(2,36)=4.75,  p=0.015]  was  found  and  post-hoc  Bonferroni 
corrected  pairwise  comparisons  indicated  that  physical  tension  of  the  QHRin 
[M=6.6(2.4)]  was  lower  than  that  of  the  control  group  [M=10.2(2.9)]  [t(20)=-3.01, 
p=0.007].  A  significant  time  effect  was  also  found  [F(1,36)=4.50,  p=0.04]  showing 
that  perception  physical  tension  had  decreased  at  the  end  of  treatment  [M=  8.0(3.4)] 
192 as  compared  to  baseline  [M=  9.0(2.9)].  No  significant  interaction  was  found 
[F(2,36)=  0.22,  n.  s.  ]  however  power  to  detect  differences  was  low  (power=0.08). 
5.4.5.4c:  Sleep  Effort 
With  regard  to  the  dimension  `sleep  effort'  of  the  SDQ  a  significant  group  effect 
[F(2,36)=6.67,  p=0.003]  was  found  and  post-hoc  Bonferroni  corrected  pairwise 
comparisons  [t(280=-3.76,  p=0.001]  indicated  that  the  QHRin  sleep  effort  was  lower 
than  that  of  the  QHRout  [M=7.0(2.4)  and  M=9.2(2.1)].  A  main  effect  of  time 
[F(1,36)=28.73,  p<0.0005]  indicated  that  the  total  score  was  higher  at  baseline  [M= 
9.7(2.5)]  than  3  weeks  after  intervention  [M=  6.8(2.3)]  (i.  e.  less  sleep  effort  at  the 
end  of  treatment).  This  result  is  similar  to  that  obtained  with  the  GSES  (section 
5.4.5.3).  No  significant  interaction  [F(2,36)=.  805,  n.  s.  ]  was  found  but  power  was 
low  (power=0.18). 
5.4.5.4d:  Sleep  Pattern  Problems 
No  significant  main  effect  of  group  was  found  [F(2,36)=0.51,  n.  s.  ]  but  a  significant 
main  effect  of  time  [F(1,36)=22.18,  p<0.0005]  showing  that  the  total  score  was 
higher  at  baseline  [M=  9.1(2.0)]  than  at  end  of  treatment  [M=  6.7(1.9)]  was  found.  A 
significant  interaction  effect  [F(2,36)=3.78,  p=0.03]  was  explored  with  post-hoc 
Bonferroni  corrected  comparisons.  Results  showed  that  sleep  patterns  problems  were 
less  at  the  end  of  treatment  as  compared  to  baseline  for  both  the  QHRout  [t(16)=4.47, 
p=0.0005]  and  the  QHRin  [t(12)=4.58,  p=0.001].  The  uncorrected  pairwise 
comparisons  were:  end  of  treatment  QHRin  vs.  control  [t(20)=-2.4,  p=0.025]  and 
QHRout  vs.  control  [t924)=-2.4,  p=0.024]. 
193 Fig.  37  -  Mean  Total  Score  for  Q3d  (sleep  pattern  problems)  for  the  3 
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As  depicted  in  figure  37  these  results  indicated  that  hui  Ii  OIIIZ  intorýýntiýýiýý 
decreased  sleep  pattern  problems  while  the  control  condition  diel  not. 
5.4.5.5  Q4:  Glasgow  Content  of  Thoughts  Inventory 
The  GCTI  comprises  three  sub-scales,  which  were  analysed  SCIMI-  tel`  as  they 
measure  different  constructs.  In  figure  38  the  mean  total  scores  of  ilir  (i('"I'I  Ior  11w 
three  groups  are  presented graphically. 
Fig.  38  Mean  Total  Score  for  Q4a  (active  problem 
Q4h  (sleep  &  wakefulness)  and  Q4c  (sonmatic  and  sensorytl 
for  the  3  Groups  at  Baseline  and  I?  nd  of 
Me  25  . 
30 
Tot  20  a''  25 
_ 
sý____" 
-"-., 
"I 
Tot10  I  -------mai 
Sc  15  sl 
ore  Sc15 
10  ore  10 
550 
Baseline  Post-Treatment  Baseline  Post-Treatment 
Q4a:  Active  Problem  Q4b:  sleep  &  w.  ºkel'ulness 
To  14 
Tel  ý2 
-+--  OHRin 
or 
o 
"s-  -er  -  CHRout 
ý*--- 
Control 
Baseline  Post-Treatment 
somatic  and 
194 5.4.5.5a:  Active  Problem  Solving 
There  were  no  significant  main  effects  of  time  [F(1,36)=  2.47,  n.  s]  or  of  group 
[F(2,36)=1.27,  n.  s.  ]  but  a  significant  interaction  effect  [F(2,36)=4.59,  p=0.02]  was 
found.  Employing  the  Bonferroni  post-hoc  correction,  only  the  difference  between 
the  baseline  and  end  of  treatment  conditions  for  the  QHRout  group  approached 
significant  difference  [t(16)=3.2,  p=0.006]  suggesting  that  the  QHRout  intervention 
decreased  active  problem  solving  (fig.  38-Q4a).  All  other  comparisons  did  not  differ 
(all  p,,  >0.05). 
5.4.5.5b:  Sleep  and  Wakefulness 
There  were  no  significant  main  effects  of  time  [F(1,36)=1.59,  n.  s.  ]  or  of  group 
[F92,36)=2.18,  n.  s.  ].  A  significant  interaction  effect  [F(2,36)=4.34,  p=0.02]  was 
explored  employing  the  Bonferroni  post-hoc  tests  which  revealed  no  significant 
differences.  The  uncorrected  t-tests  indicated  significant  differences  at  the  end  of 
treatment  between  QHRin  and  control  [t(20)=-2.43,  p=0.02  and  between  QHRout 
and  control  [t(20)=-2.54,  p=0.018];  the  baseline  vs.  end  of  treatment  difference  for 
the  QHRout  was  also  significant[t(16)=-2.61,  p=0.02].  These  results  suggest  that  the 
QHR  conditions,  compared  to  the  control  group,  decreased  sleep  and  wakefulness 
scores  following  intervention  (fig.  38-4Qb). 
5.4.5.5c:  Somatic  and  Sensory  Engagement 
There  was  no  significant  main  effect  of  time  [F(1,36)=2.67,  n.  s.  ]  but  a  significant 
main  effect  of  group  [F(2,36)=5.73,  p<0.007]  was  found.  Post-hoc  Bonferroni 
corrected  pairwise  comparisons  revealed  significant  differences  between  the  QHRin 
and  control  [t(20)=-2.88,  p=0.009]  and  the  QHRout  and  control  [t(24)=-2.74, 
195 p=0.011]  indicating  that  the  QHRin  and  the  QHRout  somatic  and  sensory 
engagement  was  lower  than  the  control  [M=12.1(2.8),  M=13.0(2.4)  and 
M=15.2(2.6)]  respectively).  A  significant  interaction  effect  [F(2,36)=6.54,  p=0.04] 
was  explored  with  Bonferroni  post-hoc  tests.  Significant  differences  between 
baseline  and  end  of  treatment  for  the  QHRout  group  [t(16)=3.42,  p=0.003]  and 
between  the  QHRout  and  Control  group  [t(24)=-3.63,  p=0.001]  were  found, 
indicating  that  the  QHRout  group  decreased  their  somatic  and  sensory  engagement 
following  intervention  and  it  was  lower  than  that  of  the  control  group  at  end  of 
treatment  (fig.  38-Q4c).  The  uncorrected  pairwise  comparison  between  QHRin  and 
Control  [t(20)=-2.6,  p=0.017]  was  significant,  however,  this  was  due  to  the  QHRin 
score  being  statistically  significantly  lower  than  the  control  group  already  at  baseline 
rather  than  to  a  difference  due  to  the  intervention. 
5.4.5.6  05:  Pre-Sleep  Arousal  Scale 
The  PSAS  comprises  two  sub-scales,  which  were  analysed  separately  as  they 
measure  different  constructs. 
5.4.5.6a:  Cognitive  Arousal 
With  regard  to  `cognitive  arousal'  there  was  no  significant  main  effect  of  group 
[F(2,36)=0.54,  n.  s.  ]  or  interaction  effect  [F(2,36)=0.92,  n.  s.  ]  but  a  significant  main 
effect  of  time  [F(1,36)=5.18,  p=0.03]  was  found  indicating  that  cognitive  arousal  was 
higher  at  baseline  [M=13.6(4.7)]  than  at  end  of  treatment  [M=12.1(4.3)]. 
196 5.4.5.6b:  Somatic  Arousal 
With  regard  to  `somatic  arousal'  a  non  significant  trend  for  the  main  effect  group 
was  found  [F(2,36)=2.65,  p=0.08].  A  significant  main  effect  of  time  [F(1,36)=7.03, 
p=0.01]  indicated  that  the  somatic  arousal  at  baseline  was  higher  [M=24.0(6.1)]  than 
at  end  of  treatment  [M=21.7(7.0)].  No  significant  interaction  effect  was  found 
[F(2,36)=  0.34,  n.  s.  ]  but  power  was  low  (power=0.10). 
5.4.5.7  06:  Dysfunctional  Beliefs  and  Attitudes  about  Sleep-l0 
The  DBAS-10  comprises  3  sub-scales,  which  were  analysed  separately  as  they 
measure  different  constructs.  However  none  of  the  main  effects  or  interaction  effects 
for  any  of  the  three  subscales  was  significant.  This  is  probably  due  to  the  fact  that 
power  to  detect  differences  was  low  ranging  from  0.9  to  0.43. 
5.4.5.8  Summary  of  the  Sleep  Related  Questionnaire  Results 
The  results  presented  above  suggest  that  the  QHR  interventions  decreased  sleep 
cognitive  activity  at  bedtime  and  improved  sleep  patterns  while  changes  were  not 
found  in  the  control  group.  Inspection  of  the  figures  reveals  that  baseline  to  treatment 
changes  evidenced  by  this  battery  of  questionnaires  were  similar  raising  the 
possibility  that  these  measures  are  not  independent  from  each  other.  A  correlation 
matrix  (table  16)  was  calculated  which  confirmed  the  overlap  across  these  scales. 
Consequently  the  results  obtained  may  suggest  changes  in  an  underlying  common 
construct  (e.  g.  decreasing  anxiety  about  sleep)  rather  than  changes  in  14  different 
constructs. 
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ON 5.4.6  Objective  Sleep  Continuity  Data 
In  this  section  sleep  continuity  parameters  gathered  via  PSG  are  reported  and  thin 
analysed.  Before  analysing  each  of  these  variables  some  points  common  toi  all  variahl("` 
should  be  made.  As  explained  in  section  5.2.5  PSG  data  for  both  haselirre  and 
intervention  periods  were  recorded  in  37  of  the  44  participants.  One-way  ANOVAs 
were  performed  on  the  baseline  mean  SOL,  WASO  TST  and  S.  F.  values  and  no 
significant  differences  were  found  for  SOL  I  F(2,34)=.  067,  n.  s.  I,  WASO  1  I'(-'.  34  )_.  2  )8, 
n.  s.  1,  TST  IF(2,34)=3.23,  n.  s.  I  or  S.  E.  IF(2,38)=.  496,  n.  s.  I  (a  11  p,  >I).  05). 
5.4.6.1  Sleep  Continuity  Data  gathered  via  Polysomnogruphy 
Table  17  presents  the  means  and  SD  for  sleep  continuity  variablrs  rrrunkdI  during 
the  second  night  of  baseline  and  the  last  night  of  treatment  for  the  Ql  IRin,  QI  IRt  it  and 
Control  groups. 
Table  17  -  Mean  and  SD  for  Objectively  Measured  Sleep  Continuity  Variables 
at  Baseline  and  End  of  Treatment  for  the  3  Groups 
QHRin  (N=13)  QHRout  (N=16)  Control  (N=8)  Total  (N=37) 
SOL 
Base  Iinc  27.73  (30.0)  24.03  (26.3) 
I?  nd  Treatment  33.92  (34.9)  17.35  (19.4) 
WASO 
Baseline  54.11  (45.4)  49.12  (38.8) 
Ind  Treatment  70.6  (58.2)  61.62  (49.9) 
TST 
Baseline  421.73  (45.3)  430.03  (60.3) 
I:  nd  Treatment  393.23  (75.9)  411.84  (55.9) 
S.  E. 
Baseline 
. 
83  (.  08) 
. 
84(.  08) 
End  Treatment 
. 
78  (.  13) 
. 
83  (.  09) 
2h.  Iý  2'1.9)  5.  (  )o.  7 
18.87  (15.3)  23.5I  (25.9) 
62.50  (32.2)  53.77 
62.18  (27.9)  0-1.90  (i  . 
3) 
376.50  (27.2)  -115.54  (52.8) 
40I.  56  (70.1)  -I03.0  (65.2) 
. 
81  (.  ()O) 
. 
83  i.  ()()) 
. 
82(.  06-) 
. 
82  (.  IO) 
Separate  mixed  model  ANOVAs  were  carried  out  on  each  of'  the  sleep  continuity 
variables  but  no  statistically  significant  differences  were  found.  'T'hem'  were  no  lime, 
OO group  or  interaction  effects  for  SOL  IF(  I 
, 
34)=.  167,  n.  s.,  F(2,34)=.  513,  n.  s.; 
F(2.34)=1.12,  n.  s.  ],  WASO  IF(I,  34)=1.130,  n.  s.,  IF(2,34)=.  264,  n.  s,  F(2.34)=.  165,  n.  s.  I, 
TST  IF(1,34)=.  373,  n.  s.,  F(2,34)=1.595.  n.  s..  F(2.34)=1.121,  n.  s.  1  or  S.  F.  IF(  I,  _ß4)=.  438, 
n.  s.;  F(2,34)=.  626,  n.  s.;  F(2.34)=.  824,  n.  s.  j.  These  results  indicate  that  1'S(;  dcl'inrd 
sleep  parameters  were  unchanged  at  end  of  treatment  as  compared  tu  ha.  seline.  The 
positive  subjective  outcomes  regarding  sleep  continuity  parameters  were,  therefore,  not 
confirmed  by  outcomes  obtained  via  PSG.  It  is,  therefore,  important  to  Consider  \w  heller 
or  not  sleep  continuity  variables  measured  subjectively  were  correlated  with  the  saine 
variables  measured  objectively  (section  5.3.7.3).  First,  however,  slrrl)  ;  irrhiti'rturc 
parameters  will  be  analysed 
5.4.6.2  Sleep  Architecture  Data 
Table  18  presents  the  means  and  SI)  for  sleep  au-rhiteetum  variables  (Stg  I,  tilg,  ?, 
Stg  3  &4  and  REM)  recorded  during  the  second  night  of'  baseline  and  the  last  night  oI' 
treatment  for  the  QHRin,  QHRout  and  Control  Groups. 
Table  18-  Mean  and  SD  for  Objectively  Measured  Sleep  ; lrchilectiu"e  Variable', 
at  Baseline  and  End  of  Treatment  fror  the  3  Groups 
QHRin  (N=13)  QIIRout  (N=16)  C  ontrol  (N=8)  Total  (N=37) 
Stg  I 
Baseline  ?  2.69(17.  x))  18.37(11.5)  17.  ih(I2.1)  11)  /1  i1-11) 
F.  nd  Treatment  21.65  (19.4)  20.78  (14.5)  I0.00  (10.0)  20.06  (I  5A)  ) 
Stg  2 
Baseline  255.03  (29.7)  247.19  (40.8)  242.50  (25.4)  248.11  (33.7) 
lind  't'reatment  226.26  (60.3)  241.35  (35.3)  25  1.00  (47.7)  238.1-1  (17.0) 
Stg3&4 
Baseline  31.96  (33.5)  39.15  (23.5)  18.50  (32.2)  (2.10  (20.9) 
End  "Treatment  34.07  (28.2)  33.68  (23.5)  17.06  (15.1)  tO?  2  (24.3) 
REM 
Baseline  112.03  (25.7)  125.34  (33.8)  97.93  (19.4)  1  1-1.7.1)  9.7) 
End  Treatment  111.23  (42.7)  116.03  (30.0)  117.68  (30.0)_ 
__] 
14.70  0.1. 
_i) 
Separate  mixed  model  ANOVAs  found  no  statistically  Significant 
Specifically,  there  were  no  time  IF(I,  34)=O.  OOI,  n.  s.  1,  group  II  (2,3-3)=().  3(I,  n.  s.  1  or 
'200 interaction  [F(2.34)=0.6.16,  n.  s.  ]  effects  for  Stg  1.,  no  time  [F(1,34)=1.102,  n.  s.  ],  group 
[F(2,34)=0.086,  n.  s.  ]  or  interaction  [F(2.34)=1.632,  n.  s.  ]  effects  for  Stg  2,  no  time 
[F(1,34)=0.367,  n.  s.  ],  main  group  [F(2,34)=1.661,  n.  s.  ]  or  interaction  [F(2.34)=0.876, 
n.  s.  ]  effects  for  Stg  3&4  and  no  time  [F(1,34)=0.342,  n.  s.  ],  no  group  [F(2,34)=0.699, 
n.  s.  ]  or  interaction  [F(2.34)=2.200,  n.  s.  ]  effects  for  REM. 
These  results  indicated  that  sleep  architecture  values  gathered  via  PSG  at  baseline 
remained  unchanged  following  the  intervention  phase. 
These  analyses  and  those  reported  in  the  previous  section  suggest  that  the  QHR 
interventions  had  no  impact  on  objective  sleep  continuity  or  sleep  architecture  variables. 
This  is  a  net  contrast  with  estimates  of  sleep  continuity  and  sleep  quality.  It  is,  therefore, 
important  to  assess  if  the  subjective  and  objective  sleep  parameters  obtained  in  this 
study  correlate. 
5.4.7  Subjective  and  Objective  Sleep  Continuity:  Association 
In  this  section  objective  and  subjective  measures  of  sleep  continuity  are  compared 
5.4.7.1  Descriptive  Subjective  and  Objective  Sleep  Continuity 
To  determine  whether  the  subjective  estimates  of  sleep  on  the  recording  nights  were 
representative  of  the  subjective  sleep  estimates  of  non-recording  nights,  the  mean  for 
self-report  SOL,  WASO,  TST  and  S.  E.  on  the  recording  nights  were  compared  to  the 
mean  for  self-report  SOL,  WASO,  TST  and  S.  E.  for  the  baseline  and  end  of 
intervention  weeks  for  each  group  (Jacobs  and  Benson,  1993).  As  depicted  in  table  19 
the  means  did  not  differ  significantly,  suggesting  that  the  sleep  recording  night  was 
representative  of  sleep  on  non-recording  nights  . 
201 Table  19  -  Wilcoxon  Signed  Rank  Test  values  and  significances  comparing  sleep  diary  data  of 
recording  night  and  mean  week  values  at  baseline  and  end  of'  intervention 
Recording  Night  V  alues  Vs  Weekly  Mean  Values 
Group  Sleep  Variable  Baseline  Intervention 
z  N-ties  p  r.  N-lies  I) 
QHRin 
SOL  (1.  I5  13  ns  0.45  13  ns 
WASO  1.15  13  ns  0.  S()  13  ns 
TST  0.31  13  ns  1.51)  13  ns 
S.  E.  0.52  13  ns  0.53  II  is 
QHRout 
SOL  0.85  14  ns  2.66  12  ns 
WASO  1.47  14  ns  H)  1  (4  n> 
TST  1.22  (4  ns  1.218  14  nti 
S.  E.  0.75  (4  ns  L55  14  n. 
Control 
SOL  1.26  8  ns  1.18  7  ns 
WASO  0.42  8  ns  0.07  8  ns 
TST  0.28  8  ns  0.84  8  ns 
S.  E.  0.14  8  ns  0.49  8  ns 
In  table  20  means  and  standard  deviations  of  snhjertivr  ant)  uhji"rtivi"  slipp 
parameters  collected  during  PSG  nights  are  presented.  As  already  discussed  a  Dull  data 
set  was  available  for  35  participants. 
Table  20  -  Mean  and  SD  for  Objective  and  Subjective  Sleep  Continuity  Variables 
at  Baseline  and  End  of  Treatment  for  the  3  Groups 
QHRin  (n=13)  QHRout  (n=14)  Control  (n=8) 
PSG  1)iarN  PSG  Diary  P.  M.,  Diary 
SOL 
Baseline  27.7(30)  63.1(95)  25.8(28)  83.1(  127)  'O  z(  25)  21.  ()(16) 
End  Treatment  33.9(35)  40.5(65)  14.1(14)  15.2(15)  18.1)(  15)  ;  S.  5(  31) 
WASO 
Baseline  54.1(45)  105.9(107)  49.3(39)  70.4(68)  62.5(32)  103.7(45) 
End  Treatment  70.6(58)  71.1(79)  57.9(42)  43.0(51)  W.  2(28)  tiO,  Oo  )) 
TST 
Baseline  421.7(45)  314.6(120)  431.1(65) 
-355.0(1.10) 
370.5(27) 
. 
32.5)  5I) 
End  Treatment  393.2(76)  362.2(73)  416.3(58)  427.1(62)  401.5(70)  370.2(102) 
S.  E. 
Baseline 
. 
83(.  08) 
. 
65(.  24) 
. 
84(.  09) 
. 
69(23) 
. 
81(.  09) 
. 
73(.  11) 
End  Treatment 
. 
79(.  13) 
. 
78(.  16) 
. 
85(.  08) 
. 
88(.  10) 
. 
82(.  07) 
. 
75(.  15) 
2O2 Inspection  of  table  20  suggests  that  the  discrepancy  between  subjectively  rcpoiied 
and  objectively  measured  sleep  continuity  (sub-ob  discrepancy)  is  wider  at  haselirr  Tian 
at  end  of  treatment. 
Taking  into  consideration  that,  when  only  a  few  PSG  nights  were  recorded,  i'ST  and 
S.  E.  showed  less  variability  than  SOL  and  WASO  (Wohlg  muth,  Edinger,  Fins  and 
Sullivan;  1999)  only  TST  and  S.  E.  were  formally  analysed. 
Figures  39  and  40  illustrate  such  sub-ob  discrepancies  for  the  TST  and  S.  F.  values. 
The  whole  rectangle  represents  the  mean  PSG  defined  TST,  the  lighter  (hutloni)  portion 
represents  the  mean  diary  value.  The  darker  (upper)  polliun  shows  the  discrepancy 
between  PSG  and  estimate  of  TST. 
Fig.  39  Subjective  and  Objective  TST  at  baseline  (b)  and  End  of  Intervention  (int) 
for  the  3  Groups  (darker  portion  indicates  the  sub-ob  discrepancy) 
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For  example,  inspection  of  figure  39  shows  that  f  0r  the  QlIRin  at  hast-111c  the 
discrepancy  between  PSG  and  estimate  of  TST  (darker  portion  01'  ihC  i, 
almost  4  times  the  discrepancy  at  the  end  of'  the  intervention.  For  the  QIIRm  l  the 
discrepancy  at  baseline  is  almost  3  times  the  discrepancy  at  end  of'  intervention. 
Similar  observations  can  be  made  for  the  QIIRin  and  the  OIIRout  data  on  S.  I.  ,.  (fig. 
40):  the  sub-ob  discrepancy  at  the  end  of  the  intervention  is  minimal  for  the  Q1  Will  and 
for  the  QHRout  as  compared  to  those  at  ha.  si'linr.  'I'hr  ,  uh-oh  (liscici',  ancv  hr  fIic 
control  group  remained,  in  contrast,  unchanged. 
2()3 FIG.  40  Subjective  and  Objective  S.  E  at  Baseline  (b)  and  End  of  Intervention  (int) 
for  the  3  groups  (darker  portion  indicates  the  sub-ob  discrepancy) 
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Wilcoxon  Matched  Pairs  Signed-Ranks  Tests  showed  that  there  were  significant 
differences  between  the  TST  sub-ob  discrepancy  at  baseline  and  end  of  inlerventlon  for 
the  QHRin  jz=2.34,  N-ties=13,  p=O.  0I91  and  the  QHRout  Ir=3.04,  N-tic`=I.  4,  p-0.0021 
but  not  for  the  control  group  Jz=O.  50,  N-ties=8,  n.  s.  I.  Similarly,  statistically  signilirant 
S.  E.  differences  between  the  sub-ob  discrepancies  at  baseline  and  end  of  intervention 
were  found  for  the  QHRin  Iz=2.7,  N-ties=12,1p=O.  OO71  and  the  Qlllzout  Ir=3.  O7,  N 
ties=14,  p=0.002]  but  not  for  the  control  group  Iz=0.42,  N-tics=h,  n.  s.  I. 
These  results  confirmed  that,  for  the  QHRin  and  the  QIlk  nit,  the  dlil'l'erenee 
between  subjectively  reported  and  objectively  measured  'IST  and  S.  I.  values  were 
smaller  at  the  end  of  the  intervention  as  compared  to  baseline.  Wilh  regard  lo  the  control 
group  no  changes  in  the  sub-ob  discrepancy  were  detected. 
5.4.7.2  Associations  between  Objective  and  Subjective  Me__isures_  01'  SILT  I)  ('0ntinuii1) 
Variables. 
As  pointed  out  in  the  previous  section  subjective  and  objective  sk'c  p  continuity 
outcomes  contrast  sharply  and  it  is,  therefore,  important  to  assess  il  thew  vari,  ºhles 
correlate  with  each  other.  Spearman's  rank  order  correlations  Who)  were  carried  out  on 
U-4 sleep  diary  and  PSG  data  separately  for  each  of  the  three  groups  but  no  significant 
correlations  were  found. 
In  table  21  the  correlation  coefficients  between  objective  and  subjective  measures  of 
sleep  are  presented. 
Table  21:  Correlations  between  objective  and  subjective  measures  of  sleep  at 
Baseline  and  End  of  Intervention  for  the  OHRin,  QHRout  and  Control 
(squared  correlations  (R2)  are  reported  below  each  r) 
2"d  Night  Baseline  Last  Night  of  Intervention 
Diary  -  PSG  Diary  -  PSG 
S.  E.  SOL  WASO  TST  S.  E.  SOL  WASO  TST 
QHRin 
N=13  r  0.55  0.51  0.19  0.46  0.48  0.14  0.29  0.47 
R2  0.30  0.26  0.03  0.21  0.23  0.05  0.08  0.22 
QHRout 
N=14  r  -0.10  0.30  -0.21  0.65 
It2  0.01  0.09  0.04  0.42 
Control 
N=8  r  0.56  0.50  0.50  0.40 
R2  0.31  0.25  0.25  0.16 
0.40  0.00  0.23  0.52 
0.16  0.00  0.05  0.27 
0.62  0.60  0.18  0.60 
0.38  0.36  0.03  0.36 
None  of  the  above  correlations  was  significant.  The  squared  correlations  show  that 
the  proportion  of  variance  in  common  between  the  two  variables  is  between  0%  and 
42%.  It  should  be  noted  that  correlations  appear  to  be  variable  and  unstable;  this  is  not 
surprising  given  that  correlations  are  heavily  dependent  on  power  (i.  e.  sample  sizes)  and 
sample  sizes  were  very  small. 
5.4.8  Adherence  with  the  Quarter  of  an  Hour  Rule 
In  this  section  subjectively  and  objectively  measured  adherence  with  the  QHR  are 
reported  descriptively. 
Subjective  measures  of  adherence  were  collected  during  the  three  weeks  of 
intervention.  However,  the  weekly  mean  adherence  scores  were  comparable  and, 
therefore,  only  the  first  week  was  considered  so  as  to  have  a  mean  of  comparison  with 
205 objectively  measured  adherence  (one  week  data)  (fig.  41).  It  should  he  noted  that  thi' 
discrepancy  between  subjectively  reported  and  objectively  measured  adherence  is  wider 
for  the  QHRout  group  than  the  QHRin.  Paired  t-tests  revealed  statistically  significant 
differences  between  subjective  and  objective  adherence  It(  13)=5.09,  p<0.  (X)05I  for  the 
QHRout  but  not  for  the  QHRin. 
Fig.  41  -  Subjective  and  Objective  Adherence  Scores  for 
the  OHRin  and  QHRout  Groups 
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The  group  SOL  change  scores  from  baseline  to  cud  of  treatment  wen'  1)  minutes  for 
QHRin  and  38  minutes  for  QHRout  and  the  WASO  change  scores  were  SIl  minutes  for 
QHRin  and  77  minutes  for  QHRout.  These  data  give  an  indication  that  statistically 
significant  improvements  in  sleep  parameters  are  obtained  even  if  adherence  to  the 
behavioural  intervention  is  not  complete.  Indeed,  the  objective  data  stwoest  that  on 
average  roughly  5O`:  '(  adherence  to  the  rule  is  sufficient  to  produce  si11nifirant  ch,  inges. 
It  should  he  noted  that  inspection  of  the  raw  data  on  adherence  indicated  that 
participants  either  adhered  or  did  not,  making  the  data  more  categorical  (i.  e.  adherril, 
not  adhered)  than  linearly  distributed  (histograms  in  appendixes  32a  and  32h).  Own 
that  correlation  cannot  be  used  for  categorical  data  (e.  g.  render,  ves/no)  it  w,  i,,  not 
deemed  correct  to  correlate  adherence  data  to  sleep  data. 
"0 5.5  -  Discussion 
Following  an  analysis  of  the  biological,  behavioural  and  cognitive  perspectives  of 
insomnia  and  related  therapies  it  appeared  that  a  closer  examination  of  the  single 
components  of  stimulus  control  was  warranted  and  the  present  experiment  was 
designed.  It  employed  subjective  and  objective  measures  of  sleep  with  the  aim  of 
investigating  whether  a  simplified  behavioural  intervention  for  insomnia,  namely  the 
QHR,  could  be  employed  to  improve  sleep.  Clinical  significance  and  response  curves 
were  also  examined.  The  target  sample  was  composed  of  people  presenting  with 
insomnia  in  primary  care  and  people  recruited  via  media  advertisements. 
A  second  aim  of  the  present  study  was  to  explore  mechanisms  of  effect  of  the  QHR. 
In  order  to  investigate  this  issue  a  group  of  participants  was  asked  to  implement  the 
QHR  out  of  bed  (QHRout,  canonical  form  of  stimulus  control)  while  another  group 
implemented  it  in  bed  (QHRin,  counter  to  stimulus  control  and  potentially  enhancing 
sleep  incompatible  associations).  It  was  reasoned  that  should  the  QHR  work  because  it 
re-establishes  the  connection  between  the  bedroom  environment  and  falling  asleep  then 
the  QHRin  condition  would  either  not  impact  on  sleep  or  impact  negatively.  In  addition, 
sleep  related  questionnaires  were  administered  to  participants  at  baseline  and  end  of 
treatment  so  as  to  assess  if  the  QHR  interventions  were  associated  with  changes  in 
cognitive  activity  (e.  g.  sleep  effort,  planning)  and  arousability. 
Finally  this  study  examined  the  relationship  between  adherence  to  treatment  and 
treatment  response.  The  feasibility  of  employing  actigraphy  with  the  added  feature  of 
light  detection  to  measure  adherence  objectively  to  a  behavioural  treatment  for  insomnia 
was  also  explored. 
207 5.5.1  -  Summary  of  Results 
Seven  specific  predictions  were  made.  These  were  based  on  theoretical 
considerations  pertaining  the  link  between  insomnia  and  poor  stimulus  control,  and  the 
main  findings  reported  in  sleep  literature. 
The  first  prediction  that,  following  the  QHRout,  participants'  estimates  of  SOL  and 
WASO  would  decrease  and  S.  E.  would  increase  was  supported.  Furthermore,  a  trend 
suggesting  TST  increase  was  found. 
The  second  prediction  was  partly  supported:  the  QHRin  increased  S.  E.  and  trends 
suggesting  an  increase  in  TST  and  a  decrease  in  WASO  were  found.  However,  SOL 
was  not  improved  following  the  QHRin. 
The  third  prediction,  that  the  QHR  interventions  would  improve  estimates  of  sleep  as 
compared  to  the  control  group,  was  also  partially  supported.  At  the  end  of  the 
intervention  the  QHRout  group's  WASO  was  shorter,  S.  E.  was  greater  and  trends 
suggesting  longer  TST  and  shorter  SOL  than  those  of  the  control  group  were  found. 
With  regard  to  the  QHRin  group  trends  suggesting  longer  TST,  greater  S.  E.  and  shorter 
WASO  than  those  of  the  control  groups  were  found. 
The  fourth  prediction,  that  the  QHR  interventions  would  reduce  the  PSQI  total  score, 
was  supported.  As  expected  the  control  group's  PSQI  total  score  remained  the  same. 
The  fifth  prediction  was  that  the  QHR  interventions  would  improve  perception  of 
sleep  quality,  restedness  and  alertness  in  the  morning.  Trends  indicated  that,  following 
either  the  QHRin  or  the  QHRout,  participants  considered  their  quality  of  sleep  better 
and  they  felt  more  rested  and  alert  than  at  baseline.  The  control  group,  in  contrast,  did 
not  change  their  ratings  of  sleep  quality,  restedness  or  alertness. 
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The  sixth  prediction,  that  the  QHR  interventions  would  meet  criteria  for  clinically 
significant  changes  as  compared  to  the  control  group,  was  supported.  Between  33  and 
57%  of  individuals  assigned  to  the  QHR  interventions  achieved  clinically  significant 
changes  at  post-treatment.  Clinically  significant  improvements  (SOL,  WASO,  TST  and 
S.  E.  )  were  evident  from  the  first  week  of  intervention  and  the  magnitude  of  effect  was 
bigger  for  the  QHRout  procedure  than  the  QHRin. 
The  seventh  prediction,  that  subjective  and  objective  measures  of  sleep  would 
correlate,  was  not  supported. 
The  eighth  prediction,  that  treatment  response  and  adherence  would  be  positively 
correlated  could  not  be  tested  because  adherence  data  tended  to  be  categorical. 
With  regard  to  the  examination  of  sleep  related  cognitions  and  arousability,  the 
detection  of  possible  changes  might  have  been  hindered  by  low  power.  Nonetheless  it 
was  found  that  both  QHR  interventions  resulted  in  reports  of  decreased  sleep  effort, 
fewer  sleep  pattern  problems  and  less  cognitive  and  somatic  arousal.  Additionally  the 
QHRout  decreased  active  problems  solving  and  somatic  and  sensory  engagement.  In 
contrast  no  changes  were  found  for  the  control  group. 
Finally  neither  the  QHR  nor  the  control  conditions  produced  changes  in  objective 
sleep  continuity  or  sleep  architecture  variables.  However,  and  importantly,  the 
discrepancy  between  subjective  and  objective  measures  of  sleep  continuity  diminished 
following  the  intervention  in  the  QHR  groups  but  not  in  the  control  group. 
These  findings  will  be  examined  and  interpreted  in  turn. 
209 5.5.2  Interpretation  of  Results 
5.5.2.1  Subjective  Sleep  Continuity  Data 
The  prediction  that  following  the  QHR  interventions  SOL  and  WASO  would 
decrease  and  TST  and  S.  E.  increase,  was  fully  supported  with  regard  to  the  QHRout  but 
only  partially  so  for  the  QHRin.  Indeed,  following  the  intervention,  the  QHRout  group 
took  less  time  to  fall  asleep,  was  awake  for  shorter  periods  during  the  night,  showed  a 
trend  suggesting  they  slept  for  longer  and  increased  the  time  actually  asleep  while  in 
bed.  In  contrast,  following  the  intervention,  the  QHRin  took  the  same  time  to  fall  asleep 
as  it  did  at  baseline.  Similar  to  the  QHRout,  the  QHRin  group  increased  the  amount  of 
time  actually  asleep  when  in  bed  and  trends  indicated  that  the  QHRin  was  less  awake 
during  the  night  and  slept  longer.  Importantly  both  QHRin  and  QHRout  groups 
decreased  their  PSQI  total  score.  The  control  group's  baseline  sleep  estimates  and  PSQI 
total  score  remained  unchanged  at  the  end  of  treatment. 
An  important  point  to  make  in  interpreting  these  data  relates  to  having  detected 
trends  rather  than  significant  effects  for  TST  (both  QHRin  and  QHRout)  and  WASO 
(QHRin).  Although  these  results  might  be  due  to  the  QHR  interventions  not  impacting 
positively  on  sleep,  it  is  plausible  that  statistical  significance  at  a<0.05  was  not 
achieved  due  to  the  Bonferroni  correction  being  very  conservative  or  to  the  low  power 
to  detect  significance  due  to  modest  sample  sizes.  However,  given  the  explorative 
nature  of  this  study,  it  was  felt  important  reporting  trends  suggesting  that  further 
research  is  worthwhile. 
The  findings  that  the  QHRout  intervention  produced  significant  changes  in  SOL  and 
WASO  corroborated  Tokarz  and  Laurence's  (1974)  findings  that  delivering  only  the 
210 situational  components  of  the  stimulus  control  package  improved  sleep.  Furthermore, 
these  results  are  not  surprising  taking  into  account  that,  in  this  research,  the  QHRout 
was  posited  to  encapsulate  the  essence  of  the  conditioning  aspects  of  stimulus  control. 
Indeed,  as  discussed  in  the  introduction,  stimulus  control  has  consistently  improved 
these  two  sleep  parameters  in  students,  GP  recruited  patients  and  older  adults  (Espie  et 
al,  1989;  Lacks  et  al,  1983a,  1983b,  Morin  et  al,  1988;  Puder  et  al  1983;  Sanavio  et  al, 
1990).  The  present  results,  therefore,  lend  support  to  the  idea  that  the  QHRout 
epitomises  stimulus  control  for  insomnia. 
Similarly  to  Davies  et  al's  (1986)  report,  that  counter-stimulus  control  improved 
WASO,  a  trend  suggesting  that  the  QHRin  improved  WASO  was  found.  However, 
unexpectedly  and  contrary  to  Zwart  and  Lisman's  (1979)  findings  with  counter-stimulus 
control,  the  QHRin  did  not  impact  on  SOL.  Obviously,  the  QHRin  is  only  one  of  the  six 
instructions  of  counter-stimulus  control  and,  therefore,  it  is  possible  that  the  positive 
outcomes  reported  by  those  authors  were  not  due  specifically  to  the  instruction  `sit  up  in 
bed  if  unable  to  sleep'  (QHRin).  If  this  was  the  case,  however,  the  QHRin  should  have 
resulted  in  no  positive  outcomes  in  both  cases:  at  sleep  onset  and  during  the  night.  This 
would  also  have  been  consistent  with  stimulus  control  theory  as  the  bedroom 
environment  rather  than  becoming  associated  with  sleep  would  signal  wakefulness. 
It  could  be  speculated  that  people  enjoyed  spending  some  time  reading  in  bed  and, 
therefore,  retired  to  bed  earlier  than  at  baseline,  with  the  intention  of  reading  rather  than 
sleeping.  However,  examination  of  TIB  showed  similar  values  at  baseline  and  end  of 
intervention  (8hr  &  7min  vs.  8hr  &  8min).  Another  possibility  is  that  the  'cosiness'  of 
reading  in  bed  at  the  beginning  of  the  night  was  a  (positive)  reinforcer  for  staying  awake 
(elicited  response).  In  the  middle  of  the  night,  in  contrast,  having  to  read  may  have  been 
unpleasant  (negative  reinforcer)  which,  in  turn,  elicited  falling  asleep  quickly.  In  other 
211 words,  falling  asleep  quickly  became  a  way  to  stop  something  unpleasant.  Of  course 
taking  into  account  the  sample  size,  it  is  possible  that  the  power  to  detect  differences 
was  too  low  (Kazdin  and  Bass,  1989). 
The  finding  that  S.  E.  increased  following  the  QHR  interventions,  is  consistent  with 
results  showing  that  significant  changes  in  S.  E.  values  were  obtained  in  CBT  trials  (e.  g. 
Backhaus,  Hohagen,  Voderholzer  and  Riemann,  2001,  Morin  et  al,  1994). 
Unfortunately  a  direct  comparison  with  stimulus  control  is  difficult  to  make  because 
during  the  1970s  and  the  1980s  (when  most  studies  on  single  therapies  were  carried  out) 
S.  E.  was  not  reported.  Calculation  of  S.  E.  from  Morin  et  al's  (1994)  stimulus  control 
findings  (S.  E.  =  0.69  at  baseline  and  0.84  at  end  of  treatment),  suggests  that  the  present 
results  are  similar  to  those  obtained  in  previous  studies  with  the  entire  stimulus  control 
package.  It  is  noteworthy  that  S.  E.  depends  on  TIB  and  TST  values  and,  as  discussed 
above,  following  the  QHR  interventions  TST  increased  while  TIB  remained  unchanged: 
it  is,  therefore,  unsurprising  that  S.  E.  increased  accordingly. 
The  present  findings  open  the  possibility  that  conditioning  operates  on  two  different, 
and  perhaps  additive,  dimensions:  an  external  environmental  dimension  and  a 
cognitive/internal  (to  the  individual)  dimension.  This  possibility  would  help  explain  the 
findings  that  the  QHRout  is  more  efficacious  than  the  QHRin:  by  getting  out  of  bed 
faulty  conditioning  is  broken  on  both  levels  and  appropriate  conditioning  is  re- 
established.  It  could  be  argued  that  the  QHRout  impacted  positively  on  sleep  for  at  least 
three  reasons.  First,  it  fosters  the  association  between  bedroom  and  sleep  by  making  the 
bedroom  an  eliciting  stimulus  for  falling  asleep.  Second,  it  helps  breaking  the 
association  between  being  in  bed  and  both  negative  (e.  g.  rumination  about  lack  of  sleep 
not  sleeping)  and/or  constructive  (planning  the  day  ahead)  cognitions.  This  possibility 
was  suggested  by  Bootzin  and  colleagues  as  a  possible  explanation  of  findings  that 
212 counter  stimulus  control  instructions  resulted  in  sleep  improvements  (Bootzin  et  al, 
1991;  2000).  Third,  it  makes  falling  asleep  a  behaviour  that  stops  an  aversive  event  (i.  e. 
getting  out  of  bed)  from  happening  or  continuing  (Bootzin  et  al,  1972).  The  QHRin, 
however,  may  work  only  on  two  levels.  For  negative  reinforcement  reasons:  falling 
asleep  quickly  if  awake  at  night  stops  an  aversive  event  (i.  e.  having  to  sit  up  in  bed  and 
read  a  book).  This  would  help  explaining  why  the  QHRin  worked  during  the  night 
(when  sitting  up  reading  is  most  likely  unpleasant)  but  not  at  bedtime  (when  reading  a 
book  in  bed  can  be  a  pleasant  activity).  In  addition,  as  in  the  case  of  the  QHRout, 
having  to  read  breaks  the  habit  to  lie  in  bed  thinking  and/or  worrying. 
5.5.2.2  The  PSOI  Total  Score 
One  of  the  outcome  measures  of  this  study,  the  PSQI  total  score,  decreased 
following  the  QHR  interventions  while  the  control  group's  PSQI  did  not  indicating  that 
individuals  in  the  QHR  groups,  but  not  in  the  control  group,  had  a  more  positive  overall 
perception  of  their  sleep  quantity  and  quality  following  intervention.  Admittedly,  the 
PSQI  at  end  of  intervention  did  not  indicate  normal  sleep  (PSQI<=5).  As  already 
proposed  in  study  two  this  could  be  because  the  PSQI  at  baseline  was  higher  (13  for  the 
QHRin  and  14  for  the  QHRout)  than  the  mean  score  (10.38)  of  the  normative 
individuals  with  insomnia  of  the  Pittsburgh  study  (Buysse  et  al,  1989).  This  difference 
is  especially  considerable  if  the  fact  that  the  individuals  in  this  trial  had  to  be  sleep 
medication  free  is  taken  into  consideration  (hence  PSQI  score  ranged  from  0  to  18 
rather  than  0  to  21).  It  is  also  important  to  consider  that  most  treatment  studies  do  not 
achieve  a  PSQI  score  below  six  and  such  an  outcome  might  be  a  (strict)  clinical  end- 
point. 
213 Importantly,  this  result  provides  further  evidence  to  that  gathered  via  sleep  diaries  that 
the  QHR  interventions  were  efficacious  at  improving  sleep  difficulties. 
5.5.2.3  Sleep  Quality  Data 
Following  the  QHR  interventions,  trends  indicating  improvements  in  perception  of 
sleep  quality,  restedness  and  alertness  emerged.  Sleep  continuity  improvements  were 
coupled  to  feeling  more  refreshed  and  alert  in  the  morning  and  to  considering  the 
quality  of  sleep  better  as  compared  to  baseline.  In  view  of  Vincent,  Penner  and 
Lewycky's  (2006)  findings  that  sleep  quality  and  duration  of  sleep  time  were  the  most 
important  predictors  of  a  patient's  perception  of  having  'improved  a  lot'  after 
completion  of  CBT-I,  these  results  are  encouraging.  Following  the  QHR  interventions 
people  rated  their  quality  of  sleep  higher  as  compared  to  baseline  and,  as  discussed  in 
the  previous  section  sleep  duration  was  increased  by  about  one  hour:  the  two  most 
important  predictors  of  'My  sleep  has  improved  a  lot',  as  defined  by  Vincent  et  al's 
(2006)  recent  study,  were  both  significantly  improved. 
With  regard  to  alertness  and  feeling  rested  the  following  comment  is  noteworthy. 
The  ICSD-R  diagnosis  of  insomnia  includes  a  'complaint  of  decreased  functioning 
during  wakefulness'.  It  is  likely  that  the  perceived  degree  of  alertness  and  restedness 
impact  on  the  overall  sense  of  being  able  to  function  well  during  the  day.  Morin  and 
Azrin  (1988)  found  that  stimulus  control  decreased  self  and  significant  others'  ratings  of 
sleep  problems'  interference  with  daily  functioning.  Unfortunately  perception  of  daily 
functioning  (e.  g.  ability  to  concentrate,  fatigue,  irritability)  was  not  measured  in  this 
study. 
Alternatively,  it  could  be  that  qualitative  aspects  of  sleep  were  rated  higher  than  at 
baseline  because  participants  perceived  fewer  sleep  difficulties  (e.  g.  shorter  SOL,  longer 
214 TST).  Indeed,  Neitzer-Semler  and  Harvey  (2005)  found  that  people  who  were  told  that 
actigraphy  revealed  they  had  had  a  bad  night  would  report  functioning  less  well  during 
the  day  as  compared  to  people  told  they  had  had  a  good  night,  independently  of  real 
sleep  continuity. 
5.5.2.4  Clinical  Changes  Associated  with  the  Quarter  of  an  Hour  Rule 
Clinically  significant  changes  were  observed  in  33  to  57%  of  individuals  assigned 
to  the  QHR  interventions  and  about  one  third  of  them  returned  to  normalcy.  These 
results  are  consistent  with  Lacks  and  Powlishta's  (1989)  claim  that  about  half  of  people 
with  insomnia  show  reliable  changes  following  insomnia  treatment  and  that  about  one 
third  return  to  normative  level  of  functioning.  The  present  results  are  also  in  line  with 
findings  from  meta-analytic  reviews  that  around  40  to  60%  of  individuals  respond 
clinically  to  CBT  treatments  (Irwin  et  al,  2006;  Morin  et  al,  1994;  Murtagh  and 
Greenwood  1995). 
Another  important  parameter  for  clinical  significance  of  results  is  the  magnitude  of 
effect.  Using  Cohen's  (1992)  scheme,  the  effect  sizes  for  WASO,  TST,  S.  E.  and  PSQI 
for  the  control  group  were  zero.  These  results  suggest  that  self-monitoring  per  se  has  no 
impact  on  these  sleep  continuity  parameters  and  on  the  PSQI.  Interestingly,  a  small 
effect  was  found  for  SOL.  It  should  be  remembered  that  SOL  deteriorated  (increased)  in 
the  control  group  during  the  intervention  phase.  Unfortunately  the  design  of  the  study 
does  not  allow  exploration  of  this  finding.  It  could  be  speculated  that  self-monitoring 
made  participant  focus  on  their  inability  to  fall  asleep  and,  in  so  doing,  increased  worry 
and  sleep  effort.  These,  in  turn,  impacted  negatively  on  SOL. 
In  contrast,  large  effect  sizes  for  PSQI  and  S.  E.  and  TST  were  found  for  both  the 
QHRout  (2.3,0.8  and  1.1  respectively)  and  the  QHRin  (1.7,0.8  and  0.8  respectively). 
215 The  TST  effect  sizes  for  both  QHR  interventions  were  in  the  large  range  while  those 
typically  reported  at  end  of  CBT  interventions  are  in  the  medium  range  (Morin  et  al, 
1994=0.42;  Murtagh  et  al,  1995=0.49,  Smith  et  al,  2002=0.46).  However,  this  result 
might  not  be  surprising  if  the  following  is  taken  into  consideration.  Both  sleep 
restriction  and  stimulus  control,  which  are  typically  included  in  CBT  packages,  by 
curtailing  sleep  opportunity  (amount  of  time  the  patient  can  be  in  bed)  often  result  in 
modest  TST  increases  during  the  treatment  phase  whereas  the  QHR  does  not  limit  the 
amount  of  time  to  be  spent  in  bed  (providing  one  is  not  in  bed  awake  for  more  than  a 
quarter  of  an  hour).  Following  three  weeks  of  QHR  interventions  TST  was  increased  by 
around  60  minutes,  in  CBT  trials,  instead,  TST  is  generally  increased  by  only  a  modest 
20-30  minutes  at  the  end  of  the  insomnia  treatment  with  further  gains  of  around  30 
minutes  at  follow-up  (Morin  et  al,  1994;  Murtagh  et  al,  1995). 
With  regard  to  WASO  medium  to  large  effects  sizes,  comparable  to  those  reported 
by  meta-analyses  of  the  whole  stimulus  control  package  (Morin  et  al,  1994)  and  those  of 
meta-analytic  studies  on  behavioural  treatment  for  insomnia  (Irwin,  et  al,  2006;  Morin, 
et  al,  1994;  Montgomery  and  Dennis,  2004;  Murtagh  and  Greenwood  1995;  Pallesen,  et 
al,  1998;  Smith,  Perlis,  et  al,  2002)  were  found. 
Furthermore,  the  QHRout  effect  size  for  SOL  was  also  consistent  with  meta-analytic 
findings  (medium  to  large  range);  in  contrast  the  QHRin  effect  size  for  SOL  was  small. 
This  finding  is  not  surprising  given  that  the  average  SOL  improvement  was  only  9 
minutes. 
An  important  finding  was  that  the  magnitude  of  effects  obtained  with  the  QHRout 
were  bigger  than  those  obtained  with  the  QHRin.  This  result  is  not  dissimilar  to  that 
obtained  by  Davies  et  al  (1986).  They  found  that  counter-stimulus  control  was  only 
moderately  effective  reducing  SOL  by  only  about  30%.  Admittedly  in  their  study  there 
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of  effects  for  counter-control  was  smaller  that  those  typically  obtained  with  stimulus 
control  (Morin  et  al,  1994;  Morin,  Mimeault  et  al,  1999;  Murtagh  et  al,  1995).  In  order 
to  interpret  the  fording,  that  the  magnitude  of  effect  was  larger  for  the  QHRout,  the 
learning  theory  perspective  is  useful.  It  could  be  argued  that  the  QHRin,  which  requires 
sitting  up  in  bed  and  reading,  is  not  as  effective  at  facilitating  new  associations  between 
the  bedroom  and  sleep  as  the  QHRout. 
With  regard  to  the  response  curve,  these  clinically  significant  changes  were  evident 
from  the  first  week  of  intervention.  It  is  important,  however,  to  remember  that  the 
present  study  does  not  allow  the  assessment  of  the  optimal  dose  needed  to  detect 
improvements,  rather  it  suggests  that  one  single  dose  of  therapy  is  sufficient  to  improve 
sleep  parameters.  The  few  minimal  telephone  contacts  following  the  intervention 
sessions  might  have  been  necessary  to  maintain  improvements  or  superfluous  but  this 
was  not  tested.  In  addition  the  present  design  does  not  permit  to  determine  if  more 
sessions  would  have  enabled  a  larger  number  of  individuals  to  reach  clinically 
significant  changes.  Nonetheless  these  findings  give  further  evidence  to  Edinger, 
Wohlgemuth,  Radtke  and  Marsh's  (2004)  findings  that  one  CBT  session  had  greater 
efficacy  in  decreasing  WASO  than  either  two  or  eight  sessions  . 
It  is  important  to  note  that  the  present  results  represent  response  to  the  acute 
treatment  phase  and  whether  treatment  gains  would  be  maintained,  enhanced  or  would 
disappear  after  last  contact  with  the  researcher  is  unknown. 
5.5.2.5  Sleep  Related  Questionnaires 
Several  interesting  findings  derived  from  questionnaires  responses.  First,  baseline 
endorsement  of  sleep  disruptive  behaviour  score  of  the  SBRS-R  was  unchanged  at  the 
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Nonetheless,  this  finding  was  not  surprising  with  regard  to  the  QHRin  because  it 
required  'remaining  in  bed  when  awake'  (q.  11)  and  `reading  in  bed'  (q.  1).  Given  that 
adherence  data  evidenced  good  adherence  with  the  QHRin,  scores  on  questions  11  and  8 
were  likely  to  increase.  Additionally,  the  QHRin  did  not  require  discontinuing 
behaviours  such  as  watching  T.  V.  (q.  2),  taking  naps  (q.  8),  or  switching  the  light  off  as 
soon  as  entering  the  bed  (q.  10).  Although  the  QHRout  did  not  comprise  instructions 
regarding  all  sleep  disruptive  behaviours  measured  in  the  scale,  it  did  require  `getting 
out  of  bed  if  not  asleep  in  20  minutes  (q.  12)  and  `not  lying  awake  in  bed  if  not  asleep' 
(q.  11).  It  was,  therefore,  expected  to  find  a  change  in  score  following  intervention. 
Indeed  inspections  of  mean  values  suggested  a  decrease  in  sleep  disruptive  behaviours 
(supported  by  repeated  measure  t-test). 
Interestingly,  responses  to  the  SDQ  evidenced  that  sleep  patterns  of  the  QHRin  and 
QHRout  groups  had  improved  following  the  intervention  while  those  of  the  control 
group  remained  unchanged.  These  results  suggest  that  despite  the  fact  that  QHR 
interventions  did  not  directly  attempt  to  regularise  sleep  schedules,  participants  started 
to  do  so  themselves.  It  could  be  speculated  that  experiencing  sleep  improvements  by 
having  a  routine  to  follow  when  not  asleep,  made  participants  seek  more  routine-like 
sleep  habits.  Alternatively,  this  could  be  the  result  of  sleep  monitoring;  this 
interpretation  is,  however,  unlikely  because  the  control  group  did  not  show  such  change. 
Analyses  of  the  GSES  and  SDQ  questionnaires  indicated  that,  following  the 
intervention,  sleep  effort,  cognitive  arousal  and  somatic  arousal  were  decreased  in  the 
QHRin  and  the  QHRout.  These  findings  are  not  surprising:  having  a  specific  activity  to 
perform  if  not  asleep  might  have  reduced  cognition  regarding  inability  to  sleep  and 
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cognitive  and  somatic  de-arousal. 
In  order  to  interpret  these  results  it  is  important  to  remember  that  although  these 
questionnaires  assess  several  distinct  constructs  (worries  about  not  sleeping,  sleep  effort 
and  sensory  and  somatic  engagement),  they  are  different  aspects  of  a  broader  construct, 
that  is  cognitive  activity.  Indeed,  the  questionnaires  were  found  to  correlate.  Although 
the  QHR  interventions  did  not  challenge  or  address  cognition  directly,  it  is  likely  that 
they  did  so  implicitly.  After  all,  the  QHR  intervention  implies  that  `it  is  ok  giving  up 
trying  to  sleep'  (read  if  you  cannot  sleep).  It  could,  therefore,  be  speculated  that 
behavioural  instructions  per  se,  changed  sleep  cognitions.  On  the  other  hand,  it  is 
plausible  that  noticing  sleep  improvements  changed  attitudes  toward  sleep. 
It  might  seem  surprising  that  a  behavioural  intervention,  intending  to  establish  a 
connection  between  the  bedroom  environment  and  falling  asleep,  influences  such 
aspects  of  cognitive  activity.  However,  the  QHR  requires  performing  and  engaging  with 
one  simple,  emotionally  neutral,  activity  (i.  e.  reading  something  light)  which  may 
inhibit  self-generated  and  sleep  related  and  emotionally  laden,  mental  activity.  Indeed, 
previous  research  evidenced  that  under  light  cognitive  load  sleep  onset  was  shortened 
(Ansfield,  Wegner  and  Bowser,  1996;  Haynes  et  al,  1981)  in  people  with  sleep 
problems. 
It  is  important  to  note  that  the  design  of  this  study  does  not  permit  to  rule  out  that 
other  generic  psychological  explanations  such  as  self-efficacy,  mastery,  placebo  effects 
or  demand  characteristics  (e.  g.  social  desirability,  reactivity)  might  have  been 
responsible  for  the  changes  evidenced  by  this  battery  of  questionnaires. 
Before  concluding  this  section,  it  is important  to  mention  that  improvement  in  sleep 
continuity  was  evidenced  by  subjective  sleep  diary,  and  that  questionnaires  are  another 
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diary  evidences  improvements  sleep  related  questionnaires  are  also  likely  to  depict 
improvement. 
5.5.2.6  Objective  Sleep  Continuity 
As  discussed  in  the  previous  sections,  subjective  measures  of  sleep  indicated  sleep 
improvements  following  the  QHR  intervention.  However,  when  sleep  was  measured 
objectively,  no  significant  changes  in  sleep  continuity  and  sleep  architecture  parameters 
were  found.  Another  finding  of  the  present  study  was  that  the  discrepancy  between 
subjectively  reported  and  objectively  measured  sleep  variables  at  baseline  decreased  in 
the  QHR  groups  but  not  in  the  control  group.  These  results  are  consistent  with  previous 
findings  that  insomnia  treatment  produces  positive  outcomes  when  sleep  continuity  is 
measured  subjectively  without  necessarily  resulting  in  changes  in  objective  sleep  (see 
Stepanski,  2000  for  a  review).  In  order  to  provide  an  interpretation  of  these  findings 
several  considerations  must  be  made. 
First,  the  logical  possibility  that  participants  may  have  presented  with  paradoxical 
insomnia  (SSM)  can  be  ruled  out  by  baseline  PSG  evidencing  sleep  maintenance  and/or 
sleep  onset  difficulties  in  most  participants.  Estimates  of  sleep  difficulties  certainly 
suggested  more  severe  insomnia  than  the  PSG  defined  sleep  implied,  however,  this  is 
not  an  atypical  finding  in  the  insomnia  literature  (Stepanski,  2000).  Importantly,  no  PSG 
improvements  were  detected  at  end  of  intervention.  These  findings  could  be  interpreted 
as  evidence  that  the  QHR  interventions  were  not  actually  efficacious  in  improving  sleep 
i.  e.  PSG  defined  sleep  did  not  change  following  intervention. 
Another  explanation  can  be  proposed  by  taking  into  account  that  the 
primary/psychophysiological  insomnia  diagnostic  criteria  characterise  insomnia  as  a 
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suggest  that  insomnia  does  not  necessarily  occur  every  night  and  clinical  evidence 
indicates  that  night-to-night  variability  and  unpredictability  of  sleep  are  considered 
classic  features  of  insomnia.  Indeed,  aetiological  models  of  insomnia  recognize  these 
characteristics  as  central  to  the  configuration  of  insomnia  (Espie,  2002;  Morin,  1993) 
and  these  characteristics  have  been  corroborated  by  empirical  findings  (Coates  et  al, 
1981;  Edinger  et  al,  1991,1997;  Vallieres,  Ivers,  Bastien,  Beaulieu-Bonneau  and  Morin, 
2005).  It  could  be  argued  that  the  QHR  interventions  decreased  sleep  difficulties  but  did 
not  eliminate  completely  the  possibility  of  `bad'  nights.  Indeed,  estimates  of  sleep 
suggested  reduction  of  sleep  problems  following  the  QHR  intervention,  but  only  one 
third  of  individuals  returned  to  normalcy:  that  is  sleep  difficulties  were  diminished  but 
still  present.  Given  nightly  variability,  recording  PSG  only  one  night  at  baseline  and  one 
at  the  end  of  the  intervention  might  not  have  permitted  detection  of  changes  reliably. 
This  possibility  finds  support  in  investigations  of  the  stability  of  PSG  measures  in 
insomniacs  and  normal  sleepers  both  at  home  and  in  laboratory  settings.  For  example, 
one  recording  night  resulted  in  inadequate  stability  (reliability)  of  measurement  because 
of  unpredictable  nightly  variations  in  both  normal  and  poor  sleepers  (Wohlgemuth  et  al, 
1999;  Bootzin,  Bell,  Halbisch,  Kuo,  Wyatt,  et  al,  1995).  In  view  of  these  findings, 
Wohlgemuth  et  al  (1999)  suggested  averaging  multiple  nights  of  recording  with  the 
number  of  recording  nights  varying  depending  on  the  sleep  variable  under  examination: 
SOL  and  WASO  being  the  most  susceptible  variables  to  nightly  variations  and  TST  the 
least.  Similarly,  Means  et  al  (2003)  found  evidence  of  variability  across  nights  for  both 
poor  and  normal  sleepers  (the  inter-night  correlations  ranged  between  0.37  and  0.64  for 
the  insomnia  group  and  between  0.35  and  0.47  for  normal  sleepers). 
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therefore,  be  due  to  the  fact  that  one  single  night  of  PSG  evaluation  did  not  provide 
stability  due  to  nightly  variations. 
A  third  possible  explanation  is  that  the  QHR  interventions  did  not  produce  sleep 
changes.  Rather,  therapeutic  outcomes  evidenced  by  estimates  of  sleep  were  due  to 
factors  such  as  desire  to  please  the  experimenter  or  simply  having  the  attention  of  a 
therapist  or  thinking  that  someone  finally  took  the  sleep  problem  seriously. 
It  is  also  plausible  that  participants  improved  their  time  perception  ability  and  this 
resulted  in  better  estimates  of  time  asleep  and  awake.  This  would  explain  the  decrease 
in  sub-ob  discrepancies  following  the  intervention.  Harvey's  (2002)  model  incorporates 
errors  in  time  perception  as  an  important  feature  in  the  experience  and  maintenance  of 
insomnia.  However,  it  is  difficult  to  relate  the  QHR  interventions  to  better  perception  of 
time  passing.  The  self-monitoring  process  is,  at  face  value,  the  best  candidate  to 
promote  better  time  perception  and  Fichten,  Creti,  Amsel,  Baffles  and  Libman  (2005) 
suggested  that  self-monitoring  could  be  of  benefit  by  demonstrating  that  the  sleep 
problem  is  not  as  severe  as  believed.  Despite  completing  a  sleep  diary  each  morning  for 
5  weeks,  the  control  group  did  not  change  their  estimates  of  sleep  continuity  and  it 
seems,  therefore,  unlikely  that  self  monitoring  alone  was  the  reason  for  a  decrease  in  the 
sub-ob  discrepancies  in  the  active  treatment  groups.  One  way  to  enhance  accuracy  of 
time  passing  is  provided  by  matching,  several  times,  one's  feeling  of  time  elapsed  with 
actual  elapsed  time.  It  could  be  argued  the  QHR  interventions  increased  accuracy 
because  every  time  participants  got  up  to  read  they  checked  the  time.  However, 
participants  were  explicitly  asked  not  to  change  their  clock  watching  behaviour  and  to 
keep  completing  their  diary  in  the  way  they  did  at  baseline.  Nonetheless,  the  present 
study  could  not  directly  control  for  clock  monitoring  and  this  remains  a  possible 
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to  clock  monitor  and  do  not  seem  to  benefit  from  it  (Harvey  and  Schmidt,  2000). 
Another  possibility  is  that  participants  in  the  QHR  interventions  knew  they  were  being 
monitored  via  actigraphy.  Although  the  rationale  for  wearing  an  actiwatch  did  not 
mention  monitoring  adherence  or  sleep,  participants  might  have  worked  this  out  and,  as 
a  result,  might  have  started  to  clock  monitor  so  as  to  provide  sleep  estimates  matching 
those  detected  by  actigraphy. 
A  further  possibility,  that  the  subjective  experience  of  change  is  only  moderately 
related  to  the  physiological  changes  measured  by  PSG  (Engle-Friedman  et  al,  1992), 
seems  to  provide  a  better  alternative. 
Several  studies  have  highlighted  that  patients  with  insomnia  routinely  report  more 
severe  sleep  disturbance  than  evidenced  by  traditional  PSG  measures.  In  contrast, 
normal  sleepers  are  generally  more  accurate  in  estimating  their  sleep  latency  (Bonnet 
and  Arand,  1997;  Edinger,  Fins,  et  al,  2000;  Means  et  al,  2003;  Mercer  et  al,  2002; 
Schramm  et  al,  1995).  For  example,  Schramm  et  al  (1995)  found  that  normal  sleepers 
sub-ob  discrepancies  were  significantly  smaller  than  those  displayed  by  people  with 
insomnia  when  PSGs  were  recorded  in  a  sleep  laboratory  setting.  Similarly,  Mercer  et  al 
(2002)  found  that  people  with  insomnia  showed  a  greater  discrepancy  than  good 
sleepers  between  PSG-defined  sleep  and  sleep  diary  reports  during  home  recordings. 
In  the  present  study:  the  sub-ob  discrepancies  for  both  TST  and  S.  E.  were 
statistically  significantly  smaller,  for  both  the  QHRin  and  the  QHRout,  at  the  end  of  the 
intervention  than  at  baseline.  In  contrast  the  control  group  sub-ob  discrepancy  did  not 
change.  Taking  into  consideration  previous  research  showing  that  the  sub-ob 
discrepancies  were  greater  for  people  with  insomnia  as  compared  to  normal  sleepers, 
the  present  results  could  be,  tentatively,  interpreted  as  a  shift  towards  normalcy 
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discrepancy  should  be  greater  in  people  with  insomnia  as  compared  to  normal  sleepers. 
The  sub-ob  discrepancy,  evidenced  in  people  complaining  of  poor  sleep,  has  been 
proposed  to  be  due  to  an  important  feature  of  insomnia:  elevated  levels  of  fast  EEG 
activity.  Indeed,  a  number  of  studies  employing  EEG  spectral  analysis  have  reported 
evidence  of  elevated  beta  and  gamma  activity  in  people  presenting  with  insomnia  as 
compared  to  normal  sleepers.  For  example,  Merica  and  Gaillard  (1992)  performed  EEG 
power  spectral  analysis  of  the  PSGs  of  26  people  complaining  of  insomnia  and  28 
normal  controls.  They  found  that  fast  EEG  frequencies  (14.7-30  Hz)  dropped  more 
slowly  and  to  a  lesser  extent  in  people  with  insomnia  as  compared  to  controls.  Similarly 
Merica  et  al  (1998)  found  greater  fast  EEG  activity  in  people  with  insomnia  as 
compared  to  controls.  Perlis,  Merica  et  at  (2001)  found  evidence  of  greater  relative 
power  (i.  e.  power  within  a  frequency  band  divided  by  the  sum  of  power  of  all  bands)  of 
activity  in  the  14-45  band  in  people  with  insomnia  as  contrasted  to  controls  and  people 
with  depression. 
Furthermore,  such  fast  EEG  activity  has  been  found  to  be  correlated  with  subjective- 
objective  TST  discrepancies  (Jacobs  and  Benson,  1993;  Krystal,  Edinger,  Wohigemuth 
and  Michaels,  2002;  Merica  et  al.  1998;  Nofzinger  et  al,  2000;  Perlis,  Merica  et  al, 
2001;  Perlis,  Smith,  Andrews,  Orff  and  Giles,  2001).  For  example  Krystal  et  al  (2002) 
found  that  greater  fast  EEG  frequencies  were  related  to  greater  TST,  S.  E.  and  WASO 
sub-ob  discrepancies.  Similarly,  Perlis,  Merica  et  al  (2001)  found  that  greater  NREM 
fast  frequencies  correlated  with  sub-ob  TST  discrepancies  and  tended  to  correlate  with 
sub-ob  SOL  discrepancies  (Perlis,  Smith  et  al,  2001). 
The  next  question  is  why  fast  EEG  activity  should  impact  on  the  perception  of  sleep 
and  wakefulness.  According  to  Perlis  et  al's  (1997)  model,  cortical  arousal  (high 
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and  increased  formation  of  long  term  memory.  Information  processing,  in  turn,  makes  it 
more  difficult  to  distinguish  sleep  from  wakefulness.  Enhanced  long-term  memory,  may 
interfere  with  the  person's  perception  of  sleep  onset.  Normally,  the  mesograde  amnesia 
related  to  sleep  onset  does  not  allow  recall  of  information  from  periods  immediately 
prior  to  sleep  and  this  enables  the  individual  to  `know'  they  were  asleep  (Perlis,  Smith 
et  al,  2001).  However,  an  enhanced  recall  and  retrieval  of  information  is  likely  to  blur 
the  ability  to  distinguish  between  sleep  and  wakefulness. 
A  well  construed  study  by  Mercer  et  al  (2002)  lent  support  to  this  hypothesis. 
Normal  sleepers  and  people  with  insomnia  were  presented  with  an  auditory  stimulus 
while  they  were  asleep.  Interestingly,  during  PSG  defined  sleep  (stage  2)  people  with 
insomnia,  differently  to  normal  sleepers,  reported  that  they  were  awake  prior  to  hearing 
the  stimulus.  This  finding  suggests  that  they  perceived  stage  2  sleep  as  wakefulness. 
The  investigators  proposed  that  nocturnal  mentation  while  awake  might  be  similar  to 
mentation  during  PSG  defined  sleep.  Importantly,  Mercer  and  colleagues  also  found 
that  people  with  insomnia  were  as  accurate  as  normal  sleepers  in  estimating  the  time 
elapsed  between  presentations  of  2  probes.  However,  unlike  normal  sleepers,  they 
underestimated  how  much  of  such  time  they  were  asleep.  This  finding  suggests  that 
poor  sleepers'  overestimation  of  time  awake  was  due  to  perceiving  stage  2  sleep  as 
wakefulness  rather  than  to  having  a  distorted  time  perception  per  se. 
Interestingly,  Jacobs  and  Benson  (1993)  employed  power  spectral  analysis  of  EEG 
activity  in  a  treatment  study.  They  found  that,  although  beta  activity  remained  higher 
than  the  matched  normal  sleepers  control  group,  it  decreased  following  CBT-I.  It  should 
be  noted  that  in  their  study  both  diary  and  PSG  defined  SOL  were  improved  following 
10-week  intervention.  More  recently  similar  findings  were  obtained  by  Cervena  and 
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Matousek,  Billiard,  and  Besset;  2004). 
It  is  important  to  note  that  the  findings  discussed  above  in  relation  to  sub-ob 
discrepancies  are  not  in  contrast  with  Harvey's  (2002)  argument  that  insomnia  is in  part 
a  disorder  of  interpretation.  Indeed,  the  research  above  provides  evidence  of 
misinterpretation:  misinterpretation  of  sleep  and  wakefulness  rather  than  misperception 
of  passage  of  time.  People  with  insomnia  may  misperceive  the  amount  of  time  they  are 
awake  because  during  PSG  sleep  defined  they  are  still  engaging  with  stimuli. 
The  present  research  did  not  employ  power  spectral  analysis.  However,  some 
indirect  evidence  for  decreased  arousal  at  bed  time  is  provided  by  sleep  related 
questionnaires:  decreased  sleep  effort,  problem  solving,  cognitive  and  somatic  arousal 
and  somatic  and  sensory  engagement  were  evidenced  at  the  end  of  the  QHR 
interventions  as  compared  to  baseline. 
In  sum,  lack  of  changes  in  PSG  defined  sleep  does  not  necessarily  mean  that  the 
QHR  intervention  was  not  efficacious  in  improving  sleep.  The  present  results  could  be 
due  to  measurement  unreliability  (one  night  PSG  recording)  or  to  the  fact  that 
conventional  sleep  staging  is  not  the  best  tool  to  measure  sleep  and  sleep  improvements. 
Importantly,  the  decrease  in  sub-ob  discrepancy,  following  the  QHR  interventions, 
suggests  that  people  may  be  better  at  distinguishing  PSG  defined  sleep  from 
wakefulness  and  it  could  be  speculated  that  the  QHR  enabled  extinction  of  classically 
conditioned  cortical  arousal  (Perlis  et  al,  1997)  i.  e.  decreased  fast  EEG  activity. 
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No  significant  correlations  between  sleep  continuity  data  measured  subjectively  and 
objectively  (i.  e.  estimated  and  PSG  SOL,  estimated  and  PSG  WASO,  etc.  )  were  found. 
This  lack  of  association  might  be  due  to  the  small  number  of  participants  in  each  group 
which  did  not  allow  sufficient  power  to  detect  associations.  However,  very  modest 
associations  between  PSG  and  sleep  diary  data  are  not  uncommon  in  the  literature.  For 
example,  Means  et  al  (2003)  looked  at  consistency  in  estimates  of  TST  with  PSG  over 
four  PSG  nights.  They  found  only  a  moderate  degree  of  consistency  between  diary  TST 
and  PSG  TST.  In  contrast,  Bastien  and  colleagues  found  no  significant  associations 
between  PSG  defined  SOL,  WASO,  TST  and  S.  E.  and  those  subjectively  reported  in 
either  good  sleepers  or  people  with  insomnia  (Bastien,  Fortier-Brochu,  Rioux,  LeBlanc, 
Daley  and  Morin,  2003). 
5.5.2.8  Adherence  with  the  Quarter  of  an  Hour  Rule 
The  finding  that  treatment  response  was  not  linearly  correlated  with  adherence  was 
unexpected.  As  discussed  in  the  introduction,  adherence  to  treatment  has  rarely  been 
measured  and,  moreover,  it  has  typically  been  measured  only  at  the  end  of  treatment  or 
at  follow  up.  Riedel  and  Lichstein  (2001)  measured  adherence  daily  and  found  that 
greater  adherence  to  a  consistent  `bed-time'  and  `wake-time'  was  associated  with  better 
outcome.  However  Vincent  and  Hameed  (2003)  failed  to  find  a  significant  association 
between  adherence  to  a  consistent  sleep  schedule  and  outcome.  Rather,  in  their  study, 
therapist-rated  adherence  and  spousal-rated  adherence  were  significantly  associated 
with  outcome.  Unfortunately  their  study  did  not  permit  the  assessment  of  adherence  to 
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associated  to  other  components  of  CBT. 
In  the  present  study,  around  80%  of  participants  in  the  QHRin  and  around  65%  of 
those  in  the  QHRout  adhered  to  the  rule  between  60  and  100  %  of  times  according  to 
objective  adherence  data.  Reported  adherence  was  much  higher:  around  85%  of 
participants  in  the  QHRin  and  95%  of  those  in  the  QHRout  reported  applying  the  rule 
between  60  and  100%  of  the  time.  Both  sets  of  data  (objective  and  subjective)  indicate 
that  there  was  adequate  adherence  with  the  behavioural  procedure  and  this  contrasts 
with  results  from  previous  research  (Chambers,  1992;  Harvey,  Inglis  et  al,  2002; 
Schramm  et  al,  1995).  For  example,  Chambers  (1992)  found  that  only  around  30%  of 
patients  consistently  adhered  to  behavioural  components.  With  regard  to  stimulus 
control,  Harvey,  Inglis  et  al  (2002)  found  that,  at  one  year  follow-up,  less  than  50%  of 
their  sample  adhered  to  sleep  scheduling  (that  is  sleep  restriction  and  stimulus  control) 
and  in  Schramm  et  al's  (1995)  study  stimulus  control  was  reported  to  be  adhered  to 
"very  rarely".  Although  adherence  rates  were  higher  in  the  present  study,  this  could  be 
due  to  measurements  being  taken  during  the  acute  treatment  phase  and  whether 
adherence  rates  would  remain  high  at  follow  up  is  unknown. 
As  already  mentioned  participants  tended  to  adhere  to  the  QHR  most  of  the  time  or 
not  to  adhere  at  all.  This  dichotomy  makes  the  adherence  data  more  similar  to  a 
categorical  (i.  e.  adhered/not  adhered)  than  a  linear  model.  A  correlation  coefficient,  as  a 
numerical  measurement  of  linear  association,  becomes  rather  meaningless.  Importantly, 
lack  of  variance  in  adherence  score  also  makes  it  difficult  to  suggest  what  amount  of 
adherence  is  necessary  to  obtain  sleep  improvements.  On  the  other  hand  the  finding  that 
sleep  improvements  were  achieved  following  the  QHR  interventions  despite  QHR  not 
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intervention  might  not  be  necessary  in  order  to  achieve  positive  clinical  outcomes. 
On  the  other  hand  the  fact  that  people  tended  to  adhere  most  of  the  times  or  not  at  all 
is  interesting  in  its  own  right.  Chambers  (1992)  pointed  out,  that  people  might  not 
adhere  to  instructions  because  they  are  poorly  understood  and/or  remembered.  Perhaps 
good  adherence  was  obtained  in  this  study  because  of  the  simplicity  of  mastering  and 
remembering  the  QHR.  Participants  had  to  follow  only  one  instruction,  they  had  a 
simple  flow-chart  showing  how  to  correctly  implement  the  QHR  and,  during  the  4 
telephone  contacts,  the  researcher  checked  that  the  QHR  was  implemented  correctly. 
One  comment  made  often  by  participants  regarded  the  difficulty  of  applying  the  rule 
and  that  some  times  "it  just  seemed  impossible  to  get  up  and  read".  This  comment 
highlights  that  difficulty  might  not  only  relate  to  understanding  but  also  to  motivation 
and  commitment  to  follow  instructions.  It,  also,  suggests  that  support  and 
encouragement  are  important  ingredients  to  `boost'  treatment  adherence. 
One  possibility  for  the  finding  that  some  people  did  not  adhere  is  that  they  were 
unmotivated  to  read.  It  would  be  incorrect  to  assume  that  all  insomnia  patients  are 
literate  to  the  extent  that  reading  at  bedtime  would  be  an  enjoyable  experience.  In 
addition,  the  QHRout  condition  might  have  been  particularly  aversive:  for  example  fear 
of  disturbing  one's  spouse  (by  getting  up  and  returning  to  bed  several  times)  or  a  cold 
sitting-room  (although  use  of  a  blanket  was  suggested). 
The  next  chapter  regards  the  theoretical  and  clinical  implications  deriving  from  the 
present  research.  In  addition  issues  limiting  the  present  research  and  informing  future 
studies  are  presented. 
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General  Issues  and  Future  Research 
In  the  previous  section  tentative  explanations  for  the  obtained  results  were  given.  In 
this  section  first  the  theoretical  and  clinical  considerations  are  extracted  and  then  the 
issues  limiting  this  piece  of  research  considered.  These  considerations  are,  in  turn,  used 
to  inform  future  research  needs  regarding  the  QHR. 
6.1  Theoretical  Implications 
The  QHR  was  proposed  to  epitomise  the  stimulus  control  package  for  insomnia 
devised  by  Bootzin  (1972)  by  employing  learning  theory  concepts.  The  present  results 
evidenced  that  the  QHR  was  as  efficacious  as  the  whole  stimulus  control  in  improving 
estimates  of  sleep  and  imply  that  the  QHR  may  be  an  essential  component  of  the  whole 
package. 
Employing  the  QHR  in  two  different  locations  (i.  e.  out  of  bed  and  in  bed)  permitted 
exploration  of  the  mechanisms  of  effects  of  the  QHR.  First  of  all,  the  finding,  that  both 
the  QHRout  and,  to  a  lesser  extent,  the  QHRin  improved  sleep,  suggest  the  mechanism 
of  effects  of  the  QHR  cannot  be  attributed  solely  to  falling  asleep  having  returned  under 
the  stimulus  control  of  the  bed  and  bedroom  environment. 
It  could  be,  as  suggested  by  Bootzin  (1972)  that  the  QHR  interventions  become  a 
`punishment'  for  wakefulness  in  bed.  This  seems  a  plausible  explanation  as  the  majority 
of  participants,  when  asked  about  implementing  the  QHR  interventions,  reported  that 
sitting  up  in  bed  to  read  and  having  to  get  out  of  their  bed  during  the  night  was 
unpleasant.  This  hypothesis  may  also  help  explain  why  the  QHRout  produced  better 
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bed  and,  therefore,  it  might  work  better  in  eliciting  a  response  to  stop  the  occurrence  of 
a  negative  event.  In  other  words  the  person  falls  asleep  more  rapidly  so  as  not  to  have  to 
apply  the  rule  (i.  e.  getting  out  of  bed  and  reading,  sitting  up  in  bed  with  the  light  on  and 
reading). 
Another  possibility  is  that  the  faulty  conditioning  hypothesised  to  underpin  insomnia 
is  both  to  the  bedroom  itself  and  to  cognitive  activity  in  bed.  The  finding  that  following 
the  QHR  interventions  aspects  of  cognitive  activity  decreased  substantiates  this 
possibility.  Indeed,  sleep  effort,  cognitive  arousal,  and  engagement  with  external  stimuli 
all  decreased.  It  is  noteworthy  that  stimulus  control  has  previously  been  thought  to 
operate  by  decreasing  cognition  at  night  (e.  g.  Hughes  and  Hughes,  1978;  Turner  and 
Ascher,  1979b;  Zwart  and  Lisman,  1979).  For  example,  Zwart  and  Lisman  (1979) 
proposed  that  stimulus  control  and  its  counter  disrupted  the  connection  between  the 
bedroom  environment  and  arousability  due  to  mentation  and  negative  emotion  (e.  g. 
worry,  frustration).  The  six  participants  in  Turner  and  Ascher's  study  (1979)  pointed  out 
that  stimulus  control  helped  to  break  up  lying  in  bed  and  thinking  and  that  it  gave  them 
a  means  of  asserting  self-control  over  the  bedtime  cognitions  by  simply  getting  out  of 
bed.  However,  this  contention  was  speculative  and  had  received  no  empirical 
confirmation.  The  results  obtained  by  analysing  the  battery  of  questionnaires  employed 
in  the  present  study,  in  contrast,  provided  some  support  to  this  hypothesis. 
The  present  findings  obviously  fall  short  of  demonstrating  a  cause  effect 
relationship.  While  it  is  plausible  that  sleep  effort  and  cognitive  activity  at  night 
decrease  in  response  to  sleep  improvements,  it  is  also  possible  that  putting  effort  into 
the  process  of  falling  asleep  support  and  sustain  sleep  problems  (Espie  et  al,  2006).  The 
researcher  speculated  that  the  QHR,  by  providing  participants  with  something  to  do  that 
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Espie's  (2002)  psychobiological  model  of  insomnia  proposes  that  `letting  go'  of  effort 
to  fall  asleep  enables  an  optimal  level  of  de-arousal,  which,  in  turn,  facilitates  `letting  go 
of  wakefulness'  typical  of  normal  sleep.  Likewise,  Morin  (1993)  proposed  that  methods 
indirectly  preventing/stopping  emotional  and  cognitive  load  in  bed  were  perhaps  more 
efficient  that  methods  drawing  attention  to  mentation.  Indeed,  rumination  theories 
suggest  that  one  way  of  reducing  negative  and  repetitive  thinking,  about  a  topic  relevant 
to  the  individual,  is  distracting  attention  away  from  the  recurrent  thought  (Martin  and 
Tesser,  1996;  Nolen-Hoeksema,  1991).  It  could  be  speculated  that  this  is  exactly  what  is 
at  play  in  the  QHR:  the  person  disengages  from  attending  to  the  sleep  process  and  from 
effortfully  trying  to  fall  asleep.  In  addition  the  QHR  faces  the  person  with  a  paradox 
(similar  to  paradoxical  intention:  Fogle  and  Dyall,  1983;  Broomfield  and  Espie,  2003)  ): 
the  person  wants  `desperately'  to  fall  asleep  and  the  QHR  asks  them  to  give  up  trying 
and,  instead,  read  for  as  long  as  they  need  to. 
The  findings  that  the  magnitude  of  effect  of  the  QHRout  was  greater  than  that  of  the 
QHRin  could  be  indicating  that  the  QHRout  operates  both  at  an  external  (e.  g.  overt 
activities  in  bed)  and  internal  (i.  e.  thinking)  level,  thus  breaking  the  connection  between 
the  bedroom  and  any  sleep  incompatible  (behavioural  and/or  cognitive)  activity.  In 
contrast  the  QHRin  disrupts  only  cognitive  activity  by  giving  something  to  do  (reading) 
instead  of  thinking.  Both  conditions  may  facilitate  breaking  the  connection  between 
cognitive  activity  and  the  bedroom  environment,  and  at  a  classical  conditioning  level 
break  the  pairing  between  the  bedroom  and  anxiety  and  frustration  (reduced  cues 
associated  with  arousal).  The  finding  that  QHR  interventions  decreased  the  sub-ob 
discrepancy  supports  this  possibility.  As  discussed  in  the  previous  chapter,  the  sub-ob 
discrepancy  has  been  hypothesised  to  arise  from  being  cortically  alert  during  NREM 
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mobile)  signalling  the  presence  of  a  pleasurable  activity  (e.  g.  watching  a  favourite  soap 
opera)  if  wakefulness  is  maintained. 
Whereas  each  of  these  possibilities  seems  reasonable,  further  research  is  obviously 
needed  to  determine  their  relative  merits. 
The  present  research  highlighted  the  possibility  of  measuring  adherence  to  a 
behavioural  treatment  objectively  via  actigraphy  and  light.  This  is  an  important  design 
advance  given  that  retrospective  reports  of  adherence  present  problems  of  validity.  It  is 
common  for  participants  to  confuse  adherence  behaviour  with  outcome  or  for  adherence 
reports  to  be  influenced  by  degree  of  improvement  (Kazantzis,  Deane  and  Ronan, 
2000). 
6.2  Clinical  Implications 
This  was  the  first  study  showing  that  a  simplified  form  of  stimulus  control  for 
insomnia,  which  takes  only  30  minutes  to  be  delivered,  produced  clinically  significant 
acute  therapeutic  gains. 
The  finding  that  after  a  single  session,  lasting  30  minutes,  participants  improved 
their  sleep  is  promising  and  opens  a  variety  of  possibilities:  the  QHR  could  be  a 
promising  first  line  intervention  for  insomnia.  At  present,  sleep  hygiene  is  a  commonly 
utilized  treatment  option  despite  little  evidence  of  its  efficacy  as  a  standalone  therapy 
for  insomnia  (Stepanski  and  Wyatt,  2003).  Its  popularity  is  most  probably  due  to  the 
fact  that  it  comprises  a  list  of  instructions  that  can  be  handed  in  to  patients  or  talked 
through  in  a  few  minutes.  The  QHR  could  be  delivered,  for  example,  by  health 
professionals  in  GP  practices.  Indeed,  one  study  has  already  shown  that  GPs  themselves 
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sessions  (Baillargeon,  Demers  and  Ladoucer,  1998). 
Additionally,  the  fact  that  the  QHR  comprises  only  one  instruction,  easy  to 
understand  and  remember,  opens  clinical  applications  targeting  people  who  find  it 
difficult  to  remember  and/or  to  assimilate  how  to  implement  more  complicated 
treatments  such  as  multi  component  CBT,  or  find  it  difficult  to  adhere  to  elaborated 
packages  due  to  lack  of  motivation  (e.  g.  due  to  depression). 
The  attrition  in  the  present  study  was  very  low  in  comparison  to  that  in  other  trials. 
Perlis,  Alloia  et  al  (2000)  averaged  attrition  rates  in  20  studies  and  the  average  drop  out 
rate  was  15.3%  with  some  studies  reaching  as  high  as  a  42%  attrition  rate.  They 
suggested  that  attrition  might  be  due  to  protocol  demands  as  some  individuals  found  the 
insomnia  interventions  too  taxing.  In  the  present  study  only  one  person  dropped  out 
during  baseline  and  none  of  the  people  who  started  the  intervention  discontinued  it. 
Admittedly  20%  of  individuals  (half  of  them  from  the  control  group)  did  not  undergo 
the  end  of  intervention  PSG.  Such  a  low  attrition  rate  might  suggest  that  the  QIIR 
intervention  is  not  only  easy  to  deliver  but  that  is  also  well  accepted  and  well  tolerated 
by  people  with  insomnia.  This  is  a  great  strength  of  this  insomnia  intervention.  Indeed  it 
has  been  pointed  out  that  notwithstanding  the  efficacy  of  a  given  treatment,  if  it  is  too 
time  consuming,  or  too  difficult  and  not  acceptable  to  patients  it  is  likely  to  be  of  little 
clinical  use  (Bell,  2001;  Morin  and  Wooten,  1996). 
Importantly  26  of  the  44  participants  who  completed  the  study  were  people  who 
sought  treatment  (asking  to  their  GPs)  and  this  group  appears  to  be  more  refractory  to 
treatment  than  people  actively  recruited  for  clinical  research  (Stepanski  et  al,  1989). 
Although  the  severity  of  sleep  disturbance  is  comparable,  individuals  seeking  treatments 
display  higher  levels  of  psychological  distress  than  those  responding  to  recruitment 
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seeking  patients  by  GPs  are  likely  to  be  the  most  generalizable  to  a  real  world  sample 
followed  by  patients  recruited  via  advertisements. 
Finally  the  finding  that  the  QHR  implemented  in  bed  is  efficacious  may  provide  an 
insomnia  intervention  for  people  who  have  problems  getting  out  of  bed  (for  example 
elderly  people  with  mobility  problems)  or  patients  who  find  it  impossible  to  comply 
with  getting  out  of  bed.  On  the  other  hand,  the  QHRin  was  found  to  have  only  moderate 
effectiveness  as  compared  to  the  QHRout.  This  finding  corroborated  Davies  and 
colleagues'  (1986)  findings  with  counter-control  and  suggests  that  the  QHR  should 
require  participants  to  go  to  another  room  if  not  asleep  within  a  quarter  of  an  hour.  As 
proposed  by  Bootzin  and  Epstein  (2000),  only  those  individuals  finding  difficult  to  get 
out  of  bed  for  mobility  or  other  issues  (e.  g.  cold  room,  pain,  fear  of  disturbing  bed 
partner)  should  implement  the  QHR  in  bed. 
As  already  discussed,  the  present  research  evidenced  an  important  application  of 
actigraphy,  with  the  added  feature  of  light  detection,  as  an  objective  measurement  of 
adherence.  Measuring  adherence  objectively  could  help  a  clinician  understand  if  the 
therapy  is  not  producing  the  expected  effects  because  of  poor  adherence  with  the 
behavioural  instructions.  In  addition,  patients  can  be  shown  their  nightly  adherence, 
and  reasons  for  non-adhering  can  be  worked  through  together  with  the  therapist. 
6.3  Limitations  of  the  Present  Study 
These  sections  discusses  several  methodological  considerations  which  preclude 
drawing  strong  conclusions  from  this  experimental  trial.  Future  research  addressing 
these  issues  is  suggested  in  the  next  section  (section  6.4). 
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Follow-ups  are  very  important  to  ascertain  if  therapeutic  gains  are  short  lived  or  will  be 
maintained  over  time.  Although  previous  research  has  found  that  psychological  and 
behavioural  therapies  for  insomnia  produced  stable  changes  in  sleep  pattern  over  time, 
with  gains  maintained  up  to  12,24  and  36  months  following  end  of  treatment  (e.  g. 
Backhaus  et  al,  2001;  Espie,  Inglis  Tessier  and  Harvey,  2001;  Morin,  Colecchi  et  al, 
1999;  Sanavio  et  al,  1990),  the  lack  of  follow-up  limits  the  conclusions  of  the  present 
investigation  to  the  time  frame  of  the  study,  and  thus  prevents  us  from  making  any 
comments  on  sustained  effects.  However,  this  was  an  experimental  trial,  designed  to  test 
the  feasibility  of  a  simplified  behavioural  intervention  for  insomnia  and  to  shed  light  on 
mechanisms  of  effect. 
It  is  important  to  remember  that  means  and  variability  were  influenced  by  the  fact 
that  some  participants  had  only  sleep  onset  insomnia,  some  had  only  sleep  maintenance 
insomnia  and  some  others  met  both  sets  of  criteria  (mixed  insomnia).  Although  there 
were  no  statistical  differences  among  the  three  groups  on  averaged  measures  of  SOL 
and  WASO  during  baseline,  the  groups  did  comprise  different  numbers  of  participants 
who  had  clinically  defined  mixed,  onset  or  sleep  maintenance  insomnia.  On  the  one 
hand,  this  suggests  that  positive  results  are  especially  meaningful  because  the  sample, 
like  so  much  of  the  clinical  population  was  heterogeneous  in  their  presentation  of 
insomnia  symptoms.  On  the  other  hand  this  might  have  had  some  influence  on  the 
treatment  outcomes. 
With  regard  to  generalisability,  the  trial  included  well-screened,  healthy,  reasonably 
well-educated  and  well  functioning  individuals.  Additionally,  only  people  who  were  not 
taking  sleep  medications  and  who  did  not  present  with  concurrent  psychopathologies 
(e.  g.  depression)  were  recruited.  Although  this  may  limit  the  generalisability  to  other 
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justifies  setting  more  strict  criteria.  Obviously  more  studies  are  needed  to  determine  if 
similar  therapeutic  outcomes  can  be  obtained  in  other  samples  (e.  g.  people  using 
hypnotic  drugs,  people  with  insomnia  and  depression). 
Another  pitfall  of  the  present  research  is  the  small  sample  size.  Small  sample  size 
might  have  reduced  the  power  of  the  statistical  analyses  to  detect  potential  differences 
among  the  conditions.  In  order  to  avoid  a  type  II  error  a  sample  size  of  minimum  27 
participants  per  group  to  detect  a  large  treatment  difference  and  minimum  70  per  group 
to  detect  smaller  differences  have  been  recommended  (Kazdin  and  Bass,  1989). 
Furthermore,  a  bigger  sample  size  would  permit  analysis  of  the  impact  of  the  QHR  on 
people  presenting  with  one  insomnia  complaint  (i.  e.  only  SOL,  only  WASO,  mixed). 
In  addition,  this  study  is  limited  by  lack  of  a  true  control  group  that  is  equivalent  to  a 
pill  placebo  in  pharmacological  studies.  However,  this  is  a  limitation  common  to  most 
psychological  research  and  one  that  is  difficult  to  address.  Nonetheless  not  having  a 
`pure'  placebo  makes  it  difficult  to  determine  what  percentage  of  the  variance  in 
outcomes  is  due  to  specific  therapeutic  ingredients  (i.  e.  stimulus  control)  the 
measurement  process  (self-monitoring),  credibility  of  treatment  rationales,  or  to  non- 
specific  factors  (therapist's  attention,  patient's  expectation). 
In  the  present  study  the  impact  of  self-monitoring  was  controlled  for,  by  having  a 
control  group  whose  only  task  was  to  monitor  daily  their  sleep  for  the  whole  duration  of 
the  study.  As  already  discussed  in  the  introduction,  credibility  of  the  treatment  rationale 
is  a  potentially  powerful  healing  aspect  of  treatment  (Baskin,  Tierney,  Minami  and 
Wampold,  2003):  if  the  rationales  are  not  equivalent  the  credibility  of  the  treatment  and 
resulting  expectations  of  participants  might  differ.  However,  the  differential  outcomes 
obtained  with  the  QHRin  and  the  QHRout  are  unlikely  to  be  due  to  credibility  of  the 
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significant  differences  at  pre-treatment  regarding  the  credibility  of  the  treatment. 
However,  the  control  group  was  aware  of  not  receiving  treatment. 
With  regard  to  structural  equivalence  (Howard,  Kopta,  Krause  and  Orlinsky,  1986), 
in  the  sense  of  dose  of  treatment,  this  was  ensured  by  providing  participants  with  equal 
number  of  therapist-patient  contacts  of  equal  length.  Importantly  both  the  QHR  and 
control  groups  were  given  the  same  number,  of  equivalent  length,  contact.  These 
features  of  experimental  control  reduced  experimenter  bias  and  controlled  for 
differential  therapist's  attention.  Nonetheless,  it  is  appreciated  that  non-verbal  behaviour 
might  have  played  an  important  role  in  treatment  outcomes. 
The  possibility  that  differential  therapist  expectancies  could  account  for  the  different 
magnitude  of  therapeutic  outcomes  should  also  be  taken  into  account.  Although  the 
therapist  was  obviously  aware  of  the  participant  treatment  allocation,  the  experimental 
methodology  followed  a  rigorous  written  protocol:  the  protocols  used  to  deliver  QHHRin 
and  QHRout  were  identical  apart  from  the  instructions  differentiating  the  QHRout  ('go 
to  another  room  and  read')  from  the  QHRin  ('sit  up  in  bed  and  read'). 
Another  methodological  flaw  of  the  present  research  was  that  the  researcher  served 
both  as  the  designer  of  the  study,  the  therapist  and  the  evaluator  of  the  treatment 
outcomes:  this  could  have  given  raise  to  biases.  Although  sleep  diary,  PSG  and 
questionnaires  were  employed  to  assess  treatment  outcome,  some  judgement  on  the  part 
of  the  scorer  was  still  involved.  In  the  present  study,  however,  an  independent 
technologist  blind  to  treatment  allocation  scored  the  PSG  data.  With  regard  to  diary 
data,  questionnaires  responses  were  inputted  into  a  spreadsheet  at  the  end  of  the  study 
by  the  researcher  who  programmed  the  spreadsheet  to  calculate  the  total  scores  for  each 
questionnaire. 
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the  QHR  intervention  and  magnitude  of  effects  warrant  further  investigation. 
6.4  Future  Research 
The  present  research  suggested  that  the  QHR  is  a  promising  intervention  for 
insomnia  warranting  further  research.  However,  the  limitations  (due  to  the  exploratory 
experimental  nature  of  the  trial)  discussed  in  the  previous  section  do  not  permit  firm 
conclusions  and  indicate  that  future  research  should  address  the  following  issues. 
First,  this  was  the  first  trial  involving  only  one  simplified  component  of  stimulus 
control  and  the  present  findings,  although  promising,  need  to  be  replicated  by  future 
investigations  and  in  different  centres. 
Second,  due  to  its  exploratory  nature,  the  present  study  comprised  only  small 
samples  and  lack  of  significant  differences  between  the  QHRin  and  QHRout  might  have 
been  due  to  power  issues.  Future  research  should  endeavour  to  employ  larger  samples. 
Importantly,  since  the  stability  of  results  is  essential  for  clinical  appreciation  of  the 
validity  of  a  psychological  treatment  for  insomnia,  future  research  should  include  a 
follow  up  so  as  to  ascertain  if  improvements  obtained with  the  QHR  are  maintained 
over  time. 
Third,  although  the  dose-response  analyses  suggested  that  therapeutic  gains  were 
achieved  after  only  one  week  of  QHR  implementation,  whether  one  session  is  sufficient 
to  maintain  such  gains  or  some  more  contacts,  even  of  a  few  minutes,  are  necessary  to 
sustain  and  consolidate  changes  remain  unclear.  Future  research  with  different  doses 
(e.  g.  similar  to  Edinger  et  al's  (2004)  study)  should  be  devised  to  determine  the  optimal 
number  of  sessions. 
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components  to  the  QHR  treatment  would  help  the  understanding  of  the  contributions  of 
single  components  to  total  effectiveness  of  multicomponent  CBT. 
Fifth,  future  research  could  investigate  the  feasibility  of  using  the  QHR  to  help  to 
withdraw  from  medication.  For  example,  Riedel,  Lichstein  et  at  (1998)  investigated  the 
efficacy  of  stimulus  control  in  medicated  and  non-medicated  people  with  insomnia  and 
found  that  stimulus  control  was  well  received  in  medicated  participants  and  resulted  in 
better  outcome  as  compared  to  the  only  medication  group.  Given  the  simplicity  and 
limited  time  necessary  to  administer  the  QHR,  it  could  be  an  important  aid  to 
withdrawal  programs. 
Sixth,  cross-sectional  research  has  consistently  evidenced  that  several  areas  (e.  g. 
daytime  functioning,  mood  and  distress)  of  health  related  quality  of  life  (IHRQoL)  are 
poor  among  people  with  insomnia.  It  seems  important  to  include  measures  of  these 
domains  because  patients  are  generally  seeking  insomnia  treatment  because  of  the  real 
(or  perceived)  negative  effects  of  insomnia  on  their  daily  lives.  In  this  regard,  the  most 
often  used  measurement  of  HRQoL  in  sleep  research  is  the  SF-36  (Ware,  Gandek,  et  al, 
1994).  Importantly  the  only  study  to  date  measuring  changes  in  HRQoL  following 
CBT-I  showed  that  CBT-I  improved  both  sleep  quality  and  HRQoL  in  older  adults 
(Dixon,  Morgan,  Mathers,  Thompson  and  Tomeny,  2006).  Their  study  also  highlighted 
that  the  SF-36  is  a  valid  instrument  to  measure  such  changes. 
Furthermore,  participants  randomised  to  the  control  group  were  aware  that  they 
were  not  receiving  therapy  and,  therefore,  this  group  did  not  represent  a  placebo 
condition.  Future  research,  could,  for  example,  simply  ask  participants  to  `sit  up  in  bed 
if  not  asleep  within  a  quarter  of  an  hour'  to  explore  if  the  QHR  break  the  connection 
between  wakefulness  and  cognitive  activity.  Alternatively  it  could  ask  participants  to 
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QHR  are  to  do  purely  with  learning  to  associate  the  bedroom  with  falling  asleep.  Just 
sitting  there,  would  presumably  not  alter  internal  states  such  as  rumination.  A  counter 
demand  condition  could  also  represent  a  feasible  control  group. 
In  addition,  the  present  study  highlighted  the  importance  of  recording  PSG  for 
multiple  nights.  In  particular,  Wohlgemuth  et  al's  (1999)  study  suggested  averaging  4-5 
nights  to  obtain  reliable  measures.  Multiple  PSG  nights  are  seldom  recorded  due  to  the 
considerable  cost,  inconvenience  and  burden  on  participants  but,  the  night-to-night 
variability  questions  the  validity  of  results  obtained  by  only  one  recording  night. 
Finally,  the  findings  that  sub-ob  discrepancies  were  reduced  following  the  QFHR 
intervention  confirmed  the  importance  of  carrying  out  power  spectral  analysis  in 
addition  to  standard  PSG.  A  few  studies  have  found  higher  beta  and  gamma  activity  in 
people  presenting  with  insomnia  and  that  such  activity  was  correlated  with  subjective- 
objective  TST  discrepancies  (Perlis  et  al,  2001).  Future  research  should  consider 
exploring  the  impact  of  the  QHR  on  fast  EEG  activity.  Power  spectral  analysis  will  be 
performed  on  the  PSG  data  collected  in  this  research  in  the  near  future. 
6.5  Concluding  Comments 
This  study  was,  of  course,  preliminary  and  future  research  is  required  to  replicate  its 
positive  findings  and  to  address  the  limitations  discussed  in  the  previous  section. 
Nonetheless,  it  provides  the  first  evidence  from  a  randomised  controlled  trial  that  the 
QHR,  a  simplified  intervention  extracted  from  the  stimulus  control  package,  is  a 
promising  insomnia  treatment.  Indeed,  the  QHR  produced  statistically  and  clinically 
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complex  CBT  packages,  within  the  first  week  of  implementation. 
Importantly,  the  QHR  required  only  30  minutes  face-to  face  contact  and  a  few 
telephone  contacts  lasting  less  than  10  minutes.  It  is  quick  to  administer,  participants 
found  it  easy  to  understand  how  to  apply  the  QHR  and  adherence  to  the  rule  was  high. 
These  findings  have  important  clinical  implications  for  prevention.  Recent  meta- 
analyses  (Cole  and  Dendukuri,  2003;  Riemann  and  Voderholzer,  2003)  have  suggested 
that  insomnia  is  a  key  risk  factor  for  first  episode  of  depression,  and  chronic  insomnia  is 
associated  with  increased  utilisation  of  health  services  (Ford  and  Kamerow,  1989). 
Early  intervention  focussing  directly  on  sleep  disturbances  which  is  easy  to  administer 
and  to  understand  may  prove  particularly  cost-effective. 
Furthermore,  this  study  highlighted  the  importance  of  investigating  critical 
components  of  CBT  so  as  to  understand  whether  multi-component  programs  are 
superior  to  mono-therapies. 
The  QHR  reduced  cognition  at  bedtime  in  that  sleep  effort,  engagement  with 
sensory  factors  and  worry  were  diminished  following  the  1intervention.  Furthermore, 
both  the  canonical  QHRout  and  its  counter  (QHRin)  impacted  positively  on  sleep. 
Theoretically  these  findings  lend  support  to  the  hypothesis  that  the  mechanisms  of 
effect  of  the  QHR  are  not  solely  due  to  poor  situational  stimulus  control.  Rather, 
classically  conditioned  cortical  arousal  might  also  play  a  role  in  insomnia  and  the  QHR 
indirectly,  by  asking  people  to  read,  breaks  the  connection  between  the  bed  and 
cognitive  engagement. 
Admittedly,  following  the  QHR  improvements  were  evidenced  by  participants' 
estimates  of  their  sleep  but  not  by  PSGs.  Obviously  this  could  be  due  to  the  QIIR  not 
impacting  on  sleep.  However,  by  taking  into  account  that  sub-ob  discrepancies 
242 decreased  following  intervention,  it  can  be  argued  that  conventional  PSG  staging  might 
not  be  the  best  tool  to  evidence  changes.  Indeed  previous  research  suggested  that  beta, 
alpha  and  gamma  activity  (as  measured  by  power  spectral  analyses)  better  correlate  with 
estimates  of  sleep  than  PSG  staging. 
The  home-based  portable  polysomnograms  were  found  to  be  an  excellent  alternative 
to  laboratory  polysomnograms.  They  were  well  tolerated  by  participants,  involved 
minimal  disruption  to  evening  activities  and  the  sleep  environment,  and  allowed 
assessment  of  sleep  naturally  in  the  home  environment.  This  might  prove  a  good 
alternative  to  laboratory  recordings  if  multiple  nights  are  to  be  recorded. 
Very  importantly  this  study  also  provided  evidence  of  the  feasibility  of  measuring 
adherence  to  a  behavioural  treatment  objectively  via  actigraphy  with  the  added  feature 
of  light  detection. 
To  conclude,  this  was  the  first  randomised  controlled  trial  in  insomnia  research 
employing  one  single  element  of  stimulus  control  needing  only  thirty  minutes  to  be 
delivered.  The  QHR  produced  statistically  and  clinically  significant  outcomes,  it 
suggested  that  mono-therapies  are  worth  investigating  because  they  could  provide  a 
cost-effective  alternative  to  more  complex  multi-component  CBT-I.  Theoretically  the 
QHR  suggested  that  stimulus  control  might  operate  both  on  operant  and  classical 
conditioning  levels  and  might  indirectly  break  the  pattern  of  ruminating  in  bed.  The 
QHR  is,  therefore,  a  line  of  research  worth  pursing  on  both  theoretical  and  clinical 
grounds. 
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266 Appendix  1:  Diagnostic  criteria  for  psychophysiological  insomnia  (ICSD-II) 
Psychophysiological  Insomnia  -  Diagnostic  criteria 
a.  The  patient's  symptoms  meet  the  criteria  for  insomnia. 
b.  The  insomnia  is  present  for  at  least  one  month. 
c.  The  patient  has  evidence  of  conditioned  sleep  difficulty  and/or 
heightened  arousal  in  bed  as  indicated  by  one  or  more  of  the  following 
i.  Excessive  focus  on  and  heightened  anxiety  about  sleep 
ii.  Difficulty  faling  asleep  in  bed  at  the  desired  bedtime  or 
during  planned  naps,  but  no  difficulty  falling  asleep  during 
other  monotonous  activities  when  not  intending  to  sleep 
iii.  Ability  to  sleep  better  away  from  home  than  at  home 
iv.  Mental  arousal  in  bed  characterised  either  by  intrusive 
thoughts  or  a  perceived  inability  to  volitionally  cease  sleep- 
preventing  mental  activity 
v.  Heightened  somatic  tension  in  bed  reflected  by  a  perceived 
inability  to  relax  the  body  sufficiently  to  allow  the  onset  of 
sleep 
d.  The  sleep  disturbance  is  not  better  explained  by  another  sleep  disorder, 
medical,  or  neurological  disorder,  mental  disorder,  medication  use,  or 
substance  use  disorder. 
267 Appendix  3:  Sleep  Diary 
SLEEP  DIARY:  We  are  interested  in  finding  out  what  normal  sleepers  do  differently  from  poor 
sleepers  both  during  a  typical  night  and  a  night  when  sleep  does  not  come  that  easily.  Plese  fill  in  the 
diary  each  morning  upon  awakening.  Thanks  very  much!!  Marina  Malaffo 
If  you  want  more  information  you  can  contact  me  on: 
01412113902  (University  of  Glasgow,  Psychological  Medicine,  Gartnavel  Royal  Hospital) 
Please  circle  as  appropriate:  I  am  generally  (last  6  months)  a  GOOD  /  POOR  Sleeper 
I  am:  M/F  My  occupation:  Student  /  Employed  /  Unemployed  /  Retired  Age:......... 
Diary  entries  started:  ...... 
J.......  2004 
What  time  did  you  rise  from  bed  this 
morning? 
What  time  did  you  wake  up  this  morning? 
Did  you  wake  up  because  of. 
1:  Alarm  clock/asked  to  be  waken  up 
2:  Noise  or  light 
3:  Just  woke  up 
What  time  did  you  go  to  bed  last  night? 
What  time  did  you  switch  off  the  light 
intending  to  sleep? 
How  long  did  you  take  to  fall  asleep? 
If  you  had  difficulties  falling  asleep,  what  did 
you  do? 
(e.  g.  just  lie  in  bed  trying,  read  a  book, 
listened  to  the  radio,  made  myself  a  hot  drink) 
How  many  times  did  you  wake  up  during  the 
night? 
How  long  were  you  awake,  in  total,  during 
the  night  after  you  first  fell  asleep? 
What  did  you  do  when  you  woke  up  during 
the  night  if  you  could  not  fall  asleep 
immediately?  (e.  g.  just  lie  there,  read  a  book, 
listened  to  the  radio,  made  myself  a  hot  drink) 
Did  you  take  any  nap  yesterday? 
If  yes  for  how  long? 
How  much  units  of  alcohol  did  you  take 
yesterday? 
Measuring  the  quality  of  your  sleep: 
How  was  your  sleep? 
0=very  bad;  1=bad;  2=so  so; 
3=  good;  4=  very  good 
How  rested  do  you  feel  this  morning? 
0=not  at  all;  1=little;  2=so  so; 
3=  quite;  4=very  rested 
How  alert  do  you  feel  this  morning? 
0=not  at  all;  1=little;  2=so  so; 
3=  quite;  4=very  alert 
273 Appendix  4:  The  PSQI 
Questionnaire  A  ID: 
The  following  questions  relate  to  your  sleep  habits  during  the  past  month  only.  Your 
answers  should  indicate  the  most  accurate  reply  for  the  majority  of  days  and  nights  in 
the  past  month.  Please  answer  all  the  questions. 
1.  During  the  past  month,  when  have  you  usually  gone  to  bed  at  night? 
Usual  bed  time:......  . 
2.  During  the  past  month,  how  long  (in  minutes)  has  it  usually  taken  you  to  fall  asleep 
each  night?  Number  of  minutes:.....  . 
3.  During  the  past  month,  when  have  you  usually  got  up  in  the  morning? 
Usual  getting  up  time:.....  . 
4.  During  the  past  month,  how  many  hours  of  actual  sleep  did  you  get  at  night?  This 
may  be  different  to  the  number  of  hours  you  spend  in  bed. 
Hours  of  sleep  per  night:.....  . 
5.  During  the  past  month,  how  often  have  you  had  trouble  sleeping  because:  you: 
Not  during  the 
past  month 
Less  than 
once  a  week 
Once  or  twice 
a  week 
Three  or  more 
time  a  week 
a.  Cannot  get  to  sleep  within 
30  minutes 
b.  Wake  up  in  the  middle  of 
the  night  or  early  morning 
c.  Have  to  get  up  and  use  the 
bathroom 
d.  Cannot  breathe  comfortabl 
e.  Cough  or  snore  loudly 
f.  Feel  too  cold 
g.  Feel  too  hot 
h.  Had  bad  dreams 
i.  have  pain 
j.  Other  reasons,  please  describe  them  and  how  orten  it  nappenea  :.......................  . 
274 6.  During  the  past  month,  how  would  you  rate  your  sleep  quality  overall?  (Please  circle  your 
choice) 
Very  Good  Fairly  good  Fairly  bad  Very  bad 
7.  During  the  past  month,  how  often  have  you  taken  medicines  (prescribed  or  `over  the 
counter')  to  help  you  sleep?  (Please  circle  your  choice) 
Not  during  the  Less  than  Once  or  twice  Three  or  more 
past  month  once  a  week  a  week  time  a  week 
8.  During  the  past  month,  how  often  have  you  had  trouble  staying  awake  while  driving,  eating 
meals,  or  engaging  in  social  activities?  (Please  circle  your  choice) 
Not  during  the  Less  than  Once  or  twice  Three  or  more 
past  month  once  a  week  a  week  time  a  week 
9.  During  the  past  month,  how  much  of  a  problem  has  it  been  for  you  to  keep  up  enough 
enthusiasm  to  get  things  done?  (Please  circle  your  choice) 
No  problem  Only  a  very  Somewhat  A  very 
at  all  slight  problem  of  a  problem  big  problem 
10.  Do  you  have  a  bed  partner  or  a  room  mate? 
No  bed  partner  Partner  or  room  mate  Partner  or  room  mate  in  Partner  in 
or  room  mate  in  other  room  same  room  but  not  same  bed  same  bed 
If  you  have  a  room  mate  or  bed/partner  ask  him/her  how  often  in  the  past  month  you  have: 
Not  during  the  Less  than  Once  or  twice  Three  or  more 
past  month  once  a  week  a  week  time  a  week 
a.  Loud  snoring 
b.  Long  pauses  between 
breaths  while  asleep 
c.  Legs  twitching  or  jerking 
while  asleep 
d.  Episodes  of  disorientation 
or  confusion  during  sleep 
e.  Other  restless  while  you  sleep:  please  describe  and  write  down  how  often:..........  . 
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SLEEP  DIARY:  BASELINE  /  INTERVENTION  ID:  ............ 
This  sleep  diary  helps  both  us  and  yourself  to  find  out  your  sleep  pattern  and  how  you  feel  about 
your  sleep.  In  order  to  get  a  precise  picture  of  your  night-by-night  sleep  and  your  feelings 
about  it,  it  is  essential  that  you  fill  the  diary  in  every  morning.  Please,  remember  that  there  is 
not  a  right  or  wrong  answer  but  just  the  way  you  slept  each  night. 
Diary  entries  started:  DATE: 
What  time  did  you  rise  from  bed  this 
morning? 
What  time  did  you  wake  up  this  morning? 
What  time  did  you  go  to  bed  last  night? 
What  time  did  you  switch  off  the  light 
intending  to  sleep? 
How  long  (rains)  did  you  take  to  fall  asleep? 
If  you  had  difficulties  falling  asleep,  what  did 
you  do?  (for  example:  just  lie  in  bed,  read  a 
book,  think,  ... 
) 
How  many  times  did  you  wake  up  during  the 
night? 
How  long  were  you  awake,  in  total,  during 
the  night  after  you  first  fell  asleep? 
What  did  you  do  when  you  woke  up  during 
the  night  if  you  could  not  fall  asleep 
immediately? 
Did  you  take  any  nap  yesterday? 
If  yes  for  how  long? 
How  much  units  of  alcohol  did  you  take 
yesterday9 
Did  you  take  an  sleeping  tablets?  (Y  /  N) 
Measuring  the  quality  of  your  sleep: 
How  was  your  sleep? 
0=very  bad;  1=bad;  2=so  so; 
3=  good;  4=  very  good 
How  rested  do  you  feel  this  morning? 
0=not  at  all;  1=little;  2=so  so; 
3=  quite;  4=very  rested 
How  alert  do  you  feel  this  morning? 
0=not  at  all;  1=little;  2=so  so; 
3=  quite;  4=very  alert 
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ID:  Date:  ............. 
QUESTIONNAIRE  B 
Please  read  each  item  below  and  circle  the  reply  which  comes  closest  to  how  you 
have  been  feeling  in  the  past  week.  Don't  take  too  long  over  your  replies,  your 
immediate  reaction  to  each  item  will  probably  be  more  accurate  than  a  long,  thought- 
out  response. 
1.  I  feel  tense  or  'wound  up' 
Most  of  the  time  A  lot  of  the  time 
From  time  to  time,  occasionally  Not  at  all 
2.  I  still  enjoy  the  things  I  used  to  enjoy 
Definitely  as  much  Not  quite  so  much 
Only  a  little  Hardly  at  all 
3.  I  get  a  sort  of  frightened  feeling  as  if  something  awful  is  about  to  happen 
Very  definitely  and  quite  badly  Yes,  but  not  too  badly 
A  little,  but  it  does  not  worry  me  Not  at  all 
4.  I  can  laugh  and  see  the  funny  side  of  things 
As  much  as  I  always  could  Not  quite  so  much  now 
Definitely  not  so  much  now  Not  at  all 
5.  Worrying  thoughts  go  through  my  minds 
A  great  deal  of  the  time  A  lot  of  the  time 
Not  too  often  Very  little 
6.1  feel  cheerful 
Never  Not  often 
Sometimes  Most  of  the  time 
277 7.  I  can  sit  at  ease  and  feel  relaxed 
Definitely  Usually 
Not  often  Not  at  all 
8.  I  feel  as  if  I  am  slowed  down 
Nearly  all  the  time  Very  often 
Sometimes  Not  at  all 
9.  I  get  a  sort  of  frightened  feeling  like  `butterflies'  in  the  stomach 
Not  at  all  Occasionally 
Quite  often  Very  often 
10.  I  have  lost  interest  in  my  appearance 
Definitely  I  don't  take  as  much  care  as  I  should 
I  may  not  take  quite  as  much  care  I  take  just  as  much  care  as  ever 
11.  I  feel  restless  as  if  I  have  to  be  on  the  move 
Very  much  indeed  Quite  a  lot 
Not  very  much  Not  at  all 
12.  I  look  forward  with  enjoyment  to  things 
As  much  as  I  ever  did  Rather  less  than  I  used  to 
Definitely  less  than  I  used  to  Hardly  at  all 
13.  I  get  sudden  feelings  of  panic 
Very  often  indeed  Quite  often 
Not  very  often  Not  at  all 
14.  I  can  enjoy  a  good  book  or  radio  or  television  programme 
Often  Sometimes 
Not  often  Very  seldom 
Please  check  that  you  have  answered  all  the  questions.  Thank  you. 
278 Appendix  7:  Monitoring  the  use  of  the  `Quarter  of  an  hour  rule': 
We  want  to  evaluate  hom  difficult  it  is  to  follow  this  rule.  Please  fill  out  the  following  table. 
For  each  day  put  your  answer  in  the  box: 
a.  If  you  followed  the  rule  write  'Y',  if  you  did  not  write  `N'. 
b.  If  the  question  is  not  applicable  to  you  write  `N/A' 
c.  When  you  are  asked  `How  many  tines..?  ',  write  the  number  apply  ing  t(1  .  uu. 
each  night. 
Weeks:  I/2/3 
RULE  TODAY'S  DATE 
1.  Did  you  take  less  than  a  quarter  of  an  hour  to 
fall  asleep  once  you  switched  off  the  light'? 
2.  If  not,  did  you  go  to  another  room? 
3.  If  you  went  to  another  room, 
after  about  how  many  minutes  did  you  do  so'? 
4.  In  order  to  follow  the  rule,  how  many  times 
alingethor  did  )zoji  have  t( 
6  If  ou  had  to  more  than  once  et  u  "d 
.  y  .  g  p 
after  how  lon  ou  do  so'?  did  "  g  y 
After  you  fell  asleep: 
7.  II  you  awoke  during  the  night, 
did  you  fall  hack  asleep  within  a  quarter  of  an  hour:  ' 
8.  If  you  did  not  fall  back  asleep  within  a  quarter  of 
an  hour,  did  you  go  to  another  room? 
9.  If  you  went  to  another  room, 
after  about  how  many  minutes  did  you  do  so? 
10.  In  order  to  follow  the  rule,  how  many  times 
altogether  did  you  have  to  get  up  during  the  night'? 
--  - 
II  If  you  had  to  get  up  more  than  once,  2'  time 
---  ---- 
after  how  long  did  you  do  so?  3"1  time 
4"  time 
12.  Please  describe  how  it  was  to  follow  the  rule 
by  circling  the  number  that  applies  to  you 
(I=  not  difficult  at  all.  I  I  I  I  I  1 
2=  a  little  difficult.  2  2  2 
3=  difficult.  3  3  l  l  l 
4=  very  difficult.  4  4  4  1  t 
5=  extremely  difficult)  5  5  5  >  ..  >  ti 
'7,  i Appendix  8:  Flowchart  QHRout 
Preparation  for  The  `QUARTER  OF  AN  HOUR  RULE' 
Decide  which  room  you  are  going  to  ii'  you  I  ºtoom 
cannot  fall  asleep  within  15  minutes  I 
.......... 
Think  about  a  couple  of  activities  you  would  wait 
to  carry  out  in  the  chosen  room  if  you  don't  Call  asleep 
within  15  minutes 
Put  the  material  needed  for  your  chosen  activities  in 
the  room  where  you  are  going  to  carry  them  out 
Make  sure  the  room  is  prepared  so  that  you  will  he 
comfortable  enough  in  it  if  awake  during  the  night 
(e.  g.  warm,  with  something  to  drink) 
LNG) 
Activities 
'till If  you  do  not  fall  asleep  within  about  15  minutes 
Leave  the  bed 
Go  to  another  room 
Do  the  chosen  activity 
Do  not  nap  or  sleep  in  this  room 
Return  to  bed  when  you  want  to  sleep 
NO  /ire  you  asleep  within 
about  15  minutes 
YES 
you  wake  up  during  the 
N() 
NO  Did  you  fall  back  to  siech-  YIDS 
within  about  15  minutes 
￿/ 
Iý;  NI) 
i Appendix  9:  Participants'  information  sheet 
This  information  sheet  will  help  you  to  understand  why  we  are  doing  this  research  and  what  it 
will  involve.  Please  take  some  time  to  read  it  and  feel  free  to  contact  me  if  something  is  not  clear 
(my  contact  numbers  are  listed  below). 
What  is  the  purpose  of  this  study? 
The  aim  of  this  study  is  to  explore  how  a  sleep  intervention  called  `the  quarter  of  an  hour  rule' 
affects  sleep.  The  study  investigates  how  you  feel  about  your  sleep  before,  during  and  after  the 
sleep  intervention,  but  it  also  investigates  your  brain  activity  during  the  night.  The  equipment 
(called  EEG)  we  have  to  measure  brain  activity  is  easy  to  use  at  home  and  is  completely  safe. 
What  do  I  have  to  do  if  I  take  part  in  this  study? 
If  you  decide  to  participate  you  would,  first  of  all,  be  asked  some  questions  about  your  sleep.  In 
addition  you  will  have  one  questionnaire  to  fill  in.  These  would  enable  the  researcher  to  find  out  if 
your  sleep  problems  are  the  kind  of  problems  we  are  investigating  in  this  research  study.  This  will 
take  approximately  10  minutes. 
If  your  sleep  difficulties  are  of  the  types  studied  in  this  research  and  you  wanted  to  participate  in 
the  study,  you  would  be  involved  in  the  research  for  6  to  8  weeks.  During  this  weeks  you  would 
have  to: 
.  meet  with  the  researcher  twice  for  about  45  minutes  each, 
.  meet  another  5  times  (for  about  5  minutes  each)  so  as  to  be  given  or  return  the  EEG 
equipment 
.  record  your  brain  activity,  using  the  EEG  home  recording  equipment  provided,  for  6  nights 
.  wear  an  `actiwatch'  (very  similar  to  a  wrist  watch),  for  the  whole  period  of  the  study,  so  as 
to  measure  your  body  movements 
. 
fill  in  a  sleep  diary  each  morning  for  the  whole  duration  of  the  study  (about  5  minutes  every 
day) 
During  the  first  meeting  with  the  researcher  you  will  have  the  opportunity  to  ask  any  questions 
you  wish  to  about  the  study,  you  will  then  be  asked  you  to  sign  a  consent  form  to  participate  in  the 
study.  The  researcher  will  then  tell  you  how  to  fill  in  the  'sleep  diary',  how  to  use  the  EEG 
recording  equipment  and  how  to  use  the  actigraph.  It  might  seem  a  lot  of  information  to  take  in:  for 
this  reason  you  will  be  given  a  short  and  easy  memo  about  what  you  are  requested  to  do. 
During  the  second  meeting,  the  researcher  will  explain  to  you  the  'quarter  of  an  hour  rule' 
intervention  for  insomnia  and  you  will  be  asked  to  start  implementing  it  from  that  very  first  night. 
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How  much  time  will  be  required  of  me? 
All  together  to  fill  in  the  sleep  diary  each  morning,  meet  with  the  researcher,  use  the  EEG  home 
recording  equipment,  you  will  be  required  to  devote  around  7  hours  of  your  time  over  a  period  of  6 
to  8  weeks. 
Benefits  to  you  in  participating 
Participating  in  this  study  will  help  you  to  understand  your  sleep  pattern  better.  In  addition,  it  is 
hoped  that  the  sleep  intervention  will  help  you  to  improve  your  sleep,  although  this  cannot  be 
guaranteed.  Finally  the  information  gathered  with  this  research  will  be  helpful  to  devise  better 
treatment  for  insomnia. 
Will  my  answers  be  covered  by  confidentiality? 
All  information  about  you  collected  during  this  research  will  be  kept  strictly  confidential.  The 
only  people  who  will  have  access  to  your  data  are  the  researcher  herself  and  her  supervisor.  Your 
name  will  not  be  kept  together  with  your  data  (an  ID  number  will  be  used  instead). 
What  if  I  chanee  my  mind? 
You  can  decide  to  withdraw  from  the  study  at  any  time  without  having  to  explain  your  decision. 
Thank  you  very  much  for  taking  the  time  to  read  this  information.  I  would  be  very 
pleased  if  you  decide  to  participate  in  this  research  study. 
If  there  is  something  you  are  not  clear  about,  or  if  you  wish  more  information,  please  do 
not  hesitate  to  contact: 
-  Ms  Marina  Malaffo,  Department  of  Psychological  Medicine,  University  of  Glasgow 
Tel:  01412113902  or  07745811303,  e-mail:  0219144m@student.  gla.  ac.  uk 
If  you  would  like  to  speak  to  an  independent  advisor  about  any  concerns  you  may  have 
regarding  this  study  please  contact: 
-  Ms.  Heidi-Louise  Kelly  (Research  Fellow)  The  sleep  clinic,  Department  of  Psychological 
Medicine,  University  of  Glasgow 
Tel:  01412113943,  e-mail:  Hk16b@clinmed.  gla.  ac.  uk 
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An  investigation  of  sleep  patterns  pre  and  post  insomnia 
intervention 
CONSENT  FORM 
1.  I  have  read  and  understood  the  `Information  Sheet'  containing  information 
regarding  the  study  I  am  going  to  participate  in. 
2.  The  researcher  explained  further  any  points  I  asked  to.  I  have  been  given  a 
contact  telephone  number  so  as  to  be  able  to  discuss  points  at  a  later  time 
should  I  wish  to. 
3.  In  addition  I  had  the  opportunity  to  discuss  any  points  and  doubts  with  an 
independent  source. 
4.  I  understand  that  I  can  decide  to  withdraw  from  this  study  at  any  moment 
without  having  to  explain  my  reasons  for  wishing  to  do  so. 
5.  I  have  been  assured  that  any  information  I  provide  is  strictly  confidential  and 
that  should  the  study  be  published  the  names  of  the  participants  to  this  study 
won't  be  available  to  third  parties. 
I 
..................................  agree  to  participate  in  this  study. 
(Name  and  Surname  in  print) 
Signature: 
........................... 
Date:.............. 
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Right  ('rnire  I 
.ý 
ft 
Step  3:  Press  the  arrow  ' 
(ý) (ý) 
I  when  you  switch  off  the  light  (attennl)ting  tO  sIreelp) 
Step  4:  Press  the  arrow  '(l)'  when  you  wake  up  in  the  morning  (ue  t  Iv  to  get  up) 
trackit 
©- 
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PROTOCOL  'QUARTER  OF  AN  HOUR  INTERVENTION' 
Today  we  are  going  to  learn  a  procedure  which  hopefully  will  help  you  sleep  better 
and  your  task  will  be  to  implement  and  follow  it  from  tonight.  It  is  called  the  'quarter 
of  an  hour  rule'  because  you'll  have  to  get  up  from  your  bed  and  do  something  in 
another  room  if  you  cannot  fall  asleep  within  around  15  minutes  of  trying  to  sleep.  In 
addition  you  will  have  to  get  up  and  do  something  in  another  room  if  you  wake  tip 
during  the  night  and  cannot  fall  asleep  again  within  15  minutes.  Although  it  might 
sound  odd  that  you  have  to  get  up  from  your  bed  when  all  you  want  to  do  is  to  stay  in 
bed  and  try  to  fall  asleep,  I  am  asking  you  to  try  to  keep  following  this  procedure. 
Please  keep  following  it  for  the  requested  3  weeks  even  if  you  do  not  feel  it  is 
working.  As  you  have  probably  already  experienced  in  other  things  in  your  life.  it 
takes  some  time  for  changes  to  happen. 
What  You  might  be  thinking:  'Why  15  minutes?  '.  This  time  has  been  chosen 
because  people  who  do  not  have  sleep  problems  are  generally  asleep  within  10/15 
minutes.  In  addition,  although  people  without  sleep  problems  do  wake  up  during  the 
night,  they  generally  fall  back  to  sleep  within  that  time.  You  might  also  be  sitting 
there  thinking:  'why  should  I  get  up  from  my  bed  when  what  I  want  is  to  stay  in  bed 
and  fall  asleep?  '.  The  idea  is  that  if  you  have  not  fallen  asleep  within  15  minutes 
chances  are  you  will  be  lying  there  awake  for  a  pretty  long  time:  getting  up  and  then 
returning  to  bed  when  ready  to  sleep  will  make  it  easier  to  fall  asleep  quite  quickly.  If 
there  is  something  you'd  like  to  ask  me  .  please  feel  free  to  interrupt  me  and  I  will 
answer  to  it  at  the  end. 
The  procedure  is  very  simple  and  today  we  are  going  to  learn  and  rehearse  it  till 
you  feel  comfortable  about  putting  it  into  practice.  In  addition  you  will  also  have  a 
memo  at  home  with  you  if  you  want  to  go  through  it  again. 
We  can  divide  the  'quarter  of  an  hour  rule  in  3  different  steps: 
The  first  2  steps  are  really  to  do  with  preparing  things  before  going  to  bed. 
1.  Decide  which  room  you  want  to  move  to  if  you  have  to  get  because  not  asleep 
within  15  minutes  and  prepare  it  with  the  material  needed  for  the  activities. 
Also  make  sure  you  will  be  warm  enough  as  it  can  be  quite  chilly  during  the 
night.  You  could  also  prepare  something  to  drink  (e.  g.  hot  milky  drink,  herbal 
tea,  a  juice)  but  make  sure  it  doesn't  contain  caffeine  or  alcohol.  We  can  write 
286 it  on  the  memo  with  a  pencil  and  if  you  realise  you'd  like  to  change  to  another 
room  just  make  the  change. 
2.  Decide  a  couple  of  activities  you  might  like  (and  is  feasible)  to  carry  out  in 
another  room  if  you  cannot  fall  asleep  within  15  minutes.  Also  think  a  couple 
of  activities  (they  can  be  the  same  ones)  you  would  like  to  do  if  you  wake  up 
in  the  middle  of  the  night.  We  can  write  the  activities  on  your  memo  and, 
again,  if  you'd  like  to  change  them  just  write  down  the  new  activities. 
You  can  do  this  preparation  stage  when  you  want  to  but  at  least  an  hour  before 
going  to  sleep.  When  do  you  think  it  will  a  good  time  to  prepare  the  room  and 
material  for  you? 
3.  Go  to  bed  as  usual.  However  if  you  are  not  asleep  within  15  minutes  from  the 
moment  when  you  have  decided  to  sleep  get  up  and  go  to  the  room  chosen  to 
carry  out  one  of  the  activities.  You  do  not  need  to  keep  looking  at  your  clock 
to  see  if  15  minutes  has  passed  as  generally  we  have  quite  a  good  sense  about 
this.  In  this  other  room  carry  out  what  you  have  chosen  and  when  you  feel 
ready  to  sleep  again  move  back  to  your  bedroom.  If  you  are  not  asleep  within 
15  minutes  just  repeat  this  step.  Eventually  you  will  be  asleep  within  15 
minutes. 
4.  If  during  the  night  you  wake  up  and  cannot  fall  back  to  sleep  within  15 
minutes  get  up  and  go  to  the  room. 
287 Appendix  13:  Actigraghy  instruction 
2.  Movement  recordine  (AM-WATCH):  INSTRUCTIONS 
a.  You  have  to  wear  your  acti-watch  24  hours  a  day  for  the  duration  of  the  experiment 
The  only  time  when  you  should  remove  the  watch  is  when  you  are  performing 
`wet  activities'  (e.  g.  shower,  bathing,  swimming,  washing-up).  This  is  because 
the  watch  is  not  waterproof.  Please  remember  to  put  your  acti-watch  back  on  as 
soon  as  you  finish  'wet  activities'. 
b.  Press  the  event  marker  on  the  acti-watch  face  when  you  switch  off  the  light  (and 
attempt  to  sleep).  Press  it  again  when  you  wake  up  in  the  morning  (ready  to  get  up). 
c.  If  during  the  night  you  get  up  (e.  g.  to  get  a  drink  or  go  to  the  bathroom)  please  press 
the  event  marker  again.  Once  you  get  back  to  bed  and  try  to  sleep  again,  please 
Event  Marker  to  be  pressed  when  attempting  to 
sleep  and  again  when  getting  up. 
I  Sleep  Diary  :  INSTRUCTIONS 
Please  remember  to  fill  in  your  daily  sleep  diary  every  morning,  possibly  when  you 
wake  up  or  while  having  breakfast,  for  the  duration  of  the  research.  Remember  to 
answer  all  questions.  As  agreed  I  will  contact  you  during  the  morning  to  get  your 
answers. 
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press  the  event  marker  again. Appendix  14:  Q1-  Sleep  Behaviour  Self  Rating  Scale-R 
Date:  ..................  ID:.....  basel  interv 
Questionnaire  One 
Please  indicate  how  often  you  have  done  the  following  things  in  your  bed  before  falling 
asleep  or  while  in  your  bedroom  during  the  last  week.  Complete  the  questionnaire  by 
considering  what  you  would  do  in  an  average  week. 
BEHAVIOUR  NEVER  RELY  SOME 
TIMES 
OFTE  VERY 
OFTEN 
Read  a  book  or  a  magazine 
Watch  TV 
Listen  to  the  radio 
Have  a  conversation  with  someone 
Speak  on  the  telephonelmobile 
Eat  or  drink 
Smoke 
Please  also  answer  the  following  questions  ---------  --"---------  -----------  ---------  --------- 
I  take  naps  during  the  day  or  evening 
I  feel  sleepy  when  I  go  to  bed 
I  switch  the  light  off  as  soon  as  I  get  into  bed 
I  spend  a  lot  of  time  lying  awake  in  bed  at  night 
If  I  cannot  get  to  sleep  within  approximately 
20  minutes  I  get  out  of  bed  and  move  to  another 
room  until  I  feel  sleepy  again 
I  set  myself  a  regularly  rising  time  each  morning 
If  I  have  a  bad  night's  sleep  I  still  get  up  at 
my  usual  time 
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Questionnaire  Two 
The  following  seven  statements  relate  to  your  night-time  sleep  pattern  in  the  past 
week.  Please  indicate  by  circlin  once  response  only  how  true  each  of  the  statement  is 
for  you. 
1.  I  put  too  much  effort  into  sleeping  at  night  when  it  should  come  naturally 
Very  much  To  some  extent  Not  at  all 
2.  I  feel  I  should  be  able  to  control  my  sleep  at  night 
Very  much  To  some  extent  Not  at  all 
3.  I  put  off  going  to  bed  at  night  for  fear  of  not  being  able  to  sleep 
Very  much  To  some  extent  Not  at  all 
4.  I  worry  about  not  sleeping  if  I  am  in  bed  at  night  and  cannot  sleep 
Very  much  To  some  extent  Not  at  all 
5.  I  am  no  good  at  sleeping  at  night 
Very  much  To  some  extent  Not  at  all 
6.  I  get  anxious  about  sleeping  before  I  go  to  bed  at  night 
Very  much  To  some  extent  Not  at  all 
7.  I  worry  about  the  long  term  consequences  of  not  sleeping  at  night 
Very  much  To  some  extent  Not  at  all 
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Questionnaire  Three 
On  the  nights  when  you  didn't  sleep  well  last  week,  the  problem  seemed  to  be: 
Never  Seldom  Sometimes  Often  Very  often 
True  true  true  true  true 
1.  I  cannot  get  into  a  comfortable 
position  in  bed 
2.  My  mind  keeps  turning 
things  over 
3.  I  cannot  get  my  sleep  pattern 
into  a  proper  routine 
4.  I  get  too  'worked  up'  at 
not  sleeping 
5.  I  find  it  hard  to  physically 
'let  go'  and  relax  my  body 
6.  My  thinking  takes  a  long 
time  to  unwind 
7.  I  don't  feel  tired  enough  at 
bed  time 
8.  I  try  too  hard  to  get  to  sleep 
9.  My  body  is full  of  tension 
10.  I  am  unable  to  unempty 
my  mind 
11.  I  spend  time  reading/ 
watching  TV  in  bed  when 
I  should  be  sleeping 
12.  I  worry  that  I  won't  cope 
tomorrow  if  I  don't  sleep  well 
Which  one  of  the  above  statement  is  most  relavant  to  you?  Item  number:.....  . 
Are  there  any  other  factors  associated  with  your  poor  sleep  pattern?  If  so,  please  write  a 
short  note  in  this  space:  ................................................... 
...................................................................... 
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Questionnaire  Four 
Here  are  some  thoughts  that  people  have  when  they  cannot  sleep.  Please  indicate  by 
placing  a  tick  in  the  appropriate  box  how  often  over  the  past  7  nights  the  following 
thoughts  have  kept  you  awake. 
Never  Sometimes  Often  Always 
1.  Things  in  the  future 
2.  How  tired/sleepy  you  feel 
3.  Things  that  happened  that  day 
4.  How  nervouslanxious  you  feel 
5.  How  mentally  awake  you  are 
6.  Checking  the  time 
7.  Trivial  things 
8.  How  you  cannot  stop  your  mind  from  racing 
9.  How  long  you  have  been  awake 
10.  Your  health 
11.  Ways  you  can  get  to  sleep 
12.  Things  you  have  to  do  tomorrow 
13.  How  hot/cold  you  feel 
14.  Your  work/responsibilities 
15.  How  frustrated/annoyed  you  feel 
16.  How  light/dark  the  room  is 
17.  Noises  you  hear 
18.  Being  awake  all  night 
19.  Pictures  in  your  mind 
20.  The  effects  of  not  sleeping  well 
21.  Your  personal  life 
22.  How  thinking  too  much  is  the  problem 
23.  Things  in  your  past 
24.  How  bad  you  are  at  sleeping 
25.  Things  to  do  to  help  you  sleep 
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Questionnaire  five 
Please  describe  how  intensely  you  experienced  each  of  the  symptoms  mentioned  below 
as  you  attempted  to  sleep  during  the  last  week. 
Not  at  all  Slightly  Moderately  A  lot  Extremely 
Heart  racing,  pounding  or 
beating  irregularly 
A  jittery,  nervous  feeling  in 
your  body 
Shortness  of  breath  or  laboured 
breathing 
A  tight,  tense  feeling  in  your 
muscles 
Cold  feeling  in  your  hands,  feet  or 
your  body  in  general 
Have  stomach  upset  (knot  or 
nervous  feeling  in  stomach, 
heartburn,  nausea,  gas,  etc.  ) 
Perspiration  in  palms  of  your  hands 
or  other  parts  of  your  body 
Dry  feeling  in  mouth  or  throat 
Worry  about  falling  asleep 
Review  or  ponder  events  of  the  day 
Depressing  or  anxious  thoughts 
Worry  about  other  problems  other 
than  sleep 
Being  mentally  alert  or  active 
Cannot  shut  off  your  thoughts 
Thoughts  keep  running  through 
your  head 
Being  distracted  by  sounds,  noise  in 
the  environment  (e.  g.  ticking  of  clock, 
traffi  c) 
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Questionnaire  6 
Statements  reflecting  people's  beliefs  and  attitudes  about  sleep  are  listed  below.  Please 
indicate  to  what  extent  you  personally  agree  or  disagree  with  each  statement  right  now. 
There  is  no  right  or  wrong  answer.  For  each  statement,  place  a  mark  (x)  along  the  line 
wherever  your  personal  rating  falls.  Try  to  use  the  whole  scale,  rather  than  placing 
your  marks  at  one  end  of  the  line. 
Example:  If  I  sleep  too  much  I  don't  perform  as  well  the  next  day 
Strongly  Disagree  Strongly  Agree 
1.1  need  8  hours  of  sleep  to  feel  refreshed  and  function  well  during  the  day 
Strongly  Disagree  Strongly  Agree 
2.  When  I  don't  get  the  proper  amount  of  sleep  on  a  given  night,  I  need  to  catch  up  on 
the  next  day  by  napping  or  on  the  next  night  by  sleeping  longer 
Strongly  Disagree  Strongly  Agree 
3.  After  a  poor  night's  sleep,  I  know  that  it  will  interfere  with  my  daily  activities  on 
the  next  day 
Strongly  Disagree  Strongly  Agree 
4.  When  I  feel  irritable,  depressed  or  anxious  during  the  day,  it  is  mostly  because  I  did 
not  sleep  the  night  before 
Strongly  Disagree  Strongly  Agree 
5.  When  I  feel  tired,  have  no  energy,  or  just  seem  not  to  function  well  during  the  day, 
it  is  generally  because  I  did  not  sleep  well  the  night  before 
Strongly  Disagree  Strongly  Agree 
294 6.1  am  concerned  that  chronic  insomnia  may  have  serious  consequences  on  my 
physical  health 
Strongly  Disagree  Strongly  Agree 
7.  I  am  worried  that  I  may  lose  control  over  my  abilities  to  sleep 
Strongly  Disagree  Strongly  Agree 
8.  When  I  sleep  poorly  on  one  night,  I  know  it  will  disturb  my  week  schedule  for  the 
whole  week 
Strongly  Disagree  Strongly  Agree 
9.  When  I  have  trouble  getting  to  sleep,  I  should  stay  in  bed  and  try  harder 
Strongly  Disagree  Strongly  Agree 
10.  I  get  overwhelmed  by  my  thoughts  at  night  and  often  feel  I  have  no  control  over 
this  racing  mind 
Strongly  Disagree  Strongly  Agree 
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ID:  Date: 
Please  indicate  how  much  you  believe,  RIGHT  NOW,  that  the  therapy  will  help  you 
reduce  your  sleeping  problems,  by  circling  the  voice  relevant  to  you.  There  is  not 
right  or  wrong  answer,  just  the  way  you  think  and  feel. 
Part  A:  -  ANSWER  IN  TERMS  OF  WHAT  YOU  THINK  RIGHT  NOW 
1.  How  logical  does  the  therapy  offered  to  you  seem? 
Not  at  all  logical  Somewhat  logical  Logical  Very  logical 
2.  How  successful  do  you  think  this  treatment  will  be  in  reducing  your  sleep 
problems? 
Not  at  all  useful  Somewhat  useful  Useful  Very  useful 
3.  How  confident  would  you  be  in  recommending  this  treatment  to  a  friend  who 
experiences  sleep  problems? 
Not  at  all  confident  Somewhat  confident  Confident  Very  confident 
Part  B:  -  ANSWER  IN  TERMS  OF  WHAT  YOU  REALLY  AND  TRULY  FEEL 
4.  How  much  do  you  really  feel  that  the  therapy  will  help  you  to  reduce  your 
sleeping  difficulties? 
Not  at  all  A  little  Quite  Very  much 
296 Appendix  21:  Nlonitorini!  the  use  of  the  'Quarter  of  an  hour  rule'  in  bed: 
We  ýýant  to  evaluate  hovv  difficult  it  is  to  follow  this  rule.  Please  fill  out  the  following  table. 
For  each  day  put  sour  answer  in  the  box: 
a.  If  you  followed  the  rule  write  `Y',  if  you  did  not  write  `N'. 
b.  If  the  question  is  not  applicable  to  you  write  `N/A' 
c.  When  %ou  are  asked  'How  mangy  times..?  ',  write  the  number  applying  to  you. 
Please  remember  that  there  is  not  a  right  or  wrong  answer  but  only  what  happened  each  night. 
Weeks:  11213 
RULE  TODAY'S  DATE 
I.  Did  Oil  take  lc,,  than  ,i  quarter  of  an  hour  to 
tall  asleep  once  you  switched  off  the  light? 
2.  If  not,  did  you  '.  it  up  in  bed? 
3.  If  you  did  sit  up  in  bed. 
after  about  how  many  minutes  did  you  do  so? 
4.  In  order  to  follow  the  rule,  how  many  times 
illing  . 
6  If  more  than  once  ou  had  to  sit  u 
f 
nd 
.  y  ,  p  = 
after  how  lon  did  ou  do  ,  o:  '  g 
After  you  fell  asleep: 
7.  It  vuu  awoke  during  the  night, 
did  you  tall  back  asleep  within  a  quarter  of  an  hour? 
8.  If  you  did  not  fall  back  asleep  within  a  quarter  of 
an  hour.  did  you  sit  uin  bed? 
9  If  you  did  sit  up  in  bed. 
after  about  how  many  minutes  did  you  do  so? 
10.  In  order  to  follow  the  rule,  how  many  times 
altogether  did  you  have  to  sit  up  during  the  night? 
1  If  you  had  to  sit  up  more  than  once,  20  time 
after  how  long  did  you  do  so"  3"'  time 
3  time 
12.  Please  describe  how  it  was  to  follow  the  rule 
by  circling  the  number  that  applies  to  you 
(I=  not  difficult  at  all,  I  I  1 
2=  a  little  difficult.  2  2  2  2  2  2  2 
3=  difficult,  3  3  3  3  3  Z  3 
4=  very  difficult,  4  4  4  4  4  4  4 
5=  extremely  difficult)  5  5  5  5  5  5  5 
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PROTOCOL  `QHR  out  of  bed  INTERVENTION' 
Today  we  are  going  to  learn  a  procedure  which  hopefully  will  help  you  sleep  better 
and  your  task  will  be  to  implement  and  follow  it  from  tonight.  It  is  called  the  `quarter 
of  an  hour  rule'  because  you'll  have  to  get  out  of  your  bed,  go  to  another  room  and 
read  the  book  I  will  give  you  today  if  you  cannot  fall  asleep  within  around  15  minutes 
of  trying  to  sleep.  In  addition  you  will  have  to  get  out  of  your  bed  and  read  the  book  if 
you  wake  up  during  the  night  and  cannot  fall  asleep  again  within  15  minutes. 
Although  it  might  sound  odd  that  you  have  to  get  to  another  room  when  all  you  want 
to  do  is  to  lie  in  your  bed  and  try  to  fall  asleep,  I  am  asking  you  to  try  to  keep 
following  this  procedure.  Please  keep  following  it  for  the  requested  3  weeks  even  if 
you  do  not  feel  it  is  working.  As  you  have  probably  already  experienced  in  other 
things  in  your  life,  it  takes  some  time  for  changes  to  happen. 
What  You  might  be  thinking:  `Why  15  minutes?  '.  This  time  has  been  chosen 
because  people  who  do  not  have  sleep  problems  are  generally  asleep  within  10/15 
minutes.  In  addition,  although  people  without  sleep  problems  do  wake  up  during  the 
night,  they  generally  fall  back  to  sleep  within  that  time.  You  might  also  be  sitting 
there  thinking:  `why  should  I  get  out  of  my  bed  when  what  I  want  is  to  lie  in  bed  and 
fall  asleep?  '.  The  idea  is  that  if  you  have  not  fallen  asleep  within  15  minutes  chances 
are  you  will  be  lying  there  awake  for  a  pretty  long  time:  going  to  another  room  and 
then  returning  to  bed  again  when  ready  to  sleep  will  make  it  easier  to  fall  asleep  quite 
quickly.  If  there  is  something  you'd  like  to  ask  me,  please  feel  free  to  interrupt  me  and 
I  will  answer  to  it  at  the  end. 
The  procedure  is  very  simple  and  today  we  are  going  to  learn  and  rehearse  it  till 
you  feel  comfortable  about  putting  it  into  practice.  In  addition  you  will  also  have  a 
memo  at  home  with  you  if  you  want  to  go  through  it  again. 
We  can  divide  the  `quarter  of  an  hour  rule  in  2  different  steps: 
The  first  step  is  really  to  do  with  preparing  things  before  going  to  bed. 
1.  Make  sure  the  book  you  will  have  to  read  if  not  asleep  in  approximately  a 
quarter  of  an  hour  is  nearby  your  bed  is  in  the  room  you  will  go  if  you  cannot 
sleep.  Also  make  sure  you  will  be  warm  enough  as  it  can  be  quite  chilly  during 
the  night.  For  example  have  a  cardigan  or  a  little  blanket  to  put  round  your 
298 shoulder.  Remember  also  to  make  sure  that  the  actiwatch  (during  the  week 
you  will  be  wearing  one)  is  not  covered  by  your  sleeve  as  it  need  to  be  able  to 
pick  up  light  from  the  lamp. 
2.  Go  to  bed  as  usual.  However  if  you  are  not  asleep  within  15  minutes  from  the 
moment  when  you  have  decided  to  sleep  get  out  of  your  bed,  go  to  the  room 
you  have  chosen  to  go  and  start  reading  your  book.  You  do  not  need  to  keep 
looking  at  your  clock  to  see  if  15  minutes  has  passed  as  generally  we  have 
quite  a  good  sense  about  this.  Keep  reading  until  you  feel  ready  to  sleep 
again:  when  this  time  arrives  go  back  to  your  bed,  lie  down  and  sleep.  If  you, 
are  not  asleep  within  15  minutes  just  repeat  this  step.  Eventually  you  will  be 
asleep  within  15  minutes. 
3.  If  during  the  night  you  wake  up  and  cannot  fall  back  to  sleep  within  15 
minutes  sit  up  and  read  your  book. 
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Today  we  are  going  to  learn  a  procedure  which  hopefully  will  help  you  sleep  better 
and  your  task  will  be  to  implement  and  follow  it  from  tonight.  It  is  called  the  'quarter  of 
an  hour  rule'  because  you'll  have  to  sit  up  in  your  bed  and  read  the  book  I  will  give  you 
today  if  you  cannot  fall  asleep  within  around  15  minutes  of  trying  to  sleep.  In  addition 
you  will  have  to  sit  up  in  your  bed  and  read  the  book  if  you  wake  up  during  the  night 
and  cannot  fall  asleep  again  within  15  minutes.  Although  it  might  sound  odd  that  you 
have  to  sit  up  in  your  bed  when  all  you  want  to  do  is  to  lie  in  your  bed  and  try  to  fall 
asleep,  I  am  asking  you  to  try  to  keep  following  this  procedure.  Please  keep  following  it 
for  the  requested  3  weeks  even  if  you  do  not  feel  it  is  working.  As  you  have  probably 
already  experienced  in  other  things  in  your  life,  it  takes  some  time  for  changes  to 
happen. 
What  You  might  be  thinking:  'Why  15  minutes?  '.  This  time  has  been  chosen  because 
people  who  do  not  have  sleep  problems  are  generally  asleep  within  10/15  minutes.  In 
addition,  although  people  without  sleep  problems  do  wake  up  during  the  night,  they 
generally  fall  back  to  sleep  within  that  time.  You  might  also  be  sitting  there  thinking: 
`why  should  I  sit  up  in  my  bed  when  what  I  want  is  to  lie  in  bed  and  fall  asleep?  '.  The 
idea  is  that  if  you  have  not  fallen  asleep  within  15  minutes  chances  are  you  will  be  lying 
there  awake  for  a  pretty  long  time:  sitting  up  and  then  lying  down  again  when  ready  to 
sleep  will  make  it  easier  to  fall  asleep  quite  quickly.  If  there  is  something  you'd  like  to 
ask  me,  please  feel  free  to  interrupt  me  and  I  will  answer  to  it  at  the  end. 
The  procedure  is  very  simple  and  today  we  are  going  to  learn  and  rehearse  it  till  you 
feel  comfortable  about  putting  it  into  practice.  In  addition  you  will  also  have  a  memo  at 
home  with  you  if  you  want  to  go  through  it  again. 
We  can  divide  the  `quarter  of  an  hour  rule  in  2  different  steps: 
The  first  step  is  really  to  do  with  preparing  things  before  going  to  bed. 
1.  Make  sure  the  book  you  will  have  to  read  if  not  asleep  in  approximately  a 
quarter  of  an  hour  is  nearby  your  bed  (possibly  on  your  bed-side  table).  Also 
make  sure  you  will  be  warm  enough  as  it  can  be  quite  chilly  during  the  night. 
For  example  have  a  cardigan  or  a  little  blanket  to  put  round  your  shoulder. 
Remember  also  to  make  sure  that  the  actiwatch  (during  the  week  you  will  be 
wearing  one)  is  on  the  wrist  on  the  side  where  the  table  lamp  is. 
2.  Go  to  bed  as  usual.  However  if  you  are  not  asleep  within  15  minutes  from  the 
moment  when  you  have  decided  to  sleep  sit  up  in  your  bed  and  start  reading 
300 your  book.  You  do  not  need  to  keep  looking  at  your  clock  to  see  if  15  minutes 
has  passed  as  generally  we  have  quite  a  good  sense  about  this.  Keep  reading 
until  you  feel  ready  to  sleep  again:  when  this  time  arrives  just  switch  on  the  light 
again,  lie  down  and  sleep.  If  you  are  not  asleep  within  15  minutes  just  repeat  this 
step.  Eventually  you  will  be  asleep  within  15  minutes. 
3.  If  during  the  night  you  wake  up  and  cannot  fall  back  to  sleep  within  15  minutes 
sit  up  and  read  your  book. 
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Preparation  for  The  `QUARTER  OF  AN  HOUR  RUDE;  ' 
Decide  which  room  you  are  going  to  if  you 
cannot  fall  asleep  within  a  quarter  cif  an  hour 
Put  the  book  in  the  room  where  you  are  going 
to  go  if  you  are  not  asleep  within  it  quarter  of  an  hour 
Make  sure  the  room  is  prepared  so  that  you  will  hr 
comfortable  enough  in  it  if  awake  during  the  night 
(e.  g.  warm,  with  something  to  drink) 
EIEEII:: 
Ioom 
;  02 The  `QUARTER  OF  AN  HOUR  RUM?.  ' 
If  you  are  not  asleep  in  about  a  quarter  of  an  hour 
Leave  the  bed 
Go  to  another  room 
Read  the  hook 
Do  not  nap  or  sleep  in  this  room 
Return  to  bed  when  you  want  to  sleep 
NO  /Ire  you  asleep  in  a 
Quarter  of  an  hour 
YES 
you  wake  tip  during  the  ni 
N() 
NO  Did  you  fall  hack  to  sleep-  YES 
within  about  15  minute' 
'ý. 
ir'ý 
303 Appendix  23b:  Flowchart  the  QHRin 
If  you  are  not  asleep  within  a  quarter  of  an  hour 
Light  on 
Sit  up  in  your  bed 
Read  (lie  hook 
Do  not  nap  or  sleep  while  sitting 
Lie  down  when  you  want  to  sleep 
NO  /Are  you  asleep 
quarter  of  an 
YES 
N() 
you  wake  up  during  the  ni 
9 
NO  Did  you  fall  hack  to  sleep  -  YEAS 
within  a  cjuarter  of  gun 
9 
FN  1) 
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Greater 
Glasgow 
UNIVERSITY 
of  r>LEEP  Rf  SF  ARCH 
GLASGOW  URou 
IO.  lanuary  2004 
Dear  Dr, 
TRIAL:  BRIEF  THERAPY  FOR  PERSISTENTINSOMNIA 
I  am  a  2°`1  year  PhD  student  supervised  by  Prof  Cohn  N.  spii'  il  I'syýhýýluýýiral 
Medicine.  We  are  planning  a  randomised  controlled  trial  (which  will  involve  5(1 
patients:  40  receiving  active  treatment  and  10  controls)  comparing  the  clinical 
effectiveness  of  a  brief,  behavioural  therapy  with  a  self-monitoring  control  group  in 
the  management  of  persistent  insomnia. 
Patients  participating  in  this  trial  will  fill  in  a  sleep  diary  and  wear  it  light  dclectur 
device  (the  size  of  a  watch)  for  5  weeks.  Their  FFG  will  he  nwnilore(I  hw  -1  nights 
and  they  will  meet  with  myself  for  the  delivery  of  the  intervention  On  _'  occasion". 
We  enclose  a  GP's  information  sheet  containing  details  Of  the  Study,  lVCF1111111CIll 
of  patients,  reimbursement  and  so  on.  NHS  Greater  Glasgow  has  granted  ethical 
approval  for  the  randomised  controlled  trial  which  will  run  for  approximately  for  the 
18next  months. 
We  would  he  grateful  it'  you  could  discuss  this  opportunity'  with  your  rullý;  i  lies. 
We  do  hope  you  will  he  interested  in  having  your  practice  parlicipatink'  in  Ihis 
clinical  trial  on  brief  treatment  for  insomnia  and  propose  to  contact  ýuur  (practice 
manager  in  2/  3  weeks  to  find  out  if  you  are  interested  or  otherwise. 
Yours  sincerely, 
Marina  M.  II  tIIO 
Tel  01412113902 
email:  02/9/  llnt<<ý'.  citrdriit.  gIa.  ur.  uk 
Department  of  Psychological  Medicine,  Academic  ('entre, 
Gartnavel  Royal  Hospital,  1055  Great  Western  Road,  Glasgow  C  12  OXII 
;  O5 Trial:  Simplified  CBT  for  Insomnia 
A  research  project,  funded  by  Greater  Glasgow  Primary  Care  NHS  Trust,  entitled  'Does  a  simplified 
treatment  for  insomnia  improve  polysomnographic  sleep  of  patients  treated  in  primary  care?  '  is 
currently  being  conducted  by  Marina  Malaffo  (PhD  student),  Department  of  Psychological  Medicine, 
under  the  supervision  of  Prof  Colin  Espie.  We  are  recruiting  50  patients  with  insomnia  from  GP 
practices.  The  study  will  run  until  September  2005  approximately. 
The  intervention  takes  the  form  of  1  individual  session  where  patients  are  given  education  and 
behavioural  techniques  to  improve  their  sleep  patterns.  Patients'  sleep  will  be  assessed  both 
via  interviews  and  questionnaires  and  PSG  (night  EEG).  Support  is  given  by  The  Sleep 
Research  Team  at  the  University  of  Glasgow.  This  includes  two  Clinical  Psychologists. 
What  the  GP  has  to  do: 
Simply  fill  in  a  referral  form  and  a  reimbursement  form  and  send  it  to  the  Sleep 
Clinic.  We  will  send  you  a  sleep  assessment  and  intervention  outcome  of  the  referred  patient 
in  due  course. 
Referred  patients  with  insomnia  will  be  randomly  allocated  to  1  of  2  groups  (3:  1  ratio): 
-  Active  Treatment  Group:  will  receive  full  assessment  of  their  sleep  (using  PSG  as 
well  as  interview  and  sleep  diary)  +  simplified  CBT  for  insomnia 
Control  Group:  will  receive  full  assessment  of  their  sleep  (including  PSG) 
What  the  patient  is  required  to  do: 
-  Consent  to  participate  in  the  study 
-  Fill  in  a  daily  sleep  questionnaire  for  5  weeks 
-4  nights  of  EEG  monitoring  in  their  own  house  (the  researcher  will  attach  electrodes 
in  the  evening  and  go  back  in  the  morning  to  remove  them) 
-  If  allocated  to  active  treatment  group,  meet  with  the  researcher  2  times  for  about  30 
minutes  each  to  learn  the  intervention 
What  the  patient  will  gain  from  participating  in  the  insomnia  trial: 
-A  full  assessment  of  their  sleep 
-A  better  understanding  of  their  sleep  patterns 
-  If  allocated  to  the  active  group,  a  good  chance  of  learning  to  sleep  better 
If  you  have  any  queries,  contact:  Marina  Malaffo  Tel:  0141  211  3902  e-mail: 
0219144m@student.  gla.  ac.  uk 
Many  thanks  for  your  help. 
Marina  Malaffo 
(Supervised  by  Professor  Colin  A.  Espie) 
306 PAGE 
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AS  ORIGINAL Appendix  25:  Referral  Criteria  for  GP  and  Referral  Form 
Simplified  CBT  for  insomnia  trial 
REFERRAL  CRITERIA 
Patients  must  : 
be  between  18  and  70  years  of  age  in  good  general  health 
Q  have  problems  getting  to  sleep  (at  least  30  minutes)  and/  or  staying  asleep  (awakenings  during 
the  night) 
Q  have  sleep  problems  at  least  4  nights  per  week 
Q  having  had  sleep  problems  for  at  least  6  months 
Patients  are  unsuitable  if  they  have  one  or  more  of  the  following  characteristics: 
1.  Depression  and/  or  psychotic  illness  and/  or  dementia 
2.  Be  currently  taking  hypnotic  medication  for  sleep  disturbance 
IF  UNSURE:  Refer  the  patient. 
HOW  ARE  REFERRRALS  MADE? 
Send  a  referral  form  to:  Marina  Malaffo,  Southern  General  Hospital,  Department  of 
Neurosurgery,  Sackler  Foundation,  1345  Govan  Rd,  Glasgow  G514TF 
We  will  then  contact  the  referred  patient  informing  him/her  of  the  insomnia  trial. 
If  you  have  any  queries,  contact:  Marina  Malaffo  Tel:  0141  232  7699  e-mail: 
0219144m@student.  gla.  ac.  uk 
Many  thanks  for  your  help. 
Professor  Colin  A.  Espie,  University  of  Glasgow 
(on  behalf  of  the  Sleep  research  group) 
1t...,..  -...............  ýw..  sý,.,.  wý.  w...  ±w.,  -H..  ý...  iý,.  _..  _ý..  aa....  s  ý  ý"ý.  'si«s.  ý. 
ý  F( 
306 SLEEP  Research  `Quarter  of  un  Flour  rule'  REFERRAL  FORM 
Patient's  NAME: 
ADDRESS: 
Id.  No. 
D.  O.  B. 
TEL: 
Brief  description  of  problem  (nature  and  duration): 
Known  or  possible  contributory  factors: 
(Confirmation  that)  the  patient  IS  NOT  currently  prescribed  sleeping  niedicalion 
Il 
(Confirmation  that)  the  patient  IS  NOT  currently  severely  depressed  Lj 
>  (TICK  TO 
('ONII  I:  M) 
GP's  printed  name 
GP's  Signature 
Practice: 
Date 
Completed  referral  forms  should  be  mailed  to 
Marina  Malapo,  Southern  General  Hospital,  Uepurtnirni  of  Nrurosurhrry,  Nick  Irr 
Foundation  of  Psychohiological  Research,  134  Govan  Road,  (ila.  tigti"  (;  5I  -I'I'I. 
107 Appendix  26:  Letter  to  consultant  referring  patient  to  sleep  clinic 
26  `h  May  2004 
Dear  Dr  , 
Name  patient  (DoB) 
As  already  communicated  to  you,  Prof  Colin  Espie  will  not  be  able  to  see  the 
above  named  patient  whom  you  recently  referred  to  the  Sleep  Clinic. 
However,  our  Sleep  Research  Group  is  currently  running  an  insomnia  clinical 
trial  funded  by  Greater  Glasgow  Primary  Care  NHS  Trust.  We  would,  therefore,  be 
happy  to  contact  your  patient  to  propose  participating  in  the  clinical  trial.  If  the 
patient  consents  to  it,  his/her  sleep  will  be  fully  assessed  (including  PSG)  and  a  copy 
of  the  assessment  result  would  be  sent  to  you.  In  addition  the  patient  might  be 
randomised  into  an  insomnia  intervention. 
If  we  do  not  hear  from  you  within  the  next  three  weeks,  we  will  assume 
that  you  are  satisfied  for  us  to  contact  the  above  named  patient  directly.  We  will 
send  him/her  an  information  leaflet  explaining  the  research  trial  and  a  consent  form 
to  be  filled  in  and  returned  to  us  if  the  patient  is  willing  to  take  part  in  the  clinical 
trial. 
Please  find  here  enclosed  an  information  sheet  regarding  the  clinical  trial. 
Should  you  have  any  other  patient  whom  you  wish  to  refer  for  the  study  or  would  you 
like  more  information  about  the  insomnia  trial,  please  do  not  hesitate  to  contact  us. 
Yours  sincerely, 
Marina  Malaffo 
(PhD  Student  supervised  by  Prof  Colin  Espie) 
Department  of  Psychological  Medicine, 
Academic  Centre,  Gartnavel  Royal  Hospital,  1055  Great  Western  Rd,  Glasgow  G12  OXII 
Tel  01412113902  Email  0219144m@student.  gla.  ac.  uk 
308 Trial:  Simplified  CBT  for  Insomnia 
A  research  project,  funded  by  Greater  Glasgow  Primary  Care  NHS  Trust,  entitled  `Does  a  simplified 
treatment  for  insomnia  improve  polysomnographic  sleep  of  patients  treated  in  primary  care?  '  is  currently 
being  conducted  by  Marina  Malaffo  (PhD  student),  Department  of  Psychological  Medicine,  under  the 
supervision  of  Prof  Colin  Espie.  We  are  recruiting  50  patients  with  insomnia  from  GP  practices.  The 
study  will  run  until  September  2005  approximately. 
The  intervention  takes  the  form  of  1  individual  session  where  patients  are  given  education  and 
behavioural  techniques  to  improve  their  sleep  patterns.  Patients'  sleep  will  be  assessed  both 
via  interviews  and  questionnaires  and  PSG  (night  EEG).  Support  is  given  by  The  Sleep 
Research  Team  at  the  University  of  Glasgow.  This  includes  two  Clinical  Psychologists. 
What  the  GP  has  to  do: 
Simply  fill  in  a  referral  form  and  a  reimbursement  form  and  send  it  to  the  Sleep 
Clinic.  We  will  send  you  a  sleep  assessment  and  intervention  outcome  of  the  referred  patient 
in  due  course. 
Referred  patients  with  insomnia  will  be  randomly  allocated  to  1  of  2  groups  (3:  1  ratio): 
-  Active  Treatment  Group:  will  receive  full  assessment  of  their  sleep  (using  PSG  as 
well  as  interview  and  sleep  diary)  +  simplified  CBT  for  insomnia 
-  Control  Group:  will  receive  full  assessment  of  their  sleep  (including  PSG) 
What  the  patient  is  required  to  do: 
-  Consent  to  participate  in  the  study 
-  Fill  in  a  daily  sleep  questionnaire  for  5  weeks 
-4  nights  of  EEG  monitoring  in  their  own  house  (the  researcher  will  attach  electrodes 
in  the  evening  and  go  back  in  the  morning  to  remove  them) 
.  If  allocated  to  active  treatment  group,  meet  with  the  researcher  2  times  for  about  30 
minutes  each  to  learn  the  intervention 
What  the  patient  will  gain  from  participating  in  the  insomnia  trial: 
-A  full  assessment  of  their  sleep 
-A  better  understanding  of  their  sleep  patterns 
-  If  allocated  to  the  active  group,  a  good  chance  of  learning  to  sleep  better 
309 Appendix  27:  Letter  to  participants  for  Information  Pack 
Date 
Dear.., 
Your  medical  practice  is  participating  in  a  study  Into  the  assessment  of  and  the  non- 
pharmacological  treatment  of  sleep  difficulties  being  conducted  here  at  the 
University  of  Glasgow.  Your  GP,  Dr  ...  1,  referred  you  with  a  view  to  participate  in  the 
study  as  you  have  been  troubled  by  sleeping  difficulties  for  some  time. 
The  enclosed  information  sheet  gives  you  details  of  the  study  and  includes  a 
consent  form  which,  if  you  would  like  to  be  considered  for  this  study,  you  should 
complete  and  return  to  us  In  the  freepost  envelope  here  enclosed.  Two 
questionnaires  are  also  enclosed:  please  fill  them  in  and  send  them  back  with  your 
consent  form  if  you  want  to  be  considered. 
I  will  phone  you  in  a  couple  of  weeks  to  find  out  if  you  received  the  material  and  if 
you  have  any  questions. 
We  look  forward  to  hearing  from  you. 
Yours  sincerely, 
Marina  Malaffo 
(supervised  by  Prof  Colin  Espie) 
Department  of  Psychological  Medicine 
Based  At 
Southern  General  Hospital,  Department  of  Neurosurgery,  Sackler  Foundation  of 
Psychobiological  Research,  1345  Govan  Road,  Glasgow  G51  4TF 
Tel  0141  -  232  7699 
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Appendix  28:  THE  GOOD  SLEEP  GUIDE 
DURING  THE  EVENING 
1.  Daily  exercise  is  a  good  way  to  encourage  sleep.  Try  some  light 
exercise  early  in  the  evening,  such  as  walking  or  swimming,  as  this 
will  make  your  body  ready  for  sleep  later  on. 
2.  Avoid  drinking  coffee  or  tea  or  eating  chocolate  in  the  evening 
because  they  all  contain  caffeine,  which  makes  you  more  alert.  A  hot 
milky  drink  is  it  good  alternative.  Also  don't  drink  alcohol  it,,  a 
nightcap  --  it  usually  upsets  sleep. 
3.  Wind  down  during  the  course  of  the  evening.  Try  not  U()  do 
anything  that  is  mentally  stimulating  within  9()  minutes  or  hrdltinu". 
Give  yourself  time  to  relax  and  prepare  for  sleep  -  try  having;  it  warm 
bath  or  listening  to  some  soothing  music. 
4.  Do  not  sleep  or  doze  in  the  armchair  because  this  can  upset  Your 
night  time  sleeping  patterns.  Keep  all  your  sleep  for  bedtime. 
5.  Feeling  worried  or  anxious  or  just  having  an  active  mind  can 
cause  a  sleepless  night.  Try  to  put  the  day  tu  rest.  Take  time  to  think 
it  through  and  write  down  any  worries  or  concerns  or  loose  ends  in  a 
notebook.  Say  goodbye  to  them  before  you  go  to  bed  you  can  deal 
with  them  more  effectively  in  the  morning. 
6.  Make  sure  your  bed  and  bedroom  are  comfortable  for  sleep.  Your 
room  should  he  well  ventilated,  not  too  cold  or  too  warne. 
AT  BEDTIME 
1.  Try  to  get  up  at  the  same  time  every  day,  even  at  weekends,  use 
an  alarm  clock  if'  you  need  to.  This  helps  estahlish  your  sleep  Pattern 
to  follow  a  regular  routine. 
31  3 2.  Go  to  bed  when  you  are  "sleepy  tired"  and  not  before.  Try  to 
notice  when  you  are  ready  to  sleep. 
3.  Try  to  avoid  reading  or  watching  TV  in  bed  as  this  can  stimulate  the 
brain,  sometimes  making  it  difficult  to  relax.  Keep  these  waking 
activities  for  another  room. 
4.  Put  the  light  out  when  you  get  into  bed  and  try  to  ensure  your  room 
is  as  dark  as  possible.  This  helps  signal  to  your  body  that  it's  time  for 
sleep. 
5.  Let  yourself  relax.  Tell  yourself  that  "sleep  will  come  when  it's 
ready".  Enjoy  relaxing  even  if  you  don't  at  first  fall  asleep.  If  you  are 
not  good  at  relaxing,  try  to  learn  a  relaxation  method. 
6.  Do  not  try  to  fall  asleep  -  let  sleep  find  you.  Sleep  is  not  something 
you  can  switch  on  automatically.  Trying  too  hard  can  switch  sleep  off. 
IF  YOU  HAVE  PROBLEMS  GETTING  TO  SLEEP 
1.  Remember  that  sleep  difficulties  are  quite  common,  and  are  not  as 
damaging  as  you  might  think.  Most  people  cope  quite  well  even  after  a 
disturbed  night's  sleep. 
.  2.  Try  not  to  get  upset  or  frustrated  or  to  think  about  the  next  day. 
Avoid  watching  the  clock,  as  this  will  only  make  the  time  pass  more 
slowly. 
3.  Instead,  if  you  are  awake  for  more  than  15  minutes,  you  just  might 
not  be  ready  for  sleep.  Try  getting  up,  going  into  another  room,  and 
accepting  it  philosophically. 
4.  Do  something  relaxing  while  you  are  up  like  listening  to  music  or 
reading. 
5.  Go  back  to  bed  again  when  you  feel  "sleepy  tired".  Remember  you 
may  have  to  repeat  this  rising  and  returning  to  bed  several  times  a  night 
at  first. 
6.  Whenever  you  experience  difficulties  sleeping  try  to  follow  these 
tips.  A  good  sleeping  pattern  may  take  a  number  of  weeks  to  establish. 
Be  confident  that  you  will  achieve  this  by  working  through 
"The  Good  Sleep  Guide"! 
This  guide  has  been  prepared  by  Professor  Colin  A.  Espie,  Director  of  the 
University  of  Glasgow  Sleep  Research  Laboratory,  Southern  General  Hospital, 
Glasgow 
httli:  //www.  jzla.  ac.  uk/sleepresearch 
The  Good  Sleep  Guide  is  recommended  by  the  British  Sleep  Sciety 
314 Appendix  29:  PARTICIPANT  CONSENT  FORM  (study  3) 
`Does  a  simplified  treatment  for  insomnia  improve  the  polysomnographic 
sleep  of  patients  treated  in  Primary  Care?  ' 
Name  (Mr.  /  Mrs.  /  Miss/  Ms) 
Address 
Postcode 
Telephone  Number  (day) 
(evening) 
I  confirm  that  I  have  read  the  information  sheet  for  the  above  study,  I 
understand  its  content  and  I  have  received  my  own  copy. 
I  have  also  had  the  opportunity  to  ask  any  questions  about  taking  part  to  the 
study  (and  what  it  will  involve)  with  the  research  worker. 
I  understand  that  I  am  free  to  withdraw  from  the  study  at  any  time,  without 
having  to  give  a  reason.  I  also  understand  that  if  I  withdraw,  my  care  and  treatment  will 
be  not  affected  in  any  way. 
I  understand  that  all  information  collected  during  the  study,  including 
questionnaires,  sleep  diaries  and  sleep  data  from  the  actiwatch  and  the  EEG  recorder, 
will  be  treated  confidentially. 
I  hereby  consent  to  participate  in  the  above  study. 
Signed  Date 
GP  Name 
GP  Address 
Department  of  Psychological  Medicine 
Academic  Centre,  Gartnavel  Royal  Hospital,  1055  Great  Western  Road,  Glasgow  G12 
OXH 
Based  at  Southern  general  hospital,  department  of  Neurosurgery,  Sackler  Foundation 
of  Psychobiological  Research,  1345  Govan  Rd,  Glasgow 
315 Appendix  30:  Home  visit  Protocol 
HOME  VISIT  SAFETY  PROTOCOL  FOR  PSG  STUDIES 
(01/09/2004) 
Home  based  PSG  research  projects  require  researchers  to  undertake  home  visits. 
Health,  safety  and  welfare  of  research  and  clinical  staff  are  regulated  by  the  Health 
and  Safety  at  Work  etc  Act  1974  which  also  requires  workers  themselves  to  take 
reasonable  care  of  their  own  safety. 
This  procedure  has  been  formulated  in  order  to  remind  researchers  to  adopt  a 
common  sense  approach  to  each  situation  so  as  to  take  reasonable  care  of 
themselves  and  to  be  responsible  for  their  own  safety. 
You  and  your  supervisor  should  discuss  this  protocol  and  adapt  it  to  your  specific 
project  in  order  to  make  sure  that  it  is  conducted  as  safely  as  possible.  Remember 
also  that  'Management  of  Aggression  (Breakaway)  courses'  are  made  available  on  a 
regular  basis  within  the  Trust. 
WHAT  to  do  before  offering  a  home  visit  appointment 
"  1.  Before  agreeing  with  a  participant  a  home  visit,  it  is  important  to  check  within 
yourself  whether  you  feel  comfortable  with  that  particular  participant  (e.  g.  mannerism, 
GPs  notes,  means  of  recruitment).  Inform  your  supervisor  of  participants  you  do  not 
feel  comfortable  with. 
"  2.  It  is  also  important  to  find  out  if  there  is  anything  unsafe  about  the 
neighbourhood  the  person  lives 
o  If  the  person  or  the  neighbourhood  could  pose  risks,  it  is 
important  to  attend  the  visit  accompanied  by  another  person  (e.  g. 
a  friend,  a  colleague) 
When  an  appointment  is  offered  (irrespectively  of  whether  one  or  two 
people  go  to  the  participant's  home)  the  following  must  be  in  place: 
1.  You  must  have  a  mobile  phone  with  you  and  ensure  it  is  switched  on.  If  you 
do  not  have  one,  ask  your  supervisor  to  be  provided  with  one.  Remember  to 
check  that  it  is  charged  and  has  calling  credit. 
316 2.  Inform  a  nominated  person  (family  member,  partner,  friend,  colleague),  where 
you  are  going  (full  address/name  and  telephone  of  the  person  being  visited) 
and  when  (day/date/time  and  approximately  when  the  visit should  finish). 
3.  Contact  the  nominated  person  prior  to  entering  the  premises  and  again 
immediately  after  leaving  the  participant's  home.  Obviously  your  contact  must 
be  available  for  the  time  period  you  are  paying  the  home  visit  and  must 
understand  the  importance  of  hearing  back  from  you.  Make  sure  your  contact 
person  has  your  mobile  phone  number. 
4.  You  should  carry  a  personal  attack  alarm  -  one  will  be  available  from  your 
supervisor. 
5.  Do  not  forget  that  you  might  be  at  risk  also  while  walking  to  the  participant's 
home  or  entering  the  close,  especially  if  not  well  lit. 
WHAT  THE  NOMINATED  PERSON  SHOULD  DO  IF  YOU  DON'T  CONTACT 
HIM/HER  WITHIN  15  MINUTES  FROM  THE  TIME  AGREED 
"  Phone  you  on  your  mobile  phone  and/or  at  the  patient's  home  number. 
"  If  he/she  is  unable  to  speak  to  you,  they  should  inform  the  Police  and  your 
supervisor 
"  If  you  answer  the  phone  and  are  in  a  threatening  situation,  please  state 
"My  phone  does  not  have  battery  left,  cannot  speak  just  now". 
This  will  act  as  an  alert  signal.  In  this  case  the  nominated  person 
should  inform 
the  Police  and  your  supervisor. 
During  the  home  visit: 
1.  Ensure  that  your  phone  and  attack  alarm  are  within  easy  reach. 
2.  If  you  feel  threatened  in  any  way  even  before  you  enter  the  building,  you 
should  leave.  Make  your  excuses  and  leave  if  anything  worries  you. 
3.  If  you  are  asked  to  leave  by  your  participant  you  should  go  without  hesitation. 
4.  All  significant  incidents,  in  particular  those  of  violence  or  aggression  both 
physical  and  verbal  including  inappropriate  behaviour  must  be  recorded  in  line 
with  the  Trust  and  University's  incident  reporting  procedure. 
317 Appendix  31  :  Results  of  one-way  ANOVA  on  the  baseline  scores  of  the  battery 
of  questionnaires 
Results  of  One-way  ANOVA  on  the  baseline  scores  of  sleep  related 
questionnaires  for  the  QHR1n,  QHRout  and  Control  Groups 
Mean  Scores  F  (2,36)  p  Bonferroni  corrected  t-tests 
Sleep  Behaviour  Self  Rating  Scale-R  1.9  n.  s. 
The  Glasgow  Sleep  Effort  Scale  0.5  n.  s 
Sleep  Disturbance  Questionnaire. 
physical  tension  3.7  0.04  U.  S. 
sleep  pattern  problems  0.7  n.  s. 
cognitive  arousal  0.8  as. 
sleep  effort  1.9  n.  s. 
Glasgow  Content  of  Thoughts  Inventory 
active  problem  solving  12  n.  s. 
sleep  and  wakefulness  1.4  n.  s. 
somatic  and  sensory  engagement  5.3  0.01  QHR.  in  a  QHRout  pr  0.01 
Pre-Sleep  Arousal  Scale  QHRin  y  Control  p-  0.009 
cognitive  arousal  0.1  n.  s. 
somatic  arousal  2S  n.  s. 
DBAS-10 
immediate  negative  consequences  0.7  n_s. 
long  term  negative  consequences  0.4  n.  s. 
need  for  control  1.2  n.  s. 
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- 
Hktnnrams:  AdhereneeRaw  Data 
Appendix  32a-  Number  of  Participants  in  the  QHRin  group  according  to 
SOL  and  WASO  adherence  score  measured  objectively  and  subjectively 
OHRin  objective  adherence  score  at  SOL  QHRin  srbieclive  adtnrerr:  e  score  at  SOI 
OHRin  objective  adherence  score  at  WASO 
r s a 
Appendix  32b  -  Number  o(  Participants  in  the  QHRout  group  according  to  SOL  and  WASO 
adherence  score  measured  objectively  and  subjectively 
_JI 
OHRuut  objective  adheres  e  score  at  SOL  OHROuI  subjective  edt  reue  o  score  at  SOL 
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z 
OHRin  sWlecM  adhoronco  score  at  WASO 
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OHRour  objective  adluorerre  score  at  WASO  QHRoin  srbIoolivo  adhorork  0  -)rv  at  WASO 
319 Appendix  33:  Results  of  Mixed  ANOVAs  for  subjective  sleep  continuity 
variables  and  PSQI  on  baseline  and  post-treatment  scores  for  the  QHRin, 
QHRout  and  Control  Groups 
Results  of  Mixed  ANOVAs  for  subjective  sleep  continuity  variables  and  PSQI 
on  baseline  and  post-treatment  scores  for  the  QHRin,  QHRout  and  Control 
Groups 
Time  Effect  p  Group  Effect  p  Interaction  p 
F(1,38)  F(2,38)  F(2,38) 
SOL  7.11  0.01  0.81  n.  s.  4.36  0.02(0 
WASO  20.41  0.0005  1.36  n.  s.  4.56  0.02(2) 
TST  13.89  0.001  2.32  n.  s.  2.89  0.07 
S.  E.  '24.79  0.0005  1.78  n.  s  8.13  0.0013) 
PSQI  46.04  0.0005  2.00  n.  s.  13.38  0.0005(4) 
Post-Hoc  Corrections 
(1)Bonferroni  Corrected:  QHRout  Baseline  vs  Post-Treatment  t(14)=3.99,  p=0.001 
Uncorrected  t-test:  QHRout  vs  Control  at  Post-Treatment  t(25)=2.14,  p=0.04 
(2)  Bonferroni  Corrected:  QHRout  Baseline  vs  Post-Treatment  t(14)=5.26,  p<0.0005 
QHRout  vs  Control  at  Post-Treatment  t(25)=3.63,  p=0.001 
Uncorrected  t-test:  QHRin  vs  Control  at  Post-Treatment  t(24)=2.34,  p=0.03 
(3)  Bonferroni  Corrected:  QHRout  Baseline  vs  Post-Treatment  t(14)=5.52,  p<0.0005 
QHRout  vs  Control  at  Post-Treatment  t(25)=3.27,  p=0.003 
QHRin  Baseline  vs  Post-Treatment  t(13)=3.68,  p=0.003 
Uncorrected  t-test:  QHRin  vs  Control  at  Post-Treatment  t(24)=2.51,  p=0.02 
(4)  Bonferroni  Corrected:  QHRout  Baseline  vs  Post-Treatment  t(14)=6.68,  p<0.0005 
QHRout  vs  Control  at  Post-Treatment  t(25)=3.95,  p=0.001 
QHRin  Baseline  vs  Post-Treatment  t(13)=4.19,  p=0.001 
QHRin  vs  Control  at  Post-Treatment  t(24)=3.54,  p=0.003 
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